FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Pereira, VCS
   Fontes-Dantas, FL
   Paradela, ER
   Malfetano, FR
   Scherpenhuijzen, SDB
   Mansur, LF
   Luiz, RR
   De Oliveira, AP
   Farinhas, JGD
   Maiolino, A
   Alves-Leon, SV
AF Santa Rita Pereira, Valeria Coelho
   Fontes-Dantas, Fabricia Lima
   Paradela, Eduardo Ribeiro
   Malfetano, Fabiola Rachid
   Batista Scherpenhuijzen, Simone de Souza
   Mansur, Leticia Fezer
   Luiz, Ronir Raggio
   De Oliveira, Andre Peres
   Dib Farinhas, Joao Gabriel
   Maiolino, Angelo
   Alves-Leon, Soniza Vieira
TI Polymorphisms in the CIITA-168A/G (rs3087456) and CIITA+1614G/C (rs4774)
   may influence severity in multiple sclerosis patients
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE Multiple sclerosis; Polymorphism; Genetic; Therapeutics; Disease
   progression
ID SINGLE NUCLEOTIDE POLYMORPHISMS; CLASS-II; INTERFERON-BETA; GENETIC
   SUSCEPTIBILITY; RHEUMATOID-ARTHRITIS; ACTIVE REPLICATION; DISABILITY;
   MHC2TA; CIITA; RISK
AB It is currently unknown how genetic factors may influence the clinical course of multiple sclerosis (MS). Objective: We examined the impact of CIITA polymorphisms -168A/G (rs3087456) and +1614G/C (rs4774) on the risk of disability progression, severity and on responses to first-line immunomodulator treatments. Methods: Genomic DNA was extracted from blood samples. We used ABI3730xl and GeneMapper v.4.0 software to identify genotype variations. All patients were followed up and clinically reassessed at three-month intervals. Disability progression was measured by the Expanded Disability Status Scale and disease severity by the Multiple Sclerosis Spasticity Scale (MSSS). Results: We included 37 men and 80 women. We found no evidence regarding the influence of the single nucleotide polymorphisms studied in the Expanded Disability Status Scale or therapeutic response of the evaluated drugs. We performed a logistic regression analysis with the MSSS and found that a less severe MS course was associated with wild type CIITA -168AA and CIITA +1614GG, as the chance of the patient progressing to MSSS2 and MSSS3 decreased in 61% and 75% with CIITA -168AA and 66% and 75% with CIITA +1614GG, respectively (p < 0.0001). Although less significant, the CIITA +1614 GC also pointed to a less severe MS course and the chance of the patient progressing to MSSS3 decreased 79% (p = 0.015). We also observed that the CIITA -168GG genotype was more frequent in MSSS2 and MSSS3 and had 40% lower odds ratio to becoming more severe MS. Conclusion: These data suggest that CIITA -168AA, CIITA +1614GG and CIITA +1614 GC polymorphisms may be associated with a better MS clinical course. This knowledge may be useful for a better understanding of MS and its therapeutic management.
C1 [Santa Rita Pereira, Valeria Coelho; Malfetano, Fabiola Rachid; Batista Scherpenhuijzen, Simone de Souza; Luiz, Ronir Raggio; Maiolino, Angelo; Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Dept Neurol, Rio De Janeiro, RJ, Brazil.
   [Fontes-Dantas, Fabricia Lima; Paradela, Eduardo Ribeiro; Mansur, Leticia Fezer; De Oliveira, Andre Peres; Dib Farinhas, Joao Gabriel; Alves-Leon, Soniza Vieira] Univ Fed Estado Rio de Janeiro, Lab Neurociencias Translac, Program Postgrad Neurol, Rio De Janeiro, RJ, Brazil.
RP Alves-Leon, SV (corresponding author), Univ Fed Rio de Janeiro, HUCFF, Dept Neurol, Rua Prof Rodolpho Paulo Rocco 255,Cidade Univ, BR-21941913 Rio de Janeiro, RJ, Brazil.
EM sonizavleon@globo.com
RI Leon, Soniza V Alves/J-7786-2012; PARADELA, EDUARDO/AAW-6807-2020;
   Fontes-Dantas, Fabricia Lima/Y-1330-2019; Luiz, Ronir/C-3372-2013;
   Malfetano, Fabiola/B-1787-2014
OI Fontes-Dantas, Fabricia Lima/0000-0002-5201-0927; Maiolino,
   Angelo/0000-0003-0140-9548; Paradela, Eduardo/0000-0003-4048-3900; Luiz,
   Ronir/0000-0002-7784-9905; Scherpenhuijzen, Simone/0000-0002-3555-5693;
   Malfetano, Fabiola/0000-0002-8275-3801
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq-Brazil)National Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES-Brazil)CAPES
FX This study was funded by support from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil).
CR Akkad DA, 2006, INT J IMMUNOGENET, V33, P59, DOI 10.1111/j.1744-313X.2006.00568.x
   Alvarez-Lafuente R, 2010, EUR J NEUROL, V17, P129, DOI 10.1111/j.1468-1331.2009.02758.x
   Alves-Leon SV, 2007, ACTA NEUROL SCAND, V115, P306, DOI 10.1111/j.1600-0404.2006.00750.x
   Ascherio A, 2012, NAT REV NEUROL, V8, P602, DOI 10.1038/nrneurol.2012.198
   Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223
   Bereczky S, 2005, AM J TROP MED HYG, V72, P249, DOI 10.4269/ajtmh.2005.72.249
   Bronson PG, 2010, HUM MOL GENET, V19, P2331, DOI 10.1093/hmg/ddq101
   Brum DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058925
   CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765
   Cierny D, 2015, J NEUROIMMUNOL, V282, P80, DOI 10.1016/j.jneuroim.2015.03.010
   Cree BAC, 2016, ANN NEUROL, V80, P499, DOI 10.1002/ana.24747
   Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954
   Fernandez O, 2005, ACTA NEUROL SCAND, V112, P391, DOI 10.1111/j.1600-0404.2005.00415.x
   Garcia-Montojo M, 2011, J NEUROL SCI, V311, P98, DOI 10.1016/j.jns.2011.09.001
   George Michaela F, 2016, Neurol Genet, V2, pe87, DOI 10.1212/NXG.0000000000000087
   Hillert J, 2010, RESULTS PROBL CELL D, V51, P1, DOI 10.1007/400_2009_13
   Hollenbach JA, 2015, J AUTOIMMUN, V64, P13, DOI 10.1016/j.jaut.2015.06.010
   Dominguez-Mozo MI, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-107
   Koizumi K, 2005, ANN RHEUM DIS, V64, P947, DOI 10.1136/ard.2004.025767
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964
   Lin R, 2014, MULT SCLER J, V20, P313, DOI 10.1177/1352458513496882
   Lindholm E, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000064
   Liu JH, 2016, META GENE, V9, P97, DOI 10.1016/j.mgene.2016.04.005
   Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560
   Martinez A, 2007, HUM IMMUNOL, V68, P685, DOI 10.1016/j.humimm.2007.05.005
   Martinez A, 2007, ANN RHEUM DIS, V66, P325, DOI 10.1136/ard.2006.059428
   Masternak K, 2000, GENE DEV, V14, P1156
   Miljkovic D, 2013, ANTIOXID REDOX SIGN, V19, P2286, DOI 10.1089/ars.2012.5068
   MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851
   Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307
   Orozco G, 2006, RHEUMATOLOGY, V45, P1442, DOI 10.1093/rheumatology/kel272
   Pan Gb, 2016, J NEUROL NEUROSUR PS, V87, P1204, DOI 10.1136/jnnp-2016-313722
   Paradela ER, 2015, ARQ NEURO-PSIQUIAT, V73, P283, DOI 10.1590/0004-282X20150012
   Patarroyo JC, 2002, GENES IMMUN, V3, P34, DOI 10.1038/sj.gene.6363808
   Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366
   Rasmussen HB, 2001, HUM IMMUNOL, V62, P371, DOI 10.1016/S0198-8859(01)00215-4
   Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740
   Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8
   Sanchez E, 2008, RHEUMATOLOGY, V47, P102, DOI 10.1093/rheumatology/kem242
   Pereira VCS, 2012, ARQ NEURO-PSIQUIAT, V70, P774, DOI 10.1590/S0004-282X2012001000005
   Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544
   Weinshenker BG, 1998, SEMIN NEUROL, V18, P301, DOI 10.1055/s-2008-1040881
NR 43
TC 1
Z9 1
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD MAR
PY 2019
VL 77
IS 3
BP 166
EP 173
DI 10.1590/0004-282X20190026
PG 8
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA HR7OG
UT WOS:000463343500005
PM 30970129
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Alves-Leon, SV
   Lima, MD
   Nunes, PCG
   Chimelli, LMC
   Rabelo, K
   Nogueira, RMR
   de Bruycker-Nogueira, F
   de Azeredo, EL
   Bahia, PR
   Lopes, FCR
   de Souza, JPBM
   Fontes-Dantas, FL
   Paes, MV
   Lemos, ERS
   Santos, FB
AF Alves-Leon, Soniza Vieira
   Lima, Monique da Rocha
   Guerra Nunes, Priscila Conrado
   Cardao Chimelli, Leila Maria
   Rabelo, Kissila
   Ribeiro Nogueira, Rita Maria
   de Bruycker-Nogueira, Fernanda
   de Azeredo, Elzinandes Leal
   Bahia, Paulo Roberto
   Rueda Lopes, Fernanda Cristina
   Barreto Marcondes de Souza, Jorge P.
   Fontes-Dantas, Fabricia Lima
   Paes, Marciano Viana
   Lemos, Elba R. S.
   Santos, Flavia Barreto
TI Zika virus found in brain tissue of a multiple sclerosis patient
   undergoing an acute disseminated encephalomyelitis-like episode
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Article
DE Multiple sclerosis; Zika virus; acute disseminated encephalomyelitis;
   differential diagnosis; immunotherapy
AB Background: A range of different neurological manifestations has been reported in fetuses and adults after Zika virus (ZIKV) infection.
   Objective: We describe a detection of the ZIKV in the brain tissue from a multiple sclerosis (MS) patient with acute disseminated encephalomyelitis (ADEM)-like event in Rio de Janeiro, Brazil.
   Methods: Biological samples collected during the hospitalization were tested by serology and molecular diagnostic for various infectious agents. Histopathological analysis was performed using the anti-flavivirus group 4G2 monoclonal antibody, anti-ZIKV non-structural 1 (NS1) monoclonal antibody, and anti-CD4, CD8, and CD11b antibodies.
   Results: Anti-ZIKV IgM and IgG antibodies were positive in the serum and urine. A brain biopsy showed ZIKV protein in brain cells and T CD8 infiltration in brain tissue.
   Conclusion: Our data describe the coexistence of a recent central nervous system (CNS) ZIKV infection accompanied by a severe ADEM-like syndrome outcome in a patient with clinical history of MS. A de novo immune response concomitant with ZIKV infection might be involved in the mechanism of the ADEM-like syndrome and response to immunotherapy. The present report reinforces the importance of providing the differential diagnosis of acute episodes of MS exacerbation in an environment prone to ZIKV expression.
C1 [Alves-Leon, Soniza Vieira; Bahia, Paulo Roberto; Rueda Lopes, Fernanda Cristina] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, SNC, Ctr Referencia & Pesquisa Esclerose Multipla & Ou, Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza Vieira; Barreto Marcondes de Souza, Jorge P.; Fontes-Dantas, Fabricia Lima] Univ Fed Estado Rio de Janeiro UNIRIO, Programa Posgrad Neurol, Rio De Janeiro, Brazil.
   [Lima, Monique da Rocha; Guerra Nunes, Priscila Conrado; de Bruycker-Nogueira, Fernanda; de Azeredo, Elzinandes Leal; Santos, Flavia Barreto] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.
   [Cardao Chimelli, Leila Maria] Inst Estadual Cerebro Paulo Niemeyer, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Rabelo, Kissila] Univ Estado Rio de Janeiro UNIRIO, Lab Ultraestrutura & Biol Tecidual, Rio De Janeiro, Brazil.
   [Ribeiro Nogueira, Rita Maria] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Paes, Marciano Viana] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
   [Lemos, Elba R. S.] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Hantaviroses & Rickettsioses, Rio De Janeiro, Brazil.
RP Alves-Leon, SV (corresponding author), Neurol Dept, Rua Mariz & Barros 775, BR-20270901 Rio De Janeiro, RJ, Brazil.
EM sonizavleon@globo.com
RI Fontes-Dantas, Fabricia Lima/Y-1330-2019; Fontes, Fabricia
   Lima/K-1998-2015; Leon, Soniza V Alves/J-7786-2012
OI Fontes-Dantas, Fabricia Lima/0000-0002-5201-0927; Fontes, Fabricia
   Lima/0000-0002-5201-0927; Santos, Flavia/0000-0002-1309-5366; Paes,
   Marciano/0000-0002-2266-2801; Rabelo, Kissila/0000-0001-7579-7788
FU Brazilian National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES; Department of Science and Technology (DECIT)Department of
   Science & Technology (India) [14/2016]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: Brazilian
   National Council for Scientific and Technological Development (CNPq),
   Coordination for the Improvement of Higher Education Personnel (CAPES),
   and Department of Science and Technology (DECIT No. 14/2016).
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Das Sarma J, 2014, J NEUROVIROL, V20, P122, DOI 10.1007/s13365-013-0188-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Lassmann H, 2010, BRAIN, V133, P317, DOI 10.1093/brain/awp342
   McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsai TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27670
NR 10
TC 2
Z9 2
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD MAR
PY 2019
VL 25
IS 3
BP 427
EP 430
DI 10.1177/1352458518781992
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HO1ST
UT WOS:000460691800018
PM 30226115
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Sousa, NAC
   Alves-Leon, SV
   Dias, RM
   Pimentel, MLV
   Gomes, S
   Goncalves, MVM
   Stella, CV
   Tauil, CB
   Anacleto, A
   Spessotto, CV
   Correa, EC
   Eboni, ACB
   Damasceno, A
   Damasceno, B
   Farinhas, JGD
   Mota, RSD
   Nogueira, EGA
   Pereira, VCSR
   Scorcine, C
   Bacon, T
   Kister, I
AF Fragoso, Yara Dadalti
   Sousa, Nise Alessandra C.
   Alves-Leon, Soniza Vieira
   Dias, Ronaldo Maciel
   Pimentel, Maria Lucia, V
   Gomes, Sidney
   Goncalves, Marcus Vinicius M.
   Stella, Carla Vieira
   Tauil, Carlos Bernardo
   Anacleto, Andrea
   Spessotto, Caroline Vieira
   Correa, Eber Castro
   Biondo Eboni, Audred C.
   Damasceno, Alfredo
   Damasceno, Benito
   Farinhas, Joao Gabriel D.
   de Souza Mota, Rhea Sylvia
   Almeida Nogueira, Eduardo G.
   Pereira, Valeria Coelho S. R.
   Scorcine, Claudio
   Bacon, Tamar
   Kister, Ilya
TI Clinical characteristics of 153 Brazilian patients with neuromyelitis
   optica spectrum disorder (NMOSD)
SO MULTIPLE SCLEROSIS AND RELATED DISORDERS
LA English
DT Article
DE Neuromyelitis optica spectrum disorder; NMOSD; Myelitis; Optic neuritis;
   Brainstem; Disability
ID MULTIPLE-SCLEROSIS; PREVALENCE; ANTIBODIES; CRITERIA; MALAYSIA; COHORT
AB Background: The 2015 criteria for diagnosing neuromyelitis optica spectrum disorder (NMOSD) have encouraged several groups across the world to report on their patients using these criteria. The disease typically manifests with severe relapses of optic neuritis, longitudinally extensive myelitis and/or brainstem syndromes, often leading to severe disability. Some patients are seropositive for antibodies against aquaporin-4 (AQP4), others are positive for anti-myelin oligodendrocyte glycoprotein (MOG), while a few are negative for both biomarkers. The disease is complex, and only now are specific therapeutic clinical trials being carried out The present study adds to the literature through detailed clinical data from 153 medical records of Brazilian patients.
   Methods: Retrospective assessment of medical records from nine specialized units in Brazil.
   Results: NMOSD was more prevalent in females (4.1:1), who had significantly fewer relapses than males (p = 0.007) but presented similar levels of disability over time. African ancestry was associated with higher levels of disability throughout the disease course (p < 0.001), although the number of relapses was similar to that observed in white patients. Concomitant autoimmune diseases were relatively rare in this population (6.5%). Positivity for anti-AQP4 antibodies was identified in 62% of the patients tested, while 3% presented anti-MOG antibodies. Anti-AQP4 antibodies were not associated to worse disease course. The last medical record showed that six patients had died and 13 were wheelchair-bound. Seventy percent of the patients did not respond to first-line therapy (azathioprine and/or corticosteroids), and five patients continued to relapse even after four different courses of treatment.
   Conclusion: The present study adds to the reports from other countries presenting original data on Brazilian patients diagnosed with NMOSD according to the 2015 criteria.
C1 [Fragoso, Yara Dadalti; Anacleto, Andrea; Almeida Nogueira, Eduardo G.; Scorcine, Claudio] Univ Metropolitana Santos, Dept Neurol, Ave Conselheiro Nebias, Santos, SP, Brazil.
   [Sousa, Nise Alessandra C.; de Souza Mota, Rhea Sylvia] Univ Hosp Getulio Vargas, Dept Neurol, Manaus, Amazonas, Brazil.
   [Alves-Leon, Soniza Vieira; Farinhas, Joao Gabriel D.; Pereira, Valeria Coelho S. R.] Univ Fed Rio de Janeiro, Dept Neurol, Rio De Janeiro, RJ, Brazil.
   [Dias, Ronaldo Maciel; Tauil, Carlos Bernardo; Correa, Eber Castro] Hosp Base Dist Fed, Dept Neurol, Brasilia, DF, Brazil.
   [Pimentel, Maria Lucia, V] Santa Casa Misericordia Rio de Janeiro, Dept Neurol, Rio De Janeiro, RJ, Brazil.
   [Gomes, Sidney] Hosp Beneficencia Portuguesa Sao Paulo, Dept Neurol, Sao Paulo, SP, Brazil.
   [Gomes, Sidney] Hosp Paulistano, Sao Paulo, SP, Brazil.
   [Goncalves, Marcus Vinicius M.; Biondo Eboni, Audred C.] Univ Regiao Joinville, Dept Neurol, Joinville, SC, Brazil.
   [Stella, Carla Vieira; Damasceno, Alfredo; Damasceno, Benito] Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil.
   [Spessotto, Caroline Vieira] Santa Casa Misericordia Aracatuba, Dept Neurol, Aracatuba, SP, Brazil.
   [Bacon, Tamar; Kister, Ilya] NYU, Dept Neurol, New York, NY 10016 USA.
RP Fragoso, YD (corresponding author), Univ Metropolitana Santos, Dept Neurol, Ave Conselheiro Nebias, Santos, SP, Brazil.
EM yara@bsnet.com.br
RI Tauil, Carlos Bernardo/T-3095-2019; Leon, Soniza V Alves/J-7786-2012;
   Fragoso, Yara/B-1761-2015
OI Tauil, Carlos Bernardo/0000-0003-1137-2398; Kister,
   Ilya/0000-0003-3549-949X; Fragoso, Yara/0000-0001-8726-089X
CR Altintas A, 2015, NEUROLOGIST, V20, P61, DOI 10.1097/NRL.0000000000000057
   Alvarenga M P, 2017, Mult Scler J Exp Transl Clin, V3, p2055217317730098, DOI 10.1177/2055217317730098
   Ashtari F, 2017, J RES MED SCI, V22, DOI 10.4103/1735-1995.202142
   Borisow N, 2017, MULT SCLER J, V23, P1092, DOI 10.1177/1352458516671203
   Bouzar M, 2017, J NEUROL SCI, V381, P240, DOI 10.1016/j.jns.2017.08.3254
   Bukhari W, 2017, J NEUROL NEUROSUR PS, V88, P632, DOI 10.1136/jnnp-2016-314839
   Cabrera-Gomez JA, 2009, MULT SCLER J, V15, P828, DOI 10.1177/1352458509104585
   Contentti EC, 2018, MULT SCLER RELAT DIS, V20, P109, DOI 10.1016/j.msard.2018.01.001
   Cree BAC, 2016, MULT SCLER J, V22, P862, DOI 10.1177/1352458515620934
   Daoudi S, 2016, MULT SCLER RELAT DIS, V6, P37, DOI 10.1016/j.msard.2015.12.005
   Pereira WLDJ, 2017, ACTA NEUROPSYCHIATR, V29, P170, DOI 10.1017/neu.2016.49
   Eaneff S, 2017, MULT SCLER RELAT DIS, V17, P116, DOI 10.1016/j.msard.2017.07.014
   Eskandarieh S, 2017, MULT SCLER RELAT DIS, V18, P209, DOI 10.1016/j.msard.2017.10.007
   Franciotta D, 2011, J NEUROL SCI, V303, P139, DOI 10.1016/j.jns.2011.01.011
   Freitas E, 2015, RHEUMATOL INT, V35, P243, DOI 10.1007/s00296-014-3066-3
   Hamid SHM, 2017, MULT SCLER J, V23, P228, DOI 10.1177/1352458516663853
   Holroyd Kathryn B, 2018, Clin Exp Neuroimmunol, V9, P155, DOI 10.1111/cen3.12458
   Hor JY, 2018, MULT SCLER RELAT DIS, V19, P20, DOI 10.1016/j.msard.2017.10.015
   Houzen H, 2017, NEUROLOGY, V89, P1995, DOI 10.1212/WNL.0000000000004611
   Jarius S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0718-0
   Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14
   Jasiak-Zatonska M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030273
   Kleiter I, 2016, ANN NEUROL, V79, P206, DOI 10.1002/ana.24554
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X
   Mealy MA, 2018, NEUROL-NEUROIMMUNOL, V5, DOI 10.1212/NXI.0000000000000468
   Papais-Alvarenga RM, 2008, ARCH OPHTHALMOL-CHIC, V126, P12, DOI 10.1001/archophthalmol.2007.26
   Seok JM, 2017, MULT SCLER J, V23, P1748, DOI 10.1177/1352458516685416
   Sepulveda M, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000225
   van Pelt ED, 2016, EUR J NEUROL, V23, P580, DOI 10.1111/ene.12898
   Viswanathan S, 2018, MULT SCLER RELAT DIS, V25, P300, DOI 10.1016/j.msard.2018.07.003
   Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729
   ZhangBao JZ, 2017, J NEUROIMMUNOL, V302, P49, DOI 10.1016/j.jneuroim.2016.11.010
NR 33
TC 5
Z9 5
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2211-0348
EI 2211-0356
J9 MULT SCLER RELAT DIS
JI Mult. Scler. Relat. Disord.
PD JAN
PY 2019
VL 27
BP 392
EP 396
DI 10.1016/j.msard.2018.11.031
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA HH1SR
UT WOS:000455500500070
PM 30504040
DA 2020-12-01
ER

PT J
AU Lourenco, MV
   Frozza, RL
   de Freitas, GB
   Zhang, H
   Kincheski, GC
   Ribeiro, FC
   Goncalves, RA
   Clarke, JR
   Beckman, D
   Staniszewski, A
   Berman, H
   Guerra, LA
   Forny-Germano, L
   Meier, S
   Wilcock, DM
   de Souza, JM
   Alves-Leon, S
   Prado, VF
   Prado, MAM
   Abisambra, JF
   Tovar-Moll, F
   Mattos, P
   Arancio, O
   Ferreira, ST
   De Felice, FG
AF Lourenco, Mychael V.
   Frozza, Rudimar L.
   de Freitas, Guilherme B.
   Zhang, Hong
   Kincheski, Grasielle C.
   Ribeiro, Felipe C.
   Goncalves, Rafaella A.
   Clarke, Julia R.
   Beckman, Danielle
   Staniszewski, Agnieszka
   Berman, Hanna
   Guerra, Lorena A.
   Forny-Germano, Leticia
   Meier, Shelby
   Wilcock, Donna M.
   de Souza, Jorge M.
   Alves-Leon, Soniza
   Prado, Vania F.
   Prado, Marco A. M.
   Abisambra, Jose F.
   Tovar-Moll, Fernanda
   Mattos, Paulo
   Arancio, Ottavio
   Ferreira, Sergio T.
   De Felice, Fernanda G.
TI Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory
   defects in Alzheimer's models
SO NATURE MEDICINE
LA English
DT Article
ID DEPRESSIVE-LIKE BEHAVIOR; AMYLOID-BETA OLIGOMERS; HIPPOCAMPAL
   INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; MOUSE MODEL; EIF2-ALPHA KINASES;
   GENE-EXPRESSION; ENERGY-INTAKE; BRAIN; DISEASE
AB Defective brain hormonal signaling has been associated with Alzheimer's disease (AD), a disorder characterized by synapse and memory failure. Irisin is an exercise-induced myokine released on cleavage of the membrane-bound precursor protein fibronectin type III domain-containing protein 5 (FNDC5), also expressed in the hippocampus. Here we show that FNDC5/irisin levels are reduced in AD hippocampi and cerebrospinal fluid, and in experimental AD models. Knockdown of brain FNDC5/irisin impairs long-term potentiation and novel object recognition memory in mice. Conversely, boosting brain levels of FNDC5/irisin rescues synaptic plasticity and memory in AD mouse models. Peripheral overexpression of FNDC5/irisin rescues memory impairment, whereas blockade of either peripheral or brain FNDC5/irisin attenuates the neuroprotective actions of physical exercise on synaptic plasticity and memory in AD mice. By showing that FNDC5/irisin is an important mediator of the beneficial effects of exercise in AD models, our findings place FNDC5/irisin as a novel agent capable of opposing synapse failure and memory impairment in AD.
C1 [Lourenco, Mychael V.; Frozza, Rudimar L.; de Freitas, Guilherme B.; Kincheski, Grasielle C.; Ribeiro, Felipe C.; Clarke, Julia R.; Beckman, Danielle; Guerra, Lorena A.; Forny-Germano, Leticia; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Lourenco, Mychael V.; Kincheski, Grasielle C.; Ribeiro, Felipe C.; Guerra, Lorena A.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Lourenco, Mychael V.; Zhang, Hong; Staniszewski, Agnieszka; Berman, Hanna; Arancio, Ottavio] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.
   [Frozza, Rudimar L.] Fiocruz MS, Oswaldo Cruz Fdn, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
   [de Freitas, Guilherme B.; Goncalves, Rafaella A.; De Felice, Fernanda G.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, Brazil.
   [Meier, Shelby; Wilcock, Donna M.; Abisambra, Jose F.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.
   [de Souza, Jorge M.; Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Div Neurosurg, Rio De Janeiro, Brazil.
   [de Souza, Jorge M.; Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Epilepsy Program, Div Neurol, Rio De Janeiro, Brazil.
   [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada.
   [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.
   [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada.
   [Tovar-Moll, Fernanda; Mattos, Paulo] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Mattos, Paulo] Univ Fed Rio de Janeiro, Inst Psychiat, Rio De Janeiro, Brazil.
   [Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.
   [Arancio, Ottavio] Columbia Univ, Dept Med, New York, NY 10027 USA.
   [De Felice, Fernanda G.] Queens Univ, Dept Psychiat, Kingston, ON, Canada.
RP Ferreira, ST; De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.; Arancio, O (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.; De Felice, FG (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.; Arancio, O (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.; Arancio, O (corresponding author), Columbia Univ, Dept Med, New York, NY 10027 USA.; De Felice, FG (corresponding author), Queens Univ, Dept Psychiat, Kingston, ON, Canada.
EM oa1@cumc.columbia.edu; ferreira@biof.ufrj.br;
   fernanda.defelice@queensu.ca
RI Forny-Germano, Leticia/D-1342-2017; Prado, Marco Antonio
   Maximo/K-7638-2013; Lourenco, Mychael/G-2614-2014; Clarke,
   Julia/AAF-9434-2019; Ribeiro, Felipe Campos/W-9758-2019; Ferreira,
   Sergio/AAZ-1576-2020; arancio, ottavio/AAB-7959-2019; Leon, Soniza V
   Alves/J-7786-2012; Moll, Fernanda Tovar/N-3320-2018; Abisambra,
   Jose/V-6860-2019; Lourenco, Mychael/AAG-9732-2020; Abisambra,
   Joe/AAP-3269-2020; Forny-Germano, Leticia/L-6639-2019; Prado, Vania
   Ferreira/K-7630-2013; de Mattos, Paulo Eduardo Luiz/D-2328-2014
OI Forny-Germano, Leticia/0000-0001-8301-0711; Prado, Marco Antonio
   Maximo/0000-0002-3028-5778; Lourenco, Mychael/0000-0002-1078-0296;
   Ribeiro, Felipe Campos/0000-0003-3028-3307; Ferreira,
   Sergio/0000-0001-7160-9866; Moll, Fernanda Tovar/0000-0002-0292-5985;
   Abisambra, Jose/0000-0001-6341-679X; Lourenco,
   Mychael/0000-0002-1078-0296; Forny-Germano, Leticia/0000-0001-8301-0711;
   Prado, Vania Ferreira/0000-0003-4994-6393; de Mattos, Paulo Eduardo
   Luiz/0000-0003-0709-3783; De Freitas, Guilherme/0000-0003-4614-4280;
   Meier, Shelby/0000-0003-1946-9004; Frozza, Rudimar
   Luiz/0000-0003-0918-4128; Berman, Hanna/0000-0002-8616-8167
FU Alzheimer Society of Canada; Weston Brain Institute; National Institute
   for Translational Neuroscience (INNT/Brazil) [465346/2014-6]; Human
   Frontier Science ProgramHuman Frontier Science Program; International
   Society for Neurochemistry (CAEN 1B); National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [NIH-R01NS049442]; Canadian Institutes
   of Health ResearchCanadian Institutes of Health Research (CIHR) [CIHR
   MOP 136940, MOP 89919]; Brazilian funding agency Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [451195/2017-5,
   406436/2016-9, 473324/2013-0]; Brazilian funding agency Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [202.817/2016, 201.432/2014, 202.944/2015];
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); Comissao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES/Brazil)CAPES [001]; NIH T32 grantUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AG057461]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND
   STROKEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01NS091329, R01NS091329, R01NS091329]
   Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute on Aging (NIA) [P30AG028383, P30AG028383,
   P30AG028383, P30AG028383, P30AG028383, T32AG057461, P30AG028383,
   P30AG028383, P30AG028383, P30AG028383, P30AG028383, P30AG028383,
   P30AG028383, P30AG028383, P30AG028383, T32AG057461, P30AG028383,
   P30AG028383, P30AG028383, P30AG028383, T32AG057461, P30AG028383,
   P30AG028383, P30AG028383, P30AG028383, P30AG028383, P30AG028383,
   P30AG028383, P30AG028383, P30AG028383, P30AG028383, T32AG057461,
   P30AG028383, P30AG028383] Funding Source: NIH RePORTER
FX This work was supported by grants from Alzheimer Society of Canada (to
   F.G.D.F.) and the Weston Brain Institute (to F.G.D.F.), National
   Institute for Translational Neuroscience (INNT/Brazil) (465346/2014-6 to
   S.T.F. and F.G.F.), Human Frontier Science Program (to F.G.D.F.),
   International Society for Neurochemistry (CAEN 1B to M.V.L.), National
   Institutes of Health (NIH-R01NS049442 to O.A.), Canadian Institutes of
   Health Research (CIHR MOP 136940 and MOP 89919 to V.F.P. and M.A.M.P.),
   and from the Brazilian funding agencies Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (451195/2017-5 to
   M.V.L., 406436/2016-9 to S.T.F., and 473324/2013-0 to F.G.D.F.) and
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ) (202.817/2016 to M.V.L., 201.432/2014 to S.T.F., and
   202.944/2015 to F.G.D.F.). R.L.F, G.B.d.F., G.C.K., F.C.R., J.R.C.,
   D.B., and L.F.-G. were supported by fellowships granted by FAPERJ, CNPq,
   or Comissao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/Brazil; financial code 001). S.M. was supported by an NIH T32
   grant (AG057461). We acknowledge the University of Kentucky Alzheimer's
   Disease Center and its Neuropathology Core, which is supported by
   NIH/NIA P30 AG028383, for brain samples. We thank W.L. Klein
   (Northwestern University) for the kind gift of oligomer-specific NU4
   antibodies, B.M. Spiegelman (Harvard University) for sharing AdGFP and
   AdFNDC5 adenoviral constructs, and J. Wang (Queen's University, Canada)
   for help with mass spectrometry analyses. We also thank A. Lepelley, M.
   Oliveira, M. Melo, A.C. Rangel, and the CENABIO team for technical
   and/or administrative assistance.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275
   Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889
   Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307
   Beckman D, 2015, J BIOL CHEM, V290, P20488, DOI 10.1074/jbc.M115.666156
   Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189
   Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35
   Chen K, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao6298
   Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Colaianni G, 2015, P NATL ACAD SCI USA, V112, P12157, DOI 10.1073/pnas.1516622112
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2014, ALZHEIMERS DEMENT, V10, pS26, DOI 10.1016/j.jalz.2013.12.004
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   Drummond C, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00096
   During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919
   Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831
   Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046
   Grillo CA, 2015, DIABETES, V64, P3927, DOI 10.2337/db15-0596
   Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097
   Irving AJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0155
   Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3
   Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001
   Katsnelson A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aal2074
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017
   Lepeta K, 2016, J NEUROCHEM, V138, P785, DOI 10.1111/jnc.13713
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lourenco MV, 2015, PROG NEUROBIOL, V129, P37, DOI 10.1016/j.pneurobio.2015.03.003
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486
   Madeira C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.52
   Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9
   Mattson MP, 2012, CELL METAB, V16, P706, DOI 10.1016/j.cmet.2012.08.012
   McEwen BS, 2015, P NATL ACAD SCI USA, V112, P15544, DOI 10.1073/pnas.1521416112
   Mendes ND, 2018, J NEUROSCI METH, V307, P203, DOI 10.1016/j.jneumeth.2018.05.021
   Moon HY, 2016, CELL METAB, V24, P332, DOI 10.1016/j.cmet.2016.05.025
   Mucke L, 2012, COLD SPRING HARB PER, V2
   Muller S, 2018, ALZHEIMERS DEMENT, V14, P1427, DOI 10.1016/j.jalz.2018.06.3059
   Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011
   Okonkwo OC, 2014, NEUROLOGY, V83, P1753, DOI 10.1212/WNL.0000000000000964
   Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007
   Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009
   Schaefer N, 2017, J NEUROCHEM, V142, P790, DOI 10.1111/jnc.14107
   Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]
   Schumacher MA, 2013, J BIOL CHEM, V288, P33738, DOI 10.1074/jbc.M113.516641
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   da Silva GSS, 2017, J BIOL CHEM, V292, P7395, DOI 10.1074/jbc.M116.753525
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Sleiman SF, 2016, ELIFE, V5, DOI 10.7554/eLife.15092
   Smith RW, 2007, PROTEOMICS, V7, P4171, DOI 10.1002/pmic.200700573
   Suwabe K, 2018, P NATL ACAD SCI USA, V115, P10487, DOI 10.1073/pnas.1805668115
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364
   Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254
   Trinh MA, 2013, NEUROBIOL LEARN MEM, V105, P93, DOI 10.1016/j.nlm.2013.04.013
   van Praag H, 2014, J NEUROSCI, V34, P15139, DOI 10.1523/JNEUROSCI.2814-14.2014
   Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199
   Wadman M, 2012, NATURE, V485, P426, DOI 10.1038/485426a
   Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008
   Yang WZ, 2016, NEUROBIOL AGING, V41, P19, DOI 10.1016/j.neurobiolaging.2016.02.005
   Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106
NR 70
TC 109
Z9 112
U1 20
U2 108
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD JAN
PY 2019
VL 25
IS 1
BP 165
EP +
DI 10.1038/s41591-018-0275-4
PG 26
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA HG5OR
UT WOS:000455027700034
PM 30617325
OA Green Accepted
DA 2020-12-01
ER

PT J
AU Eugenio, M
   Campanati, L
   Muller, N
   Romao, LF
   de Souza, J
   Alves-Leon, S
   de Souza, W
   Sant'Anna, C
AF Eugenio, Mateus
   Campanati, Loraine
   Mueller, Nathalia
   Romao, Luciana F.
   de Souza, Jorge
   Alves-Leon, Soniza
   de Souza, Wanderley
   Sant'Anna, Celso
TI Silver/silver chloride nanoparticles inhibit the proliferation of human
   glioblastoma cells
SO CYTOTECHNOLOGY
LA English
DT Article
DE Cancer; Glioblastoma; Antiproliferative effect; Metallic nanoparticles;
   Silver; silver chloride nanoparticles; High-content analysis
ID BIOGENIC SILVER NANOPARTICLES; MALIGNANT GLIOMAS; GREEN SYNTHESIS;
   TUMOR-GROWTH; TEMOZOLOMIDE; MODULATION; APOPTOSIS; DELIVERY; CULTURE;
   AGCL
AB Glioblastomas (GBM) are aggressive brain tumors with very poor prognosis. While silver nanoparticles represent a potential new strategy for anticancer therapy, the silver/silver chloride nanoparticles (Ag/AgCl-NPs) have microbicidal activity, but had not been tested against tumor cells. Here, we analyzed the effect of biogenically produced Ag/AgCl-NPs (from yeast cultures) on the proliferation of GBM02 glioblastoma cells (and of human astrocytes) by automated, image-based high-content analysis (HCA). We compared the effect of 0.1-5.0 mu gmL(-1) Ag/AgCl-NPs with that of 9.7-48.5 mu gmL(-1) temozolomide (TMZ, chemotherapy drug currently used to treat glioblastomas), alone or in combination. At higher concentrations, Ag/AgCl-NPs inhibited GBM02 proliferation more effectively than TMZ (up to 82 and 62% inhibition, respectively), while the opposite occurred at lower concentrations (up to 23 and 53% inhibition, for Ag/AgCl-NPs and TMZ, respectively). The combined treatment (Ag/AgCl-NPs+TMZ) inhibited GBM02 proliferation by 54-83%. Ag/AgCl-NPs had a reduced effect on astrocyte proliferation compared with TMZ, and Ag/AgCl-NPs+TMZ inhibited astrocyte proliferation by 5-42%. The growth rate and population doubling time analyses confirmed that treatment with Ag/AgCl-NPs was more effective against GBM02 cells than TMZ (similar to 67-fold), and less aggressive to astrocytes, while Ag/AgCl-NP+TMZ treatment was no more effective against GBM02 cells than Ag/AgCl-NPs monotherapy. Taken together, our data indicate that 2.5 mu gmL(-1) Ag/AgCl-NPs represents the safest dose tested here, which affects GBM02 proliferation, with limited effect on astrocytes. Our findings show that HCA is a useful approach to evaluate the antiproliferative effect of nanoparticles against tumor cells.
C1 [Eugenio, Mateus; Mueller, Nathalia; Sant'Anna, Celso] Natl Inst Metrol Qual & Technol Inmetro, Lab Microscopy Appl Life Sci Lamav, Av Nossa Senhora das Gracas 50,Predio 27, BR-25250020 Duque De Caxias, RJ, Brazil.
   [Eugenio, Mateus; de Souza, Wanderley; Sant'Anna, Celso] Postgrad Program Translat Biomed Biotrans, Duque De Caxias, RJ, Brazil.
   [Campanati, Loraine] Univ Fed Rio de Janeiro, Lab Cellular Morphogenesis, Rio De Janeiro, RJ, Brazil.
   [de Souza, Wanderley; Sant'Anna, Celso] Natl Inst Sci & Technol Struct Biol & Bioimaging, Rio De Janeiro, RJ, Brazil.
   [de Souza, Wanderley] Univ Fed Rio de Janeiro, Lab Cellular Ultrastruct Hertha Meyer, Rio De Janeiro, RJ, Brazil.
   [Romao, Luciana F.] Univ Fed Rio de Janeiro, Biomed Sci, Duque De Caxias, RJ, Brazil.
   [de Souza, Jorge; Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Univ Hosp Clementino Fraga Filho, Rio De Janeiro, RJ, Brazil.
RP Sant'Anna, C (corresponding author), Natl Inst Metrol Qual & Technol Inmetro, Lab Microscopy Appl Life Sci Lamav, Av Nossa Senhora das Gracas 50,Predio 27, BR-25250020 Duque De Caxias, RJ, Brazil.
EM cbfilho@inmetro.gov.br
RI Campanati, Loraine/V-2632-2018; Leon, Soniza V Alves/J-7786-2012
OI Campanati, Loraine/0000-0001-9172-1951; Vieira Muller,
   Nathalia/0000-0003-1635-2927
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Coordination for the
   Improvement of Higher Education Personnel (CAPES)CAPES
FX This work was supported by the National Council for Scientific and
   Technological Development (CNPq), the Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) and the
   Coordination for the Improvement of Higher Education Personnel (CAPES).
CR Aggarwal P.J.A.V., 2012, INT J NANO MAT SCI, V1, P108
   Allahverdiyev AM, 2011, INT J NANOMED, V6, P2705, DOI 10.2147/IJN.S23883
   Alves TR, 2011, LIFE SCI, V89, P532, DOI 10.1016/j.lfs.2011.04.022
   Arvold ND, 2014, CLIN INTERV AGING, V9, P357, DOI 10.2147/CIA.S44259
   AshaRani PV, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-65
   ASSANGA I, 2013, INT J BIOTECHNOLOGY, V4, P60, DOI DOI 10.5897/IJBMBR2013.0154
   Balca-Silva J, 2015, BBA-GEN SUBJECTS, V1850, P722, DOI 10.1016/j.bbagen.2014.12.022
   Beier D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-128
   Brayden DJ, 2015, DRUG DISCOV TODAY, V20, P942, DOI 10.1016/j.drudis.2015.04.001
   Buttacavoli Miriam, 2018, Oncotarget, V9, P9685, DOI 10.18632/oncotarget.23859
   Chan GKY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063583
   Devi TB, 2016, NEW J CHEM, V40, P1497, DOI 10.1039/c5nj02367j
   Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824
   Duran N, 2016, APPL MICROBIOL BIOT, V100, P6555, DOI 10.1007/s00253-016-7657-7
   Duran N, 2016, NANOMED-NANOTECHNOL, V12, P789, DOI 10.1016/j.nano.2015.11.016
   Eugenio M, 2016, RSC ADV, V6, P9893, DOI 10.1039/c5ra22727e
   Faria J, 2006, DIFFERENTIATION, V74, P562, DOI 10.1111/j.1432-0436.2006.00090.x
   Gavish A, 2016, ARCH MED RES, V47, P271, DOI 10.1016/j.arcmed.2016.07.007
   Glaser T, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00166
   Goldlust SA, 2008, HOSP PHYS, V1, P9
   Hsin YH, 2008, TOXICOL LETT, V179, P130, DOI 10.1016/j.toxlet.2008.04.015
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Jeyaraj M, 2013, COLLOID SURFACE B, V106, P86, DOI 10.1016/j.colsurfb.2013.01.027
   Kang YO, 2016, MATERIALS, V9, DOI 10.3390/ma9040215
   Liang P, 2017, ONCOTARGET, V8, P7533, DOI 10.18632/oncotarget.13503
   Locatelli E, 2014, NANOMEDICINE-UK, V9, P839, DOI [10.2217/NNM.14.1, 10.2217/nnm.14.1]
   Locatelli E, 2012, ADV HEALTHC MATER, V1, P342, DOI 10.1002/adhm.201100047
   Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4
   MacEwan SR, 2010, NANOMEDICINE-UK, V5, P793, DOI [10.2217/nnm.10.50, 10.2217/NNM.10.50]
   Naqvi SZH, 2013, INT J NANOMED, V8, DOI 10.2147/IJN.S49284
   Piao MJ, 2011, TOXICOL LETT, V201, P92, DOI 10.1016/j.toxlet.2010.12.010
   Raizer JJ, 2015, J ONCOL PRACT, V11, pE59, DOI 10.1200/JOP.2012.000560
   Ramery E, 2014, ENVIRON TOXICOL, V29, P310, DOI 10.1002/tox.21759
   Ramirez YP, 2013, PHARMACEUTICALS, V6, P1475, DOI 10.3390/ph6121475
   Rosarin FS, 2013, ASIAN PAC J TROP MED, V6, P1, DOI 10.1016/S1995-7645(12)60193-X
   Rutberg FG, 2008, DOKL BIOCHEM BIOPHYS, V421, P191, DOI 10.1134/S1607672908040078
   Sharma S, 2014, ADV HEALTHC MATER, V3, P106, DOI 10.1002/adhm.201300090
   SHERLEY JL, 1995, CELL PROLIFERAT, V28, P137, DOI 10.1111/j.1365-2184.1995.tb00062.x
   Silva HFO, 2015, RSC ADV, V5, P66886, DOI 10.1039/c5ra10880b
   Sriram MI, 2010, INT J NANOMED, V5, P753, DOI 10.2147/IJN.S11727
   Stengl A, 2017, SLAS DISCOV, V22, P309, DOI 10.1177/1087057116677821
   Stojiljkovic A, 2016, NANOSCALE, V8, P16650, DOI 10.1039/c6nr05723c
   Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7
   Urbanska K, 2015, NANOSCALE RES LETT, V10, P1, DOI 10.1186/s11671-015-0823-5
   Usaj MM, 2016, TRENDS CELL BIOL, V26, P598, DOI 10.1016/j.tcb.2016.03.008
   Vigneshwaran N, 2007, MATER LETT, V61, P1413, DOI 10.1016/j.matlet.2006.07.042
   Villanueva-Ibanez M, 2015, MATER LETT, V152, P166, DOI 10.1016/j.matlet.2015.03.097
   Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126
   Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005
NR 49
TC 3
Z9 4
U1 1
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-9069
EI 1573-0778
J9 CYTOTECHNOLOGY
JI Cytotechnology
PD DEC
PY 2018
VL 70
IS 6
BP 1607
EP 1618
DI 10.1007/s10616-018-0253-1
PG 12
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA HC4GE
UT WOS:000451760200012
PM 30203320
OA Green Published
DA 2020-12-01
ER

PT J
AU Correa, DG
   Pereira, M
   Zimmermann, N
   Doring, T
   Ventura, N
   Rego, C
   Marcondes, J
   Alves-Leon, SV
   Gasparetto, EL
AF Correa, Diogo Goulart
   Pereira, Mariana
   Zimmermann, Nicolle
   Doring, Thomas
   Ventura, Nina
   Rego, Claudia
   Marcondes, Jorge
   Alves-Leon, Soniza Vieira
   Gasparetto, Emerson Leandro
TI Widespread white matter DTI alterations in mesial temporal sclerosis
   independent of disease side
SO EPILEPSY & BEHAVIOR
LA English
DT Article
DE Mesial temporal sclerosis; Hippocampal sclerosis; Magnetic resonance
   imaging; White matter; Diffusion tensor imaging
ID VOXEL-BASED MORPHOMETRY; LOBE EPILEPSY TLE; HIPPOCAMPAL SCLEROSIS;
   GRAY-MATTER; ILAE COMMISSION; DIFFUSION; ABNORMALITIES; BRAIN; ONSET;
   MRI
AB Purpose: The aim of this study was to evaluate white matter (WM) integrity in vivo in patients with unilateral mesial temporal sclerosis (MTS).
   Methods: Diffusion tensor imaging (DTI) findings from patients with left-sided MTS (L-MTS; N = 14) and right-sided MTS (R-MTS; N = 13), all taking antiepileptic medication, were compared with those from gender- and age-matched controls; DTI was performed along 30 noncollinear directions in a 1.5-T scanner. Tract-based spatial statistics (TBSS) analysis was performed by creating a WM skeleton; 5000-permutation-based inference (threshold, p < 0.05) was used to identify fractional anisotropy (FA) abnormalities. Mean (MD), radial (RD), and axial diffusivities (AD) were projected onto the mean FA skeleton.
   Results: Compared with the control groups, patients with MIS had decreased FA affecting widespread WM tracts as well as extensive areas with increased RD. bilaterally and independent of the disease side. Areas with decreased FA and increased RD overlapped substantially. There were no significant differences in DTI parameters between L-M1S and R-MTS patients.
   Conclusion: Diffusion tensor imaging abnormalities were observed within and beyond the temporal lobe in patients with MTS. Patients with R- and L-MTS had extensive bilateral abnormalities in comparison to controls. These findings suggest that MTS pathobiology involves diffuse dysfunction of WM tracts, even in areas with no direct connections to the hippocampus. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Correa, Diogo Goulart; Pereira, Mariana; Zimmermann, Nicolle; Ventura, Nina; Gasparetto, Emerson Leandro] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Radiol, Rua Rodolpho Paulo Rocco 255,Cidade Univ, BR-21941913 Rio De Janeiro, RJ, Brazil.
   [Correa, Diogo Goulart; Doring, Thomas; Ventura, Nina; Gasparetto, Emerson Leandro] Clin Diagnost Imagem CDPI, Ave Amer 4666,302A, BR-2640102 Rio De Janeiro, RJ, Brazil.
   [Rego, Claudia; Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Neurol Epilepsy Ctr, Rua Rodolpho Paulo Rocco 255,Cidade Univ, BR-21941913 Rio De Janeiro, RJ, Brazil.
   [Marcondes, Jorge] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Neurosurg, Rua Rodolpho Paulo Rocco 255,Cidade Univ, BR-21941913 Rio De Janeiro, RJ, Brazil.
RP Correa, DG (corresponding author), Hosp Univ Clementino Fraga Filho, Rua Rodolpho Paulo Rocco 255,Cidade Univ, BR-21941913 Rio De Janeiro, RJ, Brazil.
EM diogogoulartcorrea@yahoo.com.br
RI Leon, Soniza V Alves/J-7786-2012; Correa, Diogo/AAZ-1590-2020
OI ZIMMERMANN, NICOLLE/0000-0003-4771-4070
CR Ahmadi ME, 2009, AM J NEURORADIOL, V30, P1740, DOI 10.3174/ajnr.A1650
   Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011
   Bao YX, 2018, EPILEPSY BEHAV, V83, P44, DOI 10.1016/j.yebeh.2017.12.002
   Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x
   Bonilha L, 2007, J NEUROL NEUROSUR PS, V78, P286, DOI 10.1136/jnnp.2006.103994
   Bonilha L, 2006, NEUROIMAGE, V32, P1070, DOI 10.1016/j.neuroimage.2006.05.038
   Bonilha L, 2015, QUANT IMAG MED SURG, V5, P204, DOI 10.3978/j.issn.2223-4292.2015.01.01
   Bonilha L, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2011.03298.x
   Bonilha L, 2010, EPILEPSIA, V51, P519, DOI 10.1111/j.1528-1167.2009.02506.x
   Bote RP, 2008, SEMIN ULTRASOUND CT, V29, P2, DOI 10.1053/j.sult.2007.11.005
   Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041
   Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308
   Curia G, 2014, CURR MED CHEM, V21, P663, DOI 10.2174/0929867320666131119152201
   Dong Q, 2004, J MAGN RESON IMAGING, V19, P6, DOI 10.1002/jmri.10424
   Fisher RS, 2017, EPILEPSIA, V58, P522, DOI 10.1111/epi.13670
   Focke NK, 2008, NEUROIMAGE, V40, P728, DOI 10.1016/j.neuroimage.2007.12.031
   Gross DW, 2006, EPILEPSIA, V47, P1360, DOI 10.1111/j.1528-1167.2006.00603.x
   Gross DW, 2011, EPILEPSIA, V52, P32, DOI 10.1111/j.1528-1167.2011.03149.x
   Hermann B, 2002, EPILEPSIA, V43, P1062, DOI 10.1046/j.1528-1157.2002.49901.x
   Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787
   Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081
   Kaaden S, 2011, EPILEPSY BEHAV, V20, P694, DOI 10.1016/j.yebeh.2011.02.020
   Keller SS, 2008, EPILEPSIA, V49, P741, DOI 10.1111/j.1528-1167.2007.01485.x
   Kemmotsu N, 2011, EPILEPSIA, V52, P2257, DOI 10.1111/j.1528-1167.2011.03278.x
   Liu M, 2016, BRAIN, V139, P2431, DOI 10.1093/brain/aww167
   Liu M, 2012, NEUROIMAGE-CLIN, V1, P99, DOI 10.1016/j.nicl.2012.09.010
   Liu RSN, 2003, ANN NEUROL, V53, P312, DOI 10.1002/ana.10463
   Lyra KP, 2017, EPILEPSY RES, V137, P112, DOI 10.1016/j.eplepsyres.2017.09.008
   Mueller SG, 2006, EPILEPSIA, V47, P900, DOI 10.1111/j.1528-1167.2006.00512.x
   Nagae LM, 2016, CLIN IMAG, V40, P624, DOI 10.1016/j.clinimag.2016.02.012
   Nagy SA, 2016, EPILEPSY BEHAV, V61, P14, DOI 10.1016/j.yebeh.2016.04.019
   Norris DG, 2001, NMR BIOMED, V14, P77, DOI 10.1002/nbm.682
   Pail M, 2010, EPILEPSIA, V51, P511, DOI 10.1111/j.1528-1167.2009.02324.x
   Richardson MP, 2012, J NEUROL NEUROSUR PS, V83, P1238, DOI 10.1136/jnnp-2011-301944
   Riederer F, 2008, NEUROLOGY, V71, P419, DOI 10.1212/01.wnl.0000324264.96100.e0
   Riley JD, 2010, EPILEPSIA, V51, P536, DOI 10.1111/j.1528-1167.2009.02508.x
   Sanches P, 2017, EPILEPSY RES, V132, P100, DOI 10.1016/j.eplepsyres.2017.03.004
   Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016
   Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Sone D, 2016, EPILEPSY RES, V127, P221, DOI 10.1016/j.eplepsyres.2016.09.011
   Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x
   Stafstrom CE, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022426
   Tae WS, 2005, NEUROIMAGE, V24, P101, DOI 10.1016/j.neuroimage.2004.08.005
   Whelan CD, 2018, BRAIN, V141, P391, DOI 10.1093/brain/awx341
NR 45
TC 2
Z9 2
U1 2
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1525-5050
EI 1525-5069
J9 EPILEPSY BEHAV
JI Epilepsy Behav.
PD OCT
PY 2018
VL 87
BP 7
EP 13
DI 10.1016/j.yebeh.2018.08.013
PG 7
WC Behavioral Sciences; Clinical Neurology; Psychiatry
SC Behavioral Sciences; Neurosciences & Neurology; Psychiatry
GA GY7PW
UT WOS:000448805600002
PM 30149360
DA 2020-12-01
ER

PT J
AU Mendes, ND
   Fernandes, A
   Almeida, GM
   Santos, LE
   Selles, MC
   Silva, NMLE
   Machado, CM
   Horta, JAC
   Louzada, PR
   De Felice, FG
   Alves-Leon, S
   Marcondes, J
   Assirati, JA
   Matios, CM
   Klein, WL
   Garcia-Cairasco, N
   Ferreira, ST
   Neder, L
   Sebollela, A
AF Mendes, Niele D.
   Fernandes, Artur
   Almeida, Glaucia M.
   Santos, Luis E.
   Selles, Maria Clara
   Lyra e Silva, N. M.
   Machado, Carla M.
   Horta-Junior, Jose A. C.
   Louzada, Paulo R.
   De Felice, Fernando G.
   Alves-Leon, Soniza
   Marcondes, Jorge
   Assirati Jr, Joao Alberto
   Matios, Caio M.
   Klein, William L.
   Garcia-Cairasco, Norberto
   Ferreira, Sergio T.
   Neder, Luciano
   Sebollela, Adriano
TI Free-floating adult human brain-derived slice cultures as a model to
   study the neuronal impact of Alzheimer's disease-associated A beta
   oligomers
SO JOURNAL OF NEUROSCIENCE METHODS
LA English
DT Article
DE Tissue slices; Organotypic culture; Human brain; Alzheimer's disease; A
   beta oligomers; Epilepsy
ID POSTMORTEM CHANGES; PATHOGENESIS; MECHANISMS; HYPOTHESIS; EVOLUTION;
   RELEASE; GROWTH; NEED
AB Background: Slice cultures have been prepared from several organs. With respect to the brain, advantages of slice cultures over dissociated cell cultures include maintenance of the cytoarchitecture and neuronal connectivity. Slice cultures from adult human brain have been reported and constitute a promising method to study neurological diseases. Despite this potential, few studies have characterized in detail cell survival and function along time in short-term, free-floating cultures.
   New Method: We used tissue from adult human brain cortex from patients undergoing temporal lobectomy to prepare 200 pm-thick slices. Along the period in culture, we evaluated neuronal survival, histological modifications, and neurotransmitter release. The toxicity of Alzheimer's-associated A beta oligomers (A beta Os) to cultured slices was also analyzed.
   Results: Neurons in human brain slices remain viable and neurochemically active for at least four days in vitro, which allowed detection of binding of A beta Os. We further found that slices exposed to A beta Os presented elevated levels of hyperphosphorylated Tau, a hallmark of Alzheimer's disease.
   Comparison with Existing Method(s): Although slice cultures from adult human brain have been previously prepared, this is the first report to analyze cell viability and neuronal activity in short-term free-floating cultures as a function of days in vitro.
   Conclusions: Once surgical tissue is available, the current protocol is easy to perform and produces functional slices from adult human brain. These slice cultures may represent a preferred model for translational studies of neurodegenerative disorders when long term culturing in not required, as in investigations on A beta O neurotoxicity.
C1 [Mendes, Niele D.; Fernandes, Artur; Almeida, Glaucia M.; Sebollela, Adriano] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Ribeirao Preto, SP, Brazil.
   [Mendes, Niele D.; Neder, Luciano] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol & Forens Med, Ribeirao Preto, SP, Brazil.
   [Fernandes, Artur; Garcia-Cairasco, Norberto] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Physiol, Ribeirao Preto, SP, Brazil.
   [Santos, Luis E.; Selles, Maria Clara; Lyra e Silva, N. M.; De Felice, Fernando G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, RJ, Brazil.
   [Machado, Carla M.; Horta-Junior, Jose A. C.] Sao Paulo State Univ, Inst Biosci, Dept Anat, Sao Paulo, Brazil.
   [Louzada, Paulo R.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernando G.] Queens Univ, Ctr Neurosci Studies, Dept Biomed & Mol Sci, Kingston, ON, Canada.
   [Alves-Leon, Soniza; Marcondes, Jorge] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, RJ, Brazil.
   [Assirati Jr, Joao Alberto; Matios, Caio M.] Univ Sao Paulo, Ribeirao Preto Med Sch, Clin Hosp, Ribeirao Preto, SP, Brazil.
   [Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.
   [Neder, Luciano] Barretos Canc Hosp, Barretos, SP, Brazil.
RP Sebollela, A (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Ribeirao Preto, SP, Brazil.
EM sebollela@fmrp.usp.br
RI Santos, Luis/B-4961-2015; Leon, Soniza V Alves/J-7786-2012; Sebollela,
   Adriano/O-4385-2014; Almeida, Glaucia Maria/AAC-4390-2019; Machado,
   Carla M/M-7479-2015; Ferreira, Sergio/AAZ-1576-2020; de Anchieta C
   Horta-Junior, Jose/X-7878-2019
OI Santos, Luis/0000-0002-0694-733X; Sebollela,
   Adriano/0000-0002-7444-9156; Almeida, Glaucia Maria/0000-0003-4149-5313;
   Machado, Carla M/0000-0002-6640-8186; Ferreira,
   Sergio/0000-0001-7160-9866; de Anchieta C Horta-Junior,
   Jose/0000-0003-3639-9861
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); FAEPA; National
   Institute for Translational Neuroscience; Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES;
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX This work was supported by grants from Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) and FAEPA to AS and NGC; National Institute
   for Translational Neuroscience, Fundacao de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ) and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) to STF and FGDF; and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES). We thank Deise L
   Chesca and Silvana El-Chaedroui, and CIREP staff (especially Tania A. C.
   Becker and Adriana A. C. Ferrari) for excellent technical assistance.
   NGC holds a CNPq Researcher fellowship.
CR Alzheimer's Association, 2016, Alzheimers Dement, V12, P459
   Andersson M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24818
   Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028
   Brewer GJ, 2001, J NEUROSCI METH, V107, P15, DOI 10.1016/S0165-0270(01)00342-9
   Cazemier JL, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00110
   Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q
   Dai JP, 2004, BRIT J PHARMACOL, V143, P606, DOI 10.1038/sj.bjp.0705995
   Darlington PJ, 2008, J NEUROCHEM, V104, P1201, DOI 10.1111/j.1471-4159.2007.05043.x
   Dash A, 2017, TOXICOL IN VITRO, V39, P93, DOI 10.1016/j.tiv.2016.11.014
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   Elkayam T, 2006, TISSUE ENG, V12, P1357, DOI 10.1089/ten.2006.12.1357
   Eugene E, 2014, J NEUROSCI METH, V235, P234, DOI 10.1016/j.jneumeth.2014.07.009
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Fountoulakis M, 2001, EXP NEUROL, V167, P86, DOI 10.1006/exnr.2000.7529
   Freiman TM, 2006, NEUROSCI RES, V55, P204, DOI 10.1016/j.neures.2006.01.007
   GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0
   Gilbride CJ, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12889
   Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017
   Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013
   Hoffman R. M., 2001, HISTOCULTURES ORGAN
   Horta-Junior JAC, 2008, J COMP NEUROL, V507, P1763, DOI 10.1002/cne.21625
   Humpel C, 2015, NEUROSCIENCE, V305, P86, DOI 10.1016/j.neuroscience.2015.07.086
   Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008
   Jones RSG, 2016, J NEUROSCI METH, V260, P221, DOI 10.1016/j.jneumeth.2015.09.021
   Kadar A, 2009, J NEUROSCI METH, V184, P115, DOI 10.1016/j.jneumeth.2009.07.010
   Kowalska Anna, 2004, Neurol Neurochir Pol, V38, P405
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lavenex P, 2009, J COMP NEUROL, V512, P27, DOI 10.1002/cne.21906
   Born JPL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182765
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   MILLER BE, 1985, CANCER RES, V45, P4200
   Monge-Acuna AA, 2009, J NEUROSCI METH, V183, P176, DOI 10.1016/j.jneumeth.2009.06.042
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701
   Mucke L., 2012, PERSPECT MED, V2
   MULLEN RJ, 1992, DEVELOPMENT, V116, P201
   Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7
   Olinga P, 2013, J HEPATOL, V58, P1252, DOI 10.1016/j.jhep.2013.01.009
   PATERNITI I, 2013, J NEUROINFLAMM, V10
   Przedborski S, 2003, J CLIN INVEST, V111, P3, DOI 10.1172/JCI200317522
   Puzzo D, 2015, NEUROSCIENCE, V307, P26, DOI 10.1016/j.neuroscience.2015.08.039
   Puzzo D, 2015, EXPERT OPIN DRUG DIS, V10, P703, DOI 10.1517/17460441.2015.1041913
   Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719
   Risher WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022351
   SCHWARZ N, 2017, SCI REP UK, V7
   Sebollela A., 2017, J NEUROCHEM, V3
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   da Silva GSS, 2017, J BIOL CHEM, V292, P7395, DOI 10.1074/jbc.M116.753525
   Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
   Selkoe DJ, 2001, PHYSIOL REV, V81, P741
   Sobieski C, 2015, J NEUROSCI, V35, P11105, DOI 10.1523/JNEUROSCI.1289-15.2015
   Staal JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022040
   Steinstraesser Lars, 2009, Eplasty, V9, pe5
   STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M
   Tobita T, 2010, INT J ORAL MAX SURG, V39, P364, DOI 10.1016/j.ijom.2009.12.020
   Trevelyan AJ, 2016, TRENDS NEUROSCI, V39, P502, DOI 10.1016/j.tins.2016.06.002
   Um S.-H., 2013, PLOS ONE, V8
   Velasco PT, 2012, ACS CHEM NEUROSCI, V3, P972, DOI 10.1021/cn300122k
   Verhoog MB, 2013, J NEUROSCI, V 33, P17197, DOI 10.1523/JNEUROSCI.3158-13.2013
   Verwer RWH, 2002, FASEB J, V16, P54, DOI 10.1096/fj.01-0504com
   Viola KL, 2015, ACTA NEUROPATHOL, V129, P183, DOI 10.1007/s00401-015-1386-3
   Wallach G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003964
   Walsh DM, 2012, PROG MOL BIOL TRANSL, V107, P101, DOI 10.1016/B978-0-12-385883-2.00012-6
   Wang L, 2010, ACTA PHARMACOL SIN, V31, P470, DOI 10.1038/aps.2009.202
NR 65
TC 8
Z9 8
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0165-0270
EI 1872-678X
J9 J NEUROSCI METH
JI J. Neurosci. Methods
PD SEP 1
PY 2018
VL 307
BP 203
EP 209
DI 10.1016/j.jneumeth.2018.05.021
PG 7
WC Biochemical Research Methods; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA GQ8ZN
UT WOS:000442055800021
PM 29859877
OA Green Published
DA 2020-12-01
ER

PT J
AU Rueda-Lopes, FC
   Pessoa, FMC
   Tukamoto, G
   Malfetano, FR
   Scherpenhuijzen, SB
   Alves-Leon, S
   Gasparetto, EL
AF Rueda-Lopes, Fernanda C.
   Pessoa, Fernanda M. C.
   Tukamoto, Gustavo
   Malfetano, Fabiola Rachid
   Scherpenhuijzen, Simone Batista
   Alves-Leon, Soniza
   Gasparetto, Emerson L.
TI Default-mode network and deep gray-matter analysis in neuromyelitis
   optica patients
SO JOURNAL OF NEURORADIOLOGY
LA English
DT Article
ID RESTING-STATE NETWORKS; DIFFUSION TENSOR MRI; MULTIPLE-SCLEROSIS;
   COGNITIVE IMPAIRMENT; DIAGNOSTIC-CRITERIA; FUNCTIONAL MRI; BRAIN;
   ABNORMALITIES; SPECTRUM; DAMAGE
AB Objective. - The aim of our study was to detect functional changes in default-mode network of neuromyelitis optica (NMO) patients using resting-state functional magnetic resonance images and the evaluation of subcortical gray-matter structures volumes.
   Materials and methods. - NMO patients (n = 28) and controls patients (n = 19) were enrolled. We used the integrated registration and segmentation tool, part of FMRIB's Software Library (FSL) to segment subcortical structures including the thalamus, caudate nucleus, putamen, hippocampus and amygdalae. Resting-state functional magnetic resonance images were post-processed using the Multivariate Exploratory Linear Optimized Decomposition into Independent Components, also part of FSL. Average Z-values extracted from the default-mode network were compared between patients and controls using t-tests (P values <0.05 were considered statistically significant).
   Results. - There were areas of increased synchronization in the default-mode network of patients compared to controls, notably in the precuneus and right hippocampus (corrected P < 0.01). The frontal area had decreased synchronization in patients compared to controls (corrected P < 0.01). There were no observed differences between patients and controls in subcortical volumes or average Z-values values for default-mode network.
   Conclusion. - The hyperactivity of certain default-mode network areas may reflect cortical compensation for subtle structural damage in NMO patients. (C) 2018 Elsevier Masson SAS. All rights reserved.
C1 [Rueda-Lopes, Fernanda C.] Fluminense Fed Univ UFF, Diagnost Amer DASA, Rua Presidente Joao Pessoa,385 Apto 704, BR-24220330 Niteroi, RJ, Brazil.
   [Pessoa, Fernanda M. C.; Malfetano, Fabiola Rachid; Scherpenhuijzen, Simone Batista; Alves-Leon, Soniza] Fed Univ Rio de Janeiro UFRJ, Rua Brigadeiro Trompowisky S-N, Rio De Janeiro, RJ, Brazil.
   [Tukamoto, Gustavo] Diagnost Amer DASA, Ave Amer 4666,Sala 325, Barra Da Tijuca, RJ, Brazil.
   [Gasparetto, Emerson L.] Fed Univ Rio de Janeiro UFRJ, Diagnost Amer DASA, Rua Brigadeiro Trompowisky S-N, Rio De Janeiro, RJ, Brazil.
RP Rueda-Lopes, FC (corresponding author), Fluminense Fed Univ UFF, Diagnost Amer DASA, Rua Presidente Joao Pessoa,385 Apto 704, BR-24220330 Niteroi, RJ, Brazil.
EM frueda81@hotmail.com
RI Leon, Soniza V Alves/J-7786-2012
CR Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634
   Beckmann CF, 2009, NEUROIMAGE S1, V47, P539
   Chanson JB, 2013, EUR J NEUROL, V20, P361, DOI 10.1111/j.1468-1331.2012.03867.x
   Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103
   Doche E, 2017, J NEURORADIOLOGY, V44, P158, DOI 10.1016/j.neurad.2016.10.001
   Eshaghi A, 2015, NEUROIMAGE-CLIN, V7, P306, DOI 10.1016/j.nicl.2015.01.001
   Finke C, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000229
   Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059
   Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101
   Hyun JW, 2017, EUR J NEUROL, V24, P437, DOI 10.1111/ene.13224
   Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X
   Li Y, 2008, ACTA NEUROL SCAND, V118, P218, DOI 10.1111/j.1600-0404.2008.01012.x
   Liang PP, 2011, CLIN NEUROPHYSIOL, V122, P121, DOI 10.1016/j.clinph.2010.05.026
   Liu Y, 2017, MULT SCLER, V1
   Liu YO, 2015, RADIOLOGY, V277, P784, DOI 10.1148/radiol.2015142786
   Liu Y, 2015, NEUROLOGY, V85, P1491, DOI 10.1212/WNL.0000000000002067
   Liu Y, 2011, EUR J RADIOL, V80, P407, DOI 10.1016/j.ejrad.2010.05.002
   Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046
   Pires CE, 2012, J CLIN NEUROSCI, V19, P969, DOI 10.1016/j.jocn.2011.10.009
   Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P964, DOI 10.1001/archneur.63.7.964
   Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P390, DOI 10.1001/archneur.63.3.390
   Rocca MA, 2004, NEUROLOGY, V62, P476, DOI 10.1212/01.WNL.0000106946.08741.41
   Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058
   Lopes FCR, 2012, RADIOLOGY, V263, P235, DOI 10.1148/radiol.12111241
   Lopes FCR, 2015, J NEUROIMAGING, V25, P807, DOI 10.1111/jon.12191
   Schoonheim MM, 2010, NEUROLOGY, V74, P1246, DOI 10.1212/WNL.0b013e3181db9957
   Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061
   van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008
   Wang Q, 2015, AM J NEURORADIOL, V36, P1822, DOI 10.3174/ajnr.A4403
   Ward AM, 2014, HUM BRAIN MAPP, V35, P1061, DOI 10.1002/hbm.22234
   Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74
   Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729
   Yu CS, 2008, RADIOLOGY, V246, P222, DOI 10.1148/radiol.2461062075
NR 33
TC 0
Z9 0
U1 0
U2 1
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0150-9861
EI 1773-0406
J9 J NEURORADIOLOGY
JI J. Neuroradiol.
PD JUL
PY 2018
VL 45
IS 4
BP 256
EP 260
DI 10.1016/j.neurad.2018.01.053
PG 5
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA GN4RE
UT WOS:000439018900008
PM 29470996
DA 2020-12-01
ER

PT J
AU Ferreira, TB
   Hygino, J
   Wing, AC
   Kasahara, TM
   Sacramento, PM
   Camargo, S
   Rueda, F
   Alves-Leon, SV
   Alvarenga, R
   Vasconcelos, CC
   Agrawal, A
   Gupta, S
   Bento, CAM
AF Ferreira, Thais B.
   Hygino, Joana
   Wing, Ana Cristina
   Kasahara, Taissa M.
   Sacramento, Priscila M.
   Camargo, Solange
   Rueda, Fernanda
   Alves-Leon, Soniza V.
   Alvarenga, Regina
   Vasconcelos, Claudia Cristina
   Agrawal, Anshu
   Gupta, Sudhir
   Bento, Cleonice A. M.
TI Different interleukin-17-secreting Toll-like receptor(+) T-cell subsets
   are associated with disease activity in multiple sclerosis
SO IMMUNOLOGY
LA English
DT Article
DE Multiple sclerosis; PAMP; Th17; Tc-17 cell subsets; TLR
ID EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GM-CSF; TGF-BETA; TH17;
   EXPRESSION; ACTIVATION; TLR9; PATHOGENESIS; RECOGNITION; LYMPHOCYTES
AB Signalling through Toll-like receptors (TLRs) may play a role in the pathogenesis of autoimmune diseases, such as multiple sclerosis (MS). In the present study, the expression of TLR-2, -4 and -9 was significantly higher on CD4(+) and CD8(+) T-cells from MS patients compared to healthy individuals. Following in-vitro activation, the proportion of interleukin (IL)-17(+) and IL-6(+) CD4(+) and CD8(+) T-cells was higher in the patients. In addition, the proportion of IFN--secreting TLR+ CD8(+) T-cells was increased in MS patients. Among different IL-17(+) T-cell phenotypes, the proportion of IL-17(+) TLR+ CD4(+) and CD8(+) T-cells producing IFN- or IL-6 were positively associated with the number of active brain lesions and neurological disabilities. Interestingly, activation of purified CD4(+) and CD8(+) T-cells with ligands for TLR-2 (Pam3Csk4), TLR-4 [lipopolysaccharide (LPS)] and TLR-9 [oligodeoxynucleotide (ODN)] directly induced cytokine production in MS patients. Among the pathogen-associated molecular patterns (PAMPs), Pam3Csk4 was more potent than other TLR ligands in inducing the production of all proinflammatory cytokines. Furthermore, IL-6, IFN-, IL-17 and granulocyte-macrophage colony-stimulating factor (GM-CSF) levels produced by Pam3Csk4-activated CD4(+) cells were directly associated with disease activity. A similar correlation was observed with regard to IL-17 levels released by Pam3Csk4-stimulated CD8(+) T-cells and clinical parameters. In conclusion, our data suggest that the expansion of different T helper type 17 (Th17) phenotypes expressing TLR-2, -4 and -9 is associated with MS disease activity, and reveals a preferential ability of TLR-2 ligand in directly inducing the production of cytokines related to brains lesions and neurological disabilities.
C1 [Ferreira, Thais B.; Kasahara, Taissa M.; Sacramento, Priscila M.; Bento, Cleonice A. M.] Univ Estado Rio De Janeiro, Postgrad Program Microbiol, Rio De Janeiro, Brazil.
   [Hygino, Joana; Bento, Cleonice A. M.] Fed Univ State Rio de Janeiro, Dept Microbiol & Parasitol, Frei Caneca 94, BR-20261040 Rio De Janeiro, RJ, Brazil.
   [Wing, Ana Cristina; Alves-Leon, Soniza V.; Alvarenga, Regina; Vasconcelos, Claudia Cristina; Bento, Cleonice A. M.] Fed Univ State Rio de Janeiro, Postgrad Program Neurol, Rio De Janeiro, Brazil.
   [Camargo, Solange] Lagoa Hosp, Barra Tijuca Unity, Rio De Janeiro, Brazil.
   [Rueda, Fernanda] Clin Diag Image, Barra Tijuca Unity, Rio De Janeiro, Brazil.
   [Agrawal, Anshu; Gupta, Sudhir] Univ Calif Irvine, Irvine, CA USA.
RP Bento, CAM (corresponding author), Fed Univ State Rio de Janeiro, Dept Microbiol & Parasitol, Frei Caneca 94, BR-20261040 Rio De Janeiro, RJ, Brazil.
EM cbento@globo.com
RI Leon, Soniza V Alves/J-7786-2012; de Matos Kasahara,
   Taissa/AAC-9399-2020
OI de Matos Kasahara, Taissa/0000-0002-1366-1049; Hygino,
   Joana/0000-0002-5934-8779
FU Fundacao de Amparo a Pesquisa Carlos Chagas Filho [26/201.208/2014];
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [302714/2013-8]
FX This work was supported by Fundacao de Amparo a Pesquisa Carlos Chagas
   Filho (Grant number: 26/201.208/2014) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (Grant number: 302714/2013-8)].
CR Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Aquino DA, 1997, J NEUROPATH EXP NEUR, V56, P664
   Barros PO, 2017, J NEUROIMMUNOL, V307, P82, DOI 10.1016/j.jneuroim.2017.04.001
   Bendigs S, 1999, EUR J IMMUNOL, V29, P1209, DOI 10.1002/(SICI)1521-4141(199904)29:04<1209::AID-IMMU1209>3.0.CO;2-J
   Bhaumik S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00254
   Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289
   Chen JQ, 2016, CLIN REV ALLERG IMMU, V50, P1, DOI 10.1007/s12016-015-8473-z
   Chen QY, 2017, J AUTOIMMUN, V77, P1, DOI 10.1016/j.jaut.2016.10.006
   Chen X, 2009, BLOOD, V114, P891, DOI 10.1182/blood-2009-01-197178
   Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005
   Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7
   Cree BAC, 2016, ANN NEUROL, V80, P443, DOI 10.1002/ana.24718
   Dowling JK, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.22
   Dunne A, 2005, FEBS LETT, V579, P3330, DOI 10.1016/j.febslet.2005.04.024
   Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775
   Ferreira TB, 2014, IMMUNOLOGY, V143, P560, DOI 10.1111/imm.12334
   Fujimoto M, 2011, J IMMUNOL, V186, P32, DOI 10.4049/jimmunol.0903314
   Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447
   Hansen BS, 2006, J NEUROIMMUNOL, V172, P94, DOI 10.1016/j.jneuroim.2005.11.006
   Hernandez-Pedro Norma, 2016, Front Biosci (Schol Ed), V8, P13
   Igoe A, 2013, CURR OPIN RHEUMATOL, V25, P480, DOI 10.1097/BOR.0b013e32836200d2
   Jimenez-Dalmaroni MJ, 2016, AUTOIMMUN REV, V15, P1, DOI 10.1016/j.autrev.2015.08.009
   Klonowska-Szymczyk A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/381418
   Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500
   Lossius A, 2012, VIRUSES-BASEL, V4, P3701, DOI 10.3390/v4123701
   Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012
   Lund BT, 2006, J NEUROL SCI, V249, P122, DOI 10.1016/j.jns.2006.05.066
   Mansilla MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105737
   Marsland BJ, 2007, CURR OPIN IMMUNOL, V19, P611, DOI 10.1016/j.coi.2007.07.022
   Marta M, 2008, EUR J IMMUNOL, V38, P565, DOI 10.1002/eji.200737187
   Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206
   McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539
   McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698
   da Costa DSMM, 2016, J NEUROIMMUNOL, V299, P8, DOI 10.1016/j.jneuroim.2016.08.005
   Mercier BC, 2009, J IMMUNOL, V182, P1860, DOI 10.4049/jimmunol.0801167
   Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095
   Miranda-Hernandez S, 2013, AM J CLIN EXP IMMUNO, V2, P75
   Miranda-Hernandez S, 2011, J IMMUNOL, V187, P791, DOI 10.4049/jimmunol.1001992
   Miya S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122902
   Mortezagholi S, 2017, IMMUNOPHARM IMMUNOT, V39, P11, DOI 10.1080/08923973.2016.1263859
   Mufazalov IA, 2017, EMBO J, V36, P102, DOI 10.15252/embj.201694615
   Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653
   Nakanishi Y, 2014, MUCOSAL IMMUNOL, V8, P1
   Nogai A, 2005, J IMMUNOL, V175, P959, DOI 10.4049/jimmunol.175.2.959
   Nyirenda MH, 2015, J IMMUNOL, V194, P5761, DOI 10.4049/jimmunol.1400472
   PANITCH HS, 1994, ANN NEUROL, V36, pS25, DOI 10.1002/ana.410360709
   Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366
   Pouly S, 2000, J NEUROPATH EXP NEUR, V59, P280, DOI 10.1093/jnen/59.4.280
   Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078
   Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301
   Rasouli J, 2015, J IMMUNOL, V194, P5085, DOI 10.4049/jimmunol.1403243
   Restorick SM, 2017, BRAIN BEHAV IMMUN, V64, P71, DOI 10.1016/j.bbi.2017.03.008
   Reynolds JM, 2012, P NATL ACAD SCI USA, V109, P13064, DOI 10.1073/pnas.1120585109
   Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010
   Rolla S, 2014, J LEUKOCYTE BIOL, V96, P1
   Rudd BD, 2008, J IMMUNOL, V181, P5199, DOI 10.4049/jimmunol.181.8.5199
   Salehi Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159565
   Samoilova EB, 1998, J IMMUNOL, V161, P6480
   Shi GP, 2013, J IMMUNOL, V191, P415, DOI 10.4049/jimmunol.1201732
   Spath S, 2017, IMMUNITY, V46, P245, DOI 10.1016/j.immuni.2017.01.007
   Steelman AJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00520
   Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003
   Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186
   Teixeira B, 2013, CLIN IMMUNOL, V148, P209, DOI 10.1016/j.clim.2013.05.012
   Thwaites R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00001
   Varrin-Doyer M, 2012, ANN NEUROL, V72, P53, DOI 10.1002/ana.23651
   VARTANIAN T, 1995, MOL MED, V1, P732, DOI 10.1007/BF03401888
   Voo KS, 2014, J IMMUNOL, V193, P627, DOI 10.4049/jimmunol.1203334
   Wing AC, 2016, IMMUNOLOGY, V147, P212, DOI 10.1111/imm.12552
   Zastepa E, 2014, NEUROLOGY, V82, P681, DOI 10.1212/WNL.0000000000000146
   Zhen J, 2017, MOL IMMUNOL, V82, P84, DOI 10.1016/j.molimm.2016.12.020
NR 73
TC 7
Z9 7
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD JUN
PY 2018
VL 154
IS 2
BP 239
EP 252
DI 10.1111/imm.12872
PG 14
WC Immunology
SC Immunology
GA GO2HR
UT WOS:000439790700009
PM 29168181
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Neri, V
   Lopes, AB
   Brandao, C
   Leon, SV
   Vasconcelos, CCF
   Alvarenga, MP
   Alvarenga, RMP
AF Neri, V.
   Lopes, A. B.
   Brandao, Co.
   Vieira Leon, S.
   Ferreira Vasconcelos, C. C.
   Papais Alvarenga, M.
   Papais Alvarenga, R. M.
TI Intrathecal IGM synthesis in multiple sclerosis and neuromyelitis optica
   spectrum disorders: Clinical and laboratory analysis
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Meeting Abstract
CT 23rd World Congress of Neurology (WCN)
CY SEP 16-21, 2017
CL Kyoto, JAPAN
SP World Federat Neurol
C1 [Neri, V.; Lopes, A. B.; Vieira Leon, S.; Ferreira Vasconcelos, C. C.; Papais Alvarenga, M.; Papais Alvarenga, R. M.] Univ Fed Estado Rio de Janeiro, Neurol, Rio De Janeiro, Brazil.
   [Brandao, Co.] Univ Estadual Campinas, Neuroimmunol, Campinas, SP, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD OCT 15
PY 2017
VL 381
SU S
MA 2199
BP 790
EP 790
DI 10.1016/j.jns.2017.08.2230
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FZ2YT
UT WOS:000427450303095
DA 2020-12-01
ER

PT J
AU Farinhas, JGD
   Dantas, FLF
   Franca, LC
   de Araujo, AD
   Pereira, VCSR
   Malfetano, FR
   Scherpenhuijzen, SB
   de Oliveira, AP
   Neri, VC
   Alves-Leon, SV
AF Farinhas, J. G. D.
   Dantas, F. L. -F.
   Franca, L. C.
   de Araujo, A. D.
   Pereira, V. C. S. R.
   Malfetano, F. R.
   Scherpenhuijzen, S. B.
   de Oliveira, A. P.
   Neri, V. C.
   Alves-Leon, S. V.
TI Lethality rates in multiple sclerosis and neuromyelitis optic spectrum
   disorders patients in a Brazilian cohort of mixed ancestrality
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Joint
   European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis
   (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Scle
   rosis (ACTRIMS)
CY OCT 25-28, 2017
CL Paris, FRANCE
SP European Comm Treatment & Res Multiple Sclerosis, Americas Comm Treatment & Res Multiple Sclerosis
C1 [Farinhas, J. G. D.; Pereira, V. C. S. R.; Malfetano, F. R.; Scherpenhuijzen, S. B.; de Oliveira, A. P.; Alves-Leon, S. V.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio de Janeiro, Brazil.
   [Farinhas, J. G. D.; Alves-Leon, S. V.] Programa Pos Grad Neurol, Rio De Janeiro, Brazil.
   [Dantas, F. L. -F.; Franca, L. C.] UNIRIO HUGG, Rio De Janeiro, Brazil.
   [de Araujo, A. D.; Neri, V. C.] UNIRIO HUGG, Programa Pos Grad Neurol, Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD OCT
PY 2017
VL 23
SU 3
MA P884
BP 457
EP 458
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FK8AS
UT WOS:000413730203056
DA 2020-12-01
ER

PT J
AU Fontes-Dantas, F
   Araujo, A
   Franca, L
   Farinhas, J
   Paschoal, I
   Barbosa, R
   Nogueira, B
   Abboud, F
   Rego, C
   Pereira, V
   Malfetano, F
   Scherpenhuijzen, S
   Oliveira, A
   Neri, V
   Vasconcelos, C
   Alves-Leon, S
AF Fontes-Dantas, F.
   Araujo, A.
   Franca, L.
   Farinhas, J.
   Paschoal, I.
   Barbosa, R.
   Nogueira, B.
   Abboud, F.
   Rego, C.
   Pereira, V.
   Malfetano, F.
   Scherpenhuijzen, S.
   Oliveira, A.
   Neri, V.
   Vasconcelos, C.
   Alves-Leon, S.
TI A comprehensive in silico analysis of transcripts upregulated in
   multiple scleroses patients and ZIkV infection: identification of
   similar pathways
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Joint
   European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis
   (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Scle
   rosis (ACTRIMS)
CY OCT 25-28, 2017
CL Paris, FRANCE
SP European Comm Treatment & Res Multiple Sclerosis, Americas Comm Treatment & Res Multiple Sclerosis
C1 [Fontes-Dantas, F.; Araujo, A.; Franca, L.; Farinhas, J.; Paschoal, I.; Barbosa, R.; Nogueira, B.; Abboud, F.; Neri, V.; Vasconcelos, C.; Alves-Leon, S.] Univ Fed Estado Rio de Janeiro, Hosp Univ Gaffree & Guinle, Posgrad Neurol, Rio de Janeiro, Brazil.
   [Rego, C.; Pereira, V.; Malfetano, F.; Scherpenhuijzen, S.; Oliveira, A.; Alves-Leon, S.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Neurol, Rio de Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD OCT
PY 2017
VL 23
SU 3
MA EP1607
BP 841
EP 842
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FK8AS
UT WOS:000413730205093
DA 2020-12-01
ER

PT J
AU Diniz, LP
   Tortelli, V
   Matias, I
   Morgado, J
   Araujo, APB
   Melo, HM
   da Silva, GSS
   Alves-Leon, SV
   de Souza, JM
   Ferreira, ST
   De Felice, FG
   Gomes, FCA
AF Diniz, Luan Pereira
   Tortelli, Vanessa
   Matias, Isadora
   Morgado, Juliana
   Bergamo Araujo, Ana Paula
   Melo, Helen M.
   Seixas da Silva, Gisele S.
   Alves-Leon, Soniza V.
   de Souza, Jorge M.
   Ferreira, Sergio T.
   De Felice, Fernanda G.
   Alcantara Gomes, Flavia Carvalho
TI Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against A
   beta Oligomers in Alzheimer's Disease Model
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE Alzheimer's disease; astrocyte; synapse loss; TGF-beta 1
ID RECEPTOR-DEPENDENT MECHANISM; TRANSGENIC ANIMAL-MODEL; TGF-BETA;
   SYNAPTIC PLASTICITY; CNS SYNAPTOGENESIS; MEMORY LOSS;
   HIPPOCAMPAL-NEURONS; SECRETED PROTEINS; AMPA RECEPTORS; MOUSE MODEL
AB Alzheimer's disease (AD) is characterized by progressive cognitive decline, increasingly attributed to neuronal dysfunction induced by amyloid-beta oligomers (A beta Os). Although the impact of A beta Os on neurons has been extensively studied, only recently have the possible effects ofA beta Os on astrocytes begun to be investigated. Given the key roles of astrocytes in synapse formation, plasticity, and function, we sought to investigate the impact ofA beta Os on astrocytes, and to determine whether this impact is related to the deleterious actions ofA beta Os on synapses. Wefound thatA beta Os interact with astrocytes, cause astrocyte activation and trigger abnormal generation of reactive oxygen species, which is accompanied by impairment of astrocyte neuroprotective potential in vitro. We further show that both murine and human astrocyte conditioned media (CM) increase synapse density, reduce A beta Os binding, and prevent A beta O-induced synapse loss in cultured hippocampal neurons. Both a neutralizing anti-transforming growth factor-beta 1 (TGF-beta 1) antibody and siRNA-mediated knockdown of TGF-beta 1, previously identified as an important synaptogenic factor secreted by astrocytes, abrogated the protective action of astrocyteCMagainstA beta O-induced synapse loss. Notably, TGF-beta 1 prevented hippocampal dendritic spine loss and memory impairment in mice that received an intracerebroventricular infusion of A beta Os. Results suggest that astrocyte-derived TGF-beta 1 is part of an endogenous mechanism that protects synapses against A eta Os. By demonstrating that A beta Os decrease astrocyte ability to protect synapses, our results unravel a new mechanism underlying the synaptotoxic action of A beta Os in AD.
C1 [Diniz, Luan Pereira; Tortelli, Vanessa; Matias, Isadora; Morgado, Juliana; Bergamo Araujo, Ana Paula; Alcantara Gomes, Flavia Carvalho] Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Melo, Helen M.; Seixas da Silva, Gisele S.; Ferreira, Sergio T.; De Felice, Fernanda G.] Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza V.; de Souza, Jorge M.] Hosp Univ Clementino Fraga Filho, BR-21941913 Rio De Janeiro, RJ, Brazil.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Seixas da Silva, Gisele S.] Inst Fed Educ Ciencia & Tecnol Rio de Janeiro, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.
RP Gomes, FCA (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM fgomes@icb.ufrj.br
RI Leon, Soniza V Alves/J-7786-2012; Ferreira, Sergio/AAZ-1576-2020; Diniz,
   Luan/AAN-6788-2020; Gomes, Flavia/C-5383-2013
OI Ferreira, Sergio/0000-0001-7160-9866; Diniz, Luan/0000-0002-2986-4043;
   Gomes, Flavia/0000-0003-2966-0638; Marcondes desouza,
   Jorge/0000-0003-2412-8239
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Ministerio da Saude, Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Ministerio da Saude,
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ). We thank Marcelo Meloni and Grasiela Ventura for
   technical assistance.
CR Abbott A, 2011, NATURE, V475, pS2, DOI 10.1038/475S2a
   Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5
   Alarcon R, 2005, J BIOL CHEM, V280, P30406, DOI 10.1074/jbc.M414686200
   Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010
   Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010
   Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059
   Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6
   Bae J.J, 2011, INT J PHYSL PATH PHA, V3, P9
   BEACH TG, 1988, BRAIN RES, V463, P357, DOI 10.1016/0006-8993(88)90410-6
   Beauquis J, 2013, EXP NEUROL, V239, P28, DOI 10.1016/j.expneurol.2012.09.009
   Beraldo FH, 2016, J BIOL CHEM, V291, P21945, DOI 10.1074/jbc.M116.738286
   Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560
   Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189
   Caraci F, 2015, SCI REP-UK, V5, DOI 10.1038/srep11252
   Chalmers KA, 2007, J NEUROPATH EXP NEUR, V66, P158, DOI 10.1097/nen.0b013e3180303b93
   Chen JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116549
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   Ding MZ, 1998, J IMMUNOL, V160, P2560
   Diniz LP, 2014, NEUROCHEM INT, V78, P18, DOI 10.1016/j.neuint.2014.07.008
   Diniz LP, 2014, GLIA, V62, P1917, DOI 10.1002/glia.22713
   Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824
   Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Fisichella V, 2016, EUR J PHARMACOL, V787, P72, DOI 10.1016/j.ejphar.2016.02.002
   Fong SW, 2010, P NATL ACAD SCI USA, V107, P13515, DOI 10.1073/pnas.1001695107
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Fukushima T, 2007, HIPPOCAMPUS, V17, P5, DOI 10.1002/hipo.20243
   Furman JL, 2012, J NEUROSCI, V32, P16129, DOI 10.1523/JNEUROSCI.2323-12.2012
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Graciarena M, 2010, BRAIN BEHAV IMMUN, V24, P1301, DOI 10.1016/j.bbi.2010.06.005
   Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015
   Heupel K, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-25
   Hippius Hanns, 2003, Dialogues Clin Neurosci, V5, P101
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Jo S, 2014, NAT MED, V20, P886, DOI 10.1038/nm.3639
   Juraskova B, 2010, J NUTR HEALTH AGING, V14, P758, DOI 10.1007/s12603-010-0325-1
   Krieglstein K, 2011, TRENDS NEUROSCI, V34, P421, DOI 10.1016/j.tins.2011.06.002
   Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108
   Kulijewicz-Nawrot M, 2012, J ANAT, V221, P252, DOI 10.1111/j.1469-7580.2012.01536.x
   Lacmann A, 2007, NEUROSCIENCE, V150, P647, DOI 10.1016/j.neuroscience.2007.09.046
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   LaFerla FM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006320
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Lee HG, 2006, J NEUROSCI RES, V84, P1856, DOI 10.1002/jnr.21072
   Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200
   Matsunaga W, 2003, NEUROSCI LETT, V342, P129, DOI 10.1016/S0304-3940(03)00240-4
   Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354
   Mocali A, 2004, EXP GERONTOL, V39, P1555, DOI 10.1016/j.exger.2004.07.007
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Nagele RG, 2003, BRAIN RES, V971, P197, DOI 10.1016/S0006-8993(03)02361-8
   Olabarria M, 2010, GLIA, V58, P831, DOI 10.1002/glia.20967
   Orre M, 2014, NEUROBIOL AGING, V35, P2746, DOI 10.1016/j.neurobiolaging.2014.06.004
   Osborn LM, 2016, PROG NEUROBIOL, V144, P121, DOI 10.1016/j.pneurobio.2016.01.001
   Packard M, 2003, NAT REV NEUROSCI, V4, P113, DOI 10.1038/nrn1036
   Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583
   Qiao JP, 2016, GLIA, V64, P240, DOI 10.1002/glia.22926
   Rao KVR, 2013, J NEUROPATH EXP NEUR, V72, P735, DOI 10.1097/NEN.0b013e31829bd082
   Rodriguez-Arellano JJ, 2016, NEUROSCIENCE, V323, P170, DOI 10.1016/j.neuroscience.2015.01.007
   Sanyal S, 2004, NEURON, V41, P845, DOI 10.1016/S0896-6273(04)00152-7
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Sun M, 2010, J NEUROSCI, V30, P6025, DOI 10.1523/JNEUROSCI.0789-10.2010
   Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341
   Tichauer JE, 2014, BRAIN BEHAV IMMUN, V37, P187, DOI 10.1016/j.bbi.2013.12.018
   Ueberham U, 2006, EUR J NEUROSCI, V24, P2327, DOI 10.1111/j.1460-9568.2006.05109.x
   Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017
   Vivien D, 2006, CYTOKINE GROWTH F R, V17, P121, DOI 10.1016/j.cytogfr.2005.09.011
   von Bernhardi R, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00426
   Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838
   Yeh CY, 2011, ASN NEURO, V3, DOI 10.1042/AN20110025
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
   Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182
NR 83
TC 53
Z9 54
U1 1
U2 11
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JUL 12
PY 2017
VL 37
IS 28
BP 6797
EP 6809
DI 10.1523/JNEUROSCI.3351-16.2017
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA FA2VZ
UT WOS:000405300600018
PM 28607171
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Aguiar, TS
   Honorio, GLDF
   Silva, SO
   Coutinho, RA
   da Silva, MM
   Rego, CCD
   de Lima, MASD
   Alves-Leon, SV
AF Aguiar, Tiago Silva
   de Freitas Honorio, Gustavo Lopes
   Silva, Samila Oliveira
   Coutinho, Renan Amaral
   da Silva, Marcos Martins
   da Silva Rego, Claudia Cecilia
   Sales Dantas de Lima, Marco Antonio
   Alves-Leon, Soniza Vieira
TI Epilepsia partialis continua induces transient brain edema
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Editorial Material
ID STATUS EPILEPTICUS
C1 [Aguiar, Tiago Silva; de Freitas Honorio, Gustavo Lopes; Silva, Samila Oliveira; Coutinho, Renan Amaral; da Silva, Marcos Martins; da Silva Rego, Claudia Cecilia; Sales Dantas de Lima, Marco Antonio; Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Fac Med, Hosp Univ Clementino Fraga Filho, Serv Neurol,Dept Clin Med, Rio De Janeiro, RJ, Brazil.
   [da Silva Rego, Claudia Cecilia; Alves-Leon, Soniza Vieira] Univ Fed Estado Rio de Janeiro, Fac Med, Dept Neurol, Rio De Janeiro, RJ, Brazil.
RP Alves-Leon, SV (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Neurol, Rua Rodolpho Paulo Rocco 255,Cidade Univ, BR-21941913 Rio de Janeiro, RJ, Brazil.
EM sonizavleon@globo.com
RI Leon, Soniza V Alves/J-7786-2012
FU FAPERJ - Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ)
FX FAPERJ - Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro.
CR Cartagena AM, 2014, EPILEPSY BEHAV, V33, P24, DOI 10.1016/j.yebeh.2014.02.003
   Chatzikonstantinou A, 2011, EPILEPSY RES, V97, P45, DOI 10.1016/j.eplepsyres.2011.07.002
   Hong KS, 2004, SEIZURE-EUR J EPILEP, V13, P317, DOI 10.1016/j.seizure.2003.08.004
   Mendes A, 2016, SEIZURE-EUR J EPILEP, V38, P63, DOI 10.1016/j.seizure.2016.04.007
NR 4
TC 1
Z9 1
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 2017
VL 75
IS 6
BP 405
EP 406
DI 10.1590/0004-282X20170047
PG 2
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA EZ1MZ
UT WOS:000404476400014
PM 28658412
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Brito-Moreira, J
   Lourenco, MV
   Oliveira, MM
   Ribeiro, FC
   Ledo, JH
   Diniz, LP
   Vital, JFS
   Magdesian, MH
   Melo, HM
   Barros-Aragao, F
   de Souza, JM
   Alves-Leon, SV
   Gomes, FCA
   Clarke, JR
   Figueiredo, CP
   De Felice, FG
   Ferreira, ST
AF Brito-Moreira, Jordano
   Lourenco, Mychael V.
   Oliveira, Mauricio M.
   Ribeiro, Felipe C.
   Ledo, Jose Henrique
   Diniz, Luan P.
   Vital, Juliana F. S.
   Magdesian, Margaret H.
   Melo, Helen M.
   Barros-Aragao, Fernanda
   de Souza, Jorge M.
   Alves-Leon, Soniza V.
   Gomes, Flavia C. A.
   Clarke, Julia R.
   Figueiredo, Claudia P.
   De Felice, Fernanda G.
   Ferreira, Sergio T.
TI Interaction of amyloid- (A) oligomers with neurexin 2 and neuroligin 1
   mediates synapse damage and memory loss in mice
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Alzheimer disease; amyloid (A); brain; neuron; synapse; amyloid
   oligomers; memory; neurexin; neuroligin
ID A-BETA OLIGOMERS; DEPRESSIVE-LIKE BEHAVIOR; LONG-TERM POTENTIATION;
   ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; BRAIN; RECOGNITION;
   INHIBITION; ADHESION; DYSFUNCTION
AB Brain accumulation of the amyloid- protein (A) and synapse loss are neuropathological hallmarks of Alzheimer disease (AD). A oligomers (AOs) are synaptotoxins that build up in the brains of patients and are thought to contribute to memory impairment in AD. Thus, identification of novel synaptic components that are targeted by AOs may contribute to the elucidation of disease-relevant mechanisms. Trans-synaptic interactions between neurexins (Nrxs) and neuroligins (NLs) are essential for synapse structure, stability, and function, and reduced NL levels have been associated recently with AD. Here we investigated whether the interaction of AOs with Nrxs or NLs mediates synapse damage and cognitive impairment in AD models. We found that AOs interact with different isoforms of Nrx and NL, including Nrx2 and NL1. Anti-Nrx2 and anti-NL1 antibodies reduced AO binding to hippocampal neurons and prevented AO-induced neuronal oxidative stress and synapse loss. Anti-Nrx2 and anti-NL1 antibodies further blocked memory impairment induced by AOs in mice. The results indicate that Nrx2 and NL1 are targets of AOs and that prevention of this interaction reduces the deleterious impact of AOs on synapses and cognition. Identification of Nrx2 and NL1 as synaptic components that interact with AOs may pave the way for development of novel approaches aimed at halting synapse failure and cognitive loss in AD.
C1 [Brito-Moreira, Jordano; Lourenco, Mychael V.; Oliveira, Mauricio M.; Ribeiro, Felipe C.; Ledo, Jose Henrique; Vital, Juliana F. S.; Magdesian, Margaret H.; Melo, Helen M.; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [Lourenco, Mychael V.; Oliveira, Mauricio M.; Ribeiro, Felipe C.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [Diniz, Luan P.; Barros-Aragao, Fernanda; Gomes, Flavia C. A.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [de Souza, Jorge M.; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Div Neurosurg, Clementino Fraga Filho Univ Hosp, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [de Souza, Jorge M.; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Div Neurol, Epilepsy Program, Clementino Fraga Filho Univ Hosp, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [Clarke, Julia R.; Figueiredo, Claudia P.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21947902 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21947902 Rio De Janeiro, RJ, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21947902 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Clarke, Julia/AAF-9434-2019; Lourenco, Mychael/AAG-9732-2020; Ribeiro,
   Felipe Campos/W-9758-2019; Ferreira, Sergio/AAZ-1576-2020; Lourenco,
   Mychael/G-2614-2014; Leon, Soniza V Alves/J-7786-2012; Figueiredo,
   Claudia P/F-8424-2012; Gomes, Flavia/C-5383-2013
OI Lourenco, Mychael/0000-0002-1078-0296; Ribeiro, Felipe
   Campos/0000-0003-3028-3307; Ferreira, Sergio/0000-0001-7160-9866;
   Lourenco, Mychael/0000-0002-1078-0296; Figueiredo,
   Claudia/0000-0001-9467-9891; Gomes de Queiroz Barros-Aragao,
   Fernanda/0000-0002-1663-8346; Gomes, Flavia/0000-0003-2966-0638
FU National Institute for Translational Neuroscience (INNT/Brazil);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Human Frontiers Science ProgramHuman
   Frontier Science Program; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ); CAPES
   (Brazil)CAPES
FX This work was supported by grants from National Institute for
   Translational Neuroscience (INNT/Brazil) (to S. T. F.), the Brazilian
   funding agencies Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ) (to S. T. F. and F. G. F.), and the Human Frontiers
   Science Program (to F. G. F.). The authors declare that they have no
   conflicts of interest with the contents of this article.; Supported by
   predoctoral fellowships from CNPq, FAPERJ, or CAPES (Brazil).
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010
   Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011
   Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159
   Bemben MA, 2015, TRENDS NEUROSCI, V38, P496, DOI 10.1016/j.tins.2015.06.004
   Bie BH, 2014, NAT NEUROSCI, V17, P223, DOI 10.1038/nn.3618
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101
   Chen GQ, 2000, NATURE, V408, P975
   Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016
   Choi YB, 2011, NEURON, V70, P468, DOI 10.1016/j.neuron.2011.03.020
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Dachtler J, 2015, BEHAV NEUROSCI, V129, P765, DOI 10.1037/bne0000108
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Dinamarca MC, 2015, BIOCHEM BIOPH RES CO, V466, P66, DOI 10.1016/j.bbrc.2015.08.107
   Dinamarca MC, 2011, BIOCHEMISTRY-US, V50, P8127, DOI 10.1021/bi201246t
   Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824
   Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603
   Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Jiang M, 2017, MOL PSYCHIATR, V22, P375, DOI 10.1038/mp.2016.80
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234
   Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
   Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016
   Lepeta K, 2016, J NEUROCHEM, V138, P785, DOI 10.1111/jnc.13713
   Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011
   Liu A, 2016, J CELL BIOL, V212, P449, DOI 10.1083/jcb.201509023
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200
   Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200
   MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464
   Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011
   MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4
   Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338
   Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102
   Nery AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067194
   Nunomura A, 1999, J NEUROSCI, V19, P1959
   Paula-Lima AC, 2013, J NEUROCHEM, V126, P191, DOI 10.1111/jnc.12304
   SanMartin CD, 2012, NEURODEGENER DIS, V10, P34, DOI 10.1159/000334901
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Shen HT, 2015, STROKE, V46, P2607, DOI 10.1161/STROKEAHA.115.009729
   Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x
   Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0
   Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108
   Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100
   Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Tristan-Clavijo E, 2015, NEUROBIOL AGING, V36, P3171, DOI 10.1016/j.neurobiolaging.2015.09.004
   Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199
   Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010
NR 64
TC 42
Z9 43
U1 1
U2 19
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 5
PY 2017
VL 292
IS 18
BP 7327
EP 7337
DI 10.1074/jbc.M116.761189
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EU1FY
UT WOS:000400761300005
PM 28283575
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU da Silva, GSS
   Melo, HM
   Lourenco, MV
   Silva, NMLE
   de Carvalho, MB
   Alves-Leon, SV
   de Souza, JM
   Klein, WL
   da-Silva, WS
   Ferreira, ST
   De Felice, FG
AF Seixas da Silva, Gisele S.
   Melo, Helen M.
   Lourenco, Mychael V.
   Lyra e Silva, Natalia M.
   de Carvalho, Marcelo B.
   Alves-Leon, Soniza V.
   de Souza, Jorge M.
   Klein, William L.
   da-Silva, Wagner S.
   Ferreira, Sergio T.
   De Felice, Fernanda G.
TI Amyloid- oligomers transiently inhibit AMP-activated kinase and cause
   metabolic defects in hippocampal neurons
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Alzheimer disease; AMP-activated kinase (AMPK); ATP; energy metabolism;
   N-methyl-d-aspartate receptor (NMDA receptor; NMDAR); GLUTs; amyloid-
   oligomers
ID A-BETA OLIGOMERS; GROWTH-FACTOR-I; RECEPTOR-DEPENDENT MECHANISM;
   ALZHEIMERS-DISEASE; PROTEIN-KINASE; INSULIN-RESISTANCE;
   TAU-HYPERPHOSPHORYLATION; GLUCOSE TRANSPORTERS; HYBRID RECEPTORS;
   OXIDATIVE STRESS
AB AMP-activated kinase (AMPK) is a key player in energy sensing and metabolic reprogramming under cellular energy restriction. Several studies have linked impaired AMPK function to peripheral metabolic diseases such as diabetes. However, the impact of neurological disorders, such as Alzheimer disease (AD), on AMPK function and downstream effects of altered AMPK activity on neuronal metabolism have been investigated only recently. Here, we report the impact of A oligomers (AOs), synaptotoxins that accumulate in AD brains, on neuronal AMPK activity. Short-term exposure of cultured rat hippocampal neurons or ex vivo human cortical slices to AOs transiently decreased intracellular ATP levels and AMPK activity, as evaluated by its phosphorylation at threonine residue 172 (AMPK-Thr(P)(172)). The AO-dependent reduction in AMPK-Thr(P)(172) levels was mediated by glutamate receptors of the N-methyl-d-aspartate (NMDA) subtype and resulted in removal of glucose transporters (GLUTs) from the surfaces of dendritic processes in hippocampal neurons. Importantly, insulin prevented the AO-induced inhibition of AMPK. Our results establish a novel toxic impact of AOs on neuronal metabolism and suggest that AO-induced, NMDA receptor-mediated AMPK inhibition may play a key role in early brain metabolic defects in AD.
C1 [Seixas da Silva, Gisele S.; Melo, Helen M.; Lourenco, Mychael V.; Lyra e Silva, Natalia M.; de Carvalho, Marcelo B.; da-Silva, Wagner S.; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Hosp, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Lourenco, Mychael V.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Hosp, Inst Biophys Carlos Chagas Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Hosp, Div Neurol, Epilepsy Program, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [de Souza, Jorge M.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Hosp, Div Neurosurg, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.
RP De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM felice@bioqmed.ufrj.br
RI da Silva, Wagner/A-7835-2008; Lourenco, Mychael/AAG-9732-2020; Ferreira,
   Sergio/AAZ-1576-2020; Lourenco, Mychael/G-2614-2014; Leon, Soniza V
   Alves/J-7786-2012
OI da Silva, Wagner/0000-0002-0001-0386; Lourenco,
   Mychael/0000-0002-1078-0296; Ferreira, Sergio/0000-0001-7160-9866;
   Lourenco, Mychael/0000-0002-1078-0296; 
FU Human Frontiers Science Program (HFSP)Human Frontier Science Program;
   John Simon Guggenheim Foundation; National Institute for Translational
   Neuroscience (INNT/Brazil); Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); CNPqNational
   Council for Scientific and Technological Development (CNPq);
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ)
FX This work was supported by grants from Human Frontiers Science Program
   (HFSP) and John Simon Guggenheim Foundation (to F.G.F.), the National
   Institute for Translational Neuroscience (INNT/Brazil), the Brazilian
   funding agencies Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ) (to S. T. F. and F. G. F.), and pre doctoral
   fellowships from CNPq or FAPERJ (to G. S. S., H. M. M., M. V. L, and N.
   L. S.). W. L. K. is co-founder of Acumen Pharmaceuticals, which has been
   licensed by Northwestern University to develop ADDL technology for AD
   therapeutics and diagnostics.
CR Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010
   Ashrafi G, 2017, NEURON, V93, P606, DOI 10.1016/j.neuron.2016.12.020
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Cidad P, 2004, BIOCHEM J, V384, P629, DOI 10.1042/BJ20040886
   Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112
   Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233
   Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2014, ALZHEIMERS DEMENT, V10, pS26, DOI 10.1016/j.jalz.2013.12.004
   De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   Dineley KT, 2010, J NEUROSCI RES, V88, P2923, DOI 10.1002/jnr.22445
   Dixon-Salazar TJ, 2014, J NEUROSCI, V34, P11844, DOI 10.1523/JNEUROSCI.4642-12.2014
   Duarte AI, 2006, DIABETES, V55, P2863, DOI 10.2337/db06-0030
   Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209
   Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014
   Ghasemi R, 2013, MOL NEUROBIOL, V47, P1045, DOI 10.1007/s12035-013-8404-z
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100
   Grillo CA, 2009, BRAIN RES, V1296, P35, DOI 10.1016/j.brainres.2009.08.005
   Guerrieri D, 2015, ONCOTARGET, V6, P18293, DOI 10.18632/oncotarget.4715
   Hoyer S, 2004, EUR J PHARMACOL, V490, P115, DOI 10.1016/j.ejphar.2004.02.049
   Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108
   Ju TC, 2011, J CELL BIOL, V194, P209, DOI 10.1083/jcb.201105010
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lesne S, 2008, NEUROSCIENCE, V151, P745, DOI 10.1016/j.neuroscience.2007.10.054
   Li J, 2007, STROKE, V38, P2992, DOI 10.1161/STROKEAHA.107.490904
   Liu Y, 2008, FEBS LETT, V582, P359, DOI 10.1016/j.febslet.2007.12.035
   Lopez-Lopez C, 2007, J NEUROSCI, V27, P824, DOI 10.1523/JNEUROSCI.4345-06.2007
   Lourenco MV, 2015, PROG NEUROBIOL, V129, P37, DOI 10.1016/j.pneurobio.2015.03.003
   Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002
   Ma T, 2014, J NEUROSCI, V34, P12230, DOI 10.1523/JNEUROSCI.1694-14.2014
   Madeira C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.52
   Mairet-Coello G, 2013, NEURON, V78, P94, DOI 10.1016/j.neuron.2013.02.003
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   Mochel F, 2012, J BIOL CHEM, V287, P1361, DOI 10.1074/jbc.M111.309849
   Orr AG, 2015, NAT NEUROSCI, V18, P423, DOI 10.1038/nn.3930
   Pamplona R, 2005, J BIOL CHEM, V280, P21522, DOI 10.1074/jbc.M502255200
   Park H, 2012, HUM MOL GENET, V21, P2725, DOI 10.1093/hmg/dds100
   Paula-Lima AC, 2005, NEUROPHARMACOLOGY, V49, P1140, DOI 10.1016/j.neuropharm.2005.06.015
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Ramamurthy Santosh, 2012, Exp Neurobiol, V21, P52, DOI 10.5607/en.2012.21.2.52
   Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36
   Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005
   Saez-Orellana F, 2016, NEUROPHARMACOLOGY, V100, P116, DOI 10.1016/j.neuropharm.2015.04.005
   Saha AK, 2010, DIABETES, V59, P2426, DOI 10.2337/db09-1870
   Sanz JM, 2009, J IMMUNOL, V182, P4378, DOI 10.4049/jimmunol.0803612
   Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460
   SIMPSON IA, 1994, ANN NEUROL, V35, P546, DOI 10.1002/ana.410350507
   Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200
   Son SM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.039
   SOOS MA, 1990, BIOCHEM J, V270, P383, DOI 10.1042/bj2700383
   Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008
   Talantova M, 2013, P NATL ACAD SCI USA, V110, pE2518, DOI 10.1073/pnas.1306832110
   Terni B, 2010, BRAIN PATHOL, V20, P222, DOI 10.1111/j.1750-3639.2009.00266.x
   Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900
   Thornton C, 2011, BIOCHEM J, V434, P503, DOI 10.1042/BJ20101485
   Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010
   Vingtdeux V, 2011, ACTA NEUROPATHOL, V121, P337, DOI 10.1007/s00401-010-0759-x
   Wang JY, 2010, FASEB J, V24, P2066, DOI 10.1096/fj.09-142315
   Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010
   Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565
   Yoon SO, 2012, NEURON, V75, P824, DOI 10.1016/j.neuron.2012.06.024
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182
NR 76
TC 25
Z9 27
U1 0
U2 15
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 5
PY 2017
VL 292
IS 18
BP 7395
EP 7406
DI 10.1074/jbc.M116.753525
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EU1FY
UT WOS:000400761300011
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Dezonne, RS
   Sartore, RC
   Nascimento, JM
   Saia-Cereda, VM
   Romao, LF
   Alves-Leon, SV
   de Souza, JM
   Martins-de-Souza, D
   Rehen, SK
   Gomes, FCA
AF Dezonne, Romulo Sperduto
   Sartore, Rafaela Costa
   Nascimento, Juliana Minardi
   Saia-Cereda, Veronica M.
   Romao, Luciana Ferreira
   Alves-Leon, Soniza Vieira
   de Souza, Jorge Marcondes
   Martins-de-Souza, Daniel
   Rehen, Stevens Kastrup
   Alcantara Gomes, Flvia Carvalho
TI Derivation of Functional Human Astrocytes from Cerebral Organoids
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PLURIPOTENT STEM-CELLS; HORMONE-TREATED ASTROCYTES; RADIAL GLIAL-CELLS;
   GROWTH-FACTOR; THYROID-HORMONE; CORTICAL-NEURONS; PROGENITOR CELLS;
   GAP-JUNCTIONS; SPINAL-CORD; HUMAN BRAIN
AB Astrocytes play a critical role in the development and homeostasis of the central nervous system (CNS). Astrocyte dysfunction results in several neurological and degenerative diseases. However, a major challenge to our understanding of astrocyte physiology and pathology is the restriction of studies to animal models, human post-mortem brain tissues, or samples obtained from invasive surgical procedures. Here, we report a protocol to generate human functional astrocytes from cerebral organoids derived from human pluripotent stem cells. The cellular isolation of cerebral organoids yielded cells that were morphologically and functionally like astrocytes. Immunolabelling and proteomic assays revealed that human organoid-derived astrocytes express the main astrocytic molecular markers, including glutamate transporters, specific enzymes and cytoskeletal proteins. We found that organoid-derived astrocytes strongly supported neuronal survival and neurite outgrowth and responded to ATP through transient calcium wave elevations, which are hallmarks of astrocyte physiology. Additionally, these astrocytes presented similar functional pathways to those isolated from adult human cortex by surgical procedures. This is the first study to provide proteomic and functional analyses of astrocytes isolated from human cerebral organoids. The isolation of these astrocytes holds great potential for the investigation of developmental and evolutionary features of the human brain and provides a useful approach to drug screening and neurodegenerative disease modelling.
C1 [Dezonne, Romulo Sperduto; Sartore, Rafaela Costa; Romao, Luciana Ferreira; Rehen, Stevens Kastrup; Alcantara Gomes, Flvia Carvalho] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, RJ, Brazil.
   [Sartore, Rafaela Costa; Nascimento, Juliana Minardi; Rehen, Stevens Kastrup] Inst DOr Pesquisa & Ensino IDOR, Rio De Janeiro, RJ, Brazil.
   [Nascimento, Juliana Minardi; Saia-Cereda, Veronica M.; Martins-de-Souza, Daniel] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil.
   [Romao, Luciana Ferreira] Univ Fed Rio de Janeiro, Campus Xerem, Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza Vieira; de Souza, Jorge Marcondes] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, RJ, Brazil.
RP Gomes, FCA (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, RJ, Brazil.
EM fgomes@icb.ufrj.br
RI Leon, Soniza V Alves/J-7786-2012; Martins-de-Souza, Daniel/E-7021-2010;
   Rehen, Stevens K/J-5874-2012; Gomes, Flavia/C-5383-2013; Nascimento,
   Juliana/B-8764-2009
OI Martins-de-Souza, Daniel/0000-0003-3595-5846; Rehen, Stevens
   K/0000-0003-4216-9501; Sartore, Rafaela/0000-0002-1801-8650; Gomes,
   Flavia/0000-0003-2966-0638; Nascimento, Juliana/0000-0003-3126-4984
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   JaneiroCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Conselho
   Nacional para o Desenvolvimento Cientifico e Tecnologico; CNPqNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; CAPESCAPES;
   Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [13/08711-3, 14/10068-4,
   14/21035-0, 16/07332-7]
FX This work was supported by grants from Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ, ( F.C.A. G.;
   R.S.D; S.R.); Conselho Nacional para o Desenvolvimento Cientifico e
   Tecnologico, CNPq, ( F.C.A.G.; S.R.; R.C.S.); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior, CAPES, ( F.C.A.G.);
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP (grants
   13/08711-3, 14/10068-4, 14/21035-0 and 16/07332-7), ( J.M.; D.S).
CR Acker T, 2001, MECH DEVELOP, V108, P45, DOI 10.1016/S0925-4773(01)00471-3
   Allen NJ, 2014, ANNU REV CELL DEV BI, V30, P439, DOI 10.1146/annurev-cellbio-100913-013053
   Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059
   Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912
   Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105
   Anton ES, 1997, DEVELOPMENT, V124, P3501
   BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847
   Barry G, 2008, J NEUROSCI, V28, P12328, DOI 10.1523/JNEUROSCI.4000-08.2008
   Bernstein HG, 2015, SCHIZOPHR RES, V161, P4, DOI 10.1016/j.schres.2014.03.035
   BIGNAMI A, 1974, NATURE, V252, P55, DOI 10.1038/252055a0
   Buosi AS, 2018, MOL NEUROBIOL, V55, P751, DOI 10.1007/s12035-016-0343-z
   CHAMAK B, 1987, J NEUROSCI, V7, P3163
   Chen C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5430
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Cirillo G, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/425818
   Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484
   CULICAN SM, 1990, J NEUROSCI, V10, P684
   DAHL D, 1981, J NEUROSCI RES, V6, P741, DOI 10.1002/jnr.490060608
   Spohr TCLDE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00296
   DeGroot CJA, 1997, J NEUROSCI RES, V49, P342, DOI 10.1002/(SICI)1097-4547(19970801)49:3<342::AID-JNR9>3.0.CO;2-C
   Dezonne RS, 2015, J NEUROENDOCRINOL, V27, P435, DOI 10.1111/jne.12283
   Dezonne RS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00125
   Diniz LP, 2014, NEUROCHEM INT, V78, P18, DOI 10.1016/j.neuint.2014.07.008
   Diniz LP, 2014, GLIA, V62, P1917, DOI 10.1002/glia.22713
   Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824
   Distler U, 2014, NAT METHODS, V11, P167, DOI [10.1038/nmeth.2767, 10.1038/NMETH.2767]
   Dou CL, 2000, MOL CELL BIOL, V20, P6201, DOI 10.1128/MCB.20.17.6201-6211.2000
   Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007
   Emborg ME, 2013, CELL REP, V3, P646, DOI 10.1016/j.celrep.2013.02.016
   Emdad L, 2012, STEM CELLS DEV, V21, P404, DOI 10.1089/scd.2010.0560
   ENG LF, 1992, PROG BRAIN RES, V94, P353
   ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1
   ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x
   Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612
   FAIVREBAUMAN A, 1984, NEUROSCI LETT, V44, P83, DOI 10.1016/0304-3940(84)90225-8
   Fraga AM, 2011, CELL TRANSPLANT, V20, P431, DOI 10.3727/096368910X522261
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Ghashghaei HT, 2007, GENE DEV, V21, P3258, DOI 10.1101/gad.1580407
   Giger RJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001867
   Gomes FCA, 1999, GLIA, V26, P97
   Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015
   Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962
   Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673
   HUNTER KE, 1995, P NATL ACAD SCI USA, V92, P2061, DOI 10.1073/pnas.92.6.2061
   Juopperi TA, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-17
   Kojima T, 2007, AM J PATHOL, V170, P764, DOI 10.2353/ajpath.2007.060487
   Kornyei Z, 2007, FASEB J, V21, P2496, DOI 10.1096/fj.06-7756com
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Spohr TCLDE, 2012, J NEUROSCI RES, V90, P1892, DOI 10.1002/jnr.23076
   Spohr TCLDE, 2011, J NEUROCHEM, V119, P113, DOI 10.1111/j.1471-4159.2011.07421.x
   Li H, 2008, GLIA, V56, P646, DOI 10.1002/glia.20643
   Lind BL, 2013, P NATL ACAD SCI USA, V110, pE4678, DOI 10.1073/pnas.1310065110
   Liu SH, 2017, CEREB CORTEX, V27, P3152, DOI 10.1093/cercor/bhw169
   Lu JF, 2013, CELL REP, V3, P1580, DOI 10.1016/j.celrep.2013.04.004
   Martinez R, 2002, J BIOL CHEM, V277, P49311, DOI 10.1074/jbc.M209284200
   Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194
   Mendes-de-Aguiar CBN, 2008, J NEUROSCI RES, V86, P3117, DOI 10.1002/jnr.21755
   Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004
   Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3
   Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009
   Orellana JA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00193
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Pennypacker K, 1997, HISTOL HISTOPATHOL, V12, P1125
   PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X
   Rouach N, 2006, EUR J NEUROSCI, V23, P1453, DOI 10.1111/j.1460-9568.2006.04671.x
   Sakurai K, 2008, J NEUROSCI, V28, P4604, DOI 10.1523/JNEUROSCI.5074-07.2008
   Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009
   Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100
   Shibata T, 1997, J NEUROSCI, V17, P9212
   Shigetomi E, 2016, TRENDS CELL BIOL, V26, P300, DOI 10.1016/j.tcb.2016.01.003
   Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019
   Sochacki J, 2016, STEM CELL RES, V17, P97, DOI 10.1016/j.scr.2016.05.017
   Spohr TCDSE, 2008, J BIOL CHEM, V283, P7470, DOI 10.1074/jbc.M707758200
   Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036
   Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5
   VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106
   XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7
   Yang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6627
   Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7
   Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013
NR 84
TC 32
Z9 32
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 27
PY 2017
VL 7
AR 45091
DI 10.1038/srep45091
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EQ1IT
UT WOS:000397824100001
PM 28345587
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Aguiar, TS
   Fragoso, A
   de Albuquerque, CR
   Teixeira, PD
   de Souza, MVL
   Zajdenverg, L
   Alves-Leon, SV
   Rodacki, M
   de Lima, MASD
AF Aguiar, Tiago Silva
   Fragoso, Andrea
   Rouanet de Albuquerque, Carolina
   Teixeira, Patrcia de Fatima
   Leitao de Souza, Marcus Vincius
   Zajdenverg, Lenita
   Alves-Leon, Soniza Vieira
   Rodacki, Melanie
   Sales Dantas de Lima, Marco Antonio
TI Clinical characteristics of patients with cerebellar ataxia associated
   with anti-GAD antibodies
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE autoimmunity; cerebellar ataxia; diabetes mellitus
ID GLUTAMIC-ACID DECARBOXYLASE; STIFF PERSON SYNDROME; AUTOANTIBODIES;
   DISORDERS; NYSTAGMUS; SPECTRUM; DISEASE
AB The enzyme glutamic acid decarboxylase (GAD), present in GABAergic neurons and in pancreatic beta cells, catalyzes the conversion of gamma-aminobutyric acid (GABA). The cerebellum is highly susceptible to immune-mediated mechanisms, with the potentially treatable autoimmune cerebellar ataxia associated with the GAD antibody (CA-GAD-ab) being a rare, albeit increasingly detected condition. Few cases of CA-GAD-ab have been described. Methods: This retrospective and descriptive study evaluated the clinical characteristics and outcomes of patients with CA-GAD-ab. Result: Three patients with cerebellar ataxia, high GAD-ab titers and autoimmune endocrine disease were identified. Patients 1 and 2 had classic stiff person syndrome and insidious-onset cerebellar ataxia, while Patient 3 had pure cerebellar ataxia with subacute onset. Patients received intravenous immunoglobulin therapy with no response in Patients 1 and 3 and partial recovery in Patient 2. Conclusion: CA-GAD-ab is rare and its clinical presentation may hamper diagnosis. Clinicians should be able to recognize this potentially treatable autoimmune cerebellar ataxia.
C1 [Aguiar, Tiago Silva; Rouanet de Albuquerque, Carolina; Alves-Leon, Soniza Vieira; Sales Dantas de Lima, Marco Antonio] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Fac Med, Dept Clin Med,Serv Neurol, Rio De Janeiro, Brazil.
   [Fragoso, Andrea; Rodacki, Melanie] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Fac Med, Dept Clin Med,Serv Netrol, Rio De Janeiro, Brazil.
   [Teixeira, Patrcia de Fatima; Leitao de Souza, Marcus Vincius] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Fac Med, Dept Clin Med,Serv Endocrinol, Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Estado Rio Janeiro, Fac Med, Dept Neurol, Rio De Janeiro, RJ, Brazil.
RP de Lima, MASD (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Neurol, Rua Rodolpho Paulo Rocco 255, BR-21941913 Rio de Janeiro, Brazil.
EM masdlima@gmail.com
RI Leon, Soniza V Alves/J-7786-2012
OI Souza, Marcus/0000-0002-9901-6138
FU Rio de Janeiro State Foundation (FAPERJ - Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro)
FX Rio de Janeiro State Foundation for the Support of Research (FAPERJ -
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro).
CR Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081
   Ances BM, 2005, AM J OPHTHALMOL, V140, P142, DOI 10.1016/j.ajo.2004.12.052
   Antonini G, 2003, J NEUROL NEUROSUR PS, V74, P998, DOI 10.1136/jnnp.74.7.998
   Arino H, 2014, JAMA NEUROL, V71, P1009, DOI 10.1001/jamaneurol.2014.1011
   Balint B, 2016, CURR OPIN NEUROL, V29, P496, DOI 10.1097/WCO.0000000000000351
   Barker RA, 1998, J NEUROL NEUROSUR PS, V65, P633, DOI 10.1136/jnnp.65.5.633
   Betterle C, 2004, CLIN EXP IMMUNOL, V137, P225, DOI 10.1111/j.1365-2249.2004.02561.x
   Dalakas MC, 2009, CURR TREAT OPTION NE, V11, P102, DOI 10.1007/s11940-009-0013-9
   Dogan VB, 2015, NEUROL SCI, V36, P1929, DOI 10.1007/s10072-015-2280-4
   Dubbioso R, 2013, J NEUROL, V260, P2675, DOI 10.1007/s00415-013-7110-0
   Fenalti G, 2010, AUTOIMMUN REV, V9, P148, DOI 10.1016/j.autrev.2009.05.003
   Fernandes M, 2012, ARQ NEURO-PSIQUIAT, V70, P657, DOI 10.1590/S0004-282X2012000900002
   Gordon CR, 2007, NEUROLOGY, V68, P1161, DOI 10.1212/01.wnl.0000261162.61360.a2
   Honnorat J, 2001, ARCH NEUROL-CHICAGO, V58, P225, DOI 10.1001/archneur.58.2.225
   Ishida K, 2007, J NEUROL NEUROSUR PS, V78, P190, DOI 10.1136/jnnp.2006.091116
   LORISH TR, 1989, MAYO CLIN PROC, V64, P629, DOI 10.1016/S0025-6196(12)65339-7
   Manto MU, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-3
   Manto MU, 2007, ANN NEUROL, V61, P544, DOI 10.1002/ana.21123
   Mitoma H, 2016, CEREBELLUM, V15, P213, DOI 10.1007/s12311-015-0664-x
   Mitoma Hiroshi, 2015, Cerebellum Ataxias, V2, P14, DOI 10.1186/s40673-015-0034-y
   Nanri K, 2013, CEREBELLUM, V12, P171, DOI 10.1007/s12311-012-0411-5
   Nanri K, 2009, INTERNAL MED, V48, P783, DOI 10.2169/internalmedicine.48.1802
   Pedroso JL, 2011, ARQ NEURO-PSIQUIAT, V69, P993, DOI 10.1590/S0004-282X2011000700030
   Rakocevic G, 2006, NEUROLOGY, V67, P1068, DOI 10.1212/01.wnl.0000237558.83349.d0
   Saiz A, 2008, BRAIN, V131, P2553, DOI 10.1093/brain/awn183
   Tilikete C, 2005, ANN NY ACAD SCI, V1039, P446, DOI 10.1196/annals.1325.042
   Tilikete C, 2005, ARCH NEUROL-CHICAGO, V62, P1300, DOI 10.1001/archneur.62.8.1300
   Vale TC, 2015, J NEUROL SCI, V359, P21, DOI 10.1016/j.jns.2015.10.024
   Vianello M, 2003, CEREBELLUM, V2, P77, DOI 10.1080/14734220309432
   Vianello M, 2002, NEUROL SCI, V23, P145, DOI 10.1007/s100720200055
NR 30
TC 2
Z9 3
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD MAR
PY 2017
VL 75
IS 3
BP 142
EP 146
DI 10.1590/0004-282X20170011
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA EQ2BL
UT WOS:000397873200003
PM 28355320
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Correa, DG
   Ventura, N
   Zimmermann, N
   Doring, TM
   Tukamoto, G
   Leme, J
   Pereira, M
   D'Andrea, I
   Rego, C
   Alves-Leon, SV
   Gasparetto, EL
AF Correa, D. G.
   Ventura, N.
   Zimmermann, N.
   Doring, T. M.
   Tukamoto, G.
   Leme, J.
   Pereira, M.
   D'Andrea, I.
   Rego, C.
   Alves-Leon, S. V.
   Gasparetto, E. L.
TI Evaluation of deep gray matter volume, cortical thickness and white
   matter integrity in patients with typical absence epilepsy: a study
   using voxelwise-based techniques
SO NEURORADIOLOGY
LA English
DT Article
DE Absence epilepsy; Magnetic resonance imaging; Cortical thickness;
   Diffusion tensor imaging
ID IDIOPATHIC GENERALIZED EPILEPSY; HUMAN CEREBRAL-CORTEX; SEIZURES;
   DIFFUSION; CHILDHOOD; CLASSIFICATION; BRAIN; CHILDREN; TERMINOLOGY;
   MORPHOMETRY
AB Introduction The objective of this study was to evaluate the cortical thickness and the volume of deep gray matter structures, measured from 3D T1-weighted gradient echo imaging, and white matter integrity, by diffusion tensor imaging (DTI) in patients with typical absence epilepsy (AE).
   Methods Patients (n = 19) with typical childhood AE and juvenile AE, currently taking antiepileptic medication, were compared with control subjects (n = 19), matched for gender and age. 3D T1 magnetization-prepared rapid gradient echo-weighted imaging and DTI along 30 noncolinear directions were performed using a 1.5-T MR scanner. FreeSurfer was used to perform cortical volumetric reconstruction and segmentation of deep gray matter structures. For tract-based spatial statistics analysis of DTI, a white matter skeleton was created, along with a permutation-based inference with 5000 permutations. A threshold of p < 0.05 was used to identify abnormalities in fractional anisotropy (FA). The mean, radial, and axial diffusivities were also projected onto the mean FA skeleton.
   Results Patients with AE presented decreased FA and increased mean diffusivity and radial diffusivity values in the genu and the body of the corpus callosum and right anterior corona radiata, as well as decreased axial diffusivity in the left posterior thalamic radiation, inferior cerebellar peduncle, right cerebral peduncle, and right corticospinal tract. However, there were no significant differences in cortical thickness or deep gray matter structure volumes between patients with AE and controls.
   Conclusion Abnormalities found in white matter integrity may help to better understand the pathophysiology of AE and optimize diagnosis and treatment strategies.
C1 [Correa, D. G.; Ventura, N.; Zimmermann, N.; Tukamoto, G.; Leme, J.; Pereira, M.; Gasparetto, E. L.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Radiol, Rua Rodolpho Paulo Rocco 255,Cidade Univ, BR-21941913 Rio De Janeiro, RJ, Brazil.
   [Correa, D. G.; Ventura, N.; Doring, T. M.; Tukamoto, G.; Gasparetto, E. L.] CDPI, Rio De Janeiro, Brazil.
   [Zimmermann, N.] Pontif Cathol Univ Rio De Janeiro, Dept Psychol, Porto Alegre, RS, Brazil.
   [D'Andrea, I.; Rego, C.; Alves-Leon, S. V.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Epilepsy Ctr, Dept Neurol, Rio De Janeiro, Brazil.
RP Correa, DG (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Radiol, Rua Rodolpho Paulo Rocco 255,Cidade Univ, BR-21941913 Rio De Janeiro, RJ, Brazil.; Correa, DG (corresponding author), CDPI, Rio De Janeiro, Brazil.
EM diogogoulartcorrea@yahoo.com.br
RI Correa, Diogo/AAZ-1590-2020; Leon, Soniza V Alves/J-7786-2012
OI ZIMMERMANN, NICOLLE/0000-0003-4771-4070
CR Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x
   Bernhardt BC, 2009, NEUROIMAGE, V46, P373, DOI 10.1016/j.neuroimage.2009.01.055
   Betting LE, 2006, NEUROIMAGE, V32, P498, DOI 10.1016/j.neuroimage.2006.04.174
   Betting LE, 2006, EPILEPSY BEHAV, V8, P575, DOI 10.1016/j.yebeh.2006.02.002
   Blumenfeld H, 2005, PROG BRAIN RES, V150, P271, DOI 10.1016/S0079-6123(05)50020-7
   Braga AMD, 2015, EPILEPSIA, V56, P1803, DOI 10.1111/epi.13205
   Caplan R, 2009, EPILEPSIA, V50, P2466, DOI 10.1111/j.1528-1167.2009.02198.x
   Chahboune H, 2009, NEUROIMAGE, V47, P459, DOI 10.1016/j.neuroimage.2009.04.060
   Chan CH, 2006, EPILEPSIA, V47, P399, DOI 10.1111/j.1528-1167.2006.00435.x
   Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308
   Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021
   Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x
   Engel J, 2006, EPILEPSIA, V47, P1558, DOI 10.1111/j.1528-1167.2006.00215.x
   Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X
   Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797
   Gaillard WD, 2009, EPILEPSIA, V50, P2147, DOI 10.1111/j.1528-1167.2009.02075.x
   Guerrini R, 1998, EPILEPSIA, V39, P27, DOI 10.1111/j.1528-1157.1998.tb01270.x
   Guilhoto LMFF, 2003, ARQ NEURO-PSIQUIAT, V61, P580, DOI 10.1590/S0004-282X2003000400010
   Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510
   HOLMES GL, 1987, ANN NEUROL, V21, P268, DOI 10.1002/ana.410210308
   Holmes MD, 2004, EPILEPSIA, V45, P1568, DOI 10.1111/j.0013-9580.2004.23204.x
   Kim JB, 2014, EPILEPSIA, V55, P592, DOI 10.1111/epi.12580
   Luo C, 2011, EPILEPSIA, V52, P1092, DOI 10.1111/j.1528-1167.2011.03045.x
   Marsh ED, 2006, EPILEPSIA, V47, P1999, DOI 10.1111/j.1528-1167.2006.00894.x
   Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371
   Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002
   Panayiotopoulos CP, 2008, EPILEPSIA, V49, P2131, DOI 10.1111/j.1528-1167.2008.01777.x
   Pardoe H, 2008, NEUROIMAGE, V42, P611, DOI 10.1016/j.neuroimage.2008.05.007
   Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023
   Seidenbecher T, 1998, EUR J NEUROSCI, V10, P1103, DOI 10.1046/j.1460-9568.1998.00123.x
   Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061
   Stoeter P, 2008, CLIN NEURORADIOL, V18, P155, DOI 10.1007/s00062-008-8019-3
   Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x
   Wirrell EC, 2003, CAN J NEUROL SCI, V30, P184, DOI 10.1017/S0317167100002560
   Yang TH, 2012, EPILEPSY RES, V99, P267, DOI 10.1016/j.eplepsyres.2011.12.006
NR 37
TC 7
Z9 7
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0028-3940
EI 1432-1920
J9 NEURORADIOLOGY
JI Neuroradiology
PD MAR
PY 2017
VL 59
IS 3
BP 237
EP 245
DI 10.1007/s00234-017-1782-6
PG 9
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA EQ4FN
UT WOS:000398030700005
PM 28083644
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Adoni, T
   Alves-Leon, SV
   Apostolos-Pereira, SL
   Arruda, WO
   Brooks, JBB
   Cal, HSR
   Damasceno, CAA
   Gama, PD
   Goncalves, MVM
   de Jesus, CAD
   Machado, SCN
   Mansur, LF
   Matta, APD
   Mendes, MF
   Morales, RR
   da Nobrega, AW
   Parolin, MKF
   Peres, MP
   Ribeiro, MD
   Ruocco, HH
   Scherpenhuijzen, S
   Siquinelli, F
   Stoney, PN
   Varela, DL
   Eboni, ACB
   Spessotto, CV
   da Rocha, ET
   Lacerda, PE
AF Fragoso, Yara Dadalti
   Adoni, Torso
   Alves-Leon, Soniza Vieira
   Apostolos-Pereira, Samira L.
   Arruda, Walter Oleschko
   Bidin Brooks, Joseph B.
   Rodrigues Cal, Henrique S.
   Albuquerque Damasceno, Carlos A.
   Gama, Paulo Diniz
   Magno Goncalves, Marcus V.
   da Silva de Jesus, Carlos A.
   Nunes Machado, Suzana C.
   Mansur, Leticia Fezer
   da Cunha Matta, Andre P.
   Mendes, Maria Fernanda
   Morales, Rogerio Rizo
   da Nobrega-, Adaucto Wanderley, Jr.
   Fiuza Parolin, Monica K.
   Peres, Mario Pietro
   Ribeiro, Marlise de Castro
   Ruocco, Heloisa Helena
   Scherpenhuijzen, Simone
   Siquinelli, Fabio
   Stoney, Patrick N.
   Varela, Daniel Lima
   Biondo Eboni, Audred Cristina
   Spessotto, Caroline Vieira
   da Rocha, Elisa Teixeira
   Lacerda, Pamela Emanuele
TI No correlation was observed between vitamin D levels and disability of
   patients with multiple sclerosis between latitudes 18 degrees and 30
   degrees South
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE vitamin D; multiple sclerosis; latitude
ID D SUPPLEMENTATION; SUN EXPOSURE; SYSTEMATIC REVIEWS; RISK-FACTORS;
   RELAPSE RATE; ASSOCIATION; METAANALYSES; INFLAMMATION; SUNLIGHT; DISEASE
AB Objective: Vitamin D has taken center stage in research and treatment of multiple sclerosis (MS). The objective of the present study was to assess the serum vitamin D levels of a large population of patients with MS and controls living in a restricted tropical area. Methods: Data from 535 patients with MS and 350 control subjects were obtained from 14 cities around the Tropic of Capricorn. Results: The mean serum 25-OH vitamin D level was 26.07 +/- 10.27 ng/mL for the control subjects, and 28.03 +/- 12.19 ng/mL for patients with MS. No correlation was observed between vitamin D levels and the disability of patients over the disease duration. Conclusion: At least for the region around the Tropic of Capricorn, serum levels of vitamin D typically are within the range of 20 to 30 ng/mL for controls and patients with MS.
C1 [Fragoso, Yara Dadalti; Bidin Brooks, Joseph B.; Spessotto, Caroline Vieira] Univ Metropolitana Santos, Dept Neurol, Santos, SP, Brazil.
   [Adoni, Torso] Hosp Sirio Libanes, Dept Neurol, Sao Paulo, SP, Brazil.
   [Alves-Leon, Soniza Vieira; Scherpenhuijzen, Simone] Univ Fed Rio de Janeiro, Dept Neurol, Rio De Janeiro, RJ, Brazil.
   [Apostolos-Pereira, Samira L.] Univ Sao Paulo, Dept Neurol, Sao Paulo, SP, Brazil.
   [Arruda, Walter Oleschko] Univ Fed Parana, Dept Neurol, Curitiba, Parana, Brazil.
   [Rodrigues Cal, Henrique S.] Univ Fed Fluminense, Dept Neurol, Niteroi, RJ, Brazil.
   [Albuquerque Damasceno, Carlos A.; da Rocha, Elisa Teixeira; Lacerda, Pamela Emanuele] Univ Fed Juiz de Fora, Dept Neurol, Juiz De Fora, MG, Brazil.
   [Gama, Paulo Diniz] Pontificia Univ Catolica, Dept Neurol, Sorocaba, SP, Brazil.
   [Magno Goncalves, Marcus V.; Biondo Eboni, Audred Cristina] Ctr Hosp Unimed, Dept Neurol, Joinville, SC, Brazil.
   [da Silva de Jesus, Carlos A.; Peres, Mario Pietro] Univ Fed Sao Paulo, Dept Neurol, Sao Paulo, SP, Brazil.
   [Nunes Machado, Suzana C.; da Nobrega-, Adaucto Wanderley, Jr.] Hosp Caridade, Dept Neurol, Florianopolis, SC, Brazil.
   [Mendes, Maria Fernanda] Clin Neurol Sao Paulo, Dept Neurol, Sao Paulo, SP, Brazil.
   [Morales, Rogerio Rizo] Univ Fed Uberlandia, Dept Neurol, Uberlandia, MG, Brazil.
   [Fiuza Parolin, Monica K.] Clin Neurol Curitiba, Dept Neurol, Curitiba, Parana, Brazil.
   [Ribeiro, Marlise de Castro] Univ Fed Ciencias Saude Porto Alegre, Dept Neurol, Porto Alegre, RS, Brazil.
   [Ruocco, Heloisa Helena] Univ Jundiai, Dept Neurol, Jundiai, SP, Brazil.
   [Siquinelli, Fabio] Univ Reg Blumenau, Dept Neurol, Blumenau, SC, Brazil.
   [Stoney, Patrick N.] Univ Aberdeen, Inst Med Sci, Aberdeen AB9 1FX, Scotland.
   [Varela, Daniel Lima] Serv Neurol & Neurocirurgia Passo Fundo, Dept Neurol, Passo Fundo, RS, Brazil.
RP Fragoso, YD (corresponding author), Univ Metropolitana Santos, Dept Neurol, Fac Med, Rua Constituicao 374, BR-11015470 Santos, SP, Brazil.
EM yara@bsnet.com.br
RI Mendes, Maria Fernanda/AAQ-1170-2020; Leon, Soniza V Alves/J-7786-2012;
   Peres, Mario/U-6148-2019; Arruda, Walter Oleschko/AAJ-8256-2020
OI Peres, Mario/0000-0002-0068-1905; 
CR Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7
   Becker J, 2016, J NEUROL SCI, V363, P236, DOI 10.1016/j.jns.2016.02.064
   Belbasis L, 2015, LANCET NEUROL, V14, P263, DOI 10.1016/S1474-4422(14)70267-4
   Brenton JN, 2014, MULT SCLER RELAT DIS, V3, P684, DOI 10.1016/j.msard.2014.07.004
   Byrne SN, 2014, PHOTOCH PHOTOBIO SCI, V13, P840, DOI 10.1039/c4pp00051j
   Calton EK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141770
   Cree BAC, 2014, HAND CLINIC, V122, P193, DOI 10.1016/B978-0-444-52001-2.00009-1
   Espinosa-Ramirez G, 2014, NEUROL RES, V36, P647, DOI 10.1179/1743132813Y.0000000307
   Fitzgerald KC, 2015, JAMA NEUROL, V72, P1458, DOI 10.1001/jamaneurol.2015.2742
   Fragoso YD, 2014, ARQ NEURO-PSIQUIAT, V72, P889, DOI 10.1590/0004-282X20140159
   Fragoso YD, 2014, CNS DRUGS, V28, P291, DOI 10.1007/s40263-014-0148-4
   Galland L, 2014, J MED FOOD, V17, P1261, DOI 10.1089/jmf.2014.7000
   Glendenning P, 2016, CRIT REV CL LAB SCI, V53, P13, DOI 10.3109/10408363.2015.1074157
   Hart PH, 2012, DISCOV MED, V13, P397
   Heydarpour P, 2014, NEUROEPIDEMIOLOGY, V43, P233, DOI 10.1159/000368553
   Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385
   Hollenbach JA, 2015, J AUTOIMMUN, V64, P13, DOI 10.1016/j.jaut.2015.06.010
   Institute of Medicine Food and Nutrition Board, 2010, DIETARY REFERENCE IN
   Jagannath VA, 2010, COCHRANE DB SYST REV, V12
   James E, 2013, MULT SCLER J, V19, P1571, DOI 10.1177/1352458513489756
   Kuhle J, 2015, MULT SCLER J, V21, P1013, DOI 10.1177/1352458514568827
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Liu J, 2012, PHOTOCH PHOTOBIO SCI, V11, P1802, DOI 10.1039/c2pp25150g
   Loken-Amsrud KI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054417
   Lucas RM, 2011, NEUROLOGY, V76, P540, DOI 10.1212/WNL.0b013e31820af93d
   Lucas RM, 2015, NEURODEGENER DIS MAN, V5, P413, DOI 10.2217/nmt.15.33
   Mowry EM, 2012, ANN NEUROL, V72, P234, DOI 10.1002/ana.23591
   Muris AH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156122
   Nikanfar M, 2015, IRAN J NEUROL, V14, P17
   Osmola-Mankowska A, 2012, ANN AGR ENV MED, V19, P805
   Pakpoor J, 2015, CURR TOP BEHAV NEURO, V26, P105, DOI 10.1007/7854_2014_358
   Pierrot-Deseilligny C, 2012, THER ADV NEUROL DISO, V5, P187, DOI 10.1177/1756285612447090
   Rito Y, 2016, MULT SCLER J, V22, P126, DOI 10.1177/1352458515576986
   Rosjo E, 2015, J NEUROL, V262, P2713, DOI 10.1007/s00415-015-7902-5
   Rosjo E, 2014, J NEUROIMMUNOL, V271, P60, DOI 10.1016/j.jneuroim.2014.03.014
   Scott TF, 2013, J NEUROL SCI, V330, P27, DOI 10.1016/j.jns.2013.03.020
   Shirvani-Farsani Z, 2015, LIFE SCI, V134, P63, DOI 10.1016/j.lfs.2015.05.017
   Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043
   Stein MS, 2011, NEUROLOGY, V77, P1611, DOI 10.1212/WNL.0b013e3182343274
   Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035
   Thouvenot E, 2015, EUR J NEUROL, V22, P564, DOI 10.1111/ene.12617
   Zivadinov R, 2013, J NEUROL NEUROSUR PS, V84, P1075, DOI 10.1136/jnnp-2012-304661
NR 42
TC 3
Z9 3
U1 0
U2 4
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JAN
PY 2017
VL 75
IS 1
BP 3
EP 8
DI 10.1590/0004-282X20160173
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA EJ5OU
UT WOS:000393268400002
PM 28099554
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Salomao, RM
   Cervante, TP
   Salomao, JFM
   Leon, SVA
AF Salomao, Renato Manganelli
   Cervante, Tatiana Protzenko
   Manganelli Salomao, Jose Francisco
   Alves Leon, Soniza Vieira
TI The mortality rate after hospital discharge in patients with
   myelomeningocele decreased after implementation of mandatory flour
   fortification with folic acid
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE meningomyelocele; mortality; folic acid
ID NEURAL-TUBE DEFECTS; OPEN SPINA-BIFIDA; II MALFORMATION; FOLLOW-UP;
   SURVIVAL; COHORT; PREVALENCE; INFANTS
AB Objective: To evaluate the mandatory folic acid fortification of flour on mortality rates after the hospital discharge of children born with myelomeningocele, the most affected age group and the most frequent cause of death. Methods: A retrospective study of 383 children born with myelomeningocele from January 1990 to December 2013 in a high-fetal-risk reference hospital. Results:A ]total of 39 patients died (10.1%), of which 23 (6%) died after discharge. Most children who died were younger than 12 months of age. The most frequent cause of death was infection of the central nervous system, followed by urinary tract sepsis and infections of the respiratory system. Symptomatic Chiari II malformation was the most frequent comorbidity factor. Conclusion: Although there was no significant difference in infant mortality before and after folic acid fortification, there was a significant reduction in deaths after hospital discharge in babies born after implementation of mandatory folic acid fortification
C1 [Salomao, Renato Manganelli] Univ Fed Estado Rio de Janeiro, Escola Med & Cirurgia, Rio De Janeiro, RJ, Brazil.
   [Cervante, Tatiana Protzenko; Manganelli Salomao, Jose Francisco] Fundacao Oswaldo Cruz IFF Fiocruz, Dept Cirurgia Pediat, Setor Neurocirurgia, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
   [Alves Leon, Soniza Vieira] Univ Fed Estado Rio de Janeiro, Dept Neurol, Rio De Janeiro, RJ, Brazil.
RP Salomao, RM (corresponding author), Univ Fed Estado Rio de Janeiro, Escola Med & Cirurgia, Rua Silva Ramos 32, BR-22290240 Rio de Janeiro, RJ, Brazil.
EM renatomsal@gmail.com
RI Leon, Soniza V Alves/J-7786-2012
OI Manganelli Salomao, Jose Francisco/0000-0001-7301-9130
CR Adzick NS, 2010, SEMIN FETAL NEONAT M, V15, P9, DOI 10.1016/j.siny.2009.05.002
   ALTHOUSE R, 1980, ARCH DIS CHILD, V55, P845, DOI 10.1136/adc.55.11.845
   Blencowe H, 2010, INT J EPIDEMIOL, V39, P110, DOI 10.1093/ije/dyq028
   Bol KA, 2006, PEDIATRICS, V117, P803, DOI 10.1542/peds.2005-1364
   Botto LD, 2000, AM J EPIDEMIOL, V151, P878, DOI 10.1093/oxfordjournals.aje.a010291
   Botto LD, 2005, BMJ-BRIT MED J, V330, P571, DOI 10.1136/bmj.38336.664352.82
   Bowman RM, 2001, PEDIATR NEUROSURG, V34, P114, DOI 10.1159/000056005
   Busby A, 2005, BMJ-BRIT MED J, V330, P574, DOI 10.1136/bmj.330.7491.574
   CHARNEY EB, 1991, AM J DIS CHILD, V145, P287, DOI 10.1001/archpedi.1991.02160030055020
   Barboza-Arguello MD, 2013, REV PANAM SALUD PUBL, V34, P304
   De Marco P, 2011, CHILD NERV SYST, V27, P1073, DOI 10.1007/s00381-010-1372-y
   Faraji M, 2006, NEUROSURG QUART, V16, P85, DOI 10.1097/00013414-200606000-00007
   Lopez-Camelo JS, 2010, AM J MED GENET A, V152A, P2444, DOI 10.1002/ajmg.a.33479
   McLone D G, 1983, Clin Neurosurg, V30, P407
   Oakeshott P, 2003, BRIT J GEN PRACT, V53, P632
   Oakeshott P, 2015, DEV MED CHILD NEUROL, V57, P634, DOI 10.1111/dmcn.12698
   Orioli IM, 2011, BIRTH DEFECTS RES A, V91, P831, DOI 10.1002/bdra.20830
   Padmanabhan Rengasamy, 2006, Congenital Anomalies, V46, P55, DOI 10.1111/j.1741-4520.2006.00104.x
   Piatt JH, 2010, J NEUROSURG-PEDIATR, V6, P515, DOI 10.3171/2010.9.PEDS10266
   Salomao JF, 1998, ARQ NEURO-PSIQUIAT, V56, P98, DOI 10.1590/S0004-282X1998000100016
   SALOMAO JF, 1995, ARQ NEURO-PSIQUIAT, V53, P444, DOI 10.1590/S0004-282X1995000300013
   Sandler AD, 2010, PEDIATR CLIN N AM, V57, P879, DOI 10.1016/j.pcl.2010.07.009
   Sayed AR, 2008, BIRTH DEFECTS RES A, V82, P211, DOI 10.1002/bdra.20442
   Schuler-Faccini L, 2014, J COMMUN GENET, V5, P147, DOI 10.1007/s12687-013-0165-x
   Sutton M, 2008, BIRTH DEFECTS RES A, V82, P701, DOI 10.1002/bdra.20498
   Talamonti G, 2007, J NEUROSURG, V107, P368, DOI 10.3171/PED-07/11/368
   Tubbs RS, 2004, CHILD NERV SYST, V20, P375, DOI 10.1007/s00381-004-0969-4
   Tuli S, 2004, J NEUROSURG, V100, P442, DOI 10.3171/ped.2004.100.5.0442
   Ulsenheimer MMM, 2004, ARQ NEURO-PSIQUIAT, V62, P963, DOI 10.1590/S0004-282X2004000600006
   Veenboer PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048399
   Woodhouse CRJ, 2008, PEDIATR NEPHROL, V23, P1223, DOI 10.1007/s00467-007-0663-3
NR 31
TC 1
Z9 1
U1 0
U2 1
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JAN
PY 2017
VL 75
IS 1
BP 20
EP 24
DI 10.1590/0004-282X20160184
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA EJ5OU
UT WOS:000393268400005
PM 28099558
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Alves-Leon, SV
   Becker, J
   Brooks, JBB
   Correa, EC
   Damasceno, A
   da Gama, PD
   da Gama, RA
   Matta, APD
   Maciel, EP
   Winckler, TCD
AF Fragoso, Yara Dadalti
   Alves-Leon, Soniza Vieira
   Becker, Jefferson
   Bidin Brooks, Joseph Bruno
   Correa, Eber Castro
   Damasceno, Alfredo
   da Gama, Paulo Diniz
   da Gama, Rodrigo Assad
   da Cunha Matta, Andre Palma
   Maciel, Ernane Pires
   d'Avila Winckler, Thereza Cristina
TI Safety of switching from natalizumab straight into fingolimod in a group
   of JCV-positive patients with multiple sclerosis
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE multiple sclerosis; natalizumab; fingolimod hydrochloride; therapeutics
ID THERAPY
AB Objective: To assess safety of the switch between natalizumab and fingolimod without a washout period. Methods: Prospective data on 25 JCV positive patients who underwent this medication switch were collected and analyzed. Results: After a median period of nine months from the medication switch, there were no safety issues to report. The patients had good disease control and no adverse events were reported. Conclusion: Washout may not be necessary in daily practice when switching from natalizumab to fingolimod. Expertise on multiple sclerosis management, however, is essential for drug switching.
C1 [Fragoso, Yara Dadalti; Bidin Brooks, Joseph Bruno] Univ Metropolitana Santos, Dept Neurol, Santos, SP, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Estado Rio de Janeiro, Dept Neurol, Rio De Janeiro, RJ, Brazil.
   [Becker, Jefferson] Pontificia Univ Catolica Rio Grande do Sul, Dept Neurol, Porto Alegre, RS, Brazil.
   [Correa, Eber Castro] Clin Neurol & Endocrinol CLINEN, Dept Neurol, Brasilia, DF, Brazil.
   [Damasceno, Alfredo] Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil.
   [da Gama, Paulo Diniz; da Gama, Rodrigo Assad] Pontificia Univ Catolica Sorocaba, Dept Neurol, Sorocaba, SP, Brazil.
   [da Cunha Matta, Andre Palma] Univ Fed Fluminense, Dept Neurol, Niteroi, RJ, Brazil.
   [Maciel, Ernane Pires] Hosp Base Dist Fed, Dept Neurol, Brasilia, DF, Brazil.
   [d'Avila Winckler, Thereza Cristina] Univ Posit, Dept Neurol, Curitiba, Parana, Brazil.
RP Fragoso, YD (corresponding author), Rua Constituicao 374, BR-11015470 Santos, SP, Brazil.
EM yara@bsnet.com.br
RI da Gama, Paulo Diniz/Q-7962-2019; Leon, Soniza V Alves/J-7786-2012;
   Becker, Jefferson/G-6417-2012
CR Baumgartner A, 2012, INT J NEUROSCI, V122, P35, DOI 10.3109/00207454.2011.622452
   Capobianco M, 2015, EUR J NEUROL, V22, P585, DOI 10.1111/ene.12487
   Derfuss T, 2013, SEMIN NEUROL, V33, P26, DOI 10.1055/s-0033-1343793
   Fragoso YD, 2016, EXP REV CLIN PHARM, V9
   Kappos L, 2015, NEUROLOGY, V85, P29, DOI 10.1212/WNL.0000000000001706
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Laffaldano P, 2015, BRAIN, V138, P3275, DOI DOI 10.1093/BRAIN/AWV260
   Rispens T, 2012, MULT SCLER J, V18, P899, DOI 10.1177/1352458511431073
   Stuve O, 2009, NEUROLOGY, V72, P396, DOI 10.1212/01.wnl.0000327341.89587.76
   Tur C, 2014, CNS DRUGS, V28, P641, DOI 10.1007/s40263-014-0168-0
NR 10
TC 3
Z9 3
U1 0
U2 3
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD AUG
PY 2016
VL 74
IS 8
BP 650
EP 652
DI 10.1590/0004-282X20160090
PG 3
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA DU7UJ
UT WOS:000382419800010
PM 27556377
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Gasparetto, EL
   Alves-Leon, S
   Domingues, FS
   Frossard, JT
   Lopes, SP
   de Souza, JM
AF Gasparetto, Emerson Leandro
   Alves-Leon, Soniza
   Domingues, Flavio Sampaio
   Frossard, Joao Thiago
   Lopes, Selva Paraguassu
   de Souza, Jorge Marcondes
TI Neurocysticercosis, familial cerebral cavernomas and intracranial
   calcifications: differential diagnosis for adequate management
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Review
DE neurocysticercosis; epilepsy; cavernomas; familial cerebral cavernous
   malformation; computerized tomography; magnetic resonance
ID NATURAL-HISTORY; MALFORMATIONS; EPILEPSY; RECOMMENDATIONS;
   CYSTICERCOSIS; SEIZURES
AB Neurocysticercosis (NCC) is an endemic disease and important public health problem in some areas of the World and epilepsy is the most common neurological manifestation. Multiple intracranial lesions, commonly calcified, are seen on cranial computed tomography (CT) in the chronic phase of the disease and considered one of the diagnostic criteria of the diagnosis. Magnetic resonance imaging (MRI) is the test that better depicts the different stages of the intracranial cysts but does not show clearly calcified lesions. Cerebral cavernous malformations (CCM), also known as cerebral cavernomas, are frequent vascular malformations of the brain, better demonstrated by MRI and have also epilepsy as the main form of clinical presentation. When occurring in the familial form, cerebral cavernomas typically present with multiple lesions throughout the brain and, very often, with foci of calcifications in the lesions when submitted to the CT imaging. In the countries, and geographic areas, where NCC is established as an endemic health problem and neuroimaging screening is done by CT scan, it will be important to consider the differential diagnosis between the two diseases due to the differences in adequate management.
C1 [Gasparetto, Emerson Leandro] Univ Fed Rio de Janeiro, Dept Radiol, Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza] Univ Fed Estado Rio de Janeiro, Dept Neurol, Programa Epilepsias, Rio De Janeiro, RJ, Brazil.
   [Domingues, Flavio Sampaio; Frossard, Joao Thiago; de Souza, Jorge Marcondes] Univ Fed Rio de Janeiro, Dept Neurocirurgia, Rio De Janeiro, RJ, Brazil.
   [Lopes, Selva Paraguassu] Alianca Cavernoma Brasil, Brasilia, DF, Brazil.
RP de Souza, JM (corresponding author), Univ Fed Rio de Janeiro, Dept Neurocirurgia, Univ Hosp, Rua Rodolpho Rocco 255, BR-25622826 Rio De Janeiro, RJ, Brazil.
EM Jormarcondes@gmail.com
RI Leon, Soniza V Alves/J-7786-2012
CR Awad Issam, 2006, Neurosurg Focus, V21, pe7
   Batra S, 2011, CAVERNOUS MALFORMATI, P1
   Batra S, 2009, NAT REV NEUROL, V5, P659, DOI 10.1038/nrneurol.2009.177
   Berg MJ, 2011, CAVERNOUS MALFORMATI, V2011, P65
   Carabin H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001152
   CARPIO A, 1992, NEUROSURGERY, V30, P968, DOI 10.1097/00006123-199206000-00035
   Carpio A, 2002, LANCET INFECT DIS, V2, P751, DOI 10.1016/S1473-3099(02)00454-1
   Carpio A, 2014, ARQ NEURO-PSIQUIAT, V72, P383, DOI 10.1590/0004-282X20140024
   Choquet H, 2014, CEREBROVASC DIS, V38, P440, DOI 10.1159/000369200
   Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188
   Domingues F, 2008, ARQ NEURO-PSIQUIAT, V66, P795, DOI 10.1590/S0004-282X2008000600003
   Englot DJ, 2011, J NEUROSURG, V115, P1169, DOI 10.3171/2011.7.JNS11536
   Fabiani S, 2013, ACTA TROP, V128, P18, DOI 10.1016/j.actatropica.2013.06.020
   Fleury A, 2010, T ROY SOC TROP MED H, V104, P243, DOI 10.1016/j.trstmh.2010.01.005
   Garcia HH, 2014, LANCET NEUROL, V13, P1202, DOI 10.1016/S1474-4422(14)70094-8
   Goodman KA, 1999, AM J TROP MED HYG, V60, P70, DOI 10.4269/ajtmh.1999.60.70
   Gross BA, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS1165
   Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4
   Leigh R, 2011, CAVERNOUS MALFORMATI, P185
   Lin DDM, 2011, CAVERNOUS MALFORMATI, P49
   Lucato LT, 2007, AM J NEURORADIOL, V28, P1501, DOI 10.3174/ajnr.A0623
   Machado LD, 2010, ARQ NEURO-PSIQUIAT, V68, P1, DOI 10.1590/S0004-282X2010000100001
   MEDINA MT, 1990, ARCH INTERN MED, V150, P325, DOI 10.1001/archinte.150.2.325
   Mondejar R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086286
   Montano SM, 2005, NEUROLOGY, V65, P229, DOI 10.1212/01.wnl.0000168828.83461.09
   Morrison L., 2011, CAVERNOUS MALFORMATI, P181
   Riant F, 2013, NEUROGENETICS, V14, P133, DOI 10.1007/s10048-013-0362-0
   Rosenow F, 2013, EPILEPSIA, V54, P2025, DOI 10.1111/epi.12402
   Salman RA, 2012, EPILEPSIA, V53, P34, DOI 10.1111/j.1528-1167.2012.03611.x
   Salman RAS, 2012, LANCET NEUROL, V11, P217, DOI 10.1016/S1474-4422(12)70004-2
   Santos GT, 2013, AM J NEURORADIOL, V34, P310, DOI 10.3174/ajnr.A3198
   Shenkar R, 2015, GENET MED, V17, P188, DOI 10.1038/gim.2014.97
   Singh G, 2006, ACTA NEUROL SCAND, V113, P233, DOI 10.1111/j.1600-0404.2005.00575.x
   Souza JM, 2008, AM J NEURORADIOL, V29, P154, DOI [10.3174/ajnr.A0748, DOI 10.3174/AJNR.A0748]
   Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x
NR 35
TC 0
Z9 0
U1 0
U2 4
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 2016
VL 74
IS 6
BP 495
EP 500
DI 10.1590/0004-282X20160054
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA DQ5YP
UT WOS:000379281500012
PM 27332076
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Dos Santos, AC
   Hygino, J
   Ferreira, T
   Kasahara, T
   Barros, P
   Sacramento, P
   Andrade, R
   Camargo, SMD
   Rueda, F
   Alves-Leon, S
   Alvarenga, R
   Bento, C
   Vasconcelos, CC
AF Dos Santos, Ana Cristina
   Hygino, Joana
   Ferreira, Thais
   Kasahara, Taissa
   Barros, Priscila
   Sacramento, Priscila
   Andrade, Regis
   Camargo, Solange Maria Das Gr
   Rueda, Fernanda
   Alves-Leon, Soniza
   Alvarenga, Regina
   Bento, Cleonice
   Vasconcelos, Claudia Cristina
TI IL-17 and IL-22-Secreting Myelin-Specific CD4+T Cells Corticosteroid
   Resistant Are Related to Active Brain Lesions in Multiple Sclerosis
   Patients
SO NEUROLOGY
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the American-Academy-of-Neurology (AAN)
CY APR 15-21, 2016
CL Vancouver, CANADA
SP Amer Acad Neurol
C1 [Rueda, Fernanda] Clin Diag Image Barra Tijuca Unity, Rio De Janeiro, Brazil.
   [Bento, Cleonice; Vasconcelos, Claudia Cristina] Fed Univ State Rio de Janeiro, Rio De Janeiro, Brazil.
   [Hygino, Joana] Fed Univ State Rio de Janeiro, Postgrad Program Neurol, Rio De Janeiro, Brazil.
   [Hygino, Joana; Ferreira, Thais; Barros, Priscila; Sacramento, Priscila; Andrade, Regis] Fed Univ State Rio de Janeiro, Dept Microbiol & Parasitol, Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza] Fed Univ State Rio de Janeiro, Dept Gen Med, Rio De Janeiro, Brazil.
   [Dos Santos, Ana Cristina] Univ Fed Estado Rio de Janeiro, Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
FU GenzymeGenzyme Corporation
FX Dr. Dos Santos has received personal compensation for activities with
   Genzyme. Dr. Hygino has nothing to disclose. Dr. Ferreira has nothing to
   disclose. Dr. Kasahara has nothing to disclose. Dr. Barros has nothing
   to disclose. Dr. Sacramento has nothing to disclose. Dr Andrade has
   nothing to disclose. Dr. Camargo has nothing to disclose. Dr. Rueda has
   nothing to disclose. Dr. Alves-Leon has nothing to disclose. Dr.
   Alvarenga has nothing to disclose. Dr. Bento has nothing to disclose.
   Dr. Vasconcelos has nothing to disclose.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD APR 5
PY 2016
VL 86
SU 16
MA P5.345
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA FH6YZ
UT WOS:000411328604234
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Adoni, T
   Alves-Leon, SV
   Apostolos-Pereira, SL
   de Araujo, YR
   Becker, J
   Brooks, JBB
   Correa, EC
   Damasceno, A
   Damasceno, CAD
   Ferreira, MLB
   da Gama, PD
   da Gama, RAD
   Gomes, S
   Goncalves, MVM
   Grzesiuk, AK
   Machado, SCN
   Matta, APD
   Mendes, MF
   Ribeiro, TAGJ
   da Rocha, CF
   Ruocco, HH
   Sato, H
   Simm, RF
   Tauil, CB
   Vasconcelos, CCF
   Vieira, VLF
AF Fragoso, Yara Dadalti
   Adoni, Tarso
   Alves-Leon, Soniza Vieira
   Apostolos-Pereira, Samira Luisa
   de Araujo, Yuna Ribeiro
   Becker, Jefferson
   Bidin Brooks, Joseph Bruno
   Correa, Eber Castro
   Damasceno, Alfredo
   de Albuquerque Damasceno, Carlos Augusto
   Ferreira, Maria Lucia B.
   da Gama, Paulo Diniz
   Diniz da Gama, Rodrigo Assad
   Gomes, Sidney
   Magno Goncalves, Marcus Vinicius
   Grzesiuk, Anderson Kuntz
   Nunes Machado, Suzana Costa
   da Cunha Matta, Andre Palma
   Mendes, Maria Fernanda
   Goncalves Jube Ribeiro, Taysa Alexandrino
   da Rocha, Cristiane Franklin
   Ruocco, Heloisa Helena
   Sato, Henry
   Simm, Renata Faria
   Tauil, Carlos Bernardo
   Ferreira Vasconcelos, Claudia Cristina
   Ferreira Vieira, Vera Lucia
TI Alternatives for reducing relapse rate when switching from natalizumab
   to fingolimod in multiple sclerosis
SO EXPERT REVIEW OF CLINICAL PHARMACOLOGY
LA English
DT Article
DE fingolimod; Natalizumab; progressive multifocal leukoencephalopathy;
   multiple sclerosis
ID PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; DISCONTINUING NATALIZUMAB;
   TREATMENT INTERRUPTION; DISEASE REACTIVATION; GLATIRAMER ACETATE;
   PREVIOUS EXPOSURE; THERAPY; RISK; CESSATION; WASHOUT
AB Natalizumab is a therapeutic option for treating multiple sclerosis (MS) and is particularly efficacious for patients with highly active disease. A long washout period has been recommended between withdrawal of natalizumab and start of fingolimod (another option for treating MS). This long washout period has been associated with a significant increase in MS activity. In the present study, a group of 96 patients who were switched from natalizumab to fingolimod had short washout periods between drugs, or monthly corticosteroid pulse therapy if longer washout periods were recommended. This therapeutic approach led to the lowest reported relapse rate so far, among patients with MS switching from natalizumab to fingolimod (8.3%). No complications from short withdrawal were observed in this group of patients.
C1 [Fragoso, Yara Dadalti; Bidin Brooks, Joseph Bruno] Univ Metropolitana Santos, Dept Neurol, Santos, Brazil.
   [Adoni, Tarso] Hosp Sirio Libanes, Dept Neurol, Sao Paulo, Brazil.
   [Alves-Leon, Soniza Vieira; Ferreira Vasconcelos, Claudia Cristina] Univ Fed Estado Rio de Janeiro, Dept Neurol, Rio De Janeiro, Brazil.
   [Apostolos-Pereira, Samira Luisa; Simm, Renata Faria] Univ Sao Paulo, Hosp Clin, Dept Neurol, Sao Paulo, Brazil.
   [de Araujo, Yuna Ribeiro; Tauil, Carlos Bernardo] Hosp Base Dist Fed, Dept Neurol, Brasilia, DF, Brazil.
   [Becker, Jefferson] Pontificia Univ Catolica Rio Grande do Sul, Dept Neurol, Porto Alegre, RS, Brazil.
   [Correa, Eber Castro] CLINEN, Dept Neurol, Brasilia, DF, Brazil.
   [Damasceno, Alfredo] Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil.
   [de Albuquerque Damasceno, Carlos Augusto] Univ Fed Juiz de Fora, Dept Neurol, Juiz De Fora, Brazil.
   [Ferreira, Maria Lucia B.] Hosp Restauracao, Dept Neurol, Recife, PE, Brazil.
   [da Gama, Paulo Diniz; Diniz da Gama, Rodrigo Assad] Pontificia Univ Catolica Sorocaba, Dept Neurol, Sorocaba, Brazil.
   [Gomes, Sidney] Hosp Beneficencia Portuguesa Sao Paulo, Dept Neurol, Sao Paulo, Brazil.
   [Magno Goncalves, Marcus Vinicius] Ctr Hosp Unimed, Reg Hans Dieter Schimidt, Dept Neurol, Joinville, Brazil.
   [Grzesiuk, Anderson Kuntz] CRIDAC, Dept Neurol, Cuiaba, Brazil.
   [Nunes Machado, Suzana Costa] Hosp Caridade, Dept Neurol, Florianopolis, SC, Brazil.
   [da Cunha Matta, Andre Palma] Univ Fed Fluminense, Dept Neurol, Niteroi, RJ, Brazil.
   [Mendes, Maria Fernanda] Irmandade Santa Casa Misericordia Sao Paulo, Dept Neurol, Sao Paulo, Brazil.
   [Goncalves Jube Ribeiro, Taysa Alexandrino] Univ Fed Goias, Dept Neurol, Goiania, Go, Brazil.
   [da Rocha, Cristiane Franklin] Neurol Clin Belo Horizonte, Dept Neurol, Belo Horizonte, MG, Brazil.
   [Ruocco, Heloisa Helena] Univ Jundiai, Dept Neurol, Jundiai, Brazil.
   [Sato, Henry] Neurol Inst Curitiba, Dept Neurol, Curitiba, Parana, Brazil.
   [Ferreira Vieira, Vera Lucia] Univ Fed Espirito Santo, Dept Neurol, Vitoria, Brazil.
RP Fragoso, YD (corresponding author), Univ Metropolitana Santos, Sch Med, Dept Neurol, Rua Constituicao 374, BR-11015470 Santos, SP, Brazil.
EM yara@bsnet.com.br
RI Mendes, Maria Fernanda/AAQ-1170-2020; Leon, Soniza V Alves/J-7786-2012;
   da Gama, Paulo Diniz/Q-7962-2019; Tauil, Carlos Bernardo/T-3095-2019
OI Tauil, Carlos Bernardo/0000-0003-1137-2398
CR Baldi E, 2014, CURR MED RES OPIN, V30, P1849, DOI 10.1185/03007995.2014.921144
   Berger JR, 2010, ANN NEUROL, V68, P409, DOI 10.1002/ana.22083
   Bianco A, 2015, EUR NEUROL, V73, P57, DOI 10.1159/000365968
   Borriello G, 2012, EUR J NEUROL, V19, P783, DOI 10.1111/j.1468-1331.2011.03577.x
   Capobianco M, 2015, EUR J NEUROL, V22, P585, DOI 10.1111/ene.12487
   Chataway J, 2013, NEUROTHERAPEUTICS, V10, P19, DOI 10.1007/s13311-012-0171-4
   Cohen M, 2014, JAMA NEUROL, V71, P436, DOI 10.1001/jamaneurol.2013.6240
   Comi G, 2015, MULT SCLER J, V21, P786, DOI 10.1177/1352458514549404
   Cross AH, 2014, J INTERN MED, V275, P350, DOI 10.1111/joim.12203
   Daelman L, 2012, MULT SCLER J, V18, P1647, DOI 10.1177/1352458512458009
   de Seze J, 2013, MULT SCLER J, V19, P1248, DOI 10.1177/1352458513490551
   Fox RJ, 2014, NEUROLOGY, V82, P1491, DOI 10.1212/WNL.0000000000000355
   Fragoso YD, 2014, EXPERT REV NEUROTHER, V14, P127, DOI 10.1586/14737175.2014.874947
   Fragoso YD, 2015, HEADACHE, V55, P578, DOI 10.1111/head.12526
   Fragoso YD, 2014, ARQ NEURO-PSIQUIAT, V72, P712, DOI 10.1590/0004-282X20140102
   Fragoso YD, 2013, ARQ NEURO-PSIQUIAT, V71, P137, DOI 10.1590/S0004-282X2013000300002
   Giovannoni G, 2014, NEUROLOGY, V82, P1196, DOI 10.1212/WNL.0000000000000296
   Gobbi C, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-101
   Havla J, 2013, J NEUROL, V260, P1382, DOI 10.1007/s00415-012-6808-8
   Havla J, 2011, J NEUROL, V258, P1665, DOI 10.1007/s00415-011-5996-y
   Hoepner R, 2014, MULT SCLER J, V20, P1714, DOI 10.1177/1352458514533398
   Jander S, 2012, MULT SCLER J, V18, P1650, DOI 10.1177/1352458512463768
   Jokubaitis VG, 2014, NEUROLOGY, V82, P1204, DOI 10.1212/WNL.0000000000000283
   Magraner MJ, 2011, J NEUROL, V258, P1805, DOI 10.1007/s00415-011-6019-8
   Kappos L, 2015, NEUROLOGY, V85, P29, DOI 10.1212/WNL.0000000000001706
   Killestein J, 2014, CASE REP NEUROL MED, DOI 10.1155/2014/307872
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Laroni A, 2013, MULT SCLER J, V19, P1236, DOI 10.1177/1352458512468498
   Maillart E, 2014, MULT SCLER J, V20, P505, DOI 10.1177/1352458513516530
   O'Connor PW, 2011, NEUROLOGY, V76, P1858, DOI 10.1212/WNL.0b013e31821e7c8a
   Peaureaux D, 2015, MULT SCLER J, V21, P671, DOI 10.1177/1352458514549823
   Prosperini L, 2015, MULT SCLER J, V21, P1713, DOI 10.1177/1352458515570768
   Rigau V, 2012, NEUROLOGY, V79, P2214, DOI 10.1212/WNL.0b013e318275979d
   Rinaldi F, 2012, MULT SCLER J, V18, P1640, DOI 10.1177/1352458512464282
   Rispens T, 2012, MULT SCLER J, V18, P899, DOI 10.1177/1352458511431073
   Rossi S, 2013, EUR J NEUROL, V20, P87, DOI 10.1111/j.1468-1331.2012.03794.x
   Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396
   Salhofer-Polanyi S, 2014, ACTA NEUROL SCAND, V130, P97, DOI 10.1111/ane.12250
   Sempere AP, 2013, ACTA NEUROL SCAND, V128, pE6, DOI 10.1111/ane.12082
   Stangel M, 2014, NAT REV NEUROL, V10, P311, DOI 10.1038/nrneurol.2014.82
   Stuve O, 2009, NEUROLOGY, V72, P396, DOI 10.1212/01.wnl.0000327341.89587.76
   Tur C, 2014, CNS DRUGS, V28, P641, DOI 10.1007/s40263-014-0168-0
NR 42
TC 1
Z9 1
U1 0
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1751-2433
EI 1751-2441
J9 EXPERT REV CLIN PHAR
JI Expert Rev. Clin. Pharmacol.
PD APR 2
PY 2016
VL 9
IS 4
BP 541
EP 546
DI 10.1586/17512433.2016.1145053
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DH5CA
UT WOS:000372801600001
PM 26794493
DA 2020-12-01
ER

PT J
AU Wing, AC
   Hygino, J
   Ferreira, TB
   Kasahara, TM
   Barros, PO
   Sacramento, PM
   Andrade, RM
   Camargo, S
   Rueda, F
   Alves-Leon, SV
   Vasconcelos, CC
   Alvarenga, R
   Bento, CAM
AF Wing, Ana Cristina
   Hygino, Joana
   Ferreira, Thais B.
   Kasahara, Taissa M.
   Barros, Priscila O.
   Sacramento, Priscila M.
   Andrade, Regis M.
   Camargo, Solange
   Rueda, Fernanda
   Alves-Leon, Soniza V.
   Vasconcelos, Claudia Cristina
   Alvarenga, Regina
   Bento, Cleonice A. M.
TI Interleukin-17-and interleukin-22-secreting myelin-specific CD4+ T cells
   resistant to corticoids are related with active brain lesions in
   multiple sclerosis patients
SO IMMUNOLOGY
LA English
DT Article
DE CD4(+) T cells; interleukin-17; interleukin-22; multiple sclerosis;
   myelin basic protein
ID GM-CSF; AFRICAN-AMERICANS; EXPRESSION; DISABILITY; THERAPY; TRIALS;
   PHASE; BETA; TH17
AB Multiple sclerosis (MS) is thought to be an autoimmune disorder. It is believed that immunological events in the early stages have great impact on the disease course. Therefore, we aimed to evaluate the cytokine profile of myelin basic protein (MBP)-specific T cells from MS patients in the early phase of the disease and correlate it to clinical parameters, as well as to the effect of in vitro corticoid treatment. Peripheral T cells from MS patients were stimulated with MBP with our without hydrocortisone for 5 days. The cytokines level were determined by ELISA. The number of active brain lesions was determined by MRI scans, and the neurological disabilities were assessed by Expanded Disability Status Scale scores. Our results demonstrated that MS-derived T cells responded to MBP by producing high levels of T helper type 1 (Th1) and Th17 cytokines. Although the production of interleukin-6 (IL-6), granulocyte-macrophage colony-stimulating factor, IL-17 and IL-22 was less sensitive to hydrocortisone inhibition, only IL-17 and IL-22 levels correlated with active brain lesions. The ability of hydrocortisone to inhibit IL-17 and IL-22 production by MBP-specific CD4(+) T cells was inversely related to the number of active brain lesions. Finally, the production of both cytokines was significantly higher in cell cultures from Afrodescendant patients and it was less sensitive to hydrocortisone inhibition. In summary, our data suggest that IL-17- and IL-22-secreting CD4(+) T cells resistant to corticoids are associated with radiological activity of the MS in early stages of the disease, mainly among Afrodescendant patients who, normally, have worse prognosis.
C1 [Wing, Ana Cristina; Alves-Leon, Soniza V.; Vasconcelos, Claudia Cristina; Alvarenga, Regina; Bento, Cleonice A. M.] Univ Fed Rio de Janeiro, Postgrad Programme Neurol, BR-20261040 Rio De Janeiro, RJ, Brazil.
   [Hygino, Joana; Ferreira, Thais B.; Kasahara, Taissa M.; Barros, Priscila O.; Sacramento, Priscila M.; Bento, Cleonice A. M.] Univ Fed Rio de Janeiro, Dept Microbiol & Parasitol, Frei Caneca 94, BR-20261040 Rio De Janeiro, RJ, Brazil.
   [Andrade, Regis M.] Univ Fed Rio de Janeiro, Dept Gen Med, BR-20261040 Rio De Janeiro, RJ, Brazil.
   [Camargo, Solange] Lagoa Hosp, Rio De Janeiro, Brazil.
   [Rueda, Fernanda] Barra Tijuca Unity, Clin Diag Image, Rio De Janeiro, Brazil.
RP Bento, CAM (corresponding author), Univ Fed Rio de Janeiro, Dept Microbiol & Parasitol, Frei Caneca 94, BR-20261040 Rio De Janeiro, RJ, Brazil.
EM cbento@globo.com
RI Leon, Soniza V Alves/J-7786-2012; de Oliveira Barros,
   Priscila/AAA-3188-2020; de Matos Kasahara, Taissa/AAC-9399-2020
OI de Oliveira Barros, Priscila/0000-0002-6173-0416; de Matos Kasahara,
   Taissa/0000-0002-1366-1049; Hygino, Joana/0000-0002-5934-8779; Wing, Ana
   Cristina/0000-0003-4145-2874
FU Fundacao de Amparo a Pesquisa Carlos Chagas Filho (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX This work was supported by Fundacao de Amparo a Pesquisa Carlos Chagas
   Filho (FAPERJ) and Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq).
CR Adams RD, 1989, PRINC NEUROL, V4, P755
   Beyeen AD, 2010, J IMMUNOL, V185, P6883, DOI 10.4049/jimmunol.1001392
   Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2
   Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289
   Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027
   Cree BAC, 2005, ARCH NEUROL-CHICAGO, V62, P1681, DOI 10.1001/archneur.62.11.1681
   Cree BAC, 2004, NEUROLOGY, V63, P2039, DOI 10.1212/01.WNL.0000145762.60562.5D
   Cree B, 2010, NEUROLOGY, V74, P532, DOI 10.1212/WNL.0b013e3181d0374f
   de Kloet CS, 2007, MOL PSYCHIATR, V12, P443, DOI 10.1038/sj.mp.4001934
   Debouverie M, 2007, NEUROLOGY, V68, P29, DOI 10.1212/01.wnl.0000250347.51674.d7
   Ferreira TB, 2014, BRAIN BEHAV IMMUN, V41, P182, DOI 10.1016/j.bbi.2014.05.013
   Vasconcelos CCF, 2010, MULT SCLER J, V16, P597, DOI 10.1177/1352458509360987
   Freedman MS, 2014, MULT SCLER RELAT DIS, V3, P147, DOI 10.1016/j.msard.2013.07.001
   Gold SM, 2012, J CLIN ENDOCR METAB, V97, pE1402, DOI 10.1210/jc.2012-1294
   Jeannin S, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/950126
   Jia L, 2014, ADV EXP MED BIOL, V841, P209, DOI 10.1007/978-94-017-9487-9_8
   Johnson BA, 2010, GENES IMMUN, V11, P343, DOI 10.1038/gene.2009.81
   Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748
   Kister I, 2010, NEUROLOGY, V75, P217, DOI 10.1212/WNL.0b013e3181e8e72a
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500
   Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012
   Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206
   Matysiak M, 2008, MULT SCLER J, V14, P919, DOI 10.1177/1352458508090666
   Mihara M, 2005, INT IMMUNOPHARMACOL, V5, P1731, DOI 10.1016/j.intimp.2005.05.010
   Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39
   Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301
   Rasouli J, 2015, J IMMUNOL, V194, P5085, DOI 10.4049/jimmunol.1403243
   Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716
   Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740
   Rolla S, 2014, J LEUKOCYTE BIOL, V96, P1155, DOI 10.1189/jlb.5A0813-463RR
   Sadaka Y, 2012, ANN NEUROL, V72, P211, DOI 10.1002/ana.23575
   Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118
   SCHUMACHER GA, 1965, ANN NY ACAD SCI, V122, P552
   Sun B, 2014, ADV EXP MED BIOL, V841, P1, DOI 10.1007/978-94-017-9487-9_1
   Teixeira B, 2013, CLIN IMMUNOL, V148, P209, DOI 10.1016/j.clim.2013.05.012
   Terhune J, 2013, VACCINES-BASEL, V1, DOI 10.3390/vaccines1040527
   Vasconcelos CCF, 2012, ISRN NEUROL, V2012, P410
   Vasquez EM, 2001, TRANSPLANTATION, V71, P229, DOI 10.1097/00007890-200101270-00010
   Xu W, 2013, J NEUROIMMUNOL, V261, P87, DOI 10.1016/j.jneuroim.2013.04.021
NR 40
TC 21
Z9 23
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD FEB
PY 2016
VL 147
IS 2
BP 212
EP 220
DI 10.1111/imm.12552
PG 9
WC Immunology
SC Immunology
GA DH6TY
UT WOS:000372926100008
PM 26781085
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Adoni, T
   Alves-Leon, SV
   Apostolos-Pereira, SL
   Barreira, AA
   Brooks, JBB
   Claudino, R
   Correa, EC
   Ferreira, MLB
   Finkelsztejn, A
   Finkelsztejn, J
   da Gama, PD
   Goncalves, MVM
   Guerreiro, CT
   Matta, APD
   Marques, VD
   Morales, RR
   Parolin, MFK
   Ribeiro, MD
   Ribeiro, TAGJ
   Ruocco, HH
   Sato, H
   Scherpenhuijzen, S
   Siquineli, F
   Sousa, NAD
   Varela, DL
   Tauil, CB
   Winckler, TC
AF Fragoso, Yara Dadalti
   Adoni, Tarso
   Alves-Leon, Soniza Vieira
   Apostolos-Pereira, Samira Luisa
   Barreira, Amilton Antunes
   Bidin Brooks, Joseph Bruno
   Claudino, Rinaldo
   Correa, Eber Castro
   Brito Ferreira, Maria Lucia
   Finkelsztejn, Alessandro
   Finkelsztejn, Juliana
   da Gama, Paulo Diniz
   Magno Goncalves, Marcus Vinicius
   Guerreiro, Carlos Tostes
   da Cunha Matta, Andre Palma
   Marques, Vanessa Daccach
   Morales, Rogerio Rizo
   Koncke Parolin, Monica Fiuza
   Ribeiro, Marlise de Castro
   Gonsalves Jube Ribeiro, Taysa Alexandrino
   Ruocco, Heloisa Helena
   Sato, Henry
   Scherpenhuijzen, Simone
   Siquineli, Fabio
   de Carvalho Sousa, Nise Alessandra
   Varela, Daniel Lima
   Tauil, Carlos Bernardo
   Winckler, Thereza Cristina
TI Real-life experience with fampridine (Fampyra (R)) for patients with
   multiple sclerosis and gait disorders
SO NEUROREHABILITATION
LA English
DT Article
DE Multiple sclerosis; gait; walking; fampridine
ID PROLONGED-RELEASE FAMPRIDINE; 4-AMINOPYRIDINE; WALKING; MS
AB BACKGROUND: Fampridine is a broad-spectrum voltage-dependent potassium channel blocker that enhances synaptic transmission. The drug has been shown to be able to ameliorate conduction in demyelinated axons, thereby leading to improved gait in patients with multiple sclerosis (MS).
   OBJECTIVE: To assess the "real-life" efficacy and safety of fampridine prescribed for gait disorders in MS. This was an observational and prospective study carried out at MS Units participating in the Brazilian Multiple Sclerosis Study Group.
   METHODS: Patients with MS and gait disorders were prescribed fampridine (10 mg twice a day), irrespectively of the degree of disability determined by MS. Neurological disability determined by MS was assessed with the expanded disability scale score (EDSS). Outcomes for efficacy and safety of the drug were evaluated by the 25 foot-walk test and by the adverse events of fampridine.
   RESULTS: The time taken to walk 25 feet decreased by 20% or more in 62 patients (70%). Twenty-five patients were considered to be non-responders to this treatment. Improvement in walking speed was independent of improvement of disability. Mild or moderate adverse events were reported in 8% of patients.
   CONCLUSION: Fampridine is an efficient and safe therapeutic option for patients with MS and gait disorders.
C1 [Fragoso, Yara Dadalti; Bidin Brooks, Joseph Bruno] Univ Metropolitana Santos, Dept Neurol, Santos, SP, Brazil.
   [Adoni, Tarso] Hosp Sirio Libanes, Dept Neurol, Sao Paulo, SP, Brazil.
   [Alves-Leon, Soniza Vieira; Scherpenhuijzen, Simone] Univ Fed Estado Rio de Janeiro, Dept Neurol, Rio De Janeiro, RJ, Brazil.
   [Apostolos-Pereira, Samira Luisa] Univ Sao Paulo, Dept Neurol, Sao Paulo, SP, Brazil.
   [Barreira, Amilton Antunes; Guerreiro, Carlos Tostes; Marques, Vanessa Daccach] Univ Sao Paulo Campus Ribeirao Preto, Dept Neurol, Ribeirao Preto, SP, Brazil.
   [Claudino, Rinaldo] Univ Fed Santa Catarina, Dept Neurol, Florianopolis, SC, Brazil.
   [Correa, Eber Castro] CLINEN, Dept Neurol, Brasilia, DE, Brazil.
   [Brito Ferreira, Maria Lucia] Hosp Restauracao, Dept Neurol, Recife, PE, Brazil.
   [Finkelsztejn, Alessandro; Finkelsztejn, Juliana] Hosp Clin Porto Alegre, Dept Neurol, Porto Alegre, RS, Brazil.
   [da Gama, Paulo Diniz] Pontificia Univ Catolica Campus Sorocaba, Dept Neurol, Sorocaba, SP, Brazil.
   [Magno Goncalves, Marcus Vinicius] Ctr Hosp Unimed, Dept Neurol, Joinville, SC, Brazil.
   [da Cunha Matta, Andre Palma] Univ Fed Fluminense, Dept Neurol, Niteroi, RJ, Brazil.
   [Morales, Rogerio Rizo] Univ Fed Uberlandia, Dept Neurol, Uberlandia, MG, Brazil.
   [Koncke Parolin, Monica Fiuza] Neurol Clin, Dept Neurol, Curitiba, PR, Brazil.
   [Ribeiro, Marlise de Castro] Univ Fed Ciencias Saude Porto Alegre, Dept Neurol, Porto Alegre, RS, Brazil.
   [Gonsalves Jube Ribeiro, Taysa Alexandrino] Univ Fed Goias, Dept Neurol, Goiania, Go, Brazil.
   [Ruocco, Heloisa Helena] Fac Med Jundiai, Dept Neurol, Jundiai, SP, Brazil.
   [Sato, Henry] Neurol Inst Curitiba, Dept Neurol, Curitiba, PR, Brazil.
   [Siquineli, Fabio] Univ Reg Blumenau, Dept Neurol, Blumenau, SC, Brazil.
   [de Carvalho Sousa, Nise Alessandra] Hosp Univ Getulio Vargas, Dept Neurol, Manaus, Amazonas, Brazil.
   [Varela, Daniel Lima] Serv Neurol & Neurocirurgia Passo Fundo, Dept Neurol, Passo Fundo, RS, Brazil.
   [Tauil, Carlos Bernardo] Hosp Base Dist Fed, Dept Neurol, Brasilia, DE, Brazil.
   [Winckler, Thereza Cristina] Univ Posit, Dept Neurol, Curitiba, PR, Brazil.
RP Fragoso, YD (corresponding author), Univ Metropolitana Santos, Sch Med, Dept Neurol, Rua Constituicao 374, BR-11015470 Santos, SP, Brazil.
EM yara@bsnet.com.br
RI Tauil, Carlos Bernardo/T-3095-2019; da Gama, Paulo Diniz/Q-7962-2019;
   Leon, Soniza V Alves/J-7786-2012
OI Tauil, Carlos Bernardo/0000-0003-1137-2398; Barreira,
   Amilton/0000-0002-4791-223X
CR Hobart J, 2013, NEUROLOGY, V80, P1509, DOI 10.1212/WNL.0b013e31828cf7f3
   Hupperts R, 2016, MULT SCLER J, V22, P212, DOI 10.1177/1352458515581436
   Jensen HB, 2014, THER ADV NEUROL DISO, V7, P97, DOI 10.1177/1756285613512712
   JONES RE, 1983, J NEUROL SCI, V60, P353, DOI 10.1016/0022-510X(83)90145-4
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Mathiesen HK, 2013, EXPERT REV NEUROTHER, V13, P1309, DOI 10.1586/14737175.2013.859523
   Prugger M, 2013, PATIENT-RELAT OUTCOM, V4, P75, DOI 10.2147/PROM.S42957
   Smrtka J, 2016, POSTGRAD MED, V128, P145, DOI 10.1080/00325481.2016.1120162
   STEFOSKI D, 1987, ANN NEUROL, V21, P71, DOI 10.1002/ana.410210113
   VANDIEMEN HAM, 1993, J NEUROL SCI, V116, P220, DOI 10.1016/0022-510X(93)90329-W
NR 10
TC 8
Z9 8
U1 0
U2 7
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1053-8135
EI 1878-6448
J9 NEUROREHABILITATION
JI Neurorehabilitation
PY 2016
VL 39
IS 2
BP 301
EP 304
DI 10.3233/NRE-161361
PG 4
WC Clinical Neurology; Rehabilitation
SC Neurosciences & Neurology; Rehabilitation
GA DT7HD
UT WOS:000381656800013
PM 27372365
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Adoni, T
   Alves-Leon, SV
   Azambuja, ND
   Barreira, AA
   Brooks, JBB
   Carneiro, DSD
   Carvalho, MJ
   Claudino, R
   Comini-Frota, ER
   Domingues, RB
   Finkelsztejn, A
   Gama, PD
   Giacomo, MCB
   Gomes, S
   Goncalves, MVM
   Grzesiuk, AK
   Kaimen-Maciel, DR
   Mendes, MF
   Morales, NMO
   Morales, RR
   Muniz, A
   Papais-Alvarenga, RM
   Parolin, MKF
   Ribeiro, SBF
   Ruocco, HH
   Salgado, PR
   Siquineli, F
   Souza, DB
   Tosta, ED
   Vasconcelos, CCF
   Almeida, SMG
   Bernardes, DFR
   Castro, SN
   Gama, RAD
   Gomide, FAR
   Finkelzstejn, J
   Lopes, J
   Lourenco, FHdB
   Lourenco, GA
   Oliveira, CLS
   Oliveira, FTM
   Oliveira, LF
   Patroclo, CB
   Pereira, WLDJ
   Safanelli, J
   Sahdo, AM
   Saldanha, PCD
   Shinzato, YF
   Souza, JMB
   Zani, DE
AF Fragoso, Yara Dadalti
   Adoni, Tarso
   Alves-Leon, Soniza Vieira
   Azambuja, Nerio Dutra, Jr.
   Barreira, Amilton Antunes
   Bidin Brooks, Joseph Bruno
   Diniz Carneiro, Denise Sisteroli
   Carvalho, Margarete J.
   Claudino, Rinaldo
   Comini-Frota, Elizabeth Regina
   Domingues, Renan Barros
   Finkelsztejn, Alessandro
   Gama, Paulo Diniz
   Brandao Giacomo, Maria Cristina
   Gomes, Sidney
   Magno Goncalves, Marcus Vinicius
   Grzesiuk, Anderson Kuntz
   Kaimen-Maciel, Damacio Ramon
   Mendes, Maria Fernanda
   Oliveira Morales, Nivea Macedo
   Morales, Rogerio Rizo
   Muniz, Andre
   Papais-Alvarenga, Regina Maria
   Fiuza Parolin, Monica Koncke
   Felix Ribeiro, Sonia Beatriz
   Ruocco, Heloisa Helena
   Salgado, Pedro Rippel
   Siquineli, Fabio
   Souza, Doralina Brum
   Tosta, Elza Dias
   Ferreira Vasconcelos, Claudia Cristina
   Garcia Almeida, Sandra Maria
   Ribeiro Bernardes, Daniella Freire
   Castro, Simone Nascimento
   Diniz Gama, Rodrigo Assad
   Resende Gomide, Fabrizio Antonio
   Finkelzstejn, Juliana
   Lopes, Josiane
   de Barros Lourenco, Fabiani Honorato
   Lourenco, Gisele A.
   Silva Oliveira, Celso Luis
   Meneses Oliveira, Francisco Tomaz
   Oliveira, Lucas Felix
   Patroclo, Cristiane Borges
   de Carvalho Jennings Pereira, Wildea Lice
   Safanelli, Juliana
   Sahdo, Alinne Martiniano
   de Oliveira Saldanha, Patricia Correa
   Shinzato, Yves Fumio
   Barbosa Souza, Jorge Murilo
   Zani, Denis Evandro
TI Postpartum Treatment With Immunoglobulin Does Not Prevent Relapses of
   Multiple Sclerosis in the Mother
SO HEALTH CARE FOR WOMEN INTERNATIONAL
LA English
DT Article
ID DISEASE-MODIFYING DRUGS; INTRAVENOUS IMMUNOGLOBULIN; PREGNANCY; WOMEN
AB Multiple sclerosis (MS) is a chronic, neurological, immune-mediated disease that can worsen in the postpartum period. There is no consensus on the use of immunoglobulin for prevention of disease relapses after delivery. We have shown that the controversial beneficial effect of immunoglobulin given immediately after birth could not be observed in patients with MS.
C1 [Fragoso, Yara Dadalti] Univ Metropolitana Santos, Sch Med, Dept Neurol, Santos, Brazil.
   [Adoni, Tarso] Hosp Sirio Libanes, Dept Neurol, Sao Paulo, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Dept Neurol, Rio De Janeiro, Brazil.
   [Azambuja, Nerio Dutra, Jr.] Neurol & Neurosurg Passo Fundo, Passo Fundo, Brazil.
   [Barreira, Amilton Antunes] Univ Sao Paulo, Dept Neurol, BR-14049 Ribeirao Preto, Brazil.
   [Bidin Brooks, Joseph Bruno] Univ Metropolitana Santos, Dept Neurol, Santos, Brazil.
   [Diniz Carneiro, Denise Sisteroli] Univ Fed Goias, Dept Neurol, Goiania, Go, Brazil.
   [Carvalho, Margarete J.] Fundacao ABC, Dept Neurol, Santo Andre, Brazil.
   [Claudino, Rinaldo; Barbosa Souza, Jorge Murilo] Univ Fed Santa Catarina, Dept Neurol, Florianopolis, SC, Brazil.
   [Comini-Frota, Elizabeth Regina] Univ Fed Minas Gerais, Dept Neurol, Belo Horizonte, MG, Brazil.
   [Domingues, Renan Barros; de Oliveira Saldanha, Patricia Correa] Santa Casa Vitoria, Dept Neurol, Sch Hlth Sci, Vitoria, Brazil.
   [Finkelsztejn, Alessandro] Hosp Clin Porto Alegre, Dept Neurol, Porto Alegre, RS, Brazil.
   [Gama, Paulo Diniz; Shinzato, Yves Fumio; Zani, Denis Evandro] Pontificia Univ Catolica, Dept Neurol, Sorocaba, Brazil.
   [Brandao Giacomo, Maria Cristina] Neurol Clin, Sao Paulo, Brazil.
   [Gomes, Sidney] Hosp Beneficencia Portuguesa, Dept Neurol, Sao Paulo, Brazil.
   [Gomes, Sidney] Hosp Paulistano, Sao Paulo, Brazil.
   [Magno Goncalves, Marcus Vinicius; Safanelli, Juliana] Univ Regiao Joinville, Dept Neurol, Joinville, Brazil.
   [Grzesiuk, Anderson Kuntz] Rehabil Ctr Dom Aquino Correa, Dept Neurol, Cuiaba, Brazil.
   [Kaimen-Maciel, Damacio Ramon] Univ Estadual Londrina, Dept Neurol, Londrina, Brazil.
   [Mendes, Maria Fernanda] Santa Casa Sao Paulo, Dept Neurol, Sao Paulo, Brazil.
   [Oliveira Morales, Nivea Macedo; Morales, Rogerio Rizo] Univ Fed Uberlandia, Dept Neurol, BR-38400 Uberlandia, MG, Brazil.
   [Muniz, Andre] Hosp Sao Rafael, Dept Neurol, Salvador, BA, Brazil.
   [Papais-Alvarenga, Regina Maria] Univ Fed Estado Rio de Janeiro, Dept Neurol, Rio De Janeiro, Brazil.
   [Fiuza Parolin, Monica Koncke] Neurol Clin, Curitiba, Parana, Brazil.
   [Felix Ribeiro, Sonia Beatriz] Univ Fed Triangulo Mineiro, Dept Neurol, Uberaba, Brazil.
   [Ruocco, Heloisa Helena] MS Ctr Jundiai, Dept Neurol, Jundiai, Brazil.
   [Salgado, Pedro Rippel] Univ Fed Mato Grosso do Sul, Dept Neurol, Campo Grande, Brazil.
   [Siquineli, Fabio] Univ Reg Blumenau, Dept Neurol, Blumenau, Brazil.
   [Souza, Doralina Brum] Univ Sao Paulo, Dept Neurol, BR-14049 Ribeirao Preto, Brazil.
   [Tosta, Elza Dias; Sahdo, Alinne Martiniano] Hosp Base Distrito Fed, Dept Neurol, Brasilia, DF, Brazil.
   [Garcia Almeida, Sandra Maria] Univ Fed Estado Rio de Janeiro, Dept Neurol, Rio De Janeiro, Brazil.
   [Garcia Almeida, Sandra Maria] Univ Fed Rio de Janeiro, Dept Neurol, Rio De Janeiro, Brazil.
   [Ribeiro Bernardes, Daniella Freire] Hosp Sao Rafael, Dept Neurol, Salvador, BA, Brazil.
   [Castro, Simone Nascimento] Univ Fed Mato Grosso do Sul, Dept Neurol, Campo Grande, Brazil.
   [Diniz Gama, Rodrigo Assad] Pontificia Univ Catolica, Dept Neurol, Sorocaba, Brazil.
   [Resende Gomide, Fabrizio Antonio] Univ Fed Triangulo Mineiro, Dept Neurol, Uberaba, Brazil.
   [Finkelzstejn, Juliana] Hosp Clin Porto Alegre, Dept Neurol, Porto Alegre, RS, Brazil.
   [Lopes, Josiane; de Carvalho Jennings Pereira, Wildea Lice] Univ Estadual Londrina, Dept Neurol, Londrina, Brazil.
   [de Barros Lourenco, Fabiani Honorato] Univ Fed Mato Grosso do Sul, Dept Neurol, Campo Grande, Brazil.
   [Lourenco, Gisele A.; Patroclo, Cristiane Borges] Univ Fed Rio de Janeiro, Dept Neurol, Rio De Janeiro, Brazil.
   [Silva Oliveira, Celso Luis] Univ Metropolitana Santos, Dept Neurol, Santos, Brazil.
   [Meneses Oliveira, Francisco Tomaz] Hosp Beneficencia Portuguesa, Dept Neurol, Sao Paulo, Brazil.
   [Meneses Oliveira, Francisco Tomaz] Hosp Paulistano, Sao Paulo, Brazil.
   [Oliveira, Lucas Felix] Univ Fed Triangulo Mineiro, Dept Neurol, Uberaba, Brazil.
RP Fragoso, YD (corresponding author), Univ Metropolitana Santos, Sch Med, Dept Neurol, Santos, Brazil.
EM yara@bsnet.com.br
RI Domingues, Renan/N-6003-2019; Leon, Soniza V Alves/J-7786-2012; Mendes,
   Maria Fernanda/AAQ-1170-2020; Domingues, Renan B/H-1351-2012; Fragoso,
   Yara/B-1761-2015
OI Domingues, Renan/0000-0002-6058-7937; Domingues, Renan
   B/0000-0002-6058-7937; Fragoso, Yara/0000-0001-8726-089X;
   Papais-Alvarenga, Regina Maria/0000-0002-1141-8619; Barreira,
   Amilton/0000-0002-4791-223X; De Sousa, Jorge Murilo
   Barbosa/0000-0003-2701-8940; SIQUINELI, FABIO/0000-0002-5380-3654
CR Achiron A, 2004, J NEUROL, V251, P1133, DOI 10.1007/s00415-004-0495-z
   Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501
   do Nascimento MBR, 2010, BREASTFEED MED, V5, P79, DOI 10.1089/bfm.2009.0008
   Dudesek A, 2006, J NEUROL, V253, P50, DOI 10.1007/s00415-006-5007-x
   Elovaara I, 2010, ACTA NEUROL SCAND, V122, P309, DOI 10.1111/j.1600-0404.2009.01317.x
   Fazekas F, 2008, NEUROLOGY, V71, P265, DOI 10.1212/01.wnl.0000318281.98220.6f
   Finkelsztejn A, 2011, CLIN NEUROL NEUROSUR, V113, P277, DOI 10.1016/j.clineuro.2010.11.016
   Fragoso YD, 2010, CNS DRUGS, V24, P969, DOI 10.2165/11538960-000000000-00000
   Fragoso YD, 2013, CLIN NEUROL NEUROSUR, V115, P154, DOI 10.1016/j.clineuro.2012.04.024
   Fragoso YD, 2009, ARQ NEURO-PSIQUIAT, V67, P657, DOI 10.1590/S0004-282X2009000400015
   Haas J, 2007, MULT SCLER J, V13, P900, DOI 10.1177/1352458506075654
   Hellwig Kerstin, 2009, Ther Adv Neurol Disord, V2, P7, DOI 10.1177/1756285608100416
   Langer-Gould A, 2009, ARCH NEUROL-CHICAGO, V66, P958, DOI 10.1001/archneurol.2009.132
   Lu E, 2012, NEUROLOGY, V79, P1130, DOI 10.1212/WNL.0b013e3182698c64
   Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907
   Pakpoor J, 2012, J NEUROL, V259, P2246, DOI 10.1007/s00415-012-6553-z
   Portaccio E, 2011, NEUROLOGY, V77, P145, DOI 10.1212/WNL.0b013e318224afc9
   Sorensen PS, 2003, NEUROL SCI, V24, pS227, DOI 10.1007/s10072-003-0083-5
NR 18
TC 8
Z9 8
U1 0
U2 2
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-9332
EI 1096-4665
J9 HEALTH CARE WOMEN IN
JI Health Care Women Int.
PD OCT 3
PY 2015
VL 36
IS 10
BP 1072
EP 1080
DI 10.1080/07399332.2014.948627
PG 9
WC Public, Environmental & Occupational Health; Women's Studies
SC Public, Environmental & Occupational Health; Women's Studies
GA CS3OD
UT WOS:000361983000002
PM 25187102
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Alves-Leon, SV
   Apostolos-Pereira, SL
   Barreira, AA
   Brooks, JB
   Callegaro, D
   Ferreira, ML
   Finkelsztejn, A
   Gomes, S
   Goncalves, MV
   Grzesiuk, AK
   Machado, MI
   Marques, VD
   Matta, AP
   Papais-Alvarenga, RM
   Ruocco, HH
   Sato, H
   Tauil, CB
AF Fragoso, Y. D.
   Alves-Leon, S. V.
   Apostolos-Pereira, S. L.
   Barreira, A. A.
   Brooks, J. B.
   Callegaro, D.
   Ferreira, M. L.
   Finkelsztejn, A.
   Gomes, S.
   Goncalves, M. V.
   Grzesiuk, A. K.
   Machado, M. I.
   Marques, V. D.
   Matta, A. P.
   Papais-Alvarenga, R. M.
   Ruocco, H. H.
   Sato, H.
   Tauil, C. B.
TI Prospective observational data on 30 patients starting fingolimod before
   the age of 21 years
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 31st Congress of the
   European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis
   (ECTRIMS)
CY OCT 07-10, 2015
CL Barcelona, SPAIN
SP European Comm Treatment & Res Multiple Sclerosis
C1 [Fragoso, Y. D.; Brooks, J. B.] Univ Metropolitana Santos, Santos, Brazil.
   [Alves-Leon, S. V.] Univ Fed Estado Rio de Janeiro, Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Apostolos-Pereira, S. L.; Callegaro, D.] Univ Sao Paulo, Hosp Clin, Sao Paulo, Brazil.
   [Barreira, A. A.; Marques, V. D.] Univ Sao Paulo Campus Ribeirao Preto, Ribeirao Preto, Brazil.
   [Ferreira, M. L.; Machado, M. I.] Hosp Restauracao Recife, Recife, PE, Brazil.
   [Finkelsztejn, A.] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   [Gomes, S.] Hosp Paulistano, Hosp Beneficencia Portuguesa, Sao Paulo, Brazil.
   [Goncalves, M. V.] Hosp Reg Hans Dieter Schimidt, Joinville, Brazil.
   [Grzesiuk, A. K.] Ctr Reabilitacao Integral Dom Aquino Correa, Cuiaba, Brazil.
   [Matta, A. P.] Univ Fed Fluminense, Niteroi, RJ, Brazil.
   [Papais-Alvarenga, R. M.] Univ Fed Estado Rio de Janeiro, Rio De Janeiro, Brazil.
   [Ruocco, H. H.] Fac Med Junidia, Jundiai, Brazil.
   [Sato, H.] Inst Neurol Curitiba, Curitiba, Parana, Brazil.
   [Tauil, C. B.] Hosp Base Distrito Fed, Brasilia, DF, Brazil.
RI Leon, Soniza V Alves/J-7786-2012; Tauil, Carlos Bernardo/T-3095-2019
OI Tauil, Carlos Bernardo/0000-0003-1137-2398
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD SEP
PY 2015
VL 21
SU 11
MA P262
BP 90
EP 90
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA CX5GF
UT WOS:000365729400153
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Adoni, T
   Alves-Leon, SV
   Apostolos-Pereira, SL
   Araujo, YR
   Becker, J
   Brooks, JB
   Correa, EC
   Damasceno, A
   Damasceno, CA
   Ferreira, ML
   Gama, PD
   Gama, RA
   Gomes, S
   Goncalves, MV
   Grzesiuk, AK
   Machado, SC
   Matta, AP
   Mendes, MF
   Ribeiro, TA
   Rocha, CF
   Ruocco, HH
   Sato, H
   Simm, RF
   Tauil, CB
   Vasconcelos, CC
AF Fragoso, Y. D.
   Adoni, T.
   Alves-Leon, S. V.
   Apostolos-Pereira, S. L.
   Araujo, Y. R.
   Becker, J.
   Brooks, J. B.
   Correa, E. C.
   Damasceno, A.
   Damasceno, C. A.
   Ferreira, M. L.
   Gama, P. D.
   Gama, R. A.
   Gomes, S.
   Goncalves, M. V.
   Grzesiuk, A. K.
   Machado, S. C.
   Matta, A. P.
   Mendes, M. F.
   Ribeiro, T. A.
   Rocha, C. F.
   Ruocco, H. H.
   Sato, H.
   Simm, R. F.
   Tauil, C. B.
   Vasconcelos, C. C.
TI Reduced risk of relapses in the switch between natalizumab and
   fingolimod in 91 patients
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 31st Congress of the
   European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis
   (ECTRIMS)
CY OCT 07-10, 2015
CL Barcelona, SPAIN
SP European Comm Treatment & Res Multiple Sclerosis
C1 [Fragoso, Y. D.; Brooks, J. B.] Univ Metropolitana Santos, Santos, Brazil.
   [Adoni, T.] Hosp Sirio Libanes Sao Paulo, Sao Paulo, Brazil.
   [Alves-Leon, S. V.] Univ Fed Rio de Janeiro, Univ Fed Estado Rio de Janeiro, Rio De Janeiro, Brazil.
   [Apostolos-Pereira, S. L.; Simm, R. F.] Univ Sao Paulo, Hosp Clin, Sao Paulo, Brazil.
   [Araujo, Y. R.; Tauil, C. B.] Hosp Base Dist Fed, Brasilia, DF, Brazil.
   [Becker, J.] Pontificia Univ Catolica Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Correa, E. C.] CLINEN Brasilia, Brasilia, DF, Brazil.
   [Damasceno, A.] Univ Estadual Campinas, Campinas, SP, Brazil.
   [Damasceno, C. A.] Univ Fed Juiz de Fora, Juiz De Fora, Brazil.
   [Ferreira, M. L.] Hosp Restauracao Recife, Recife, PE, Brazil.
   [Gama, P. D.; Gama, R. A.] Pontificia Univ Catolica Campus Sorocaba, Sorocaba, Brazil.
   [Gomes, S.] Hosp Paulistano, Hosp Beneficencia Portuguesa, Sao Paulo, Brazil.
   [Goncalves, M. V.] Hosp Reg Hans Dieter Schimidt, Joinville, Brazil.
   [Grzesiuk, A. K.] Ctr Reabilitacao Integral Dom Aquino Correa, Cuiaba, Brazil.
   [Machado, S. C.] Hosp Caridade Florianopolis, Florianopolis, SC, Brazil.
   [Matta, A. P.] Univ Fed Fluminense, Niteroi, RJ, Brazil.
   [Mendes, M. F.] Fac Med Santa Casa Sao Paulo, Sao Paulo, Brazil.
   [Ribeiro, T. A.] Univ Fed Goias, Goiania, Go, Brazil.
   [Rocha, C. F.] Neurol Clin Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Ruocco, H. H.] Fac Med Junidiai, Jundiai, Brazil.
   [Sato, H.] Inst Neurol Curitiba, Curitiba, Parana, Brazil.
   [Vasconcelos, C. C.] Univ Fed Estado Rio de Janeiro, Rio De Janeiro, Brazil.
RI Mendes, Maria Fernanda/AAQ-1170-2020; Leon, Soniza V Alves/J-7786-2012;
   Tauil, Carlos Bernardo/T-3095-2019
OI Tauil, Carlos Bernardo/0000-0003-1137-2398
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD SEP
PY 2015
VL 21
SU 11
MA P1116
BP 578
EP 579
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA CX5GF
UT WOS:000365729401493
DA 2020-12-01
ER

PT J
AU Horta, WG
   Paradela, E
   Figueiredo, A
   Meira, ID
   Pereira, VCSR
   Rego, CC
   Oliveira, R
   Andraus, MEC
   de Lacerda, GCB
   Moura, P
   de Souza, JPM
   Paiva, CLA
   Alves-Leon, SV
AF Horta, Wagner G.
   Paradela, Eduardo
   Figueiredo, Andre
   Meira, Isabella D'Andrea
   Santa Rita Pereira, Valeria C.
   Rego, Claudia C.
   Oliveira, Raquel
   Andraus, Maria Emilia C.
   Borges de lacerda, Glenda C.
   Moura, Polyana
   Marcondes de Souza, Jorge P.
   Paiva, Carmen Lucia A.
   Alves-Leon, Soniza V.
TI Genetic association study of the HLA class II alleles DRB1, DQA1, and
   DQB1 in patients with pharmacoresistant temporal lobe epilepsy
   associated with mesial hippocampal sclerosis
SO SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
LA English
DT Article
DE Temporal lobe epilepsy; Mesial sclerosis; Pharmacoresistant; Class II
   HLA; HLA DR
ID SEIZURES; EPILEPTOGENESIS
AB Purpose: Temporal lobe epilepsy (TLE) is the most common variety of focal epilepsy among adults. The neuroinflammatory mechanisms of epilepsies may be involved in the genesis of seizures and refractory epilepsies, particularly in the case of progressive syndromes such as TLE associated with mesial hippocampal sclerosis (TLE-HS). The goal of the present study is investigate the genetic profile of susceptibility of individuals with TLE-HS by analyzing the possible association of TLE-HS with human leukocyte antigen (HLA) DRB1, DQA1 and DQB1 alleles.
   Methods: Peripheral blood samples were collected from 42 individuals with pharmacoresistant TLE-HS and 89 healthy controls. The typing of the HLA class II alleles from DRB1, DQB1, and DQA1 loci were analyzed using sequence-specific primer-polymerase chain reaction (SSP-PCR) and identified through sequencing. Statistical analysis of relative allele frequencies was performed using an Excel spreadsheet; p-value, relative risk (RR), and odds ratio (OR) were calculated using the software Epi Info 6.0. p-values <0.05 following Bonferroni's method correction were considered statistically significant.
   Results: HLA-DRB1*13:02 was the only allele with a statistically significant difference (p = 0.01) in frequency between patients and controls. However, the significance was lost following Bonferroni's method correction (p = 0.44). The remainder of the alleles in the HLA-DRB1, HLA-DQB1 and HLA-DQA1 regions did not exhibit any significant association.
   Conclusion: The allele HLA DRB1*13:02 has exhibited a tendency to behave as a susceptibility factor for TLE-HS. (C) 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
C1 [Horta, Wagner G.; Paradela, Eduardo; Figueiredo, Andre; Rego, Claudia C.; Oliveira, Raquel; Andraus, Maria Emilia C.; Borges de lacerda, Glenda C.; Moura, Polyana; Marcondes de Souza, Jorge P.; Paiva, Carmen Lucia A.; Alves-Leon, Soniza V.] Fed Univ Rio de Janeiro State UNIRIO, Postgrad Program, Rio De Janeiro, Brazil.
RP Alves-Leon, SV (corresponding author), Fed Univ Rio de Janeiro State UNIRIO, Postgrad Program, Rio De Janeiro, Brazil.
EM sonizavleon@pesquisador.cnpq.br
RI Leon, Soniza V Alves/J-7786-2012; PARADELA, EDUARDO/AAW-6807-2020;
   Paiva, C. L. A./A-1503-2010
OI Paiva, C. L. A./0000-0003-2877-0296; Borges de Lacerda,
   Glenda/0000-0003-0776-0769
CR Albrecht O, 2007, PHARM REP, V59, P129
   Cendes F, 2014, ACTA NEUROPATHOL, V128, P21, DOI 10.1007/s00401-014-1292-0
   Chatzikonstantinou A, 2014, FRONT NEUROL NEUROSC, V34, P121, DOI 10.1159/000356435
   Chiang S, 2014, CLIN NEUROPHYSIOL, V125, P1295, DOI 10.1016/j.clinph.2014.04.004
   Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x
   Engel Jerome Jr, 2003, Epilepsy Curr, V3, P37, DOI 10.1046/j.1535-7597.2003.03201.x
   Kasperaviciute D, 2013, BRAIN, V136, P3140, DOI 10.1093/brain/awt233
   Kwan P, 2004, J NEUROL NEUROSUR PS, V75, P1376, DOI 10.1136/jnnp.2004.045690
   Le Hellard S, 1999, EPILEPSIA, V40, P117
   Mumenthaler M., 2008, NEUROLOGIA
   Nakahara H, 2010, ACTA HISTOCHEM CYTOC, V43, P157, DOI 10.1267/ahc.10022
   Ozkara C, 2002, EPILEPSIA, V43, P236, DOI 10.1046/j.1528-1157.2002.13401.x
   Quirico-Santos T, 2013, BRAIN RES, V1538, P172, DOI 10.1016/j.brainres.2013.09.044
   Quirico-Santos T, 2013, J NEUROIMMUNOL, V254, P125, DOI 10.1016/j.jneuroim.2012.08.004
   Ravizza T, 2008, NEUROBIOL DIS, V31, P327, DOI 10.1016/j.nbd.2008.05.007
   Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012
   Tellez Zenteno JF, 2012, EPILEPSY RES TREAT
   Valenca-Andrade LPA, 2006, J EPILEPSY CLIN NEUR, V12, P31
   Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x
   Vezzani Annamaria, 2007, Epilepsy Curr, V7, P45, DOI 10.1111/j.1535-7511.2007.00165.x
   Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178
   Xanthos DN, 2014, NAT REV NEUROSCI, V15, P43, DOI 10.1038/nrn3617
NR 22
TC 6
Z9 6
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1059-1311
EI 1532-2688
J9 SEIZURE-EUR J EPILEP
JI Seizure
PD SEP
PY 2015
VL 31
BP 7
EP 11
DI 10.1016/j.seizure.2015.06.005
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA CS0TD
UT WOS:000361774200003
PM 26362370
OA Bronze
DA 2020-12-01
ER

PT J
AU Lopes, FCR
   Alves-Leon, SV
   Godoy, JM
   Scherpenhuijzen, SDB
   Fezer, L
   Gasparetto, EL
AF Rueda Lopes, Fernanda Cristina
   Alves-Leon, Soniza Vieira
   Godoy, Jose Mauricio
   Batista Scherpenhuijzen, Simone de Souza
   Fezer, Leticia
   Gasparetto, Emerson Leandro
TI Optic Neuritis and the Visual Pathway: Evaluation of Neuromyelitis
   Optica Spectrum by Resting-State fMRI and Diffusion Tensor MRI
SO JOURNAL OF NEUROIMAGING
LA English
DT Article
DE Neuromyelitis optica; diffusion tensor imaging; resting-state
   functional; MRI; neuritis optica
ID MULTIPLE-SCLEROSIS; VOXELWISE ANALYSIS; NEUROPLASTICITY; STIMULATION;
   RECOVERY; CORTEX; DAMAGE
AB BACKGROUND AND PURPOSEOptic neuritis (ON) is an acute episode of inflammation in the visual pathway (VP). It may occur as part of a demyelinating disease, which can affect white matter (WM) throughout the VP. Compensatory cortical adaptations may occur following WM damage to maintain visual integrity. Our aim was to investigate whether resting-state functional MRI (rsfMRI) can detect cortical adaptations following ON attacks and to correlate rsfMRI with diffusion tensor imaging (DTI) of WM within the VP.
   MATERIALS AND METHODSNeuromyelitis optica spectrum patients were compared to healthy controls at least 6 months after ON onset. DTI and rsfMRI were performed and post-processed using FSL tools (TBSS for DTI and MELODIC for fMRI).
   RESULTSPtients had higher synchronization values than controls in the visual network (3.48 vs. 2.12, P < .05). A weak trend of correlation was revealed between fMRI and structural analysis by DTI using fractional anisotropy (right side: R = -.36, P < .08; left side: R = .075, P < .73).
   CONCLUSIONSThe rsfMRI detected cortical reorganization following ON attack, but WM was considerably preserved in the posterior VP.
C1 [Rueda Lopes, Fernanda Cristina; Gasparetto, Emerson Leandro] Univ Fed Rio de Janeiro, Radiol, BR-24220330 Niteroi, RJ, Brazil.
   [Alves-Leon, Soniza Vieira; Batista Scherpenhuijzen, Simone de Souza; Fezer, Leticia] Univ Fed Rio de Janeiro, Neurol, BR-24220330 Niteroi, RJ, Brazil.
   [Godoy, Jose Mauricio] Univ Estado Rio De Janeiro, Neurol, Rio De Janeiro, RJ, Brazil.
RP Lopes, FCR (corresponding author), Univ Fed Rio de Janeiro, Radiol, Rua Presidente Joao Pessoa 385-704, BR-24220330 Niteroi, RJ, Brazil.
EM frueda81@hotmail.com
RI Leon, Soniza V Alves/J-7786-2012
CR Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011
   Andersson JLR, TR07JA1 FMRIB
   Beckmann C. F., 2009, NEUROIMAGE, V47, pS148, DOI [10.1016/S1053-8119(09)71511-3, DOI 10.1016/S1053-8119(09)71511-3]
   Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634
   Jenkins TM, 2010, ANN NEUROL, V67, P99, DOI 10.1002/ana.21823
   Kolappan M, 2009, J NEUROL, V256, P305, DOI 10.1007/s00415-009-0123-z
   Kolbe SC, 2012, INVEST OPHTH VIS SCI, V53, P825, DOI 10.1167/iovs.11-8864
   Korsholm K, 2008, NEUROIMAGE, V42, P836, DOI 10.1016/j.neuroimage.2008.05.031
   Langkilde AR, 2002, EUR J NEUROL, V9, P277, DOI 10.1046/j.1468-1331.2002.00399.x
   Levin N, 2006, NEUROIMAGE, V33, P1161, DOI 10.1016/j.neuroimage.2006.07.030
   Mascioli G, 2012, RADIOL RES PRACT, V2012, DOI 10.1155/2012/265306
   Naismith RT, 2009, NEUROLOGY, V72, P589, DOI 10.1212/01.wnl.0000335766.22758.cd
   Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366
   Reich DS, 2009, ARCH NEUROL-CHICAGO, V66, P998, DOI 10.1001/archneurol.2009.107
   Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058
   Roosendaal SD, 2010, RADIOLOGY, V255, P595, DOI 10.1148/radiol.10091433
   Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284
   Smith SA, 2011, AM J NEURORADIOL, V32, P1662, DOI 10.3174/ajnr.A2574
   Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051
   Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061
   Toosy AT, 2005, ANN NEUROL, V57, P622, DOI 10.1002/ana.20448
   Toosy AT, 2002, NEUROSCI LETT, V330, P255, DOI 10.1016/S0304-3940(02)00700-0
   Werring DJ, 2000, J NEUROL NEUROSUR PS, V68, P441, DOI 10.1136/jnnp.68.4.441
   Zhang Y, 2012, INT J OPHTHALMOL-CHI, V5, P452, DOI 10.3980/j.issn.2222-3959.2012.04.09
NR 26
TC 9
Z9 9
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1051-2284
EI 1552-6569
J9 J NEUROIMAGING
JI J. Neuroimaging
PD SEP-OCT
PY 2015
VL 25
IS 5
BP 807
EP 812
DI 10.1111/jon.12191
PG 6
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA CP3MO
UT WOS:000359783900015
PM 25588974
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Alves-Leon, SV
   Barreira, AA
   Callegaro, D
   Ferreira, MLB
   Finkelsztejn, A
   Gomes, S
   Goncalves, MVM
   Machado, MIM
   Marques, VD
   Matta, APC
   Papais-Alvarenga, RM
   Pereira, SLA
   Tauil, CB
AF Fragoso, Yara Dadalti
   Alves-Leon, Soniza Vieira
   Barreira, Amilton Antunes
   Callegaro, Dagoberto
   Brito Ferreira, Maria Lucia
   Finkelsztejn, Alessandro
   Gomes, Sidney
   Magno Goncalves, Marcus Vinicius
   Moraes Machado, Maria Iris
   Marques, Vanessa Daccach
   Cunha Matta, Andre Palma
   Papais-Alvarenga, Regina Maria
   Apostolos Pereira, Samira Luisa
   Tauil, Carlos Bernardo
TI Fingolimod Prescribed for the Treatment of Multiple Sclerosis in
   Patients Younger Than Age 18 Years
SO PEDIATRIC NEUROLOGY
LA English
DT Article
DE multiple sclerosis; children; adolescents; fingolimod
ID FTY720
AB BACKGROUND: There have been no clinical trials for approval of medications for treating multiple sclerosis in patients younger than age 18 years. All treatments are based on personal experience and data from open observational studies. Fingolimod is an oral drug for multiple sclerosis that has been shown to be efficient and safe in adults. The aim of our study is to describe patients with multiple sclerosis who started treatment with fingolimod before the age of 18 years. PARTICIPANTS AND METHODS: Seventeen patients treated with fingolimod were identified in the Brazilian database of children and adolescents with multiple sclerosis. The average time of use of the drug was 8.6 months. RESULTS: Fingolimod showed a good safety and efficacy profile in these patients, all of whom had very active multiple sclerosis. After starting treatment with fingolimod, only one patient had a relapse and a new lesion on magnetic resonance imaging. The patients' degree of disability did not progress. No major adverse events were reported in relation to the first dose of the drug, nor in the short- and medium-term treatment. No patient has been followed for longer than 18 months, thus limiting long-term conclusions. CONCLUSIONS: Off-label use of fingolimod in patients younger than age 18 years may be a good therapeutic option for multiple sclerosis control.
C1 [Fragoso, Yara Dadalti] Univ Metropolitana Santos, Dept Neurol, Santos, SP, Brazil.
   [Fragoso, Yara Dadalti] Univ Metropolitana Santos, MS Unit, Santos, SP, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Dept Neurol, Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, MS Unit, Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza Vieira; Papais-Alvarenga, Regina Maria] Univ Fed Estado Rio de Janeiro, Dept Neurol, Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza Vieira; Papais-Alvarenga, Regina Maria] Univ Fed Estado Rio de Janeiro, MS Unit, Rio De Janeiro, RJ, Brazil.
   [Barreira, Amilton Antunes; Marques, Vanessa Daccach] Univ Sao Paulo, Dept Neurol, BR-14049 Ribeirao Preto, SP, Brazil.
   [Barreira, Amilton Antunes; Marques, Vanessa Daccach] Univ Sao Paulo, MS Unit, BR-14049 Ribeirao Preto, SP, Brazil.
   [Callegaro, Dagoberto; Apostolos Pereira, Samira Luisa] Univ Sao Paulo, Hosp Clin, Dept Neurol, Sao Paulo, SP, Brazil.
   [Callegaro, Dagoberto; Apostolos Pereira, Samira Luisa] Univ Sao Paulo, Hosp Clin, MS Unit, Sao Paulo, SP, Brazil.
   [Brito Ferreira, Maria Lucia; Moraes Machado, Maria Iris] Hosp Restauracao Recife, Dept Neurol, Recife, PE, Brazil.
   [Brito Ferreira, Maria Lucia; Moraes Machado, Maria Iris] Hosp Restauracao Recife, MS Unit, Recife, PE, Brazil.
   [Finkelsztejn, Alessandro] Hosp Clin Porto Alegre, Dept Neurol, Porto Alegre, RS, Brazil.
   [Finkelsztejn, Alessandro] Hosp Clin Porto Alegre, MS Unit, Porto Alegre, RS, Brazil.
   [Gomes, Sidney] Hosp Beneficencia Portuguesa, Dept Neurol, Sao Paulo, SP, Brazil.
   [Gomes, Sidney] Hosp Beneficencia Portuguesa, MS Unit, Sao Paulo, SP, Brazil.
   [Gomes, Sidney] Hosp Paulistano, Sao Paulo, SP, Brazil.
   [Magno Goncalves, Marcus Vinicius] Hosp Reg Hans Dieter Schimidt, Dept Neurol, Joinville, SC, Brazil.
   [Magno Goncalves, Marcus Vinicius] Hosp Reg Hans Dieter Schimidt, MS Unit, Joinville, SC, Brazil.
   [Cunha Matta, Andre Palma] Univ Fed Fluminense, Dept Neurol, Niteroi, RJ, Brazil.
   [Cunha Matta, Andre Palma] Univ Fed Fluminense, MS Unit, Niteroi, RJ, Brazil.
   [Tauil, Carlos Bernardo] Hosp Base Dist Fed, Dept Neurol, Brasilia, DF, Brazil.
   [Tauil, Carlos Bernardo] Hosp Base Dist Fed, MS Unit, Brasilia, DF, Brazil.
RP Fragoso, YD (corresponding author), Univ Metropolitana Santos, Sch Med, Dept Neurol, Rua Constituicao 374, BR-11015470 Santos, SP, Brazil.
EM yara@bsnet.com.br
RI Leon, Soniza V Alves/J-7786-2012; Tauil, Carlos Bernardo/T-3095-2019
OI Tauil, Carlos Bernardo/0000-0003-1137-2398; Papais-Alvarenga, Regina
   Maria/0000-0002-1141-8619; Barreira, Amilton/0000-0002-4791-223X
CR Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3
   Chitnis T, 2013, NEUROTHERAPEUTICS, V10, P89, DOI 10.1007/s13311-012-0158-1
   Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825
   Fragoso YD, 2014, PEDIATR NEUROL, V50, P66, DOI 10.1016/j.pediatrneurol.2013.07.003
   Fragoso YD, 2013, ARQ NEURO-PSIQUIAT, V71, P783, DOI 10.1590/0004-282X20130122
   Ghezzi A, 2013, MULT SCLER J, V19, P1106, DOI 10.1177/1352458512471878
   Jain N, 2012, NEUROLOGY, V78, P672, DOI 10.1212/WNL.0b013e318248deea
   Kornek B, 2013, NEUROPEDIATRICS, V44, P309, DOI 10.1055/s-0033-1359308
   Krupp LB, 2013, MULT SCLER J, V19, P1261, DOI 10.1177/1352458513484547
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Liliom K, 2001, BIOCHEM J, V355, P189, DOI 10.1042/0264-6021:3550189
   Sanford M, 2014, DRUGS, V74, P1411, DOI 10.1007/s40265-014-0264-y
   Schmouder R, 2006, J CLIN PHARMACOL, V46, P895, DOI 10.1177/0091270006289853
   Tebembaum SN, 2013, CLIN NEUROL NEUROSUR, V115, pS21, DOI 10.1016/j.clineuro.2013.09.016
   Vanoli E, 2014, CNS NEUROSCI THER, V20, P496, DOI 10.1111/cns.12283
   Waldman A, 2014, LANCET NEUROL, V13, P936, DOI 10.1016/S1474-4422(14)70093-6
   Zarbin MA, 2013, OPHTHALMOLOGY, V120, P1432, DOI 10.1016/j.ophtha.2012.12.040
NR 17
TC 24
Z9 25
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD AUG
PY 2015
VL 53
IS 2
BP 166
EP 168
DI 10.1016/j.pediatrneurol.2015.03.024
PG 3
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA CO7HH
UT WOS:000359329700011
PM 26026897
DA 2020-12-01
ER

PT J
AU Paradela, ER
   Alves-Leon, SV
   Figueiredo, ALS
   Pereira, VCSR
   Malfetano, F
   Mansur, LF
   Scherpenhuijzen, S
   Agostinho, LA
   Rocha, CF
   Rueda-Lopes, F
   Gasparetto, E
   Paiva, CLA
AF Paradela, Eduardo R.
   Alves-Leon, Soniza V.
   Figueiredo, Andre L. S.
   Pereira, Valeria C. S. R.
   Malfetano, Fabiola
   Mansur, Leticia F.
   Scherpenhuijzen, Simone
   Agostinho, Luciana A.
   Rocha, Catielly F.
   Rueda-Lopes, Fernanda
   Gasparetto, Emerson
   Paiva, Carmen L. A.
TI The CIITA genetic polymorphism rs4774*C in combination with the
   HLA-DRB1*15:01 allele as a putative susceptibility factor to multiple
   sclerosis in Brazilian females
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE CIITA gene; HLA; rs4774*C; HLA-DRB1*15:01; multiple sclerosis
ID ASSOCIATION; MHC2TA; CITY
AB The objective of this study was to investigate the association between the HLA alleles at the DQA1, DQB1 and DRB1 loci, the CIITA genetic polymorphisms - 168A/G and +1614G/C, and susceptibility to multiple sclerosis (MS) in a sample from Rio de Janeiro State, Brazil. Furthermore, we wished to determine whether any of these associations might be more significant in women compared with men. DNA samples from 52 relapsing-remitting MS (RRMS) patients and 126 healthy controls matched for sex and age were analyzed. We identified a significant HLA-DRB1*15:01-MS association that was female-specific (Odds Ratio (OR) = 4.78; p = .001). Furthermore, we observed that the +1614G/C mutation in combination with the HLA-DRB1*15:01 allele increased susceptibility to MS in females (OR = 4.55; p = .01). Together, these findings highlight the polygenic nature of MS.
C1 [Paradela, Eduardo R.; Alves-Leon, Soniza V.; Figueiredo, Andre L. S.; Paiva, Carmen L. A.] Univ Fed Estado Rio de Janeiro, Dept Neurol, BR-20270004 Rio De Janeiro, RJ, Brazil.
   [Paradela, Eduardo R.; Alves-Leon, Soniza V.; Figueiredo, Andre L. S.; Agostinho, Luciana A.; Rocha, Catielly F.; Paiva, Carmen L. A.] Univ Fed Estado Rio de Janeiro, Dept Genet & Biol Mol, Lab Biol Mol, BR-20270004 Rio De Janeiro, RJ, Brazil.
   [Paradela, Eduardo R.] Inst Brasileiro Med & Reabilitacao, Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza V.; Pereira, Valeria C. S. R.; Malfetano, Fabiola; Mansur, Leticia F.; Scherpenhuijzen, Simone; Rueda-Lopes, Fernanda; Gasparetto, Emerson] Univ Fed Rio de Janeiro, Univ Clementino Fraga Filho, Ctr Referencia Esclerose Multipla & Outras Doenca, Rio De Janeiro, RJ, Brazil.
   [Rueda-Lopes, Fernanda; Gasparetto, Emerson] Univ Fed Rio de Janeiro, Dept Radiol, Rio De Janeiro, RJ, Brazil.
RP Alves-Leon, SV (corresponding author), Univ Fed Estado Rio de Janeiro, Programa Pos Grad Neurol, Rua Mariz & Barros,775-2 Andar Tijuca, BR-20270004 Rio De Janeiro, RJ, Brazil.
EM sonizavleon@pesquisador.cnpq.br
RI Leon, Soniza V Alves/J-7786-2012; PARADELA, EDUARDO/AAW-6807-2020;
   Paiva, C. L. A./A-1503-2010; Agostinho, Luciana/H-7994-2015
OI Paiva, C. L. A./0000-0003-2877-0296; Agostinho,
   Luciana/0000-0001-5604-8386
FU PROAP/CAPESCAPES; FINEPCiencia Tecnologia e Inovacao (FINEP)
FX The authors are grateful to PROAP/CAPES and FINEP for their financial
   support.
CR Alcina A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029819
   Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34
   Alves-Leon SV, 2007, ACTA NEUROL SCAND, V115, P306, DOI 10.1111/j.1600-0404.2006.00750.x
   Bettencourt Andreia, 2012, Acta Med Port, V25, P224
   Bronson PG, 2010, HUM MOL GENET, V19, P2331, DOI 10.1093/hmg/ddq101
   Brum DG, 2007, J NEUROIMMUNOL, V189, P118, DOI 10.1016/j.jneuroim.2007.06.009
   Caballero A, 1999, TISSUE ANTIGENS, V54, P524, DOI 10.1034/j.1399-0039.1999.540511.x
   CALLEGARO D, 1992, NEUROEPIDEMIOLOGY, V11, P11, DOI 10.1159/000110901
   Cree BAC, 2009, ARCH NEUROL-CHICAGO, V66, P226, DOI 10.1001/archneurol.2008.541
   Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X
   Friese MA, 2005, TRENDS IMMUNOL, V26, P559, DOI 10.1016/j.it.2005.08.011
   Haines J L, 1999, Curr Dir Autoimmun, V1, P273
   Hensiek AE, 2002, J NEUROL NEUROSUR PS, V72, P184, DOI 10.1136/jnnp.72.2.184
   Irizar H, 2012, MULT SCLER J, V18, P569, DOI 10.1177/1352458511426813
   Kaimen-Maciel DR, 2009, MOL MED REP, V2, P993, DOI 10.3892/mmr_00000204
   Kemppinen AK, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000053
   Kikuchi S, 2002, J NEUROIMMUNOL, V128, P77, DOI 10.1016/S0165-5728(02)00140-6
   KRIEGER H, 1965, ANN HUM GENET, V29, P113, DOI 10.1111/j.1469-1809.1965.tb00507.x
   Mehta NT, 2011, EPIGENETICS-US, V6, P517, DOI 10.4161/epi.6.4.14516
   Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997
   Patarroyo JC, 2002, GENES IMMUN, V3, P34, DOI 10.1038/sj.gene.6363808
   Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703
   Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369
   Rasmussen HB, 2001, HUM IMMUNOL, V62, P371, DOI 10.1016/S0198-8859(01)00215-4
   Lacativa MCS, 2012, MULT SCLER J, V18, P1850
   Santos CCC, 2002, ARQ NEURO-PSIQUIAT, V60, P1051, DOI 10.1590/S0004-282X2002000600037
   Silva AM, 2007, J NEUROL SCI, V258, P69, DOI 10.1016/j.jns.2007.02.033
   Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544
   Weber F, 2008, GENES IMMUN, V9, P259, DOI 10.1038/gene.2008.14
   Zuvich RL, 2011, HUM MOL GENET, V20, P3517, DOI 10.1093/hmg/ddr250
NR 30
TC 3
Z9 3
U1 0
U2 3
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD APR
PY 2015
VL 73
IS 4
BP 283
EP 288
DI 10.1590/0004-282X20150012
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA CI5IA
UT WOS:000354787600002
PM 25992516
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Diniz, LP
   Tortelli, V
   Garcia, MN
   Araujo, APB
   Melo, HM
   da Silva, GSS
   De Felice, FG
   Alves-Leon, SV
   de Souza, JM
   Romao, LF
   Castro, NG
   Gomes, FCA
AF Diniz, Luan Pereira
   Tortelli, Vanessa
   Garcia, Matheus Nunes
   Bergamo Araujo, Ana Paula
   Melo, Helen M.
   Seixas da Silva, Gisele S.
   De Felice, Fernanda G.
   Alves-Leon, Soniza Vieira
   de Souza, Jorge Marcondes
   Romao, Luciana Ferreira
   Castro, Newton Goncalves
   Alcantara Gomes, Flavia Carvalho
TI Astrocyte Transforming Growth Factor Beta 1 Promotes Inhibitory Synapse
   Formation via CaM Kinase II Signaling
SO GLIA
LA English
DT Article
DE inhibitory synapse; astrocyte; TGF-1; CaMKII; Neuroligin 2
ID RAT HIPPOCAMPAL-NEURONS; GFAP GENE PROMOTER; LONG-TERM CHANGES; CNS
   SYNAPTOGENESIS; AMPA RECEPTORS; EXCITATORY SYNAPSES; CULTURED
   ASTROCYTES; SECRETED PROTEINS; GABA(A) RECEPTORS; PROGENITOR CELLS
AB The balance between excitatory and inhibitory synaptic inputs is critical for the control of brain function. Astrocytes play important role in the development and maintenance of neuronal circuitry. Whereas astrocytes-derived molecules involved in excitatory synapses are recognized, molecules and molecular mechanisms underlying astrocyte-induced inhibitory synapses remain unknown. Here, we identified transforming growth factor beta 1 (TGF-1), derived from human and murine astrocytes, as regulator of inhibitory synapse in vitro and in vivo. Conditioned media derived from human and murine astrocytes induce inhibitory synapse formation in cerebral cortex neurons, an event inhibited by pharmacologic and genetic manipulation of the TGF- pathway. TGF-1-induction of inhibitory synapse depends on glutamatergic activity and activation of CaM kinase II, which thus induces localization and cluster formation of the synaptic adhesion protein, Neuroligin 2, in inhibitory postsynaptic terminals. Additionally, intraventricular injection of TGF-1 enhanced inhibitory synapse number in the cerebral cortex. Our results identify TGF-1/CaMKII pathway as a novel molecular mechanism underlying astrocyte control of inhibitory synapse formation. We propose here that the balance between excitatory and inhibitory inputs might be provided by astrocyte signals, at least partly achieved via TGF-1 downstream pathways. Our work contributes to the understanding of the GABAergic synapse formation and may be of relevance to further the current knowledge on the mechanisms underlying the development of various neurological disorders, which commonly involve impairment of inhibitory synapse transmission. GLIA 2014;62:1917-1931
   Main Points <list id="glia22713-list-0001" list-type="bulleted"> <list-item id="glia22713-li-0001">We identified TGF-1, derived from human and murine astrocytes, as regulator of inhibitory synapse in vitro and in vivo. <list-item id="glia22713-li-0002">This event depends on glutamatergic activity and activation of CaM kinase II pathway.
C1 [Diniz, Luan Pereira; Tortelli, Vanessa; Garcia, Matheus Nunes; Bergamo Araujo, Ana Paula; Castro, Newton Goncalves; Alcantara Gomes, Flavia Carvalho] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Melo, Helen M.; Seixas da Silva, Gisele S.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza Vieira; de Souza, Jorge Marcondes] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Romao, Luciana Ferreira] Univ Fed Rio de Janeiro, UFRJ Polo Macae, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Gomes, FCA (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM fgomes@icb.ufrj.br
RI Castro, Newton G/C-3263-2009; Romao, Luciana/I-4291-2015; Leon, Soniza V
   Alves/J-7786-2012; Gomes, Flavia/C-5383-2013
OI Castro, Newton G/0000-0001-9570-7428; Gomes, Flavia/0000-0003-2966-0638
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Institute of Glia (iGLIA/CNPq); Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES)CAPES; Fundacao Carlos Chagas Filho
   de Amparoa Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ)
FX Grant sponsors: Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Institute of Glia (iGLIA/CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao Carlos
   Chagas Filho de Amparoa Pesquisa do Estado do Rio de Janeiro (FAPERJ).
CR Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059
   Araque A, 1999, CAN J PHYSIOL PHARM, V77, P699, DOI 10.1139/cjpp-77-9-699
   Ashwood P, 2008, J NEUROIMMUNOL, V204, P149, DOI 10.1016/j.jneuroim.2008.07.006
   Bae J.J, 2011, INT J PHYSL PATH PHA, V3, P9
   Blackburn D, 2009, GLIA, V57, P1251, DOI 10.1002/glia.20848
   Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x
   Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009
   Chin J, 1999, LEARN MEMORY, V6, P317
   Chin J, 2006, J NEUROPHYSIOL, V95, P3286, DOI 10.1152/jn.00770.2005
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029
   Ciani L, 2011, P NATL ACAD SCI USA, V108, P10732, DOI 10.1073/pnas.1018132108
   Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011
   Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824
   Elmariah SB, 2005, J NEUROSCI, V25, P3638, DOI 10.1523/JNEUROSCI.3980-04.2005
   Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612
   Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008
   Fortin DA, 2012, J NEUROSCI, V32, P8127, DOI 10.1523/JNEUROSCI.6034-11.2012
   Garrett AM, 2009, J NEUROSCI, V29, P11723, DOI 10.1523/JNEUROSCI.2818-09.2009
   Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009
   Gomes FCA, 1999, GLIA, V26, P97
   Gomes FCA, 2005, INT J DEV NEUROSCI, V23, P413, DOI 10.1016/j.ijdevneu.2005.04.001
   Gomes FCA, 1999, GLIA, V25, P247, DOI 10.1002/(SICI)1098-1136(19990201)25:3<247::AID-GLIA5>3.3.CO;2-U
   Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035
   Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8
   Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015
   Hennekinne L, 2013, J NEUROSCI, V33, P11432, DOI 10.1523/JNEUROSCI.5247-12.2013
   Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108
   Houston CM, 2009, J PHYSIOL-LONDON, V587, P2115, DOI 10.1113/jphysiol.2009.171603
   Hughes EG, 2010, MOL CELL NEUROSCI, V43, P136, DOI 10.1016/j.mcn.2009.10.004
   Kalmbach Abigail, 2010, Front Synaptic Neurosci, V2, P27, DOI 10.3389/fnsyn.2010.00027
   Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684
   Koeglsperger T, 2013, GLIA, V61, P985, DOI 10.1002/glia.22490
   Kraus S, 2013, GLIA, V61, P1767, DOI 10.1002/glia.22551
   Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877
   Krieglstein K, 2011, TRENDS NEUROSCI, V34, P421, DOI 10.1016/j.tins.2011.06.002
   Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108
   Spohr TCLDE, 2011, J NEUROCHEM, V119, P113, DOI 10.1111/j.1471-4159.2011.07421.x
   Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200
   Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192
   Liu QY, 1997, J NEUROBIOL, V33, P848, DOI 10.1002/(SICI)1097-4695(19971120)33:6<848::AID-NEU11>3.3.CO;2-8
   Liu QY, 1996, J NEUROSCI, V16, P2912
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maira M, 2010, J NEURODEV DISORD, V2, P48, DOI [10.1007/s11689-009-9035-6, 10.1007/s11689-009-9040-9]
   Marsden KC, 2007, J NEUROSCI, V27, P14326, DOI 10.1523/JNEUROSCI.4433-07.2007
   Marsden KC, 2010, P NATL ACAD SCI USA, V107, P20559, DOI 10.1073/pnas.1010346107
   Martinez R, 2002, J BIOL CHEM, V277, P49311, DOI 10.1074/jbc.M209284200
   Marty S, 2000, J NEUROSCI, V20, P8087
   Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354
   Mazzanti M, 2003, GLIA, V41, P128, DOI 10.1002/glia.10135
   Noh J, 2010, NAT NEUROSCI, V13, P232, DOI 10.1038/nn.2478
   Potapenko ES, 2013, J NEUROSCI, V33, P631, DOI 10.1523/JNEUROSCI.3936-12.2013
   Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023
   Romao LF, 2008, J NEUROCHEM, V106, P746, DOI 10.1111/j.1471-4159.2008.05428.x
   Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389
   Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870
   Serio A, 2013, P NATL ACAD SCI USA, V110, P4697, DOI 10.1073/pnas.1300398110
   Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100
   Spohr TCDSE, 2008, J BIOL CHEM, V283, P7470, DOI 10.1074/jbc.M707758200
   Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522
   Stipursky J, 2012, DEV NEUROSCI-BASEL, V34, P68, DOI 10.1159/000338108
   Sun M, 2010, J NEUROSCI, V30, P6025, DOI 10.1523/JNEUROSCI.0789-10.2010
   Sutcigil L., 2007, CLIN DEV IMMUNOL, V2007, P76396, DOI DOI 10.1155/2007/76396.PMID:18317531
   Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041
   Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410
   Verbich D, 2012, GLIA, V60, P1067, DOI 10.1002/glia.22335
   Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256
   Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008
   Witcher MR, 2010, GLIA, V58, P572, DOI 10.1002/glia.20946
   Zhou YX, 2003, J BIOL CHEM, V278, P42313, DOI 10.1074/jbc.M308287200
NR 70
TC 42
Z9 44
U1 0
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0894-1491
EI 1098-1136
J9 GLIA
JI Glia
PD DEC
PY 2014
VL 62
IS 12
BP 1917
EP 1931
DI 10.1002/glia.22713
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA AS4HX
UT WOS:000344236000001
PM 25042347
DA 2020-12-01
ER

PT J
AU Correale, J
   Abad, P
   Alvarenga, R
   Alves-Leon, S
   Armas, E
   Barahona, J
   Buzo, R
   Corona, T
   Cristiano, E
   Gracia, F
   Bonitto, JG
   Macias, MA
   Soto, A
   Vizcarra, D
   Freedman, MS
AF Correale, Jorge
   Abad, Patricio
   Alvarenga, Regina
   Alves-Leon, Soniza
   Armas, Elizabeth
   Barahona, Jorge
   Buzo, Ricardo
   Corona, Teresa
   Cristiano, Edgardo
   Gracia, Fernando
   Bonitto, Juan Garcia
   Macias, Miguel Angel
   Soto, Arnoldo
   Vizcarra, Darwin
   Freedman, Mark S.
TI Management of relapsing-remitting multiple sclerosis in Latin America:
   Practical recommendations for treatment optimization
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Multiple sclerosis; Treatment; Relapses; Disability; MRI; Latin America;
   Clinical recommendations; Algorithm
ID PLACEBO-CONTROLLED TRIAL; LONG-TERM DISABILITY; PROGRESSIVE MULTIFOCAL
   LEUKOENCEPHALOPATHY; INTRAMUSCULAR INTERFERON BETA-1A; CLINICALLY
   ISOLATED SYNDROME; VITAMIN-D; NEUTRALIZING ANTIBODIES; COGNITIVE
   IMPAIRMENT; DISEASE-ACTIVITY; NEUROPSYCHOLOGICAL ASSESSMENT
AB The Latin American MS Experts' Forum has developed practical recommendations on the initiation and optimization of disease-modifying therapies in patients with relapsing-remitting multiple sclerosis (RRMS). The recommendations reflect the unique epidemiology of MS and the clinical practice -environment in Latin American countries. Treatment response may be evaluated according to changes in relapses; progression, as assessed by the Expanded Disability Status Scale and the Timed 25-foot Walk; and lesion number on magnetic resonance imaging. Follow-up assessments are recommended every six months, or annually for stable patients. Cognitive function should be evaluated in all RRMS patients at baseline and annually thereafter. These recommendations are intended to assist clinicians in Latin America in developing a rational approach to treatment selection and sequencing for their RRMS patients. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Correale, Jorge] Inst Neurol Res Dr Raul Carrea FLENI, RA-1428 Buenos Aires, DF, Argentina.
   [Abad, Patricio] Hosp Metropolitano, Quito, Ecuador.
   [Alvarenga, Regina] MS Hosp Da Lagoa, Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, BR-21941 Rio De Janeiro, Brazil.
   [Armas, Elizabeth] Hosp Univ Caracas, Catedra Neurol, Caracas, Venezuela.
   [Barahona, Jorge] Clin Alemana, Santiago, Chile.
   [Buzo, Ricardo] Hosp Clin Montevideo, Inst Neurol, Fac Med, Montevideo, Uruguay.
   [Corona, Teresa] Inst Nacl Neurol & Neurocirugia Manuel Velasco Su, Mexico City, DF, Mexico.
   [Cristiano, Edgardo] Hosp Italian Buenos Aires, Buenos Aires, DF, Argentina.
   [Gracia, Fernando] Fac Ciencias Salud ULACIT, Panama City, Panama.
   [Bonitto, Juan Garcia] Serv Neurol Clin Marty & Entidad Prestado Serv Sa, Bogota, Colombia.
   [Macias, Miguel Angel] Dept Neurociencias CUCS UdeG, Guadalajara, Jalisco, Mexico.
   [Soto, Arnoldo] Ctr Med Docente Trinidad, Caracas, Venezuela.
   [Vizcarra, Darwin] Univ Peruana Cayetano Heredia, Hypnos Inst Suerio, Lima, Peru.
   [Freedman, Mark S.] Univ Ottawa, Ottawa Hosp Res Inst, Multiple Sclerosis Res Unit, Ottawa, ON, Canada.
RP Correale, J (corresponding author), Inst Neurol Res Dr Raul Carrea FLENI, Montaneses 2325, RA-1428 Buenos Aires, DF, Argentina.
EM jcorreale@fleni.org.ar
RI Correale, Jorge/AAG-4245-2020; caputo, carlo/N-3747-2014; Leon, Soniza V
   Alves/J-7786-2012; Vizcarra, Darwin/AAM-7728-2020
OI Vizcarra, Darwin/0000-0002-8342-9640
FU Novartis Latin America; Novartis Canada Pharmaceuticals Inc.
FX The July 2013 meeting of the Latin American MS Experts' Forum was
   sponsored by Novartis Latin America. No funding was provided to the
   authors for writing the manuscript, and the sponsor did not contribute
   to the drafting, content or review of the manuscript. The authors
   acknowledge the assistance of Steven Manners of Communications
   Lansdowne, whose help was made possible through funding from Novartis
   Latin America and Novartis Canada Pharmaceuticals Inc.
CR Abad P, 2010, NEUROLOGIA, V25, P309, DOI 10.1016/j.nrl.2009.12.005
   Abad P, 2012, REV NEUROLOGIA, V55, P737, DOI 10.33588/rn.5512.2012306
   Alvarado-de la Barrera C, 2000, NEUROLOGY, V55, P1897, DOI 10.1212/WNL.55.12.1897
   Alves-Leon SV, 2007, ACTA NEUROL SCAND, V115, P306, DOI 10.1111/j.1600-0404.2006.00750.x
   Amato MP, 2013, J NEUROL, V260, P1452, DOI 10.1007/s00415-012-6678-0
   [Anonymous], 1998, FAT MULT SCLER EV BA
   [Anonymous], 2010, NEUROLOGY, V74, P1877
   [Anonymous], 2012, AUB TER PROD MON
   Arberas C, 2006, REV NEUROL, V43, P15
   Arnett PA, 1999, NEUROPSYCHOLOGY, V13, P434, DOI 10.1037/0894-4105.13.3.434
   Arruda WO, 2001, ARQ NEURO-PSIQUIAT, V59, P165, DOI 10.1590/S0004-282X2001000200002
   Bates D, 2011, NEUROLOGY, V76, pS14, DOI 10.1212/WNL.0b013e3182050388
   BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004
   Benedict RHB, 2002, CLIN NEUROPSYCHOL, V16, P381, DOI 10.1076/clin.16.3.381.13859
   Bergamaschi R, 2001, J NEUROL SCI, V189, P13, DOI 10.1016/S0022-510X(01)00572-X
   Berger JR, 2013, ANN NEUROL, V74, P84, DOI 10.1002/ana.23893
   Bergvall N, 2013, CURR MED RES OPIN, V29, P1647, DOI 10.1185/03007995.2013.847411
   Bermel RA, 2010, MULT SCLER J, V16, P588, DOI 10.1177/1352458509360549
   Brooks JBB, 2011, ARQ NEURO-PSIQUIAT, V69, P887, DOI 10.1590/S0004-282X2011000700007
   Binquet C, 2006, NEUROEPIDEMIOLOGY, V27, P45, DOI 10.1159/000094380
   Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829
   Bostrom I, 2013, MULT SCLER J, V19, P46, DOI 10.1177/1352458512446169
   Braune S, 2013, J NEUROL, V260, P2981, DOI 10.1007/s00415-013-7082-0
   Caceres F, 2011, J CLIN EXP NEUROPSYC, V33, P1094, DOI 10.1080/13803395.2011.603690
   Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174
   Calabresi PA, 2007, NEUROLOGY, V69, P1391, DOI 10.1212/01.wnl.0000277457.17420.b5
   Calabresi PA, 2012, 28 C EUR COMM TREATM
   Callegaro D, 2001, ACTA NEUROL SCAND, V104, P208, DOI 10.1034/j.1600-0404.2001.00372.x
   CALLEGARO D, 1992, NEUROEPIDEMIOLOGY, V11, P11, DOI 10.1159/000110901
   Cardoso E, 2006, ARQ NEURO-PSIQUIAT, V64, P727, DOI 10.1590/S0004-282X2006000500005
   Carra Adriana, 2011, Ther Adv Neurol Disord, V4, P349, DOI 10.1177/1756285611423560
   Castillo-Trivino T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016664
   Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839
   Cohen M, 2013, 29 C EUR COMM TREATM
   Comi G, 2013, 29 C EUR COMM TREATM
   Corona T, 2006, NEUROEPIDEMIOLOGY, V26, P1, DOI 10.1159/000089230
   Correale J, 2008, Int MS J, V15, P3
   Correale J, 2007, ANN NEUROL, V61, P97, DOI 10.1002/ana.21067
   Correale J, 2011, J NEUROL SCI, V311, P23, DOI 10.1016/j.jns.2011.06.027
   Cree BAC, 2005, ARCH NEUROL-CHICAGO, V62, P1681, DOI 10.1001/archneur.62.11.1681
   Cree BAC, 2011, ARCH NEUROL-CHICAGO, V68, P464, DOI 10.1001/archneurol.2011.45
   Cristiano E, 2009, EUR J NEUROL, V16, P183, DOI 10.1111/j.1468-1331.2008.02375.x
   Cristiano E, 2013, MULT SCLER J, V19, P844, DOI 10.1177/1352458512462918
   D'hooghe MB, 2012, MULT SCLER J, V18, P451, DOI 10.1177/1352458511423778
   Damasceno A, 2013, J NEUROL SCI, V324, P29, DOI 10.1016/j.jns.2012.09.020
   de Oliveira Tatiana de Melo Gomes, 2008, Patient Prefer Adherence, V2, P41
   de Seze J, 2013, 29 C EUR COMM TREATM
   Duque P, 2012, REV NEUROLOGIA, V54, P263, DOI 10.33588/rn.5405.2011452
   Ebers GC, 2010, J NEUROL NEUROSUR PS, V81, P907, DOI 10.1136/jnnp.2009.204123
   European S, 1998, LANCET, V352, P1491
   Evans C, 2012, CLIN THER, V34, P341, DOI 10.1016/j.clinthera.2012.01.006
   Ferreira Vasconcelos CC, 2012, ISRN NEUROL, V2012
   Feuillet L, 2007, MULT SCLER, V13, P124, DOI 10.1177/1352458506071196
   Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409
   Fleming JO, 2006, NEUROLOGY, V67, P2085, DOI 10.1212/01.wnl.0000247663.40297.2d
   Flores J, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/292631
   Fogarty E, 2013, 29 C EUR COMM TREATM
   Ford C, 2010, MULT SCLER, V16, P342, DOI 10.1177/1352458509358088
   Freedman MS, 2013, CAN J NEUROL SCI, V40, P307, DOI 10.1017/S0317167100014244
   Freedman MS, 2011, NEUROL-CLIN PRACT, V1, P66, DOI 10.1212/CPJ.0b013e31823cc2c2
   Garcea O, 2009, Mult Scler, V15 Suppl 3, pS1, DOI 10.1177/1352458509106419
   Merino AG, 2010, NEUROLOGIA, V25, P378, DOI 10.1016/j.nrl.2010.03.006
   GONZALEZ O, 1995, J NEUROL NEUROSUR PS, V59, P528, DOI 10.1136/jnnp.59.5.528
   Goodin DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022444
   Gorelik L, 2010, ANN NEUROL, V68, P295, DOI 10.1002/ana.22128
   GORODEZKY C, 1985, TISSUE ANTIGENS, V25, P38
   Handunnetthi L, 2010, NEUROLOGY, V74, P1905, DOI 10.1212/WNL.0b013e3181e24124
   Havla J, 2013, J NEUROL, V260, P1382, DOI 10.1007/s00415-012-6808-8
   Havrdova E, 2010, NEUROLOGY, V74, pS3, DOI 10.1212/WNL.0b013e3181dbb51c
   Havrdova E, 2009, LANCET NEUROL, V8, P254, DOI 10.1016/S1474-4422(09)70021-3
   Healy BC, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/189624
   Heesen C, 2010, BRAIN BEHAV IMMUN, V24, P1148, DOI 10.1016/j.bbi.2010.05.006
   Hegen H, 2012, MULT SCLER J, V18, P610, DOI 10.1177/1352458511426738
   Holmoy T, 2012, ACTA NEUROL SCAND, V126, P63, DOI 10.1111/ane.12028
   Rojas JI, 2012, MEDICINA-BUENOS AIRE, V72, P449
   Dominguez-Mozo MI, 2013, J NEUROIMMUNE PHARM, V8, P1277, DOI 10.1007/s11481-013-9496-y
   Jeannin S, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/950126
   Jokubaitis VG, 2013, 29 C EUR COMM TREATM
   Jordy SS, 2008, ARQ NEURO-PSIQUIAT, V66, P11, DOI 10.1590/S0004-282X2008000100004
   Jungedal R, 2012, MULT SCLER J, V18, P1775, DOI 10.1177/1352458512446036
   Kalmar JH, 2008, NEUROPSYCHOLOGY, V22, P442, DOI 10.1037/0894-4105.22.4.442
   Kampman MT, 2012, MULT SCLER J, V18, P1144, DOI 10.1177/1352458511434607
   Kappos L, 2005, NEUROLOGY, V65, P40, DOI 10.1212/01.wnl.0000171747.59767.5c
   Kappos L, 2011, NEUROLOGY, V76, pA563
   Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494
   Kappos L, 2009, LANCET NEUROL, V8, P987, DOI 10.1016/S1474-4422(09)70237-6
   Katrych O, 2009, CNS NEUROL DISORD-DR, V8, P512, DOI 10.2174/187152709789824598
   Kaufman M, 2000, MULT SCLER, V6, P286, DOI 10.1177/135245850000600411
   Kerbrat A, 2011, J NEUROL SCI, V308, P98, DOI 10.1016/j.jns.2011.05.043
   KETZOIAN C, 1999, ACTA NEUROL COLOMB, V15, P6
   Khan O, 2013, 29 C EUR COMM TREATM
   Khatri B, 2012, NEUROLOGY S1, V78
   Kinkel RP, 2012, ARCH NEUROL-CHICAGO, V69, P183, DOI 10.1001/archneurol.2011.1426
   Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9
   Kister I, 2010, NEUROLOGY, V75, P217, DOI 10.1212/WNL.0b013e3181e8e72a
   Klineova S, 2012, ETHNIC DIS, V22, P221
   Korteweg T, 2009, MULT SCLER, V15, P465, DOI 10.1177/1352458508100505
   KOSTYU DD, 1981, TISSUE ANTIGENS, V17, P111
   Kragt JJ, 2009, MULT SCLER J, V15, P9, DOI 10.1177/1352458508095920
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   La Mantia L, 2010, COCHRANE DB SYST REV, P5
   La Mantia L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005181.pub3
   Lana-Peixoto MA, 2012, ARQ NEURO-PSIQUIAT, V70, P102, DOI 10.1590/S0004-282X2012000200006
   Langer-Gould A, 2006, ARCH NEUROL-CHICAGO, V63, P1686, DOI 10.1001/archneur.63.12.1686
   Lanzillo R, 2013, 29 C EUR COMM TREATM
   Laplaud D, 2012, REV NEUROL-FRANCE, V168, P425, DOI 10.1016/j.neurol.2012.02.006
   Leone MA, 2008, MULT SCLER J, V14, P485, DOI 10.1177/1352458507084650
   Lucas RM, 2011, NEUROLOGY, V76, P540, DOI 10.1212/WNL.0b013e31820af93d
   Luetic G, 2008, Int MS J, V15, P6
   Lukas C, 2010, J NEUROL NEUROSUR PS, V81, P1351, DOI 10.1136/jnnp.2009.199968
   Masterman T, 2000, ANN NEUROL, V48, P211, DOI 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.0.CO;2-R
   Melcon MO, 2008, MULT SCLER J, V14, P656, DOI 10.1177/1352458507085801
   Melis M, 2014, NEUROL SCI, V35, P401, DOI 10.1007/s10072-013-1527-1
   Messina MJ, 2013, 29 C EUR COMM TREATM
   Miller A, 2013, 65 AM AC NEUR ANN M
   Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878
   Miravalle A, 2011, ARCH NEUROL-CHICAGO, V68, P186, DOI 10.1001/archneurol.2010.257
   Mirsattari SM, 2001, NEUROLOGY, V56, P317, DOI 10.1212/WNL.56.3.317
   Mowry EM, 2012, ANN NEUROL, V72, P234, DOI 10.1002/ana.23591
   Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832
   Nogales-Gaete J, 2012, REV MED CHILE, V140, P1437, DOI 10.4067/S0034-98872012001100009
   O'Connor PW, 2011, NEUROLOGY, V76, P1858, DOI 10.1212/WNL.0b013e31821e7c8a
   O'Connor P, 2011, NEW ENGL J MED, V365, P1293, DOI 10.1056/NEJMoa1014656
   Ojeda E, 2013, CLIN NEUROL NEUROSUR, V115, P381, DOI 10.1016/j.clineuro.2012.11.028
   Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6
   Panitch H, 2004, NEUROLOGY, V63, P1788
   Paolillo A, 2002, EUR J NEUROL, V9, P645, DOI 10.1046/j.1468-1331.2002.00476.x
   Paz Soldan MM, 2013, 29 C EUR COMM TREATM
   Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397
   Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703
   Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366
   Potagas C, 2008, J NEUROL SCI, V267, P100, DOI 10.1016/j.jns.2007.10.002
   Prosperini L, 2009, EUR J NEUROL, V16, P1202, DOI 10.1111/j.1468-1331.2009.02708.x
   Putzki N, 2010, EUR J NEUROL, V17, P31, DOI 10.1111/j.1468-1331.2009.02728.x
   Quelvennec E, 2003, TISSUE ANTIGENS, V61, P166, DOI 10.1046/j.0001-2815.2002.00008.x
   Rao S. M., 1990, MANUAL BRIEF REPEATA
   RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692
   Rio J, 2008, MULT SCLER J, V14, P479, DOI 10.1177/1352458507085555
   Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740
   Rio J, 2002, ANN NEUROL, V52, P400, DOI 10.1002/ana.10290
   Rio J, 2009, MULT SCLER, V15, P848, DOI 10.1177/1352458509104591
   RIVERA VM, 2000, MEDICO INTERAMERICAN, V19, P458
   Robles-Cedeno R, 2013, 29 C EUR COMM TREATM
   Rojas OL, 2010, AUTOIMMUN REV, V9, P407, DOI 10.1016/j.autrev.2009.11.001
   Rotstein DC, 2013, 29 C EUR COMM TREATM
   RUNMARKER B, 1993, BRAIN, V116, P117, DOI 10.1093/brain/116.1.117
   Pereira VCS, 2012, ARQ NEURO-PSIQUIAT, V70, P774, DOI 10.1590/S0004-282X2012001000005
   Scalfari A, 2011, NEUROLOGY, V77, P1246, DOI 10.1212/WNL.0b013e318230a17d
   Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118
   Schwab N, 2013, NEUROLOGY, V81, P865, DOI 10.1212/WNL.0b013e3182a351fb
   Schwid SR, 2002, NEUROLOGY, V58, P1294, DOI 10.1212/WNL.58.8.1294
   Scott TF, 2010, J NEUROL SCI, V292, P52, DOI 10.1016/j.jns.2010.02.008
   Shirani A, 2013, JAMA NEUROL, V70, P651, DOI 10.1001/jamaneurol.2013.2197
   Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043
   Smith A., 1982, PSYCHOL SERVICES
   Smolders J, 2008, MULT SCLER J, V14, P1220, DOI 10.1177/1352458508094399
   Soilu-Hanninen M, 2012, J NEUROL NEUROSUR PS, V83, P566, DOI 10.1136/jnnp-2011-301876
   Solomon AJ, 2012, NEUROLOGY, V78, P1986, DOI 10.1212/WNL.0b013e318259e1b2
   Sorensen PS, 2012, MULT SCLER J, V18, P143, DOI 10.1177/1352458511435105
   Sorensen PS, 2005, NEUROLOGY, V65, P33, DOI 10.1212/01.WNL.0000166049.51502.6A
   Sorensen PS, 2003, LANCET, V362, P1184, DOI 10.1016/S0140-6736(03)14541-2
   Sormani MP, 2013, MULT SCLER J, V19, P605, DOI 10.1177/1352458512460605
   Spelman T, 2013, 29 C EUR COMM TREATM
   Stein MS, 2011, NEUROLOGY, V77, P1611, DOI 10.1212/WNL.0b013e3182343274
   Strober L, 2009, MULT SCLER J, V15, P1077, DOI 10.1177/1352458509106615
   Stuve O, 2009, NEUROLOGY, V72, P396, DOI 10.1212/01.wnl.0000327341.89587.76
   Suarez-Kurtz G, 2005, TRENDS PHARMACOL SCI, V26, P196, DOI 10.1016/j.tips.2005.02.008
   Tan CS, 2010, LANCET NEUROL, V9, P425, DOI 10.1016/S1474-4422(10)70040-5
   Tremlett H, 2009, NEUROLOGY, V73, P1616, DOI 10.1212/WNL.0b013e3181c1e44f
   Tremlett H, 2008, NEUROEPIDEMIOLOGY, V31, P271, DOI 10.1159/000166602
   Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D
   Uitdehaag Bernard, 2011, Ther Adv Neurol Disord, V4, P3, DOI 10.1177/1756285610391693
   Vellinga MM, 2008, NEUROLOGY, V70, P1150, DOI 10.1212/01.wnl.0000265393.03231.e5
   Vercellino M, 2009, ACTA NEUROL SCAND, V119, P126, DOI 10.1111/j.1600-0404.2008.01076.x
   Vermersch P, 2013, MULT SCLER
   Warnke C, 2013, 29 C EUR COMM TREATM
NR 176
TC 14
Z9 15
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD APR 15
PY 2014
VL 339
IS 1-2
BP 196
EP 206
DI 10.1016/j.jns.2014.02.017
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AG0RO
UT WOS:000335123500037
PM 24607335
DA 2020-12-01
ER

PT J
AU Papais-Alvarenga, RM
   Vasconcelos, CCF
   Alves-Leon, SV
   Batista, E
   Santos, CMM
   Camargo, SMGG
   Godoy, M
   Lacativa, MC
   Lorenti, M
   Damasceno, B
   Damasceno, A
   Brum, D
   Barreira, AA
   Rocha, MSG
   Alvarenga, H
   Tilbery, CP
AF Papais-Alvarenga, Regina M.
   Vasconcelos, Claudia C. F.
   Alves-Leon, Soniza V.
   Batista, Elizabeth
   Santos, Claudia M. M.
   Camargo, Solange M. G. G.
   Godoy, Mauricio
   Lacativa, Maria C.
   Lorenti, Mariangela
   Damasceno, Benito
   Damasceno, Alfredo
   Brum, Doralina
   Barreira, Amilton A.
   Guimaraes Rocha, Maria S.
   Alvarenga, Helcio
   Tilbery, Charles P.
TI The impact of diagnostic criteria for neuromyelitis optica in patients
   with MS: a 10-year follow-up of the South Atlantic Project
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Article
DE ethnicity; Brasil; neuromyelitis optica; demyelination;
   encephalomyelitis; primary progressive multiple sclerosis;
   relapsing-remitting multiple sclerosis; epidemiology; multiple
   sclerosis; inflammation
ID MULTIPLE-SCLEROSIS; DISEASE; EPIDEMIOLOGY
AB Background: It is recognized that there is a particular geographic and ethnic distribution of neuromyelitis optica (NMO) among Caucasian and non-Caucasian populations. Objective: To review the diagnoses of patients whom were enrolled in the South Atlantic Project, a Brazilian multiple sclerosis (MS) survey performed from 1995-1998, and to identify NMO and MS case frequencies. Methods: We reviewed the data from a 10-year follow-up of MS patients. To apply the current diagnostic criteria, the neurologists were asked to collect clinical and laboratory data from the medical records of study patients treated from 1999-2009. Results: The spectrum of inflammatory demyelinating disease in 322 patients (67% white; 33% African-Brazilian) was: 49 (15%) with NMO; 14 (4%) with NMO syndromes; 10 (3%) with acute disseminated encephalomyelitis (ADEM); one isolated tumefactive brain lesion; 249 (77%) with MS (151 with relapsing-remitting MS (RRMS), 70 with secondary progressive MS (SPMS) and 27 with primary progressive MS (PPMS)). Disability was more severe in NMO and PPMS. One-third of the NMO patients had died. Conclusions: The frequency of NMO was 6.8% in Sao Paulo and 20.5% in Rio de Janeiro, and mainly seen in persons of African descent, which strengthens the hypothesis of there being an ethnic association of this disease. We recommend that epidemiological studies on MS that were performed previously be reviewed again, to ensure more accurate diagnoses.
C1 [Papais-Alvarenga, Regina M.; Batista, Elizabeth; Camargo, Solange M. G. G.] Minist Saude, Hosp Lagoa, BR-20270004 Rio De Janeiro, Brazil.
   [Papais-Alvarenga, Regina M.; Vasconcelos, Claudia C. F.; Alves-Leon, Soniza V.; Santos, Claudia M. M.; Lacativa, Maria C.; Alvarenga, Helcio] Univ Fed Estado Rio de Janeiro UNIRIO, Dept Neurol, Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Godoy, Mauricio] Univ Estado Rio de Janeiro, Hosp Univ Pedro Ernesto, BR-20550011 Rio De Janeiro, Brazil.
   [Lacativa, Maria C.] Hosp Servidores Estado Rio de Janeiro, Rio De Janeiro, Brazil.
   [Lorenti, Mariangela] Hosp Servidores Estado Sao Paulo, Sao Paulo, Brazil.
   [Damasceno, Benito; Damasceno, Alfredo] Univ Estadual Campinas, Dept Neurol, Sao Paulo, Brazil.
   [Brum, Doralina] Fac Botucatu, Dept Neurol, Sao Paulo, Brazil.
   [Barreira, Amilton A.] Univ Sao Paulo, Hosp Clin Ribeirao Preto, Dept Neurol, BR-05508 Sao Paulo, Brazil.
   [Guimaraes Rocha, Maria S.] Hosp Santa Marcelina, Sao Paulo, Brazil.
   [Tilbery, Charles P.] Santa Casa Misericordia Sao Paulo, Sao Paulo, Brazil.
RP Papais-Alvarenga, RM (corresponding author), Minist Saude, Hosp Lagoa, Rua Mariz & Barros 775,2nd Floor, BR-20270004 Rio De Janeiro, Brazil.
EM Regina_alvarenga@hotmail.com
RI ROCHA, MARIA SHEILA GUIMARAES/AAK-7584-2020; ROCHA, MARIA
   SHEILA/G-6645-2012; Miranda, Claudia/K-3786-2019; Leon, Soniza V
   Alves/J-7786-2012; Brum, Doralina/A-1225-2015
OI ROCHA, MARIA SHEILA GUIMARAES/0000-0003-4312-3994; ROCHA, MARIA
   SHEILA/0000-0003-4312-3994; Miranda, Claudia/0000-0003-2670-5247; Brum,
   Doralina/0000-0002-9050-3319; Barreira, Amilton/0000-0002-4791-223X;
   Papais-Alvarenga, Regina Maria/0000-0002-1141-8619
CR Asgari N, 2011, NEUROLOGY, V76, P1589, DOI 10.1212/WNL.0b013e3182190f74
   Asgari N, 2011, ACTA NEUROL SCAND, V123, P369, DOI 10.1111/j.1600-0404.2010.01416.x
   Bizzoco E, 2009, J NEUROL, V256, P1891, DOI 10.1007/s00415-009-5171-x
   Cabre P, 2001, NEUROLOGY, V56, P507, DOI 10.1212/WNL.56.4.507
   Cabre P, 2002, REV NEUROL, V165, P676
   Cabrera-Gomez JA, 2009, J NEUROL, V256, P35, DOI 10.1007/s00415-009-0009-0
   Collongues Nicolas, 2011, Ther Adv Neurol Disord, V4, P111, DOI 10.1177/1756285611398939
   Corona T, 2006, NEUROEPIDEMIOLOGY, V26, P1, DOI 10.1159/000089230
   Cossburn M, 2012, EUR J NEUROL, V19, P655, DOI 10.1111/j.1468-1331.2011.03529.x
   Cristiano E, 2008, EUR J NEUROL, V15, P1273, DOI 10.1111/j.1468-1331.2008.02330.x
   de Seze J, 2002, J NEUROL SCI, V197, P57, DOI 10.1016/S0022-510X(02)00043-6
   Rivera JF, 2008, J NEUROL, V255, P710, DOI 10.1007/s00415-008-0781-2
   Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X
   Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304
   MANDLER RN, 1993, ANN NEUROL, V34, P162, DOI 10.1002/ana.410340211
   McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032
   Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878
   ORiordan JI, 1996, J NEUROL NEUROSUR PS, V60, P382, DOI 10.1136/jnnp.60.4.382
   Papais-Alvarenga RM, 2002, J NEUROL NEUROSUR PS, V73, P429, DOI 10.1136/jnnp.73.4.429
   Papais-Alvarenga RM, 2003, AFRICAN J NEUROL SCI
   PAPAISALVARENGA RM, 2002, ESCLEROSIS MULTIPLE, P35
   Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703
   Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366
   Rubiera M, 2006, NEUROLOGY, V66, P1568, DOI 10.1212/01.wnl.0000216233.56611.c2
   Weinshenker BG, 1996, NEUROL CLIN, V14, P291, DOI 10.1016/S0733-8619(05)70257-7
   Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74
   Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107
   Wingerchuk DW, 2008, MULTIPLE SCLEROSIS C
   Wu JS, 2008, J NEUROL NEUROSUR PS, V79, P1022, DOI 10.1136/jnnp.2007.131177
NR 31
TC 11
Z9 11
U1 0
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD MAR
PY 2014
VL 20
IS 3
BP 374
EP 381
DI 10.1177/1352458513495580
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AB9NI
UT WOS:000332120700016
PM 23970504
DA 2020-12-01
ER

PT J
AU Alves-Leon, SV
   Pinto, MP
   Andraus, MEC
   Pereira, VCSR
   Meira, ID
   Oliveira, RD
   Boas, SV
   Rego, CCD
   De Souza, JPBM
   Pedrosa, RC
AF Alves-Leon, Soniza Vieira
   Pinto, Moises Pereira
   Cosenza Andraus, Maria Emilia
   Santa Rita Pereira, Valeria Coelho
   Meira, Isabella D'Andrea
   Oliveira, Raquel De Carvalho
   Boas, Shaylla Villas
   Da Silva Rego, Claudia Cecilia
   Barreto Marcondes De Souza, Jorge Paes
   Pedrosa, Roberto Coury
TI Syncope in patients with drug-resistant epilepsy without apparent
   cardiovascular disease
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE drug-resistant epilepsy; epilepsy; inclination test; syncope;
   pseudoseizures
ID MISDIAGNOSIS; DIAGNOSIS; SEIZURES
AB Epilepsy and syncope are clinical conditions with high prevalence rates in the general population, and the differential diagnosis between them is difficult. Objective: To assess the frequency of syncope in patients diagnosed with drug-resistant epilepsy (DRE) without apparent heart disease, to investigate the relationship between clinical and electroencephalographic (EEG) changes, and to verify the role of the inclination test (IT). Method: An open, prospective study from 2004 to 2006, including 35 consecutive patients from the Epilepsy Program of Hospital Universitario Clementino Fraga Filho who were diagnosed with DRE without apparent heart disease. Results: The frequency of syncope was 25.7% (n = 9), with a significant prevalence in women. Vasovagal syncope (VVS) was the most frequent diagnosis. Conclusion: We found a significant association between syncope and the presence of autonomic symptoms (p = 0.005). The IT plays an important role in the differential diagnosis of patients with DRE presenting with autonomic symptoms, regardless of EEG results and brain magnetic resonance imaging (MRI) abnormalities.
C1 [Alves-Leon, Soniza Vieira; Pinto, Moises Pereira; Santa Rita Pereira, Valeria Coelho; Meira, Isabella D'Andrea; Oliveira, Raquel De Carvalho; Boas, Shaylla Villas; Da Silva Rego, Claudia Cecilia; Barreto Marcondes De Souza, Jorge Paes] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Neurol, Programa Epilepsia, Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Estado Rio de Janeiro, Programa Posgrad, Rio De Janeiro, Brazil.
   [Cosenza Andraus, Maria Emilia] Santa Casa Misericordia Rio de Janeiro, Serv Neurol Prof Sergio Novis, Rio De Janeiro, Brazil.
   [Barreto Marcondes De Souza, Jorge Paes] Univ Fed Rio Janeiro, Hosp Univ Clementino Fraga Filho, Dept Neurocirurgia, Rio De Janeiro, RJ, Brazil.
   [Pedrosa, Roberto Coury] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Cardiol, Rio De Janeiro, Brazil.
RP Alves-Leon, SV (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Programa Epilepsias, Rua Prof Rodolpho Paulo Rocco 255,Cidade Univ, BR-21941617 Rio de Janeiro, Brazil.
EM sonizavleon@globo.com
RI Leon, Soniza V Alves/J-7786-2012
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq)
FX Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ),
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).
CR Barbosa Filho Jose, 2002, Arq Bras Cardiol, V78, P181
   Barbosa PRB, 2000, COMPUT CARDIOL, V27, P159, DOI 10.1109/CIC.2000.898480
   Benchimol M, 2003, ARQ NEURO-PSIQUIAT, V61, P87, DOI 10.1590/S0004-282X2003000100016
   Bergfeldt L, 2003, HEART, V89, P353, DOI 10.1136/heart.89.3.353
   Birbeck GL, 2012, EPILEPSIA, V53, P18, DOI 10.1111/j.1528-1167.2012.03554.x
   Bittencourt Marcelo Imbroinise, 2005, Arq. Bras. Cardiol., V85, P388, DOI 10.1590/S0066-782X2005001900004
   Carpio A, 2009, CURR NEUROL NEUROSCI, V9, P319, DOI 10.1007/s11910-009-0048-z
   Cosenza-Andraus ME, 2006, REV NEUROLOGIA, V43, P7, DOI 10.33588/rn.4301.2005615
   DeToledo JC, 1999, BRAIN DEV-JPN, V21, P213, DOI 10.1016/S0387-7604(99)00006-6
   Devinsky O, 1999, NEW ENGL J MED, V340, P1565, DOI 10.1056/NEJM199905203402008
   Engel J, 2006, EPILEPSIA, V47, P1558, DOI 10.1111/j.1528-1167.2006.00215.x
   Fregni B, 2003, ARQ NEURO-PSIQUIAT, V61, P95
   Goldschlager N, 2003, ARCH INTERN MED, V163, P151, DOI 10.1001/archinte.163.2.151
   Graves TD, 2004, J NEUROL NEUROSUR PS, V75, P1091, DOI 10.1136/jnnp.2003.029249
   KAPOOR WN, 1983, NEW ENGL J MED, V309, P197, DOI 10.1056/NEJM198307283090401
   Kim KH, 2005, CIRC J, V69, P1084, DOI 10.1253/circj.69.1084
   LINZER M, 1994, AM J MED, V96, P146, DOI 10.1016/0002-9343(94)90135-X
   Marques LHN, 2004, ARQ NEURO-PSIQUIAT, V62, P463, DOI 10.1590/S0004-282X2004000300016
   Mory SB, 2002, ARQ NEURO-PSIQUIAT, V60, P788, DOI 10.1590/S0004-282X2002000500020
   Nadkarni S, 2005, NEUROLOGY, V64, pS2, DOI 10.1212/WNL.64.12_suppl_3.S2
   Portella RB, 2007, CLIN ENDOCRINOL, V67, P290, DOI 10.1111/j.1365-2265.2007.02879.x
   Reuber M, 2002, EPILEPSIA, V43, P1013, DOI 10.1046/j.1528-1157.2002.52301.x
   Smars PA, 2007, CURR OPIN CARDIOL, V22, P44
   Smith D, 1999, QJM-INT J MED, V92, P15, DOI 10.1093/qjmed/92.1.15
   Smith PEM, 2001, J NEUROL NEUROSUR PS, V70, P9
   Sutton R, 1999, AM J CARDIOL, V84, p10Q
   The Steering Committee of the ISSUE 2 study, 2003, EUROPACE, V5, P317
   Thijs RD, 2004, CLIN AUTON RES, V14, P4, DOI 10.1007/s10286-004-1002-4
   Velasco TR, 2003, ARQ NEURO-PSIQUIAT, V61, P65
   Zaidi A, 2000, J AM COLL CARDIOL, V36, P181, DOI 10.1016/S0735-1097(00)00700-2
NR 30
TC 1
Z9 1
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 2013
VL 71
IS 12
BP 925
EP 930
DI 10.1590/0004-282X20130179
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 279ED
UT WOS:000328942300004
PM 24347010
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Quirico-Santos, T
   Mello, AN
   Gomes, AC
   de Carvalho, LP
   de Souza, JM
   Alves-Leon, S
AF Quirico-Santos, Thereza
   Mello, Angelica Nascimento
   Gomes, Aline Casimiro
   de Carvalho, Lian Pontes
   de Souza, Jorge Marcondes
   Alves-Leon, Soniza
TI Increased metalloprotease activity in the epileptogenic lesion-Lobectomy
   reduces metalloprotease activity and urokinase-type uPAR circulating
   levels
SO BRAIN RESEARCH
LA English
DT Article
DE Lobectomy; Mesial temporal lobe epilepsy; Seizure; Metalloprotease;
   Neuroinflammation
ID TEMPORAL-LOBE EPILEPSY; MATRIX METALLOPROTEINASES;
   PLASMINOGEN-ACTIVATOR; INTRACTABLE EPILEPSY; INCREASED EXPRESSION;
   SURGERY; BRAIN; INHIBITORS; CYTOKINES; SEIZURES
AB Inflammation influences the pathogenesis of seizures by boosting neuronal degeneration of temporal lobe epilepsy with hippocampal sclerosis (TLE-HS). This work aimed to determine the activity of metalloproteases (MMPs) in brain tissue fragments of TLE-HS patients and the effect of lobectomy on circulating inflammatory biomarkers. Surgical fragments (n=4) from epileptogenic focus (EF) e perilesion area (PL), and control hippocampus from autopsy (n=5) were processed for glial protein (GFAP), activated microglia (IB4) immunohistochemistry, and metalloprotease activity (MMP-2, -9). Perilesional area showed GFAP positive cells with morphology of activate astrocyte and reactive gliosis nearby the lesion. In the lesion foci, astrocytes had altered cytoarchitecture with disorganized stroma suggestive of necrosis, and numerous mononuclear cells with few projections and morphological characteristics of activate microglia. Analysis of MMP-9 and MMP-2 in the sera before and after hippocampectomy confirmed the inflammatory pattern of TLE-HS, with high MMP-9 activity; high MMP-9/TIMP-1 and urokinase uPAR plasma levels before lobectomy but low after surgery. Maintenance of MMP-2 activity indicates persistent tissue remodeling in both groups. The present work shows that patients with chronic and medically intractable TLE-HS that undergone amigdalo-hippocampectomy for removal of epileptogenic lesion had a clinical enduring benefit of lack seizure recurrence for up to a year, and consistent reduction of proteases (MMP-9 and uPAR) activation that participate as important inflammatory epileptogenic inducers. (C) 2013 Published by Elsevier B.V.
C1 [Quirico-Santos, Thereza; Mello, Angelica Nascimento; Gomes, Aline Casimiro; de Carvalho, Lian Pontes] Univ Fed Fluminense, Dept Cellular & Mol Biol, BR-24020141 Rio De Janeiro, Brazil.
   [de Souza, Jorge Marcondes] Univ Fed Rio de Janeiro, Epilepsy Ctr, Dept Neurosurg, Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Epilepsy Ctr, Dept Neurol, Rio De Janeiro, Brazil.
RP Quirico-Santos, T (corresponding author), Univ Fed Fluminense, Inst Biol, Lab Cellular Pathol, BR-24020141 Niteroi, RJ, Brazil.
EM tquirico@vm.uff.br
RI Leon, Soniza V Alves/J-7786-2012
FU CAPES (Coordenacao de Pessoal do Ensino Superior); FAPERJ (Fundacao de
   Amparo a Pesquisa do Rio de Janeiro)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
FX The authors thank the expertise and technical assistance of personnel
   involved in video-EEG analysis and surgical assistance, and especially
   Dr Eliene Carvalho Fonseca for skillful immunohistochemistry processing
   and analysis. This study was supported by grants from CAPES (Coordenacao
   de Pessoal do Ensino Superior) and FAPERJ (Fundacao de Amparo a Pesquisa
   do Rio de Janeiro).
CR Aarli JA, 2000, ARCH NEUROL-CHICAGO, V57, P1689, DOI 10.1001/archneur.57.12.1689
   Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a
   Amalinei C, 2010, ROM J MORPHOL EMBRYO, V51, P215
   Aronica E, 2004, EPILEPSIA, V45, P441, DOI 10.1111/j.0013-9580.2004.57703.x
   Aronica E, 2011, EPILEPSIA, V52, P26, DOI 10.1111/j.1528-1167.2011.03033.x
   Bauer S, 2009, EPILEPSY RES, V86, P82, DOI 10.1016/j.eplepsyres.2009.05.009
   Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001
   Benarroch EE, 2007, NEUROLOGY, V68, P1315, DOI 10.1212/01.wnl.0000259588.97409.8f
   Berg AT, 2009, NEUROL CLIN, V27, P1003, DOI 10.1016/j.ncl.2009.06.001
   Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003
   Choi J, 2008, YONSEI MED J, V49, P1, DOI 10.3349/ymj.2008.49.1.1
   De-Carvalho MCA, 1999, BRAZ J MED BIOL RES, V32, P583, DOI 10.1590/S0100-879X1999000500012
   Dzwonek J, 2004, FEBS LETT, V567, P129, DOI 10.1016/j.febslet.2004.03.070
   Engel J, 2006, EPILEPSY RES, V70, pS5, DOI 10.1016/j.eplepsyres.2005.11.014
   HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3
   Iyer AM, 2010, NEUROSCIENCE, V167, P929, DOI 10.1016/j.neuroscience.2010.02.047
   Jeha LE, 2006, NEUROLOGY, V66, P1938, DOI 10.1212/01.wnl.0000219810.71010.9b
   Jette N, 2013, CURR OPIN NEUROL, V26, P201, DOI 10.1097/WCO.0b013e32835ef345
   Konopka A, 2013, EPILEPSY RES, V104, P45, DOI 10.1016/j.eplepsyres.2012.09.018
   Krsek P, 2007, EPILEPTIC DISORD, V9, P82
   Lahtinen L, 2006, EUR J NEUROSCI, V24, P1935, DOI 10.1111/j.1460-9568.2006.05062.x
   Lehtimaki KA, 2007, ACTA NEUROL SCAND, V116, P226, DOI 10.1111/j.1600-0404.2007.00882.x
   Li G, 2011, SEIZURE-EUR J EPILEP, V20, P249, DOI 10.1016/j.seizure.2010.12.005
   Liu B, 2010, J NEUROSCI RES, V88, P2747, DOI 10.1002/jnr.22419
   Luders H, 1998, EPILEPSIA, V39, P1006, DOI 10.1111/j.1528-1157.1998.tb01452.x
   Maroso M, 2011, NEUROTHERAPEUTICS, V8, P304, DOI 10.1007/s13311-011-0039-z
   Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127
   Mlodzikowska-Albrecht J, 2007, PHARMACOL REP, V59, P129
   Moore CS, 2012, AM J PATHOL, V180, P12, DOI 10.1016/j.ajpath.2011.09.008
   Ng WH, 2010, J CLIN NEUROSCI, V17, P634, DOI 10.1016/j.jocn.2009.08.008
   Proper E.A., 2000, BRAIN, V123
   Quirico-Santos T, 2013, J NEUROIMMUNOL, V254, P125, DOI 10.1016/j.jneuroim.2012.08.004
   Ravizza T, 2011, NEUROSCI LETT, V497, P223, DOI 10.1016/j.neulet.2011.02.040
   Shamim S, 2009, EPILEPSY BEHAV, V16, P311, DOI 10.1016/j.yebeh.2009.07.040
   Spencer SS, 1998, EPILEPSIA, V39, P114, DOI 10.1111/j.1528-1157.1998.tb01349.x
   Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002
   TALHOUK RS, 1992, J CELL BIOL, V118, P1271, DOI 10.1083/jcb.118.5.1271
   Vale FL, 2012, J CLIN NEUROSCI, V19, P101, DOI 10.1016/j.jocn.2011.08.009
   van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318
   Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178
   Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501
   Wiebe S, 2012, CURR OPIN NEUROL, V25, P187, DOI 10.1097/WCO.0b013e328350baa6
   Wieser HG, 2004, EPILEPSIA, V45, P32
NR 43
TC 15
Z9 15
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-8993
EI 1872-6240
J9 BRAIN RES
JI Brain Res.
PD NOV 13
PY 2013
VL 1538
BP 172
EP 181
DI 10.1016/j.brainres.2013.09.044
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 266FU
UT WOS:000328009600016
PM 24095794
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Adoni, T
   Alves-Leon, SV
   Azambuja, ND
   Barreira, AA
   Brooks, JBB
   Carneiro, DSD
   Carvalho, MJ
   Claudino, R
   Comini-Frota, ER
   Domingues, R
   Finkelzstejn, A
   Gama, PD
   Giacomo, MCB
   Gomes, S
   Goncalves, MVM
   Grzesiuk, AK
   Kaimen-Maciel, DR
   Mendes, MF
   Morales, NMO
   Morales, RR
   Muniz, A
   Papais-Alvarenga, RM
   Parolin, MKF
   Ribeiro, SBF
   Ruocco, HH
   Siquineli, F
   Tosta, ED
AF Fragoso, Yara D.
   Adoni, Tarso
   Alves-Leon, Soniza V.
   Azambuja, Nerio D., Jr.
   Barreira, Amilton A.
   Brooks, Joseph B. B.
   Carneiro, Denise S. D.
   Carvalho, Margarete J.
   Claudino, Rinaldo
   Comini-Frota, Elizabeth R.
   Domingues, Renan B.
   Finkelzstejn, Alessandro
   Gama, Paulo D.
   Giacomo, Maria C. B.
   Gomes, Sidney
   Goncalves, Marcus V. M.
   Grzesiuk, Anderson K.
   Kaimen-Maciel, Damacio R.
   Mendes, Maria F.
   Morales, Nivea M. O.
   Morales, Rogerio R.
   Muniz, Andre
   Papais-Alvarenga, Regina M.
   Parolin, Monica K. F.
   Ribeiro, Sonia B. F.
   Ruocco, Heloisa H.
   Siquineli, Fabio
   Tosta, Elza D.
TI Long-Term Effects of Exposure to Disease-Modifying Drugs in the
   Offspring of Mothers with Multiple Sclerosis: A Retrospective Chart
   Review
SO CNS DRUGS
LA English
DT Article
ID PREGNANCY REGISTRIES; GLATIRAMER ACETATE; WOMEN
AB Multiple sclerosis (MS) mainly affects women of fertile age. To date, the only recommendation for women with MS intending to become pregnant is to stop all treatment. This recommendation reflects the concerns about the effects of disease-modifying drugs (DMDs) on the offspring. The objective of the present study was to assess the potential long-term effects of maternal exposure to DMDs on the offspring.
   This was a retrospective study revising medical data on the offspring of women with MS. These women now have children aged at least 1 year and include a group of patients that were not exposed to any DMDs for at least 3 months prior to pregnancy and during the whole gestation (control group). Another group of patients had at least 2 weeks of exposure to DMDs, mainly to interferon beta or glatiramer acetate
   The women with MS participating in this study have children currently aged, on average, 6.6 years (range 1-39 years). There was no pattern of drug-related adverse events or complications in the children whose mothers were exposed to DMDs. No specific long-term adverse events were observed in the offspring of women with MS who were exposed to drugs during pregnancy. The profile of relevant diagnoses in their children was similar to that of children whose mothers had not been exposed to DMDs.
   The present retrospective study did not show a specific profile of long-term deleterious drug effects on children born from mothers who were exposed to drugs for MS treatment.
C1 [Fragoso, Yara D.; Brooks, Joseph B. B.] Univ Metropolitana Santos UNIMES, Sch Med, Dept Neurol, BR-11015470 Santos, SP, Brazil.
   [Adoni, Tarso] Sirio Libanes Hosp, Dept Neurol, Sao Paulo, Brazil.
   [Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Dept Neurol, Rio De Janeiro, Brazil.
   [Azambuja, Nerio D., Jr.] Neurol & Neurosurg Passo Fundo, Passo Fundo, RS, Brazil.
   [Barreira, Amilton A.] Univ Sao Paulo, Dept Neurol, BR-14049 Ribeirao Preto, Brazil.
   [Carneiro, Denise S. D.] Univ Fed Goias, Dept Neurol, Goiania, Go, Brazil.
   [Carvalho, Margarete J.] Fundacao ABC, Sch Med, Dept Neurol, Santo Andre, SP, Brazil.
   [Claudino, Rinaldo] Univ Fed Santa Catarina, Dept Neurol, Florianopolis, SC, Brazil.
   [Comini-Frota, Elizabeth R.] Univ Fed Minas Gerais, Dept Neurol, Belo Horizonte, MG, Brazil.
   [Domingues, Renan B.] Santa Casa Vitoria, Sch Hlth Sci, Dept Neurol, Vitoria, Spain.
   [Finkelzstejn, Alessandro] Hosp Clin Porto Alegre, Dept Neurol, Porto Alegre, RS, Brazil.
   [Gama, Paulo D.] Pontificia Univ Catolica, Dept Neurol, Sorocaba, SP, Brazil.
   [Giacomo, Maria C. B.] Neurol Clin, Sao Paulo, Brazil.
   [Gomes, Sidney] Beneficencia Portuguesa Hosp, Dept Neurol, Sao Paulo, Brazil.
   [Gomes, Sidney] Paulistano Hosp, Sao Paulo, Brazil.
   [Goncalves, Marcus V. M.] Univ Regiao Joinville, Dept Neurol, Joinville, SC, Brazil.
   [Grzesiuk, Anderson K.] Rehabil Ctr Dom Aquino Correa, Cuiaba, MT, Brazil.
   [Kaimen-Maciel, Damacio R.] Univ Estadual Londrina, Dept Neurol, Londrina, PR, Brazil.
   [Mendes, Maria F.] Santa Casa Sao Paulo, Dept Neurol, Sao Paulo, Brazil.
   [Morales, Nivea M. O.; Morales, Rogerio R.] Univ Fed Uberlandia, Dept Neurol, BR-38400 Uberlandia, MG, Brazil.
   [Muniz, Andre] Sao Rafael Hosp, Dept Neurol, Salvador, BA, Brazil.
   [Papais-Alvarenga, Regina M.] Univ Fed Rio de Janeiro, Dept Neurol, Rio De Janeiro, Brazil.
   [Parolin, Monica K. F.] Neurol Clin, Curitiba, Parana, Brazil.
   [Ribeiro, Sonia B. F.] Univ Fed Triangulo Mineiro, Dept Neurol, Uberaba, MG, Brazil.
   [Ruocco, Heloisa H.] MS Ctr Jundiai, Jundiai, SP, Brazil.
   [Siquineli, Fabio] Univ Reg Blumenau, Dept Neurol, Blumenau, SC, Brazil.
   [Tosta, Elza D.] Hosp Base Dist Fed, Dept Neurol, Brasilia, DF, Brazil.
RP Fragoso, YD (corresponding author), Univ Metropolitana Santos UNIMES, Sch Med, Dept Neurol, Rua,Constitu 374, BR-11015470 Santos, SP, Brazil.
EM yara@bsnet.com.br; elizcomini@gmail.com
RI Domingues, Renan/N-6003-2019; Mendes, Maria Fernanda/AAQ-1170-2020;
   Domingues, Renan B/H-1351-2012; Comini-Frota, Elizabeth R./F-8461-2012;
   Leon, Soniza V Alves/J-7786-2012; Fragoso, Yara/B-1761-2015
OI Domingues, Renan/0000-0002-6058-7937; Domingues, Renan
   B/0000-0002-6058-7937; Comini-Frota, Elizabeth R./0000-0002-2702-0402;
   Barreira, Amilton/0000-0002-4791-223X; SIQUINELI,
   FABIO/0000-0002-5380-3654; Papais-Alvarenga, Regina
   Maria/0000-0002-1141-8619; Fragoso, Yara/0000-0001-8726-089X
CR Borchers AT, 2010, J AUTOIMMUN, V34, pJ287, DOI 10.1016/j.jaut.2009.11.015
   Finkelsztejn A, 2011, BJOG-INT J OBSTET GY, V118, P790, DOI 10.1111/j.1471-0528.2011.02931.x
   Finkelsztejn A, 2011, CLIN NEUROL NEUROSUR, V113, P277, DOI 10.1016/j.clineuro.2010.11.016
   Fragoso YD, 2010, CNS DRUGS, V24, P969, DOI 10.2165/11538960-000000000-00000
   Fragoso YD, 2013, CLIN NEUROL NEUROSUR, V115, P154, DOI 10.1016/j.clineuro.2012.04.024
   Fragoso YD, 2009, ARQ NEURO-PSIQUIAT, V67, P657, DOI 10.1590/S0004-282X2009000400015
   Gerard E, 2008, CURR NEUROL NEUROSCI, V8, P325, DOI 10.1007/s11910-008-0050-x
   Giannini M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-124
   Hellwig K, 2011, MULT SCLER J, V17, P958, DOI 10.1177/1352458511401944
   Howard TB, 2011, AM J MED GENET C, V157C, P209, DOI 10.1002/ajmg.c.30304
   Kennedy DL, 2004, DRUG SAFETY, V27, P215, DOI 10.2165/00002018-200427040-00001
   Lu E, 2012, NEUROLOGY, V79, P1130, DOI 10.1212/WNL.0b013e3182698c64
   Mehta U, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-89
   Schneider H, 2013, ACTA NEUROL SCAND, V127, pe1, DOI 10.1111/ane.12004
   Wettach C, 2013, J PERINAT MED, V41, P301, DOI 10.1515/jpm-2012-0091
NR 15
TC 11
Z9 11
U1 0
U2 4
PU ADIS INT LTD
PI NORTHCOTE
PA 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND
SN 1172-7047
EI 1179-1934
J9 CNS DRUGS
JI CNS Drugs
PD NOV
PY 2013
VL 27
IS 11
BP 955
EP 961
DI 10.1007/s40263-013-0113-7
PG 7
WC Clinical Neurology; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA 239UE
UT WOS:000326050400006
PM 24114585
DA 2020-12-01
ER

PT J
AU Miraldi, F
   Rueda-Lopes, F
   Alves-Leon, S
   Gasparetto, E
AF Miraldi, F.
   Rueda-Lopes, F.
   Alves-Leon, S.
   Gasparetto, E.
TI Deep grey matter assessment in patients with neuromyelitis optica
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 29th Congress of the
   European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis /
   18th Annual Conference of Rehabilitation in MS
CY OCT 02-05, 2013
CL Copenhagen, DENMARK
SP European Comm Treatment & Res Multiple Sclerosis
C1 [Miraldi, F.; Rueda-Lopes, F.; Alves-Leon, S.; Gasparetto, E.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD OCT
PY 2013
VL 19
IS 11
SU S
BP 177
EP 177
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 276LI
UT WOS:000328751401210
DA 2020-12-01
ER

PT J
AU Lopes, FR
   Rachid, F
   Meira, I
   Alves-Leon, S
   Gasparetto, E
AF Rueda Lopes, F.
   Rachid, F.
   Meira, I.
   Alves-Leon, S.
   Gasparetto, E.
TI Neuromyelitis optica evaluation: a functional and structural magnetic
   resonance imaging study
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 29th Congress of the
   European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis /
   18th Annual Conference of Rehabilitation in MS
CY OCT 02-05, 2013
CL Copenhagen, DENMARK
SP European Comm Treatment & Res Multiple Sclerosis
C1 [Rueda Lopes, F.; Rachid, F.; Meira, I.; Alves-Leon, S.; Gasparetto, E.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD OCT
PY 2013
VL 19
IS 11
SU S
BP 422
EP 423
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 276LI
UT WOS:000328751402371
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Adoni, T
   de Almeida, SMG
   Alves-Leon, SV
   Arruda, WO
   Barbagelata-Aguero, F
   Brooks, JBB
   Carra, A
   Claudino, R
   Comini-Frota, ER
   Correa, EC
   Damasceno, A
   Damasceno, BP
   Diaz, EC
   Elliff, DG
   Fiore, APP
   Franco, CMR
   Giacomo, MCB
   Gomes, S
   Goncalves, MVM
   Grzesiuk, AK
   Inojosa, JL
   Kaimen-Maciel, DR
   Lin, K
   Lopes, J
   Lourenco, GA
   Martinez, AD
   Melcon, MO
   Morales, NDO
   Morales, RR
   Moreira, M
   Moreira, SV
   Oliveira, CLD
   de Oliveira, FTM
   Ribeiro, JB
   Ribeiro, SBF
   Rodriguez, CC
   Russo, L
   Safanelli, J
   Shearer, KD
   Siquineli, F
   Vizcarra-Escobar, D
AF Fragoso, Yara Dadalti
   Adoni, Tarso
   Garcia de Almeida, Sandra Maria
   Alves-Leon, Soniza Vieira
   Arruda, Walter Oleschko
   Barbagelata-Aguero, Fiorella
   Bidin Brooks, Joseph Bruno
   Carra, Adriana
   Claudino, Rinaldo
   Comini-Frota, Elizabeth Regina
   Correa, Eber Castro
   Damasceno, Alfredo
   Damasceno, Benito Pereira
   Ciampi Diaz, Ethel
   Elliff, David George
   Peres Fiore, Ana Patricia
   Ribeiro Franco, Clelia Maria
   Brandao Giacomo, Maria Cristina
   Gomes, Sidney
   Magno Goncalves, Marcus Vinicius
   Grzesiuk, Anderson Kuntz
   Inojosa, Jose Luiz
   Kaimen-Maciel, Damacio Ramon
   Lin, Katia
   Lopes, Josiane
   Lourenco, Gisele Alexandre
   Diana Martinez, Alejandra
   Oscar Melcon, Mario
   Oliveira Morales, Nivea de Macedo
   Morales, Rogerio Rizo
   Moreira, Marcos
   Moreira, Shirlene Vianna
   da Silva Oliveira, Celso Luis
   Menezes de Oliveira, Francisco Tomaz
   Ribeiro, Joao Batista
   Felix Ribeiro, Sonia Beatriz
   Carcamo Rodriguez, Claudia
   Russo, Liliana
   Safanelli, Juliana
   Shearer, Kirsty Deborah
   Siquineli, Fabio
   Vizcarra-Escobar, Darwin
TI Multiple sclerosis in South America: month of birth in different
   latitudes does not seem to interfere with the prevalence or progression
   of the disease
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE South America; multiple sclerosis; sun exposure
ID DIAGNOSTIC-CRITERIA; MS PREVALENCE; SEASON; POPULATION; RISK; GUIDELINES
AB Objective: To assess whether the month of birth in different latitudes of South America might influence the presence or severity of multiple sclerosis (MS) later in life. Methods: Neurologists in four South American countries working at MS units collected data on their patients' month of birth, gender, age, and disease progression. Results: Analysis of data from 1207 MS patients and 1207 control subjects did not show any significant variation in the month of birth regarding the prevalence of MS in four latitude bands (0-10; 11-20; 21-30; and 31-40 degrees). There was no relationship between the month of birth and the severity of disease in each Latitude band. Conclusion: The results from this study show that MS patients born to mothers who were pregnant at different Southern latitudes do not follow the seasonal pattern observed at high Northern latitudes.
C1 [Fragoso, Yara Dadalti; Bidin Brooks, Joseph Bruno; Elliff, David George; da Silva Oliveira, Celso Luis] Univ Metropolitana Santos, Dept Neurol, Santos, SP, Brazil.
   [Adoni, Tarso] Hosp Sirio Libanes, Dept Neurol, Sao Paulo, Brazil.
   [Garcia de Almeida, Sandra Maria; Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Dept Neurol, Rio De Janeiro, RJ, Brazil.
   [Arruda, Walter Oleschko; Lourenco, Gisele Alexandre] Univ Fed Parana, Dept Neurol, BR-80060000 Curitiba, Parana, Brazil.
   [Barbagelata-Aguero, Fiorella; Vizcarra-Escobar, Darwin] Clin San Felipe, HYPNOS, Lima, Peru.
   [Carra, Adriana; Diana Martinez, Alejandra] Hosp Britan Buenos Aires, Dept Neurol, Buenos Aires, DF, Argentina.
   [Claudino, Rinaldo; Lin, Katia] Univ Fed Santa Catarina, Dept Neurol, Florianopolis, PR, Brazil.
   [Comini-Frota, Elizabeth Regina] Univ Fed Minas Gerais, Dept Neurol, Belo Horizonte, MG, Brazil.
   [Correa, Eber Castro] CLINEN, Brasilia, DF, Brazil.
   [Damasceno, Alfredo; Damasceno, Benito Pereira] Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil.
   [Ciampi Diaz, Ethel; Carcamo Rodriguez, Claudia] Pontificia Univ Catolica Chile, Dept Neurol, Santiago, Chile.
   [Peres Fiore, Ana Patricia] Cruzada Bandeirante Sao Camilo Assistencia Med So, Santos, SP, Brazil.
   [Ribeiro Franco, Clelia Maria; Inojosa, Jose Luiz] Univ Fed Pernambuco, Hosp Clin, Dept Neurol, Recife, PE, Brazil.
   [Brandao Giacomo, Maria Cristina; Russo, Liliana] Neurol Clin, Sao Paulo, Brazil.
   [Gomes, Sidney; Menezes de Oliveira, Francisco Tomaz] Hosp Beneficencia Portuguesa, Sao Paulo, Brazil.
   [Gomes, Sidney; Menezes de Oliveira, Francisco Tomaz] Hosp Paulistano, Sao Paulo, Brazil.
   [Magno Goncalves, Marcus Vinicius; Safanelli, Juliana] Univ Regiao Joinville, Dept Neurol, Joinville, SC, Brazil.
   [Grzesiuk, Anderson Kuntz] Ctr Reabilitacao Integral Dom Aquino Correa, Cuiaba, MT, Brazil.
   [Kaimen-Maciel, Damacio Ramon; Lopes, Josiane] Univ Estadual Londrina, Dept Neurol, Londrina, PR, Brazil.
   [Oscar Melcon, Mario] Fdn Invest Neuroepidemiol, Buenos Aires, DF, Argentina.
   [Oliveira Morales, Nivea de Macedo; Morales, Rogerio Rizo] Univ Fed Uberlandia, Dept Neurol, BR-38400 Uberlandia, MG, Brazil.
   [Moreira, Marcos; Moreira, Shirlene Vianna] FCMS Suprema, Hosp Therezinha de Jesus, Clin Neuroimmunol Unit, Juiz De Fora, MG, Brazil.
   [Ribeiro, Joao Batista; Felix Ribeiro, Sonia Beatriz] Univ Fed Triangulo Mineiro, Dept Neurol, Uberaba, MG, Brazil.
   [Siquineli, Fabio] Univ Aberdeen, Inst Med Sci, Aberdeen AB9 1FX, Scotland.
   [Shearer, Kirsty Deborah] Univ Reg Blumenau, Hosp Santa Isabel, Dept Neurol, Blumenau, SC, Brazil.
RP Fragoso, YD (corresponding author), Escola Med UNIMES, Dept Neurol, Rua Constituicao 374, BR-11015470 Santos, SP, Brazil.
EM yara@bsnet.com.br
RI Lin, Katia/G-4891-2012; Arruda, Walter Oleschko/AAJ-8256-2020; Moreira,
   Marcos A/G-2936-2014; Vizcarra, Darwin/AAM-7728-2020; Leon, Soniza V
   Alves/J-7786-2012; Comini-Frota, Elizabeth R./F-8461-2012; Fragoso,
   Yara/B-1761-2015
OI Lin, Katia/0000-0002-5401-7524; Moreira, Marcos A/0000-0002-2039-6538;
   Vizcarra, Darwin/0000-0002-8342-9640; Comini-Frota, Elizabeth
   R./0000-0002-2702-0402; Fragoso, Yara/0000-0001-8726-089X; SIQUINELI,
   FABIO/0000-0002-5380-3654
FU Latin American Congress of Treatment and Research in Multiple Sclerosis
   (LACTRIMS)
FX This study was awarded a prize for "best poster" in the Latin American
   Congress of Treatment and Research in Multiple Sclerosis (LACTRIMS)
   2012.
CR Altmann DM, 2009, IMMUNOLOGY, V126, P1, DOI 10.1111/j.1365-2567.2008.03006.x
   Bayes HK, 2010, EUR NEUROL, V63, P36, DOI 10.1159/000268163
   Bharanidharan P, 1997, INT J BIOMETEOROL, V40, P117, DOI 10.1007/s004840050030
   Correale J, 2011, MULT SCLER J, V17, P1162, DOI 10.1177/1352458511418027
   Damasceno A, 2012, EUR J NEUROL, V19, P660, DOI 10.1111/j.1468-1331.2011.03543.x
   de Abreu DAF, 2009, MULT SCLER J, V15, P1146, DOI 10.1177/1352458509106780
   Deussing EC, 2012, MIL MED, V177, P594, DOI 10.7205/MILMED-D-11-00326
   Dobson R, 2013, J NEUROL NEUROSUR PS, V84, P427, DOI 10.1136/jnnp-2012-303934
   Fragoso YD, 2012, NEUROEPIDEMIOLOGY, V39, P70, DOI 10.1159/000338788
   Givon U, 2012, NEUROEPIDEMIOLOGY, V38, P64, DOI 10.1159/000334437
   Koch M, 2008, MULT SCLER J, V14, P793, DOI 10.1177/1352458508090662
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032
   Melcon MO, 2013, MULT SCLER J, V19, P145, DOI 10.1177/1352458512441985
   Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703
   POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302
   Saastamoinen KP, 2012, MULT SCLER J, V18, P563, DOI 10.1177/1352458511426814
   Salemi G, 2000, ACTA NEUROL SCAND, V101, P381, DOI 10.1034/j.1600-0404.2000.90336.x
   Salzer J, 2010, ACTA NEUROL SCAND, V122, P70, DOI 10.1111/j.1600-0404.2010.01396.x
   Staples J, 2010, BMJ-BRIT MED J, V340, P1640
   Taylor BV, 2010, MULT SCLER J, V16, P1422, DOI 10.1177/1352458510379614
   TEMPLER DI, 1992, ACTA NEUROL SCAND, V85, P107, DOI 10.1111/j.1600-0404.1992.tb04007.x
   Tremlett HL, 2006, NEUROEPIDEMIOLOGY, V26, P195, DOI 10.1159/000092406
   Watson PE, 2007, EUR J CLIN NUTR, V61, P1271, DOI 10.1038/sj.ejcn.1602644
   Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63
NR 25
TC 8
Z9 8
U1 0
U2 12
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2013
VL 71
IS 9A
BP 573
EP 579
DI 10.1590/0004-282X20130098
PG 7
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 220RM
UT WOS:000324604600003
PM 24141434
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Miraldi, F
   Lopes, FCR
   Costa, JVA
   Alves-Leon, SV
   Gasparetto, EL
AF Miraldi, Fernanda
   Rueda Lopes, Fernanda Cristina
   Altamiro Costa, Joao Victor
   Alves-Leon, Soniza Vieira
   Gasparetto, Emerson Leandro
TI Diffusion tensor magnetic resonance imaging may show abnormalities in
   the normal-appearing cervical spinal cord from patients with multiple
   sclerosis
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE diffusion tensor imaging; multiple sclerosis; cervical spinal cord
ID NEUROMYELITIS-OPTICA; PATHOGENESIS; DAMAGE
AB Objective: This study aims to evaluate "in vivo" the integrity of the normal-appearing spinal cord (NASC) in patients with multiple sclerosis (MS) compared to controls, using diffusion tensor MR imaging. Methods: We studied 32 patients with MS and 17 without any neurologic disorder. Fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD) and mean diffusivity (MD) were calculated within regions of interest at C2 and C7 levels in the four columns of the spinal cord. Results: At C2, FA value was decreased in MS patients. Besides, RD value was higher in MS than in controls. At C7, MD values were increased in MS. Conclusion: The NASC in the right column of the cervical spinal cord showed abnormal FA, RD and MD values, which is possibly related to demyelination, since the FA abnormality was related to the RD and not to the AD.
C1 [Miraldi, Fernanda] Univ Fed Rio de Janeiro UFRJ, Rio De Janeiro, RJ, Brazil.
   [Rueda Lopes, Fernanda Cristina; Altamiro Costa, Joao Victor] Univ Fed Rio de Janeiro, Dept Radiol, Rio de Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Dept Neurol, Rio de Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza Vieira; Gasparetto, Emerson Leandro] Clin Diagnost Imagem, Rio De Janeiro, RJ, Brazil.
RP Miraldi, F (corresponding author), Rua Rodolpho Paulo Rocco 255, BR-21941913 Rio De Janeiro, RJ, Brazil.
EM fernandamiraldi@hotmail.com
RI Leon, Soniza V Alves/J-7786-2012
CR Agosta F, 2009, RADIOLOGY, V253, P209, DOI 10.1148/radiol.2532090187
   Bot JCJ, 2004, RADIOLOGY, V233, P531, DOI 10.1148/radiol.2332031572
   Freund P, 2010, MULT SCLER J, V16, P1193, DOI 10.1177/1352458510376180
   Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130
   Cruz LCH, 2009, ARQ NEURO-PSIQUIAT, V67, P391, DOI 10.1590/S0004-282X2009000300004
   Kang DW, 2000, J NEUROL SCI, V178, P167, DOI 10.1016/S0022-510X(00)00373-7
   Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703
   Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267
   Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502
   Yu CS, 2006, AM J NEURORADIOL, V27, P1009
   Yu CS, 2008, RADIOLOGY, V246, P222, DOI 10.1148/radiol.2461062075
NR 11
TC 5
Z9 8
U1 0
U2 9
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2013
VL 71
IS 9A
BP 580
EP 583
DI 10.1590/0004-282X20130099
PG 4
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 220RM
UT WOS:000324604600004
PM 24141435
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU D'Andrea-Meira, I
   Pereira, VCSR
   Baltar, AC
   Viana, SVB
   Oliveira, R
   Rego, CCDS
   de Moura, PM
   de Souza, JPBM
   Alves-Leon, SV
AF D'Andrea-Meira, I
   Pereira, V. C. S. R.
   Baltar, A. C.
   Viana, S. V. B.
   Oliveira, R.
   Rego, C. C. D. S.
   de Moura, P. M.
   de Souza, J. P. B. M.
   Alves-Leon, S., V
TI NATURAL EVOLUTION AND MORBIMORTALITY OF 75 PATIENTS WITH TEMPORAL LOBE
   EPILEPSY WITH HIPPOCAMPAL SCLEROSIS AT CLEMENTINO FRAGA FILHO UNIVERSITY
   HOSPITAL, RIO DE JANEIRO
SO EPILEPSIA
LA English
DT Meeting Abstract
CT 30th International Epilepsy Congress
CY JUN 23-27, 2013
CL Montreal, CANADA
SP Int Bur Epilepsy (IBE), Int League Against Epilepsy (ILAE)
C1 [D'Andrea-Meira, I; Pereira, V. C. S. R.; Baltar, A. C.; Viana, S. V. B.; Oliveira, R.; Rego, C. C. D. S.; de Moura, P. M.; de Souza, J. P. B. M.; Alves-Leon, S., V] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PD JUN
PY 2013
VL 54
SU 3
SI SI
BP 137
EP 138
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA 165GS
UT WOS:000320472000433
DA 2020-12-01
ER

PT J
AU D'Andrea-Meira, I
   Baltar, AC
   Pereira, VCSR
   Oliveira, R
   Rego, CCDS
   Moura, PDM
   Viana, SVB
   de Souza, JPBM
   Alves-Leon, SV
AF D'Andrea-Meira, I
   Baltar, A. C.
   Pereira, V. C. S. R.
   Oliveira, R.
   Rego, C. C. D. S.
   Moura, P. D. M.
   Viana, S. V. B.
   de Souza, J. P. B. M.
   Alves-Leon, S., V
TI EFFECTIVENESS AND TOLERABILITY OF VAGAL NERVE STIMULATION WITH
   INTRACTABLE EPILEPSY: PRACTICAL EXPERIENCE AT CLEMENTINO FRAGA FILHO
   UNIVERSITY HOSPITAL IN RIO DE JANEIRO
SO EPILEPSIA
LA English
DT Meeting Abstract
CT 30th International Epilepsy Congress
CY JUN 23-27, 2013
CL Montreal, CANADA
SP Int Bur Epilepsy (IBE), Int League Against Epilepsy (ILAE)
C1 [D'Andrea-Meira, I; Baltar, A. C.; Pereira, V. C. S. R.; Oliveira, R.; Rego, C. C. D. S.; Moura, P. D. M.; Viana, S. V. B.; de Souza, J. P. B. M.; Alves-Leon, S., V] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PD JUN
PY 2013
VL 54
SU 3
SI SI
BP 180
EP 181
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA 165GS
UT WOS:000320472000574
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Alves-Leon, SV
   Arruda, WO
   Carvalho, MD
   Comini-Frota, ER
   Correa, EC
   Ferreira, MLB
   da Gama, PD
   Gomes, S
   Goncalves, MVM
   Kaimen-Maciel, DR
   Mendes, MF
   Morales, RR
   Muniz, A
   Salgado, PR
   Ruocco, HH
   de Albuquerque, LBB
   Brooks, JBB
   Fezer, L
   Georgetto, S
   Lopes, J
   Malfetano, FR
   Meira, ID
   Oliveira, CLS
   de Oliveira, FTM
   Safanelli, F
   Satomi, M
AF Fragoso, Yara Dadalti
   Alves-Leon, Soniza Vieira
   Arruda, Walter Oleschko
   Carvalho, Margarete de Jesus
   Comini-Frota, Elizabeth Regina
   Correa, Eber Castro
   Brito Ferreira, Maria Lucia
   da Gama, Paulo Diniz
   Gomes, Sidney
   Magno Goncalves, Marcus Vinicius
   Kaimen-Maciel, Damacio Ramon
   Mendes, Maria Fernando
   Morales, Rogerio Rizo
   Muniz, Andre
   Salgado, Pedro Rippel
   Ruocco, Heloisa Helena
   Bezerra de Albuquerque, Livia Brito
   Bidin Brooks, Joseph Bruno
   Fezer, Leticia
   Georgetto, Sergio
   Lopes, Josiane
   Malfetano, Fabiola Rachid
   Meira, Isabella D'Andrea
   Silva Oliveira, Celso Luis
   Meneses de Oliveira, Francisco Tomaz
   Safanelli, Fabiana
   Satomi, Massaco
TI Natalizumab adverse events are rare in patients with multiple sclerosis
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE multiple sclerosis; natalizumab; adverse events; antibodies; monoclonal
ID INFUSION REACTIONS
AB Objective: To assess the prevalence and the profile of adverse events (AE) of natalizumab in patients with multiple sclerosis (MS). Methods: Data collection from neurologists attending to patients with MS at specialized units in Brazil. Results: Data from 103 patients attending the infusion centers of 16 MS units in 9 Brazilian states were included in the study. The total number of infusions was 1,042. Seventy-nine patients (76.7%) did not present any AE. Twenty-four patients (23.3%) presented only mild AE. There were three major AE, including two deaths. These three occurrences, although not necessarily being drug-related, must be taken into consideration. Conclusion: The profile of AEs for natalizumab shows that 97% of patients have none or only mild AE. However, still due to safety worries, the use of this medication should be restricted to MS units under the care of specialized neurologists.
C1 [Fragoso, Yara Dadalti; Bidin Brooks, Joseph Bruno; Silva Oliveira, Celso Luis] Univ Metropolitana Santos UNIMES, Santos, SP, Brazil.
   [Alves-Leon, Soniza Vieira; Fezer, Leticia; Malfetano, Fabiola Rachid; Meira, Isabella D'Andrea] Univ Fed Rio de Janeiro UFRJ, Rio De Janeiro, RJ, Brazil.
   [Arruda, Walter Oleschko] Univ Fed Parana UFPR, Curitiba, PR, Brazil.
   [Carvalho, Margarete de Jesus] Fac Med ABC FMABC, Santo Andre, SP, Brazil.
   [Comini-Frota, Elizabeth Regina] Univ Fed Minas Gerais UFMG, Belo Horizonte, MG, Brazil.
   [Correa, Eber Castro] CLINEN, Brasilia, DF, Brazil.
   [Brito Ferreira, Maria Lucia; Bezerra de Albuquerque, Livia Brito] Hosp Restauracao, Recife, PE, Brazil.
   [da Gama, Paulo Diniz] Pontificia Univ Catolica Sao Paulo PUC SP, Sorocaba, SP, Brazil.
   [Gomes, Sidney; Meneses de Oliveira, Francisco Tomaz] Hosp Beneficencia Portuguesa Sao Paulo, Sao Paulo, Brazil.
   [Gomes, Sidney; Meneses de Oliveira, Francisco Tomaz] Hosp Paulistano, Sao Paulo, Brazil.
   [Magno Goncalves, Marcus Vinicius; Safanelli, Fabiana] Univ Regiao Joinville UNIVILLE, Joinville, SC, Brazil.
   [Kaimen-Maciel, Damacio Ramon; Georgetto, Sergio; Lopes, Josiane] Univ Estadual Londrina UEL, Londrina, PR, Brazil.
   [Mendes, Maria Fernando] Fac Ciencias Med Santa Casa Sao Paulo FCMSCSP, Sao Paulo, Brazil.
   [Morales, Rogerio Rizo] Univ Fed Uberlandia UFU, Uberlandia, MG, Brazil.
   [Muniz, Andre] Hosp Sao Rafael Salvador, Salvador, BA, Brazil.
   [Salgado, Pedro Rippel; Satomi, Massaco] Univ Fed Mato Grosso Sul UFMS, Campo Grande, MS, Brazil.
   [Ruocco, Heloisa Helena] Ctr Atendimento Esclerose Multipla, Jundiai, SP, Brazil.
RP Fragoso, YD (corresponding author), Univ Metropolitana Santos, Dept Neurol, Rua Constituicao 374, BR-11015470 Santos, SP, Brazil.
EM yara@bsnet.com.br
RI Leon, Soniza V Alves/J-7786-2012; Arruda, Walter Oleschko/AAJ-8256-2020;
   da Gama, Paulo Diniz/Q-7962-2019; Comini-Frota, Elizabeth
   R./F-8461-2012; Mendes, Maria Fernanda/AAQ-1170-2020; Fragoso,
   Yara/B-1761-2015
OI Comini-Frota, Elizabeth R./0000-0002-2702-0402; Fragoso,
   Yara/0000-0001-8726-089X
CR Barbaud A, 2011, EUR J DERMATOL, V21, P667, DOI 10.1684/ejd.2011.1468
   Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829
   Casanova Estruch B, 2011, NEUROLOGIA
   Cohen M, 2009, NEUROLOGY, V72, P1616, DOI 10.1212/WNL.0b013e3181a413aa
   Finkelsztejn A, 2012, ARQ NEURO-PSIQUIAT, V70, P799, DOI 10.1590/S0004-282X2012001000009
   Goodin DS, 2008, NEUROLOGY, V71, P766, DOI 10.1212/01.wnl.0000320512.21919.d2
   Gutwinski S, 2010, NEUROLOGY, V74, P521, DOI 10.1212/WNL.0b013e3181cef810
   Hellwig K, 2008, ARCH NEUROL-CHICAGO, V65, P656, DOI 10.1001/archneur.65.5.656
   Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907
   Maclure M, 2012, PHARMACOEPIDEM DR S, V21, P50, DOI 10.1002/pds.2330
   Melges LDD, 2012, RECOMENDACOES ESCLER, P53
   Namey M, 2010, J INFUS MURS, V33, P98, DOI 10.1097/NAN.0b013e3181cfd36d
   Pucci E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007621.pub2
   Rudick RA, 2007, ANN NEUROL, V62, P335, DOI 10.1002/ana.21163
   Rudick Richard A, 2008, Biologics, V2, P189
   Singh JA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008794.pub2
   Stallmach A, 2010, BEST PRACT RES CL GA, V24, P167, DOI 10.1016/j.bpg.2010.01.002
   Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324
   Sylvestre MP, 2006, ANN INTERN MED, V145, P361, DOI 10.7326/0003-4819-145-5-200609050-00009
NR 19
TC 9
Z9 9
U1 0
U2 1
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD MAR
PY 2013
VL 71
IS 3
BP 137
EP 141
DI 10.1590/S0004-282X2013000300002
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 122JY
UT WOS:000317315600002
PM 23563711
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Rosado-de-Castro, PH
   Schmidt, FD
   Battistella, V
   de Souza, SAL
   Gutfilen, B
   Goldenberg, RCD
   Kasai-Brunswick, TH
   Vairo, L
   Silva, RM
   Wajnberg, E
   do Brasil, PEAA
   Gasparetto, EL
   Maiolino, A
   Alves-Leon, SV
   Andre, C
   Mendez-Otero, R
   de Freitas, GR
   da Fonseca, LMB
AF Rosado-de-Castro, Paulo Henrique
   Schmidt, Felipe da Rocha
   Battistella, Valeria
   Lopes de Souza, Sergio Augusto
   Gutfilen, Bianca
   dos Santos Goldenberg, Regina Coeli
   Kasai-Brunswick, Tais Hanae
   Vairo, Leandro
   Silva, Rafaella Monteiro
   Wajnberg, Eduardo
   Alvarenga Americano do Brasil, Pedro Emmanuel
   Gasparetto, Emerson Leandro
   Maiolino, Angelo
   Alves-Leon, Soniza Vieira
   Andre, Charles
   Mendez-Otero, Rosalia
   de Freitas, Gabriel Rodriguez
   Barbosa da Fonseca, Lea Mirian
TI Biodistribution of bone marrow mononuclear cells after intra-arterial or
   intravenous transplantation in subacute stroke patients
SO REGENERATIVE MEDICINE
LA English
DT Article
DE Tc-99m; bone marrow mononuclear cells; cell transplatation; cerebral
   infarct; scinitigraphy
ID MESENCHYMAL STEM-CELLS; ISCHEMIC-STROKE; STROMAL CELLS; THERAPEUTIC
   BENEFIT; CEREBRAL-ISCHEMIA; NEUROTRANSPLANTATION; SEIZURES; DELIVERY;
   SAFETY; INJURY
AB Aims: To assess the biodistribution of bone marrow mononuclear cells (BMMNC) delivered by different routes in patients with subacute middle cerebral artery ischemic stroke. Patients & methods: This was a nonrandomized, open-label Phase I clinical trial. After bone marrow harvesting, BMMNCs were labeled with technetium-99m and intra-arterially or intravenously delivered together with the unlabeled cells. Scintigraphies were carried out at 2 and 24 h after cell transplantation. Clinical follow-up was continued for 6 months. Results: Twelve patients were included, between 19 and 89 days after stroke, and received 1-5 x 10(8) BMMNCs. The intra-arterial group had greater radioactive counts in the liver and spleen and lower counts in the lungs at 2 and 24 h, while in the brain they were low and similar for both routes. Conclusion: BMMNC labeling with technetium-99m allowed imaging for up to 24 h after intra-arterial or intravenous injection in stroke patients.
C1 [Rosado-de-Castro, Paulo Henrique; Lopes de Souza, Sergio Augusto; Gutfilen, Bianca; Wajnberg, Eduardo; Gasparetto, Emerson Leandro; Barbosa da Fonseca, Lea Mirian] Univ Fed Rio de Janeiro, Ilha Fundao, Sch Med, Dept Radiol, BR-21941913 Rio De Janeiro, Brazil.
   [Schmidt, Felipe da Rocha; Battistella, Valeria; Silva, Rafaella Monteiro; Alves-Leon, Soniza Vieira; Andre, Charles] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Neurol Serv, BR-21941913 Rio De Janeiro, Brazil.
   [dos Santos Goldenberg, Regina Coeli; Kasai-Brunswick, Tais Hanae; Vairo, Leandro; de Freitas, Gabriel Rodriguez] Univ Fed Rio de Janeiro, Ilha Fundao, Inst Biofis Carlos Chagas Filho, CCS, BR-21941590 Rio De Janeiro, Brazil.
   [Alvarenga Americano do Brasil, Pedro Emmanuel; de Freitas, Gabriel Rodriguez] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Maiolino, Angelo] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Hematol Serv, BR-21941913 Rio De Janeiro, Brazil.
RP Mendez-Otero, R (corresponding author), Univ Fed Rio de Janeiro, Ilha Fundao, Inst Biofis Carlos Chagas Filho, CCS, Ave Carlos Chagas Filho 373,Bloco G,Cidad Univ, BR-21941590 Rio De Janeiro, Brazil.
EM rmotero@biof.ufrj.br
RI de Souza, Sergio Augusto Lopes/A-9431-2013; de Castro, Paulo Henrique
   Rosado/F-9310-2013; Gutfilen, Bianca/C-3116-2013; Brasil, Pedro
   Emmanuel/AAG-2280-2019; Vairo, Leandro/J-9938-2013; Leon, Soniza V
   Alves/J-7786-2012; Kasai-Brunswick, Tais Hanae/AAK-9905-2020; de
   Freitas, Gabriel R/B-1298-2013; Mendez-Otero, Rosalia/AAL-7551-2020;
   Brasil, Pedro E A A/B-4357-2008
OI de Souza, Sergio Augusto Lopes/0000-0002-7901-4805; de Castro, Paulo
   Henrique Rosado/0000-0003-0091-9714; Brasil, Pedro
   Emmanuel/0000-0002-6700-2268; Mendez-Otero, Rosalia/0000-0002-1798-9930;
   Brasil, Pedro E A A/0000-0002-6700-2268; Kasai-Brunswick, Tais
   Hanae/0000-0002-6361-5980
FU Ministry of HealthMinistry of Health - Turkey; Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [110.776/2010]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)CAPES; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); CNPqNational Council
   for Scientific and Technological Development (CNPq)
FX This study was supported by a grant from the Ministry of Health and
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ) to R Mendez-Otero (PP SUS-2009 grant 110.776/2010). PH
   Rosado-de-Castro and E Wajnberg received a PhD Scholarship from
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). TH
   Kasai-Brunswick and L Vairo received PhD Scholarships from Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). RC
   Goldenberg, EL Gasparetto, A Maiolino, B Gutfilen, LM Barbosa da Fonseca
   and R Mendez-Otero received Research Productivity Scholarships from
   CNPq. The authors have no other relevant affiliations or financial
   involvement with any organization or entity with a financial interest in
   or financial conflict with the subject matter or materials discussed in
   the manuscript apart from those disclosed.
CR Banerjee SR, 2005, NUCL MED BIOL, V32, P1, DOI 10.1016/j.nucmedbio.2004.09.001
   Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501
   da Fonseca LMB, 2011, INT J CARDIOL, V149, P310, DOI 10.1016/j.ijcard.2010.02.008
   da Fonseca LMB, 2010, EXP NEUROL, V221, P122, DOI 10.1016/j.expneurol.2009.10.010
   da Fonseca LMB, 2009, CIRCULATION, V120, P539, DOI 10.1161/CIRCULATIONAHA.109.863084
   Battistella V, 2011, REGEN MED, V6, P45, DOI 10.2217/RME.10.97
   Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617
   Bliss TM, 2010, NEUROBIOL DIS, V37, P275, DOI 10.1016/j.nbd.2009.10.003
   Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7
   Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925
   Camilo O, 2004, STROKE, V35, P1769, DOI 10.1161/01.STR.0000130989.17100.96
   Carvalho AB, 2008, STEM CELLS, V26, P1307, DOI 10.1634/stemcells.2007-0941
   Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D
   Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005
   Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6
   Correa PL, 2007, CLIN NUCL MED, V32, P839, DOI 10.1097/RLU.0b013e318156b980
   Daldrup-Link HE, 2004, EUR J NUCL MED MOL I, V31, P1312, DOI 10.1007/s00259-004-1484-2
   de Freitas GR, 2006, STROKE, V37, P624
   Detante O, 2009, CELL TRANSPLANT, V18, P1369, DOI 10.3727/096368909X474230
   Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7
   dos Santos AD, 2010, BRAIN RES, V1306, P149, DOI 10.1016/j.brainres.2009.09.094
   Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253
   Friedrich MAG, 2012, CELL TRANSPLANT, V21, pS13, DOI 10.3727/096368912X612512
   Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856
   Giraidi-Guimaraes A, 2009, BRAIN RES, V1266, P108, DOI 10.1016/j.brainres.2009.01.062
   Hess DC, 2011, CELL PROLIFERAT, V44, P1, DOI 10.1111/j.1365-2184.2010.00718.x
   Hicks A, 2009, ACTA NEUROBIOL EXP, V69, P1
   Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84
   Honmou O, 2011, BRAIN, V134, P1790, DOI 10.1093/brain/awr063
   Kamiya N, 2008, LIFE SCI, V83, P433, DOI 10.1016/j.lfs.2008.07.018
   Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565
   Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038
   Lamy C, 2003, NEUROLOGY, V60, P400, DOI 10.1212/WNL.60.3.400
   Lappalainen RS, 2008, NEUROSCI LETT, V440, P246, DOI 10.1016/j.neulet.2008.05.090
   Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430
   Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003
   Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006
   Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666
   Mendez-Otero R, 2007, REGEN MED, V2, P417, DOI 10.2217/17460751.2.4.417
   Mendonca Maria Lucia Furtado de, 2006, Arq Bras Cardiol, V86, P52
   Mitkari B, 2013, EXP NEUROL, V239, P158, DOI 10.1016/j.expneurol.2012.09.018
   Molina CA, 2011, STROKE, V42, pS16, DOI 10.1161/STROKEAHA.110.598763
   Moniche F, 2012, STROKE, V43, P2242, DOI 10.1161/STROKEAHA.112.659409
   Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4
   Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217
   Offner H, 2006, J IMMUNOL, V176, P6523, DOI 10.4049/jimmunol.176.11.6523
   Palestro CJ, 2009, Q J NUCL MED MOL IM, V53, P105
   R Development Core Team, 2008, R LANG ENV STAT COMP
   Resnick IB, 2005, TRANSPL IMMUNOL, V14, P207, DOI 10.1016/j.trim.2005.03.009
   Sarnowska A, 2009, EXP NEUROL, V215, P317, DOI 10.1016/j.expneurol.2008.10.023
   Savitz SI, 2011, ANN NEUROL, V70, P59, DOI 10.1002/ana.22458
   Savitz SI, 2005, CEREBROVASC DIS, V20, P101, DOI 10.1159/000086518
   Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019
   Schwarting S, 2008, STROKE, V39, P2867, DOI 10.1161/STROKEAHA.108.513978
   Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311
   Suarez-Monteagudo C, 2009, RESTOR NEUROL NEUROS, V27, P151, DOI 10.3233/RNN-2009-0483
   Vasconcelos-dos-Santos A, 2012, STEM CELL RES, V9, P1, DOI 10.1016/j.scr.2012.02.002
   Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047
NR 58
TC 61
Z9 63
U1 0
U2 22
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
EI 1746-076X
J9 REGEN MED
JI Regen. Med.
PD MAR
PY 2013
VL 8
IS 2
BP 145
EP 155
DI 10.2217/RME.13.2
PG 11
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 102GE
UT WOS:000315832100016
PM 23477395
OA Bronze
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Boggild, M
   Macias-Islas, MA
   Carrad, A
   Schaerer, KD
   Aguayo, A
   de Almeida, SMG
   Alvarenga, MP
   Alvarenga, RMP
   Alves-Leon, SV
   Arruda, WO
   Brooks, JBB
   Comini-Frota, ER
   Ferreira, MLB
   Finkelsztejn, A
   Finkelsztejn, JMS
   de Freitas, LD
   Gallina, AS
   da Gama, PD
   Georgetto, S
   Giacomo, MCB
   Gomes, S
   Goncalves, MVM
   Grzesiuk, AK
   Kaimen-Maciel, DR
   Lopes, J
   Lourenco, GA
   Malfetano, FR
   Morales, NMO
   Morales, RD
   Oliveira, CLS
   Onaha, P
   Patroclo, C
   Ribeiro, SBF
   Ribeiro, TAGJ
   Salminen, HJ
   Santoro, P
   Seefeld, M
   Soares, PV
   Tarulla, A
   Vasconcelos, CCF
AF Fragoso, Yara Dadalti
   Boggild, Mike
   Angel Macias-Islas, Miguel
   Carrad, Adriana
   Schaerer, Kirsty Deborah
   Aguayo, Adriana
   Garcia de Almeida, Sandra Maria
   Alvarenga, Marcos Papais
   Papais Alvarenga, Regina Maria
   Alves-Leon, Soniza Vieira
   Arruda, Walter Oleschko
   Bidin Brooks, Joseph Bruno
   Regina Comini-Frota, Elizabeth
   Brito Ferreira, Maria Lucia
   Finkelsztejn, Alessandro
   Szymanski Finkelsztejn, Juliana Marcon
   de Freitas, Lucas Dias
   Gallina, Andre Serafin
   da Gama, Paulo Diniz
   Georgetto, Sergio
   Giacomo, Maria Cristina B.
   Gomes, Sidney
   Magno Goncalves, Marcus Vinicius
   Grzesiuk, Anderson Kuntz
   Kaimen-Maciel, Damacio Ramon
   Lopes, Josiane
   Lourenco, Giselle A.
   Malfetano, Fabiola Rachid
   Oliveira Morales, Nivea Macedo
   Morales, Rogerio de Rizo
   Silva Oliveira, Celso Luis
   Onaha, Patricia
   Patroclo, Cristiane
   Felix Ribeiro, Sonia Beatriz
   Gonsalves Jube Ribeiro, Taysa Alexandrino
   Salminen, Heidi Johanna
   Santoro, Patricia
   Seefeld, Marcos
   Soares, Paula Vallegas
   Tarulla, Adriana
   Ferreira Vasconcelos, Claudia Cristina
TI The effects of long-term exposure to disease-modifying drugs during
   pregnancy in multiple sclerosis
SO CLINICAL NEUROLOGY AND NEUROSURGERY
LA English
DT Article
DE Multiple sclerosis; Pregnancy; Interferon beta; Glatiramer acetate
ID GLATIRAMER ACETATE; INTERFERON-BETA; OUTCOMES; IMMUNOMODULATORS;
   NATALIZUMAB; SAFETY; WOMEN
AB Background and objective: Women with multiple sclerosis (MS) who intend to get pregnant are often advised to discontinue disease modifying therapy (DMT) prior to conception. This recommendation is not based on medical evidence and may interfere with disease control by immunomodulatory drugs. The present study was designed to help discuss the effect of DMT for MS on pregnancy and on disease course.
   Patients and methods: Retrospective data from 152 pregnancies of 132 women with MS were collected by the physician in charge of the case. All data were entered into a specific file for qualitative and quantitative statistical analysis.
   Results: From the total group of patients, 89 pregnancies occurred without any exposure to MS drugs, while 61 pregnancies occurred with at least eight weeks of exposure to MS immunomodulatory drugs. The rate of obstetric and neonatal complications was similar in both groups, except for the newborn weight and height which was smaller for mothers receiving medications. Mothers' post-delivery relapse rate and EDSS scores in the follow-up period were significantly higher in the absence of treatment.
   Conclusion: It is possible that, with further such supportive data, international guidelines on MS treatment in young women who intend to get pregnant may need to be revised. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Fragoso, Yara Dadalti; Bidin Brooks, Joseph Bruno; Silva Oliveira, Celso Luis; Soares, Paula Vallegas] Univ Metropolitana Santos, Santos, SP, Brazil.
   [Boggild, Mike] Walton Ctr, Liverpool L9 7LJ, Merseyside, England.
   [Angel Macias-Islas, Miguel; Aguayo, Adriana] Univ Guadalajara, Guadalajara, Jalisco, Mexico.
   [Carrad, Adriana; Onaha, Patricia] Hosp Britan Buenos Aires, Buenos Aires, DF, Argentina.
   [Schaerer, Kirsty Deborah] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland.
   [Garcia de Almeida, Sandra Maria; Alves-Leon, Soniza Vieira; Lourenco, Giselle A.] Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, RJ, Brazil.
   [Alvarenga, Marcos Papais; Malfetano, Fabiola Rachid; Patroclo, Cristiane; Ferreira Vasconcelos, Claudia Cristina] Univ Fed Estado Rio de Janeiro, Rio De Janeiro, Brazil.
   [Arruda, Walter Oleschko] Univ Fed Parana, BR-80060000 Curitiba, PR, Brazil.
   [Regina Comini-Frota, Elizabeth] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Brito Ferreira, Maria Lucia; de Freitas, Lucas Dias] Hosp Restauracao, Recife, PE, Brazil.
   [Finkelsztejn, Alessandro; Szymanski Finkelsztejn, Juliana Marcon] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   [da Gama, Paulo Diniz] Pontificia Univ Catolica Sao Paulo, Sao Paulo, Brazil.
   [Georgetto, Sergio; Kaimen-Maciel, Damacio Ramon; Lopes, Josiane] Univ Estadual Londrina, Londrina, PR, Brazil.
   [Gomes, Sidney] Hosp Beneficencia Portuguesa, Sao Paulo, Brazil.
   [Gomes, Sidney] Hosp Paulistano, Sao Paulo, Brazil.
   [Magno Goncalves, Marcus Vinicius] Neurol Clin, Joinville, SC, Brazil.
   [Grzesiuk, Anderson Kuntz] INEC CRIDAC, Hosp Santa Rosa, Cuiaba, MT, Brazil.
   [Oliveira Morales, Nivea Macedo; Morales, Rogerio de Rizo] Univ Fed Uberlandia, Uberlandia, MG, Brazil.
   [Felix Ribeiro, Sonia Beatriz] Univ Fed Triangulo Mineiro, Uberaba, MG, Brazil.
   [Gonsalves Jube Ribeiro, Taysa Alexandrino] Univ Fed Goias, Goiania, Go, Brazil.
   [Salminen, Heidi Johanna] Birmingham Childrens Hosp NHS Fdn Trust, Birmingham B4 6NH, W Midlands, England.
   [Santoro, Patricia; Tarulla, Adriana] Inst Invest Med Dr Alfredo Lanari, Buenos Aires, DF, Argentina.
   [Seefeld, Marcos] Univ Hosp, Fac Evangel Parana, Curitiba, Parana, Brazil.
RP Fragoso, YD (corresponding author), Rua Constituicao 374, BR-11015470 Santos, SP, Brazil.
EM yara@bsnet.com.br
RI Comini-Frota, Elizabeth R./F-8461-2012; da Gama, Paulo
   Diniz/Q-7962-2019; aguayo, adriana/L-5255-2019; Leon, Soniza V
   Alves/J-7786-2012; Arruda, Walter Oleschko/AAJ-8256-2020; Fragoso,
   Yara/B-1761-2015
OI Comini-Frota, Elizabeth R./0000-0002-2702-0402; aguayo,
   adriana/0000-0001-6826-8976; Macias-Islas, Miguel
   Angel/0000-0002-5613-6682; Fragoso, Yara/0000-0001-8726-089X
CR Adab N, 2004, J NEUROL NEUROSUR PS, V75, P1575, DOI 10.1136/jnnp.2003.029132
   Amato MP, 2010, NEUROLOGY, V75, P1794, DOI 10.1212/WNL.0b013e3181fd62bb
   Association of British Neurologists, 2009, REV GUID PRESCR MULT
   Barros AJD, 2011, REV SAUDE PUBL, V45, P635, DOI [10.1590/S0034-89102011005000039, 10.1590/s0034-89102011005000039]
   Berger T, 2009, J NEUROL SCI, V287, pS37, DOI 10.1016/S0022-510X(09)71299-7
   Cadavid D, 2011, MULT SCLER J, V17, P1113, DOI 10.1177/1352458511405375
   do Nascimento MBR, 2010, BREASTFEED MED, V5, P79, DOI 10.1089/bfm.2009.0008
   Ferrero Simone, 2006, Expert Rev Neurother, V6, P1823, DOI 10.1586/14737175.6.12.1823
   Finkelsztejn A, 2011, BJOG-INT J OBSTET GY, V118, P790, DOI 10.1111/j.1471-0528.2011.02931.x
   Fragoso YD, 2010, CNS DRUGS, V24, P969, DOI 10.2165/11538960-000000000-00000
   Hellwig K, 2011, MULT SCLER J, V17, P958, DOI 10.1177/1352458511401944
   Hutchinson M, 2011, MULT SCLER J, V17, P380, DOI 10.1177/1352458511402114
   Koch M, 2009, J NEUROL NEUROSUR PS, V80, P676, DOI 10.1136/jnnp.2008.160911
   Patti F, 2008, J NEUROL, V255, P1250, DOI 10.1007/s00415-008-0909-4
   Prosperini L, 2012, MULT SCLER J, V18, P64, DOI 10.1177/1352458511417481
   Salminen HJ, 2010, J NEUROL, V257, P2020, DOI 10.1007/s00415-010-5652-y
   Sandberg-Wollheim M, 2011, MULT SCLER J, V17, P423, DOI 10.1177/1352458510394610
   Schaefer C, 2005, REPROD TOXICOL, V20, P331, DOI 10.1016/j.reprotox.2005.03.012
   Weber-Schoendorfer C, 2009, MULT SCLER J, V15, P1037, DOI 10.1177/1352458509106543
NR 19
TC 46
Z9 46
U1 0
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0303-8467
EI 1872-6968
J9 CLIN NEUROL NEUROSUR
JI Clin. Neurol. Neurosurg.
PD FEB
PY 2013
VL 115
IS 2
BP 154
EP 159
DI 10.1016/j.clineuro.2012.04.024
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 083FG
UT WOS:000314447500006
PM 22633835
DA 2020-12-01
ER

PT J
AU Quirico-Santos, T
   Meira, ID
   Gomes, AC
   Pereira, VC
   Pinto, M
   Monteiro, M
   Souza, JM
   Alves-Leon, SV
AF Quirico-Santos, Thereza
   Meira, Isabella D'Andrea
   Gomes, Aline C.
   Pereira, Valeria C.
   Pinto, Moises
   Monteiro, Marisa
   Souza, Jorge M.
   Alves-Leon, Soniza V.
TI Resection of the epileptogenic lesion abolishes seizures and reduces
   inflammatory cytokines of patients with temporal lobe epilepsy
SO JOURNAL OF NEUROIMMUNOLOGY
LA English
DT Article
DE Lobectomy; Mesial temporal lobe epilepsy; Seizure; Cytokine;
   Neuroinflammation
ID NECROSIS-FACTOR-ALPHA; INTERLEUKIN-1 RECEPTOR ANTAGONIST;
   CEREBROSPINAL-FLUID; TNF-ALPHA; BRAIN; ACTIVATION; CLASSIFICATION;
   HIPPOCAMPUS; IL-1-BETA; SURGERY
AB Persistent neuroinflammation is implicated in the pathogenesis of seizures and neuronal degeneration of temporal lobe epilepsy (TLE). Circulating level of inflammatory cytokines was determined during inter-ictal period of 25 non-operated and 10 patients (OP) submitted to anterior temporal lobectomy. OP patients showed marked reduction of IL-1 beta, TNF alpha, MIP-1 alpha, but not IL-6 and TGF-beta 1. Paired analysis done before and after lobectomy showed reduction of inflammatory cytokines but increased TGF-beta 1 levels, and lack of seizures for more than 6 months. Maintenance of high TGF-beta 1 and IL-6 cytokines in both groups suggests a role in down-regulation of neuroinflammation and promotion of brain tissue remodeling for neuronal reorganization. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Quirico-Santos, Thereza] Univ Fed Rio de Janeiro, Univ Fed Fluminense, Inst Biol, Dept Cellular & Mol Biol,Lab Cellular Pathol, BR-24020141 Niteroi, RJ, Brazil.
   [Meira, Isabella D'Andrea; Pereira, Valeria C.; Pinto, Moises; Monteiro, Marisa; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Dept Neurol, BR-24020141 Niteroi, RJ, Brazil.
   [Souza, Jorge M.] Univ Fed Rio de Janeiro, Dept Neurosurg, BR-24020141 Niteroi, RJ, Brazil.
RP Quirico-Santos, T (corresponding author), Univ Fed Rio de Janeiro, Univ Fed Fluminense, Inst Biol, Dept Cellular & Mol Biol,Lab Cellular Pathol, BR-24020141 Niteroi, RJ, Brazil.
EM tquirico@vm.uff.br
RI Leon, Soniza V Alves/J-7786-2012; Neurociencia, Inct/I-1011-2013
FU CAPES (Coordenacao de Pessoal do Ensino Superior); FAPERJ (Fundacao de
   Amparo a Pesquisa do Rio de Janeiro)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
FX The authors thank the expertise of Paulo Emilio Correa Leite with graph
   assistance. This study was supported by grants from the CAPES
   (Coordenacao de Pessoal do Ensino Superior) and FAPERJ (Fundacao de
   Amparo a Pesquisa do Rio de Janeiro).
CR Aarli JA, 2000, ARCH NEUROL-CHICAGO, V57, P1689, DOI 10.1001/archneur.57.12.1689
   Alapirtti T, 2009, J NEUROL SCI, V280, P94, DOI 10.1016/j.jns.2009.02.355
   Aronica E, 2011, EPILEPSIA, V52, P26, DOI 10.1111/j.1528-1167.2011.03033.x
   Balosso S, 2009, NEUROSCIENCE, V161, P293, DOI 10.1016/j.neuroscience.2009.03.005
   Bauer S, 2009, EPILEPSY RES, V86, P82, DOI 10.1016/j.eplepsyres.2009.05.009
   Berg AT, 2009, NEUROL CLIN, V27, P1003, DOI 10.1016/j.ncl.2009.06.001
   Boche D, 2006, NEUROBIOL DIS, V22, P638, DOI 10.1016/j.nbd.2006.01.004
   Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009
   Cheng X, 2010, J ALZHEIMERS DIS, V19, P621, DOI 10.3233/JAD-2010-1253
   De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x
   Engel J, 2006, EPILEPSY RES, V70, pS5, DOI 10.1016/j.eplepsyres.2005.11.014
   Fabene PF, 2010, J NEUROIMMUNOL, V224, P22, DOI 10.1016/j.jneuroim.2010.05.016
   Figiel I, 2008, ACTA NEUROBIOL EXP, V68, P526
   Flood C, 2001, J CEREBR BLOOD F MET, V21, P157, DOI 10.1097/00004647-200102000-00007
   Friedman A, 2011, EPILEPSIA, V52, P33, DOI 10.1111/j.1528-1167.2011.03034.x
   Hakkoum D, 2007, J NEUROCHEM, V100, P747, DOI 10.1111/j.1471-4159.2006.04257.x
   Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407
   Hulkkonen J, 2004, EPILEPSY RES, V59, P199, DOI 10.1016/j.eplepsyres.2004.04.007
   Ichiyama T, 2000, BRAIN RES, V857, P246, DOI 10.1016/S0006-8993(99)02439-7
   Jankowsky JL, 2001, PROG NEUROBIOL, V63, P125, DOI 10.1016/S0301-0082(00)00022-8
   Jara JH, 2007, J NEUROCHEM, V100, P1407, DOI 10.1111/j.1471-4159.2006.04330.x
   Jeha LE, 2006, NEUROLOGY, V66, P1938, DOI 10.1212/01.wnl.0000219810.71010.9b
   Krsek P, 2007, EPILEPTIC DISORD, V9, P82
   Lehtimaki KA, 2007, ACTA NEUROL SCAND, V116, P226, DOI 10.1111/j.1600-0404.2007.00882.x
   Lehtimaki KA, 2011, EPILEPSY RES, V95, P184, DOI 10.1016/j.eplepsyres.2011.03.004
   Lehtimaki KA, 2010, NEUROIMMUNOMODULAT, V17, P19, DOI 10.1159/000243081
   Lu Y, 2009, CLIN SCI, V117, P17, DOI 10.1042/CS20080347
   Luders H, 1998, EPILEPSIA, V39, P1006, DOI 10.1111/j.1528-1157.1998.tb01452.x
   MINAMI M, 1991, BIOCHEM BIOPH RES CO, V176, P593, DOI 10.1016/S0006-291X(05)80225-6
   Mlodzikowska-Albrecht J, 2007, PHARMACOL REP, V59, P129
   Nowak M, 2011, BRAIN BEHAV IMMUN, V25, P423, DOI 10.1016/j.bbi.2010.10.022
   Peltola J, 2000, EPILEPSY RES, V41, P205, DOI 10.1016/S0920-1211(00)00140-6
   Spencer SS, 1998, EPILEPSIA, V39, P114, DOI 10.1111/j.1528-1157.1998.tb01349.x
   Thomas PS, 2001, IMMUNOL CELL BIOL, V79, P132, DOI 10.1046/j.1440-1711.2001.00980.x
   Vale FL, 2012, J CLIN NEUROSCI, V19, P101, DOI 10.1016/j.jocn.2011.08.009
   Veroni C, 2010, MOL CELL NEUROSCI, V45, P234, DOI 10.1016/j.mcn.2010.06.014
   Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009
   Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178
   Vivien D, 2006, CYTOKINE GROWTH F R, V17, P121, DOI 10.1016/j.cytogfr.2005.09.011
   Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0
   Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189
   Wieser HG, 2004, EPILEPSIA, V45, P32
NR 42
TC 17
Z9 20
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-5728
EI 1872-8421
J9 J NEUROIMMUNOL
JI J. Neuroimmunol.
PD JAN 15
PY 2013
VL 254
IS 1-2
BP 125
EP 130
DI 10.1016/j.jneuroim.2012.08.004
PG 6
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA 077CO
UT WOS:000314005700016
PM 23116880
DA 2020-12-01
ER

PT J
AU Alves-Leon, SV
AF Alves-Leon, Soniza Vieira
TI When one bout and one MRI is not MS
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Congress of Lactrims
CY NOV 28-30, 2012
CL BRAZIL
C1 [Alves-Leon, Soniza Vieira] Hosp Univ Clementino Fraga Filho UFRJ, Programa Posgrad Neurol UNIRIO, Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2012
VL 18
IS 12
BP 1816
EP 1816
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 052IX
UT WOS:000312192300033
DA 2020-12-01
ER

PT J
AU Figueiredo, A
   Paradela, E
   Horta, W
   Malfetano, FR
   Pereira, VCSR
   Meira, ID
   Agostinho, L
   Rocha, C
   Paiva, CLA
   Alves-Leon, SV
AF Figueiredo, Andre
   Paradela, Eduardo
   Horta, Wagner
   Malfetano, Fabiola Rachid
   Santa Rita Pereira, Valeria Coelho
   Meira, Isabella D'Andrea
   Agostinho, Luciana
   Rocha, Catielly
   Antao Paiva, Carmen Lucia
   Alves-Leon, Soniza Vieira
TI ASSOCIATION STUDY OF IL7R alpha (CD127) GENE POLYMORPHISM (T244I) AND
   HLA CLASS II WITH SUSCEPTIBILITY TO MULTIPLE SCLEROSIS IN A BRAZILIAN
   SAMPLE
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Congress of Lactrims
CY NOV 28-30, 2012
CL BRAZIL
C1 [Figueiredo, Andre; Paradela, Eduardo; Horta, Wagner; Agostinho, Luciana; Rocha, Catielly; Alves-Leon, Soniza Vieira] Univ Fed Estado Rio de Janeiro UNIRIO, Programa Posgrad Neurol PPGNEURO, Rio De Janeiro, Brazil.
   [Figueiredo, Andre; Paradela, Eduardo; Agostinho, Luciana; Rocha, Catielly; Antao Paiva, Carmen Lucia] Univ Fed Estado Rio de Janeiro UNIRIO, Mol Biol Lab, Rio De Janeiro, Brazil.
   [Malfetano, Fabiola Rachid; Santa Rita Pereira, Valeria Coelho; Meira, Isabella D'Andrea; Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Ctr Referencia Esclerose Multipla & Outras Doenca, BR-21941 Rio De Janeiro, Brazil.
RI PARADELA, EDUARDO/AAW-6807-2020; DAndrea-Meira, Isabella/B-5341-2013;
   Paiva, C. L. A./A-1503-2010; Leon, Soniza V Alves/J-7786-2012
OI Paiva, C. L. A./0000-0003-2877-0296; 
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2012
VL 18
IS 12
BP 1823
EP 1824
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 052IX
UT WOS:000312192300051
DA 2020-12-01
ER

PT J
AU Paradela, ER
   Figueiredo, ALD
   Agostinho, L
   Rocha, C
   Horta, W
   Malfetano, FR
   Pereira, VCSR
   Meira, ID
   Paiva, CLA
   Alves-Leon, SV
AF Paradela, Eduardo Ribeiro
   dos Santos Figueiredo, Andre Luis
   Agostinho, Luciana
   Rocha, Catielly
   Horta, Wagner
   Malfetano, Fabiola Rachid
   Santa Rita Pereira, Valeria Coelho
   Meira, Isabella D'Andrea
   Antao Paiva, Carmen Lucia
   Alves-Leon, Soniza Vieira
TI Association study in multiple sclerosis (MS): CIITA gene polymorphism
   (rs4774*C) in conjunction with the HLA-DRB1*15:01+ haplotype increases
   the susceptibility to MS
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Congress of Lactrims
CY NOV 28-30, 2012
CL BRAZIL
C1 [Paradela, Eduardo Ribeiro; dos Santos Figueiredo, Andre Luis; Agostinho, Luciana; Rocha, Catielly; Horta, Wagner; Alves-Leon, Soniza Vieira] Univ Fed Estado Rio de Janeiro UNIRIO, Programa Posgrad Neurol PPGNEURO, Rio De Janeiro, Brazil.
   [Paradela, Eduardo Ribeiro; dos Santos Figueiredo, Andre Luis; Agostinho, Luciana; Rocha, Catielly; Antao Paiva, Carmen Lucia] Univ Fed Estado Rio de Janeiro UNIRIO, Mol Biol Lab, Rio De Janeiro, Brazil.
   [Malfetano, Fabiola Rachid; Santa Rita Pereira, Valeria Coelho; Meira, Isabella D'Andrea; Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Ctr Referencia Esclerose Multipla & Outras Doenca, BR-21941 Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012; PARADELA, EDUARDO/AAW-6807-2020;
   DAndrea-Meira, Isabella/B-5341-2013; Paiva, C. L. A./A-1503-2010
OI Paiva, C. L. A./0000-0003-2877-0296
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2012
VL 18
IS 12
BP 1823
EP 1823
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 052IX
UT WOS:000312192300050
DA 2020-12-01
ER

PT J
AU Pessoa, FMC
   Lopes, FCR
   Alves-Leon, SV
   Gasparetto, EL
AF Clemente Pessoa, Fernanda Miraldi
   Rueda Lopes, Fernanda Cristina
   Alves-Leon, Soniza Vieira
   Gasparetto, Emerson Leandro
TI Brain atrophy evaluation in Multiple Sclerosis patients: a comparison
   study with Clinically Isolated Syndrome and Neuromyelitis Optica
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Congress of Lactrims
CY NOV 28-30, 2012
CL BRAZIL
C1 Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2012
VL 18
IS 12
BP 1824
EP 1824
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 052IX
UT WOS:000312192300053
DA 2020-12-01
ER

PT J
AU de Almeida, SMG
   Malfetano, FR
   Meira, GAID
   LeticiaFezer
   Baptista, S
   Pereira, VCS
   Fragoso, Y
   Alves-Leon, SV
AF Garcia de Almeida, Sandra Maria
   Malfetano, Fabiola Rachid
   Isabella D'Andrea Meira, Gisele AlexandreLourenco
   LeticiaFezer
   Baptista, Simone
   Santa Rita Pereira, Valeria Coelho
   Fragoso, Yara
   Alves-Leon, Soniza Vieira
TI Analysis on neonatal newborn results among patients with multiple
   sclerosis
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Congress of Lactrims
CY NOV 28-30, 2012
CL BRAZIL
C1 [Garcia de Almeida, Sandra Maria; Malfetano, Fabiola Rachid; Isabella D'Andrea Meira, Gisele AlexandreLourenco; LeticiaFezer; Baptista, Simone; Santa Rita Pereira, Valeria Coelho; Fragoso, Yara; Alves-Leon, Soniza Vieira] Hosp Univ Clementino Fraga Filho UFRJ, Programa Posgrad Neurol UNIRIO, Rio De Janeiro, Brazil.
RI DAndrea-Meira, Isabella/B-5341-2013; Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2012
VL 18
IS 12
BP 1832
EP 1833
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 052IX
UT WOS:000312192300077
DA 2020-12-01
ER

PT J
AU Lourenco, GA
   de Almeida, SMG
   Malfetano, FR
   Meira, ID
   Pereira, VCSR
   Fezer, L
   Baptista, S
   Fragoso, YD
   Alves-Leon, SV
AF Lourenco, Gisele Alexandre
   Garcia de Almeida, Sandra Maria
   Malfetano, Fabiola Rachid
   Meira, Isabella D' Andrea
   Santa Rita Pereira, Valeria Coelho
   Fezer, Leticia
   Baptista, Simone
   Fragoso, Yara Dadalti
   Alves-Leon, Soniza Vieira
TI Determining factors in delivery route among Multiple Sclerosis patients
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Congress of Lactrims
CY NOV 28-30, 2012
CL BRAZIL
RI DAndrea-Meira, Isabella/B-5341-2013; Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2012
VL 18
IS 12
BP 1834
EP 1834
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 052IX
UT WOS:000312192300081
DA 2020-12-01
ER

PT J
AU Rueda-Lopes, FC
   Miraldi, F
   Malfetano, F
   Meira, I
   Alves-Leon, S
   Domingues, R
   Bahia, PRV
   Gasparetto, EL
AF Rueda-Lopes, F. C.
   Miraldi, F.
   Malfetano, F.
   Meira, I
   Alves-Leon, S.
   Domingues, R.
   Bahia, P. R., V
   Gasparetto, E. L.
TI Resting-state functional Magnetic Resonance Imaging in the assessment of
   patients with neuromyelitis optica
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Congress of Lactrims
CY NOV 28-30, 2012
CL BRAZIL
C1 [Rueda-Lopes, F. C.; Gasparetto, E. L.] UFRJ DASA, Rio De Janeiro, Brazil.
   [Miraldi, F.; Malfetano, F.; Meira, I; Alves-Leon, S.; Bahia, P. R., V] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
RI DAndrea-Meira, Isabella/B-5341-2013; Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2012
VL 18
IS 12
BP 1838
EP 1839
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 052IX
UT WOS:000312192300095
DA 2020-12-01
ER

PT J
AU Alves-Leon, SV
   Malfetano, FR
   Meira, ID
   Pereira, VCS
   Fezer, L
   Batista, S
   Lourenco, GA
   de Almeida, SMG
AF Alves-Leon, Soniza Vieira
   Malfetano, Fabiola Rachid
   Meira, Isabella D' Andrea
   Santa Rita Pereira, Valeria Coelho
   Fezer, Leticia
   Batista, Simone
   Lourenco, Gisele Alexandre
   Garcia de Almeida, Sandra Maria
TI Frequency of positivity in JCV testing in a cohort of MS patients and
   follow-up after natalizumab treatment
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Congress of Lactrims
CY NOV 28-30, 2012
CL BRAZIL
C1 Univ Fed Rio de Janeiro, Clementino Fraga Filho Hosp, BR-21941 Rio De Janeiro, Brazil.
   Fed Univ State Rio de Janeiro, Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012; DAndrea-Meira, Isabella/B-5341-2013
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2012
VL 18
IS 12
BP 1840
EP 1840
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 052IX
UT WOS:000312192300099
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Adoni, T
   Aguero, FB
   de Almeida, SMG
   Alves-Leon, SV
   Arruda, WO
   Brooks, JBB
   Carra, A
   Claudino, R
   Comini-Frota, ER
   Correa, EC
   Damasceno, A
   Damasceno, BP
   Diaz, EC
   Escobar, DV
   Fiore, APP
   Franco, CMR
   Giacomo, MCB
   Gomes, S
   Goncalves, MVM
   Grzesiuk, AK
   Inojosa, JL
   Kaimen-Maciel, DR
   Lin, K
   Lopes, J
   Lourenco, GA
   Martinez, AD
   Melcon, MO
   Morales, NDO
   Morales, RR
   Moreira, M
   Moreira, SV
   Oliveira, CLD
   de Oliveira, FTM
   Ribeiro, JB
   Ribeiro, SBF
   Rodriguez, CC
   Russo, L
   Safanelli, J
   Shearer, KD
   Siquineli, F
AF Fragoso, Yara Dadalti
   Adoni, Tarso
   Aguero, Fiorella Barbagelata
   de Almeida, Sandra Maria Garcia
   Alves-Leon, Soniza Vieira
   Arruda, Walter Oleschko
   Brooks, Joseph Bruno Bidin
   Carra, Adriana
   Claudino, Rinaldo
   Comini-Frota, Elizabeth Regina
   Correa, Eber Castro
   Damasceno, Alfredo
   Damasceno, Benito Pereira
   Diaz, Ethel Ciampi
   Escobar, Darwin Vizcarra
   Fiore, Ana Patricia Peres
   Franco, Clelia Maria Ribeiro
   Giacomo, Maria Cristina Baptista
   Gomes, Sidney
   Goncalves, Marcus Vinicius Magno
   Grzesiuk, Anderson K.
   Inojosa, Jose Luiz
   Kaimen-Maciel, Damacio Ramon
   Lin, Katia
   Lopes, Josiane
   Lourenco, Gisele Alexandre
   Martinez, Alejandra Diana
   Melcon, Mario Oscar
   Morales, Nvea de Macedo Oliveira
   Morales, Rogerio Rizo
   Moreira, Marcos
   Moreira, Shirlene Vianna
   Oliveira, Celso Luis da Silva
   de Oliveira, Francisco Tomaz Menezes
   Ribeiro, Joao Batista
   Ribeiro, Sonia Beatriz Felix
   Rodriguez, Claudia Carcamo
   Russo, Liliana
   Safanelli, Juliana
   Shearer, Kirsty D.
   Siquineli, Fabio
TI Month of birth does not seem to interfere with the prevalence of
   multiple sclerosis for South American patients at latitudes zero to 40
   degrees
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Congress of Lactrims
CY NOV 28-30, 2012
CL BRAZIL
RI Lin, Katia/G-4891-2012; Arruda, Walter Oleschko/AAJ-8256-2020; Leon,
   Soniza V Alves/J-7786-2012
OI Lin, Katia/0000-0002-5401-7524; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2012
VL 18
IS 12
BP 1849
EP 1849
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 052IX
UT WOS:000312192300124
DA 2020-12-01
ER

PT J
AU Lacativa, MCS
   Naylor, R
   Cagy, M
   Leon, SVA
   Pereira, VCSR
   Vasconcelos, C
   Alvarenga, MP
   Camargo, S
   Batista, E
   Alvarenga, RMP
AF Sampaio Lacativa, Maria Clinete
   Naylor, Rogerio
   Cagy, Marcelo
   Alves Leon, Soniza Vieira
   Santa Rita Pereira, Valeria Coelho
   Vasconcelos, Claudia
   Alvarenga, Marcos Papais
   Camargo, Solange
   Batista, Elizabeth
   Papais Alvarenga, Regina Maria
TI Multiple Sclerosis in the city of Rio de Janeiro
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Congress of Lactrims
CY NOV 28-30, 2012
CL BRAZIL
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 4
Z9 4
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2012
VL 18
IS 12
BP 1850
EP 1850
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 052IX
UT WOS:000312192300129
DA 2020-12-01
ER

PT J
AU Alves-Leon, SV
   Meira, ID
   Malfetano, FR
   Fezer, L
   Batista, S
   Pereira, VCSR
AF Alves-Leon, Soniza Vieira
   Meira, Isabella D'Andrea
   Malfetano, Fabiola Rachid
   Fezer, Leticia
   Batista, Simone
   Santa Rita Pereira, Valeria Coelho
TI Neuromyelitis Optica frequency in a cohort of Multiple Sclerosis
   patients and other Central Nervous System Demyelinating Diseases
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Congress of Lactrims
CY NOV 28-30, 2012
CL BRAZIL
C1 Univ Fed Rio de Janeiro, Clementino Fraga Filho Hosp, BR-21941 Rio De Janeiro, Brazil.
   Fed Univ State Rio de Janeiro, Rio De Janeiro, Brazil.
RI DAndrea-Meira, Isabella/B-5341-2013; Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2012
VL 18
IS 12
BP 1853
EP 1853
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 052IX
UT WOS:000312192300137
DA 2020-12-01
ER

PT J
AU Torres, YC
   Alves-Leon, SV
   Lima, MASD
AF Torres, Yasmine C.
   Alves-Leon, Soniza V.
   Lima, Marco Antonio S. D.
TI Prevalence of pseudotumoral demyelinating lesions in an oncology
   reference center
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Congress of Lactrims
CY NOV 28-30, 2012
CL BRAZIL
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2012
VL 18
IS 12
BP 1858
EP 1859
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 052IX
UT WOS:000312192300153
DA 2020-12-01
ER

PT J
AU Pessoa, FMC
   Lopes, FCR
   Costa, JVA
   Alves-Leon, SV
   Domingues, RC
   Gasparetto, EL
AF Clemente Pessoa, Fernanda Miraldi
   Rueda Lopes, Fernanda Cristina
   Altamiro Costa, Joao Victor
   Alves-Leon, Soniza Vieira
   Domingues, Romeu Cortes
   Gasparetto, Emerson Leandro
TI The cervical spinal cord in neuromyelitis optica patients: A comparative
   study with multiple sclerosis using diffusion tensor imaging
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Congress of Lactrims
CY NOV 28-30, 2012
CL BRAZIL
C1 Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2012
VL 18
IS 12
BP 1866
EP 1866
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 052IX
UT WOS:000312192300175
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Alves-Leon, SV
   Arruda, WO
   Carvalho, MD
   Comini-Frota, ER
   Correa, EC
   Ferreira, MLB
   da Gama, PD
   Gomes, S
   Goncalves, MVM
   Kaimen-Maciel, RD
   Mendes, MF
   Morales, RR
   Muniz, A
   Salgado, PR
   Ruocco, HH
   Brooks, JBB
   Fezer, L
   Georgetto, S
   Lopes, J
   Malfetano, FR
   Meira, ID
   Oliveira, CLS
   de Oliveira, FTM
   Safanelli, F
   Satomi, M
AF Fragoso, Yara Dadalti
   Alves-Leon, Soniza Vieira
   Arruda, Walter Oleschko
   Carvalho, Margatere de Jesus
   Comini-Frota, Elizabeth Regina
   Correa, Eber Castro
   Brito Ferreira, Maria Lucia
   da Gama, Paulo Diniz
   Gomes, Sidney
   Magno Goncalves, Marcus Vinicius
   Kaimen-Maciel, Ramon Damasio
   Mendes, Maria Fernanda
   Morales, Rogerio Rizo
   Muniz, Andre
   Salgado, Pedro Rippel
   Ruocco, Heloisa Helena
   Bidin Brooks, Joseph Bruno
   Fezer, Letcia
   Georgetto, Sergio
   Lopes, Josiane
   Malfetano, Fabiola Rachid
   Meira, Isabella D'Andrea
   Silva Oliveira, Celso Luis
   Meneses de Oliveira, Francisco Tomaz
   Safanelli, Fabiana
   Satomi, Massaco
TI The profile of natalizumab adverse events in patients with multiple
   sclerosis
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Congress of Lactrims
CY NOV 28-30, 2012
CL BRAZIL
RI Mendes, Maria Fernanda/AAQ-1170-2020; Arruda, Walter
   Oleschko/AAJ-8256-2020; da Gama, Paulo Diniz/Q-7962-2019; DAndrea-Meira,
   Isabella/B-5341-2013; Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2012
VL 18
IS 12
BP 1867
EP 1868
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 052IX
UT WOS:000312192300179
DA 2020-12-01
ER

PT J
AU Rueda-Lopes, FC
   Doring, T
   Martins, C
   Cabral, FC
   Malfetano, F
   Pereira, VC
   Alves-Leon, S
   Gasparetto, EL
AF Rueda-Lopes, F. C.
   Doring, T.
   Martins, C.
   Cabral, F. C.
   Malfetano, F.
   Pereira, V. C.
   Alves-Leon, S.
   Gasparetto, E. L.
TI Tract based spatial statistics (TBSS) in the evaluation of patients with
   neuromyelitis optica.
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Congress of Lactrims
CY NOV 28-30, 2012
CL BRAZIL
C1 [Rueda-Lopes, F. C.; Doring, T.] UFRJ DASA, Rio De Janeiro, Brazil.
   [Martins, C.; Cabral, F. C.; Malfetano, F.; Pereira, V. C.; Alves-Leon, S.; Gasparetto, E. L.] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2012
VL 18
IS 12
BP 1869
EP 1870
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 052IX
UT WOS:000312192300185
DA 2020-12-01
ER

PT J
AU Alves-Leon, SV
AF Alves-Leon, Soniza Vieira
TI Genetics aspects of MS in Brazil
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 7th Congress of Lactrims
CY NOV 28-30, 2012
CL BRAZIL
C1 [Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Fed Univ Rio de Janeiro State UNIRIO, Postgrad Program, BR-21941 Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD DEC
PY 2012
VL 18
IS 12
BP 1876
EP 1877
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 052IX
UT WOS:000312192300205
DA 2020-12-01
ER

PT J
AU Diniz, LP
   Almeida, JC
   Tortelli, V
   Lopes, CV
   Setti-Perdigao, P
   Stipursky, J
   Kahn, SA
   Romao, LF
   de Miranda, J
   Alves-Leon, SV
   de Souza, JM
   Castro, NG
   Panizzutti, R
   Gomes, FCA
AF Diniz, Luan Pereira
   Almeida, Juliana Carvalho
   Tortelli, Vanessa
   Lopes, Charles Vargas
   Setti-Perdigao, Pedro
   Stipursky, Joice
   Kahn, Suzana Assad
   Romao, Luciana Ferreira
   de Miranda, Joari
   Alves-Leon, Soniza Vieira
   de Souza, Jorge Marcondes
   Castro, Newton G.
   Panizzutti, Rogerio
   Alcantara Gomes, Flavia Carvalho
TI Astrocyte-induced Synaptogenesis Is Mediated by Transforming Growth
   Factor beta Signaling through Modulation of D-Serine Levels in Cerebral
   Cortex Neurons
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID LONG-TERM POTENTIATION; NMDA RECEPTOR-ACTIVITY; GFAP GENE PROMOTER;
   TGF-BETA; NEUROMUSCULAR-JUNCTION; CULTURED ASTROCYTES; CNS
   SYNAPTOGENESIS; SECRETED PROTEINS; SYNAPTIC ACTIVITY; NERVOUS-SYSTEM
AB Assembly of synapses requires proper coordination between pre- and postsynaptic elements. Identification of cellular and molecular events in synapse formation and maintenance is a key step to understand human perception, learning, memory, and cognition. A key role for astrocytes in synapse formation and function has been proposed. Here, we show that transforming growth factor beta (TGF-beta) signaling is a novel synaptogenic pathway for cortical neurons induced by murine and human astrocytes. By combining gain and loss of function approaches, we show that TGF-beta 1 induces the formation of functional synapses in mice. Further, TGF-beta 1-induced synaptogenesis involves neuronal activity and secretion of the co-agonist of the NMDA receptor, D-serine. Manipulation of D-serine signaling, by either genetic or pharmacological inhibition, prevented the TGF-beta 1 synaptogenic effect. Our data show a novel molecular mechanism that might impact synaptic function and emphasize the evolutionary aspect of the synaptogenic property of astrocytes, thus shedding light on new potential therapeutic targets for synaptic deficit diseases.
C1 [Diniz, Luan Pereira; Almeida, Juliana Carvalho; Tortelli, Vanessa; Lopes, Charles Vargas; Setti-Perdigao, Pedro; Stipursky, Joice; Kahn, Suzana Assad; Romao, Luciana Ferreira; de Miranda, Joari; Castro, Newton G.; Panizzutti, Rogerio; Alcantara Gomes, Flavia Carvalho] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza Vieira; de Souza, Jorge Marcondes] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, BR-21941590 Rio De Janeiro, RJ, Brazil.
RP Gomes, FCA (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21949590 Rio De Janeiro, RJ, Brazil.
EM fgomes@icb.ufrj.br
RI Stipursky, Joice/Y-1961-2019; Leon, Soniza V Alves/J-7786-2012; Castro,
   Newton G/C-3263-2009; Setti-Perdigao, Pedro/I-8191-2012; Neurociencia,
   Inct/I-1011-2013; Romao, Luciana/I-4291-2015; Gomes, Flavia/C-5383-2013
OI Castro, Newton G/0000-0001-9570-7428; Setti-Perdigao,
   Pedro/0000-0002-2105-1451; Gomes, Flavia/0000-0003-2966-0638
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Institute of Glia (iGLIA/CNPq); Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES)CAPES; Fundacao Carlos Chagas Filho
   de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ)
FX This work was supported by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Institute of Glia
   (iGLIA/CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), and Fundacao Carlos Chagas Filho de Amparo a Pesquisa
   do Estado do Rio de Janeiro (FAPERJ).
CR Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5
   Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6
   Ashwood P, 2008, J NEUROIMMUNOL, V204, P149, DOI 10.1016/j.jneuroim.2008.07.006
   Bado P, 2011, PSYCHOPHARMACOLOGY, V218, P461, DOI 10.1007/s00213-011-2330-4
   Bae J.J, 2011, INT J PHYSL PATH PHA, V3, P9
   Barker AJ, 2010, NEUROSCIENTIST, V16, P40, DOI 10.1177/1073858409339215
   Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859
   Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9
   Chin J, 2002, J NEUROSCI, V22
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Chung WS, 2012, CURR OPIN NEUROBIOL, V22, P438, DOI 10.1016/j.conb.2011.10.003
   DeGroot CJA, 1997, J NEUROSCI RES, V49, P342, DOI 10.1002/(SICI)1097-4547(19970801)49:3<342::AID-JNR9>3.0.CO;2-C
   DESAMPAIO E, 2002, EUR J NEUROSCI, V16, P2059, DOI DOI 10.1046/J.1460-9568.2002.02283.X
   DeVito LM, 2011, GENES BRAIN BEHAV, V10, P210, DOI 10.1111/j.1601-183X.2010.00656.x
   Elmariah SB, 2005, J NEUROSCI, V25, P3638, DOI 10.1523/JNEUROSCI.3980-04.2005
   Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612
   Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025
   Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008
   Fester L, 2009, HIPPOCAMPUS, V19, P692, DOI 10.1002/hipo.20548
   FLETCHER TL, 1994, J NEUROSCI, V14, P6695
   Fong SW, 2010, P NATL ACAD SCI USA, V107, P13515, DOI 10.1073/pnas.1001695107
   Fossat P, 2012, CEREB CORTEX, V22, P595, DOI 10.1093/cercor/bhr130
   Fujii K, 2006, MOL PSYCHIATR, V11, P150, DOI 10.1038/sj.mp.4001776
   Fukushima T, 2007, HIPPOCAMPUS, V17, P5, DOI 10.1002/hipo.20243
   Garcia CM, 2004, DEV BRAIN RES, V152, P25, DOI 10.1016/j.devbrainres.2004.05.008
   Garcia O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014200
   Garrett AM, 2009, J NEUROSCI, V29, P11723, DOI 10.1523/JNEUROSCI.2818-09.2009
   Gomes FCA, 1999, GLIA, V26, P97
   Gomes FCA, 2005, INT J DEV NEUROSCI, V23, P413, DOI 10.1016/j.ijdevneu.2005.04.001
   Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006
   Graciarena M, 2010, BRAIN BEHAV IMMUN, V24, P1301, DOI 10.1016/j.bbi.2010.06.005
   Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007
   Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8
   Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673
   Heupel K, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-25
   Hughes EG, 2010, MOL CELL NEUROSCI, V43, P136, DOI 10.1016/j.mcn.2009.10.004
   Ikeda H, 2010, J BIOL CHEM, V285, P38415, DOI 10.1074/jbc.M110.109827
   Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007
   Krieglstein K, 2011, TRENDS NEUROSCI, V34, P421, DOI 10.1016/j.tins.2011.06.002
   Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108
   Lacmann A, 2007, NEUROSCIENCE, V150, P647, DOI 10.1016/j.neuroscience.2007.09.046
   Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354
   McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830
   McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X
   Mecha M, 2008, DEV DYNAM, V237, P1709, DOI 10.1002/dvdy.21558
   Packard M, 2003, NAT REV NEUROSCI, V4, P113, DOI 10.1038/nrn1036
   Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051
   Panizzutti R, 2001, P NATL ACAD SCI USA, V98, P5294, DOI 10.1073/pnas.091002298
   Pfrieger FW, 2010, BRAIN RES REV, V63, P39, DOI 10.1016/j.brainresrev.2009.11.002
   Pfrieger FW, 1996, CURR OPIN NEUROBIOL, V6, P615, DOI 10.1016/S0959-4388(96)80093-6
   Pyka M, 2011, EUR J NEUROSCI, V33, P2187, DOI 10.1111/j.1460-9568.2011.07690.x
   Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#
   Romao LF, 2008, J NEUROCHEM, V106, P746, DOI 10.1111/j.1471-4159.2008.05428.x
   Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003
   Sanyal S, 2004, NEURON, V41, P845, DOI 10.1016/S0896-6273(04)00152-7
   Schell MJ, 1997, J NEUROSCI, V17, P1604
   Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471
   Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X
   Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987
   Sousa VD, 2004, EUR J NEUROSCI, V19, P1721, DOI 10.1111/j.1460.9568.2004.03249.x
   Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522
   Stipursky J, 2011, LIFE SCI, V89, P524, DOI 10.1016/j.lfs.2011.04.005
   Sun M, 2007, J NEUROSCI, V27, P7740, DOI 10.1523/JNEUROSCI.1604-07.2007
   Sun M, 2010, J NEUROSCI, V30, P6025, DOI 10.1523/JNEUROSCI.0789-10.2010
   Tomoda T, 1996, DEV BIOL, V179, P79, DOI 10.1006/dbio.1996.0242
   Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657
   Vargas-Lopes C, 2011, J NEUROCHEM, V116, P281, DOI 10.1111/j.1471-4159.2010.07102.x
   Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019
   Vincze C, 2010, J COMP NEUROL, V518, P3752, DOI 10.1002/cne.22422
   Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100
   Zhao B, 2012, CELL RES, V22, P1467, DOI 10.1038/cr.2012.92
   Zhuang P, 2004, CLIN NEUROPHYSIOL, V115, P2542, DOI 10.1016/j.clinph.2004.06.006
   Zhuang ZY, 2010, J NEUROSCI, V30, P16015, DOI 10.1523/JNEUROSCI.0481-10.2010
NR 73
TC 106
Z9 110
U1 0
U2 25
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 30
PY 2012
VL 287
IS 49
BP 41432
EP 41445
DI 10.1074/jbc.M112.380824
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 048CK
UT WOS:000311887600055
PM 23055518
OA Green Published, Other Gold
DA 2020-12-01
ER

PT J
AU Pereira, VCS
   Malfetano, FR
   Meira, ID
   de Souza, LF
   Liem, AM
   Maiolino, A
   Leon, SVA
AF Santa Rita Pereira, Valeria Coelho
   Malfetano, Fabiola Rachid
   Meira, Isabella D'Andrea
   de Souza, Leticia Fezer
   Liem, Assuncion Martinez
   Maiolino, Angelo
   Alves Leon, Soniza Vieira
TI Clinical response to interferon beta and glatiramer acetate in multiple
   sclerosis patients: a Brazilian cohort
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE multiple sclerosis; interferon-beta; glatiramer acetate; therapeutics
ID RELAPSING MS; THERAPY; CRITERIA
AB Introduction: Many patients with multiple sclerosis (MS) are currently receiving treatment with interferon beta (IFNb) and glatiramer acetate (GA). Identifying nonresponders patients is important to define therapy strategies. Several criteria for treatment response to IFNb and GA have been proposed. Objective: It was to investigate the response to treatment with IFNb-1a, IFNb-1b and GA among relapsing-remitting multiple sclerosis (RRMS) patients. Methods: We analyzed treatment response to IFNb and GA in ninety-one RRMS patients followed for at least one year. Clinical response was established by clinical criteria based on relapses, disability progression or both. Results: We observed a proportion of nonresponders, ranging from 3.3 to 42.9%, depending on the stringency of the criteria used. Conclusions: Our sample of Brazilian patients with MS has similarities when compared to other studies and there was no statistically significant difference regarding age, gender, ethnicity or disease duration between responders and nonresponders.
C1 [Alves Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Serv Neurol, BR-21941617 Rio de Janeiro, RJ, Brazil.
   [Alves Leon, Soniza Vieira] Univ Fed Estado Rio de Janeiro UNIRIO, Rio De Janeiro, RJ, Brazil.
   [Alves Leon, Soniza Vieira] Neurol Postgrad Program UNIRIO, Rio De Janeiro, RJ, Brazil.
   [Malfetano, Fabiola Rachid] Hosp Naval Marcilio Dias, Rio De Janeiro, RJ, Brazil.
   [Maiolino, Angelo] Univ Fed Rio de Janeiro, Dept Internal Med, BR-21941617 Rio de Janeiro, RJ, Brazil.
RP Leon, SVA (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Serv Neurol, Rua Prof Rodolpho Paulo Rocco 255, BR-21941617 Rio de Janeiro, RJ, Brazil.
EM sonizavleon@globo.com
RI Leon, Soniza V Alves/J-7786-2012; DAndrea-Meira, Isabella/B-5341-2013
CR *AC BRAS NEUR, 2005, ARQ NEURO-PSIQUIAT, V63, P892
   Alves-Leon SV, 2007, ACTA NEUROL SCAND, V115, P306, DOI 10.1111/j.1600-0404.2006.00750.x
   Alves-Leon SV, 2008, ARQ NEURO-PSIQUIAT, V66, P671, DOI 10.1590/S0004-282X2008000500012
   [Anonymous], 2003, MMW FORTSCHR MED, V145, pS108
   Baranzini SE, 2005, PLOS BIOL, V3, P166, DOI 10.1371/journal.pbio.0030002
   Cohen BA, 2004, NEUROLOGY, V63, pS33, DOI 10.1212/WNL.63.12_suppl_6.S33
   Cree BAC, 2005, ARCH NEUROL-CHICAGO, V62, P1681, DOI 10.1001/archneur.62.11.1681
   Cree BAC, 2004, NEUROLOGY, V63, P2039, DOI 10.1212/01.WNL.0000145762.60562.5D
   Fernandez-Fernandez O, 2006, REV NEUROLOGIA, V43, P322, DOI 10.33588/rn.4306.2005807
   Fusco C, 2001, NEUROLOGY, V57, P1976, DOI 10.1212/WNL.57.11.1976
   Imitola J, 2006, ARCH NEUROL-CHICAGO, V63, P25, DOI 10.1001/archneur.63.1.25
   Kappos L, 2001, NEUROLOGY, V57, P1969, DOI 10.1212/WNL.57.11.1969
   Kirstein-Grossman I, 2002, DRUG NEWS PERSPECT, V15, P558, DOI 10.1358/dnp.2002.15.9.740230
   Kracke A, 2000, NEUROLOGY, V54, P193, DOI 10.1212/WNL.54.1.193
   Lublin FD, 2005, NEUROL CLIN, V23, P1, DOI 10.1016/j.ncl.2004.09.003
   Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907
   Mazdeh Mehrdokht, 2010, Acta Med Iran, V48, P83
   Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366
   POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302
   Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740
   Rio J, 2002, ANN NEUROL, V52, P400, DOI 10.1002/ana.10290
   Rudick RA, 2004, ANN NEUROL, V56, P548, DOI 10.1002/ana.20224
   Trojano M, 2009, ANN NEUROL, V66, P513, DOI 10.1002/ana.21757
   Villoslada P, 2004, NEUROLOGY, V62, P1653, DOI 10.1212/WNL.62.9.1653
   Waubant E, 2003, NEUROLOGY, V61, P184, DOI 10.1212/01.WNL.0000078888.07196.0B
NR 25
TC 7
Z9 7
U1 0
U2 1
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD OCT
PY 2012
VL 70
IS 10
BP 774
EP 779
DI 10.1590/S0004-282X2012001000005
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 019EJ
UT WOS:000309719600005
PM 23060103
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Pessoa, FMC
   Lopes, FCR
   Costa, JVA
   Leon, SVA
   Domingues, RC
   Gasparetto, EL
AF Clemente Pessoa, Fernanda Miraldi
   Rueda Lopes, Fernanda Cristina
   Altamiro Costa, Joao Victor
   Alves Leon, Soniza Vieira
   Domingues, Romeu Cortes
   Gasparetto, Emerson Leandro
TI The cervical spinal cord in neuromyelitis optica patients: A comparative
   study with multiple sclerosis using diffusion tensor imaging
SO EUROPEAN JOURNAL OF RADIOLOGY
LA English
DT Article
DE Multiple sclerosis; Neuromyelitis optica; MRI; DTI
ID APPEARING WHITE-MATTER; DIAGNOSTIC-CRITERIA; DAMAGE; MRI; PATHOGENESIS;
   AQUAPORIN-4; DISTINCTION; LESIONS
AB Introduction: This study aims to evaluate "in vivo" the integrity of the normal-appearing spinal cord in patients with neuromyelitis optica (NMO), using diffusion tensor MR imaging, comparing to controls and patients with multiple sclerosis (MS).
   Materials and methods: We studied 8 patients with NMO and 17 without any neurologic disorder. Also, 32 MS patients were selected. Fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD) and mean diffusivity (MD) were calculated within regions of interest at C2 and C7 levels in the four columns of the spinal cord.
   Results: At C2, the FA value was decreased in NMO patients compared to MS and controls in the anterior column. Also in this column, RD value showed increase in NMO compared to MS and to controls. The FA value of the posterior column was decreased in NMO in comparison to controls. At C7, AD value was higher in NMO than in MS in the right column. At the same column, MD values were increased in NMO compared to MS and to controls.
   Conclusions: There is extensive NASC damage in NMO patients, including peripheral areas of the cervical spinal cord, affecting the white matter, mainly caused by demyelination. This suggests a new spinal cord lesion pattern in NMO in comparison to MS. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Clemente Pessoa, Fernanda Miraldi; Alves Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Ilha Fundao, Dept Neurol, Rio De Janeiro, RJ, Brazil.
   [Rueda Lopes, Fernanda Cristina; Altamiro Costa, Joao Victor; Gasparetto, Emerson Leandro] Univ Fed Rio de Janeiro, Dept Radiol, Rio De Janeiro, RJ, Brazil.
   [Domingues, Romeu Cortes; Gasparetto, Emerson Leandro] CDPI, Rio De Janeiro, RJ, Brazil.
RP Pessoa, FMC (corresponding author), Univ Fed Rio de Janeiro, Ilha Fundao, Dept Neurol, Rua Rodolpho Paulo Rocco,255 Cidade Univ, Rio De Janeiro, RJ, Brazil.
EM fernandamiraldi@hotmail.com; frueda81@hotmail.com;
   victoraltamiro@gmail.com; sonizavleon@globo.com; romeu@CDPi.com.br;
   egasparetto@gmail.com
RI Leon, Soniza V Alves/J-7786-2012; Neurociencia, Inct/I-1011-2013
CR Benedetti B, 2006, NEUROLOGY, V67, P161, DOI 10.1212/01.wnl.0000223637.65208.7c
   Blanco Y, 2011, REV NEUROLOGIA, V53, P146, DOI 10.33588/rn.5303.2011196
   Bot JCJ, 2004, RADIOLOGY, V233, P531, DOI 10.1148/radiol.2332031572
   Duan Y, 2011, EUR J RADIOL, V19, P13
   Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304
   Freund P, 2010, MULT SCLER J, V16, P1193, DOI 10.1177/1352458510376180
   Gass A, 2000, J NEUROL SCI, V172, pS17, DOI 10.1016/S0022-510X(99)00272-5
   Gass A, 2000, J NEUROL SCI, V55, P450
   Graber DJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-22
   Cruz LCH, 2009, ARQ NEURO-PSIQUIAT, V67, P391, DOI 10.1590/S0004-282X2009000300004
   Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X
   Marignier R, 2010, BRAIN, V133, P2578, DOI 10.1093/brain/awq177
   Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047
   ORiordan JI, 1996, J NEUROL NEUROSUR PS, V60, P382, DOI 10.1136/jnnp.60.4.382
   Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703
   Qian WS, 2011, J MAGN RESON IMAGING, V33, P1312, DOI 10.1002/jmri.22575
   Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267
   Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626
   Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74
   Yu CS, 2006, AM J NEURORADIOL, V27, P1009
   Yu CS, 2008, RADIOLOGY, V246, P222, DOI 10.1148/radiol.2461062075
NR 21
TC 13
Z9 13
U1 0
U2 13
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0720-048X
J9 EUR J RADIOL
JI Eur. J. Radiol.
PD OCT
PY 2012
VL 81
IS 10
BP 2697
EP 2701
DI 10.1016/j.ejrad.2011.11.026
PG 5
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 996IZ
UT WOS:000308079700041
PM 22192780
DA 2020-12-01
ER

PT J
AU Fragoso, Y
   Adoni, T
   Barbagelata-Aguero, F
   Almeida, S
   Alves-Leon, S
   Arruda, W
   Brooks, J
   Carra, A
   Claudino, R
   Comini-Frota, E
   Correa, E
   Damasceno, A
   Damasceno, B
   Dias, E
   Vizcarra-Escobar, D
   Fiore, A
   Franco, C
   Giacomo, M
   Gomes, S
   Goncalves, M
   Grzesiuk, A
   Inojosa, J
   Kaimen-Maciel, D
   Lin, K
   Lourenco, G
   Martinez, A
   Melcon, M
   Morales, N
   Morales, R
   Moreira, M
   Moreira, S
   Oliveira, C
   Oliveira, F
   Ribeiro, J
   Ribeiro, S
   Rodriguez, C
   Russo, L
   Safanelli, J
   Shearer, K
   Siquineli, F
AF Fragoso, Y.
   Adoni, T.
   Barbagelata-Aguero, F.
   Almeida, S.
   Alves-Leon, S.
   Arruda, W.
   Brooks, J.
   Carra, A.
   Claudino, R.
   Comini-Frota, E.
   Correa, E.
   Damasceno, A.
   Damasceno, B.
   Dias, E.
   Vizcarra-Escobar, D.
   Fiore, A.
   Franco, C.
   Giacomo, M.
   Gomes, S.
   Goncalves, M.
   Grzesiuk, A.
   Inojosa, J.
   Kaimen-Maciel, D.
   Lin, K.
   Lourenco, G.
   Martinez, A.
   Melcon, M.
   Morales, N.
   Morales, R.
   Moreira, M.
   Moreira, S.
   Oliveira, C.
   Oliveira, F.
   Ribeiro, J.
   Ribeiro, S.
   Rodriguez, C.
   Russo, L.
   Safanelli, J.
   Shearer, K.
   Siquineli, F.
TI Month of birth does not seem to interfere with the prevalence or disease
   progression in multiple sclerosis for South American patients,
   irrespectively of the latitude
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 28th Congress of the
   European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis
CY OCT 10-13, 2012
CL Lyon, FRANCE
SP European Comm Treatment & Res Multiple Sclerosis
C1 Univ Metropolitana Santos, Santos, Brazil.
   Hosp Sirio Libanes, Sao Paulo, Brazil.
   Hypnos, Lima, Peru.
   Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
   INC, Curitiba, Parana, Brazil.
   Hosp Britan, Buenos Aires, DF, Argentina.
   Univ Fed Santa Catarina, Florianopolis, SC, Brazil.
   Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   IC, Brasilia, DF, Brazil.
   Univ Estadual Campinas, Campinas, SP, Brazil.
   Pontificia Univ Catolica Chile, Santiago, Chile.
   Sao Camilo, Santos, Brazil.
   HC, Recife, PE, Brazil.
   Fundacao ABC, Sao Bernardo Do Campo, Brazil.
   HBP, Sao Paulo, Brazil.
   H Paulistano, Sao Paulo, Brazil.
   INJ, Joinville, Brazil.
   CRIDAC, Cuiaba, Brazil.
   Univ Estadual Londrina, Londrina, Brazil.
   FINEP, Buenos Aires, DF, Argentina.
   Univ Fed Uberlandia, Uberlandia, MG, Brazil.
   FCMS SUPREMA, Juiz De Fora, Brazil.
   Hosp Paulistano, Sao Paulo, Brazil.
   Univ Fed Triangulo Mineiro, Uberaba, Brazil.
   Univ Aberdeen, Aberdeen, Scotland.
   Univ Reg Blumenau, Blumenau, Brazil.
RI , Edwin/AAH-1314-2020; Vizcarra, Darwin/AAM-7728-2020; Leon, Soniza V
   Alves/J-7786-2012; Arruda, Walter Oleschko/AAJ-8256-2020
OI Vizcarra, Darwin/0000-0002-8342-9640; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD OCT
PY 2012
VL 18
SU 4
BP 314
EP 315
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 275UC
UT WOS:000328702202074
DA 2020-12-01
ER

PT J
AU Rueda-Lopes, F
   Miraldi, F
   Malfetano, F
   Meira, I
   Alvesleon, S
   Domingues, R
   Gasparetto, E
AF Rueda-Lopes, F.
   Miraldi, F.
   Malfetano, F.
   Meira, I.
   Alvesleon, S.
   Domingues, R.
   Gasparetto, E.
TI Resting-state functional magnetic resonance imaging in the assessment of
   patients with neuromyelitis optica
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 28th Congress of the
   European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis
CY OCT 10-13, 2012
CL Lyon, FRANCE
SP European Comm Treatment & Res Multiple Sclerosis
C1 [Rueda-Lopes, F.; Miraldi, F.; Malfetano, F.; Meira, I.; Alvesleon, S.; Domingues, R.; Gasparetto, E.] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD OCT
PY 2012
VL 18
SU 4
BP 383
EP 383
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 275UC
UT WOS:000328702202212
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Alves-Leon, SV
   Anacleto, AD
   Brooks, JBB
   da Gama, PD
   Gomes, S
   Goncalves, MVM
   Lin, K
   Lopes, J
   Kaimen-Maciel, DR
   Malfetano, FH
   Martins, GL
   de Oliveira, FTM
   Oliveira, LD
   Schlindwein-Zanini, R
AF Fragoso, Yara Dadalti
   Alves-Leon, Soniza Vieira
   Anacleto, Andrea de Carvalho
   Bidin Brooks, Joseph Bruno
   da Gama, Paulo Diniz
   Gomes, Sidney
   Magno Goncalves, Marcus Vinicius
   Lin, Katia
   Lopes, Josiane
   Kaimen-Maciel, Damacio Ramon
   Malfetano, Fabiola Haschid
   Martins, Gladys Lentz
   Menezes de Oliveira, Francisco Tomaz
   Oliveira, Leonardo Dornas
   Schlindwein-Zanini, Rachel
TI Neurological complications following bariatric surgery
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE bariatric surgery; demyelination; neuropathy; Wenicke syndrome
ID GASTRIC BYPASS-SURGERY; PERIPHERAL NEUROPATHY; PERONEAL NEUROPATHY;
   OBESITY
AB Objective: It was to report on Brazilian cases of neurological complications from bariatric surgery. The literature on the subject is scarce. Method: Cases attended by neurologists in eight different Brazilian cities were collected and described in the present study. Results: Twenty-six cases were collected in this study. Axonal polyneuropathy was the most frequent neurological complication, but cases of central demyelination, Wernicke syndrome, optical neuritis, radiculits, meralgia paresthetica and compressive neuropathies were also identified. Twenty-one patients (80%) had partial or no recovery from the neurological signs and symptoms. Conclusion: Bariatric surgery, a procedure that is continuously increasing in popularity, is not free of potential neurological complications that should be clearly presented to the individual undergoing this type of surgery. Although a clear cause-effect relation cannot be established for the present cases, the cumulative literature on the subject makes it important to warn the patient of the potential risks of this procedure.
C1 [Fragoso, Yara Dadalti; Bidin Brooks, Joseph Bruno] Univ Metropolitana Santos UNIMES, Sch Med, Dept Mental Hlth, Neurol Serv, BR-11015470 Santos, SP, Brazil.
   [Alves-Leon, Soniza Vieira; Malfetano, Fabiola Haschid] Univ Estado Rio De Janeiro, Neurol Serv, Rio De Janeiro, RJ, Brazil.
   [Anacleto, Andrea de Carvalho] Hosp Ana Costa, Dept Neurol, Santos, SP, Brazil.
   [da Gama, Paulo Diniz] Pontificia Univ Catolica PUC Sao Paulo, Dept Neurol, Sorocaba, SP, Brazil.
   [Gomes, Sidney; Menezes de Oliveira, Francisco Tomaz] Hosp Beneficencia Portuguesa, Dept Neurol, Sao Paulo, Brazil.
   [Gomes, Sidney; Menezes de Oliveira, Francisco Tomaz] Hosp Paulistano, Dept Neurol, Sao Paulo, Brazil.
   [Magno Goncalves, Marcus Vinicius] Neurol Clin, Joinville, SC, Brazil.
   [Lin, Katia; Martins, Gladys Lentz] Hosp Governador Celso Ramos, Dept Neurol, Florianopolis, SC, Brazil.
   [Lopes, Josiane; Kaimen-Maciel, Damacio Ramon] Univ Estadual Londrina UEL, Dept Internal Med, Neurol Serv, Londrina, PR, Brazil.
   [Oliveira, Leonardo Dornas] Univ Fed Minas Gerais, Fac Med, Dept Internal Med, Neurol Serv, Belo Horizonte, MG, Brazil.
   [Schlindwein-Zanini, Rachel] Univ Fed Santa Catarina, Univ Hosp, Dept Psychol, Florianopolis, SC, Brazil.
RP Fragoso, YD (corresponding author), Univ Metropolitana Santos UNIMES, Sch Med, Dept Neurol, Rua Constituicao 374, BR-11015470 Santos, SP, Brazil.
EM yara@bsnet.com.br
RI Leon, Soniza V Alves/J-7786-2012; Lin, Katia/G-4891-2012; da Gama, Paulo
   Diniz/Q-7962-2019; Fragoso, Yara/B-1761-2015
OI Lin, Katia/0000-0002-5401-7524; Fragoso, Yara/0000-0001-8726-089X
CR ABARBANEL JM, 1987, NEUROLOGY, V37, P196, DOI 10.1212/WNL.37.2.196
   Ba Fang, 2010, Rev Neurol Dis, V7, P119
   Berger Gregory, 2007, Manag Care Interface, V20, P36
   Berger JR, 2004, ARCH NEUROL-CHICAGO, V61, P1185, DOI 10.1001/archneur.61.8.1185
   Chang CG, 2004, OBES SURG, V14, P182, DOI 10.1381/096089204322857537
   Cruz-Martinez A, 2000, J PERIPHER NERV SYST, V5, P101, DOI 10.1046/j.1529-8027.2000.00007.x
   de Oliveira LD, 2009, OBES SURG, V19, P1102, DOI 10.1007/s11695-008-9780-8
   Dyck PJB, 2002, MUSCLE NERVE, V25, P477, DOI 10.1002/mus.10080
   Elias WJ, 2006, J NEUROSURG, V105, P631, DOI 10.3171/jns.2006.105.4.631
   FEIT H, 1982, ANN INTERN MED, V96, P453, DOI 10.7326/0003-4819-96-4-453
   HARWOOD SC, 1987, ARCH PHYS MED REHAB, V68, P310
   Juhasz-Pocsine K, 2007, NEUROLOGY, V68, P1843, DOI 10.1212/01.wnl.0000262768.40174.33
   Knecht S, 2008, PROG NEUROBIOL, V84, P85, DOI 10.1016/j.pneurobio.2007.09.003
   Koffman BM, 2006, MUSCLE NERVE, V33, P166, DOI 10.1002/mus.20394
   Kumar N, 2007, NEUROLOGY, V68, pE36, DOI 10.1212/01.wnl.0000266868.07399.8b
   Kumar N, 2010, SEMIN NEUROL, V30, P38, DOI 10.1055/s-0029-1244993
   MARYNIAK O, 1984, CAN MED ASSOC J, V131, P119
   Menezes Miriam Seligman, 2008, Rev. Bras. Anestesiol., V58, P252, DOI 10.1590/S0034-70942008000300008
   Machado FCN, 2006, ARQ NEURO-PSIQUIAT, V64, P609, DOI 10.1590/S0004-282X2006000400017
   Singh S, 2007, NEUROLOGY, V68, P807, DOI 10.1212/01.wnl.0000256812.29648.86
   Thaisetthawatkul P, 2004, NEUROLOGY, V63, P1462
NR 21
TC 7
Z9 7
U1 0
U2 4
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2012
VL 70
IS 9
BP 700
EP 703
DI 10.1590/S0004-282X2012000900010
PG 4
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 008LX
UT WOS:000308959600010
PM 22990727
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Pires, CE
   da Silva, CMC
   Lopes, FCR
   Malfetano, FR
   Pereira, VCSR
   Kubo, T
   Bahia, PRV
   Alves-Leon, SV
   Gasparetto, EL
AF Pires, Cintia Elias
   Correa da Silva, Christianne Martins
   Rueda Lopes, Fernanda Cristina
   Malfetano, Fabiola Rachid
   Pereira, Valeria C. S. R.
   Kubo, Tadeu
   Bahia, Paulo R. V.
   Alves-Leon, Soniza Vieira
   Gasparetto, Emerson L.
TI Brain MRI abnormalities in Brazilian patients with neuromyelitis optica
SO JOURNAL OF CLINICAL NEUROSCIENCE
LA English
DT Article
DE Brain abnormalities; Brazilian patients; Neuromyelitis optica; MRI
ID CRITERIA
AB Brain abnormalities in neuromyelitis optica (NMO) have been reported previously, but the pathophysiological mechanism and clinical relevance of these abnormalities are poorly understood. We assessed the prevalence and patterns of brain MRI abnormalities in a Brazilian cohort of patients with NMO. Conventional brain MRI and medical records from 24 Brazilian patients with NMO were retrospectively evaluated. Brain MRI were classified into four subgroups: normal, non-specific lesions, multiple sclerosis (MS)-like lesions, and typical lesions. Brain lesions were detected in 19 patients (79.2%). Fourteen patients (58.3%) had non-specific lesions, three (12.5%) had MS-like lesions, and two (8.3%) had typical lesions. Differences between these subgroups with respect to the Expanded Disability Status Scale (EDSS) scores (p = 0.86) were not significant. This study demonstrates a high prevalence of brain abnormalities in Brazilian patients with NMO; however, we did not find a significant relationship between these abnormalities and EDSS scores. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Pires, Cintia Elias; Correa da Silva, Christianne Martins; Rueda Lopes, Fernanda Cristina; Malfetano, Fabiola Rachid; Pereira, Valeria C. S. R.; Bahia, Paulo R. V.; Alves-Leon, Soniza Vieira; Gasparetto, Emerson L.] Univ Fed Rio de Janeiro, Diagnost Radiol & Neurol Dept, Rio De Janeiro, Brazil.
   [Pires, Cintia Elias; Rueda Lopes, Fernanda Cristina; Kubo, Tadeu; Gasparetto, Emerson L.] Diagnost Amer DASA, Clin Diagnast Imagem CDPI, BR-22649900 Rio De Janeiro, Brazil.
RP Pires, CE (corresponding author), Univ Fed Rio de Janeiro, Diagnost Radiol & Neurol Dept, Rio De Janeiro, Brazil.
EM cintiaepires@yahoo.com.br
RI Leon, Soniza V Alves/J-7786-2012
CR Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059
   Bichuetti DB, 2009, MULT SCLER, V15, P613, DOI 10.1177/1352458508101935
   Cabrera-Gomez JA, 2007, MULT SCLER, V13, P186, DOI 10.1177/1352458506070725
   Chon H. T., 2002, NEUROLOGY J S E ASIA, V7, P35
   de Seze J, 2002, J NEUROL SCI, V197, P57, DOI 10.1016/S0022-510X(02)00043-6
   Ghezzi A, 2004, J NEUROL, V251, P47, DOI 10.1007/s00415-004-0271-0
   Kim JE, 2011, J NEUROL SCI, V302, P43, DOI 10.1016/j.jns.2010.12.001
   Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304
   Li Y, 2008, ACTA NEUROL SCAND, V118, P218, DOI 10.1111/j.1600-0404.2008.01012.x
   Nakamura M, 2008, J NEUROL, V255, P163, DOI 10.1007/s00415-008-0545-z
   Nakashima I, 2006, J NEUROL NEUROSUR PS, V77, P1073, DOI 10.1136/jnnp.2005.080390
   ORiordan JI, 1996, J NEUROL NEUROSUR PS, V60, P382, DOI 10.1136/jnnp.60.4.382
   Papais-Alvarenga RM, 2002, J NEUROL NEUROSUR PS, V73, P429, DOI 10.1136/jnnp.73.4.429
   Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P964, DOI 10.1001/archneur.63.7.964
   Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P390, DOI 10.1001/archneur.63.3.390
   Poppe AY, 2005, MULT SCLER J, V11, P617, DOI 10.1191/1352458505ms1200cr
   Vernant JC, 1997, NEUROLOGY, V48, P58, DOI 10.1212/WNL.48.1.58
   Wang F, 2011, EUR J RADIOL, V80, P445, DOI 10.1016/j.ejrad.2010.06.024
   Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74
   Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107
NR 20
TC 10
Z9 13
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0967-5868
EI 1532-2653
J9 J CLIN NEUROSCI
JI J. Clin. Neurosci.
PD JUL
PY 2012
VL 19
IS 7
BP 969
EP 974
DI 10.1016/j.jocn.2011.10.009
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 040LJ
UT WOS:000311323800009
PM 22613491
DA 2020-12-01
ER

PT J
AU Schmidt, FR
   Costa, FHR
   Silva, FMLC
   Maultasch, H
   Rosso, AL
   Nicaretta, DH
   de Mottos, JP
   Novis, SAP
   Alves-Leon, SV
AF Schmidt, Felipe R.
   Costa, Flavio Henrique R.
   Silva, Fernando M. L. C.
   Maultasch, Henryk
   Rosso, Ana Lucia
   Nicaretta, Denise H.
   de Mottos, James P.
   Novis, Sergio A. P.
   Alves-Leon, Soniza V.
TI Paroxysmal dystonia and neuromyelitis optica
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE paroxysmal dyskinesias; paroxysmal dystonia; neuromyelitis optica
ID MULTIPLE-SCLEROSIS; CLINICAL SYNDROME; LESION; SPASMS; CORD
AB Paroxysmal wdyskinesias (PD) are thought to be rare movement disorders. The overwhelming majority of reported cases are primary. Secondary PD has seen reported to occur in some conditions, mainly in multiple sclerosis and head trauma. The anatomic origin of the Lesion is also rarely seen at the spinal cord. Our objective was to describe four patients with paroxysmal dystonia secondary to spinal Lesions during the recovering phase of a neuromyelitis optica (NMO) bout. In the reviewed literature, we do not find any report of PD related to NMO.
C1 [Schmidt, Felipe R.; Costa, Flavio Henrique R.; Silva, Fernando M. L. C.; Maultasch, Henryk; Rosso, Ana Lucia; de Mottos, James P.; Novis, Sergio A. P.; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro UFRJ, Serv Neurol Prof Sergio Novis, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, RJ, Brazil.
   [Nicaretta, Denise H.; Novis, Sergio A. P.] Vigesima Quinta Enfermaria Santa Casa de Miserico, Rio De Janeiro, RJ, Brazil.
RP Rosso, AL (corresponding author), Rua Santa Clara 50-702, BR-22041012 Rio De Janeiro, RJ, Brazil.
EM anarosso@gmait.com
RI Leon, Soniza V Alves/J-7786-2012
CR BERGER JR, 1984, ARCH NEUROL-CHICAGO, V41, P747, DOI 10.1001/archneur.1984.04050180069020
   BROWN P, 1991, MOVEMENT DISORD, V6, P43, DOI 10.1002/mds.870060108
   Cosentino C, 1996, MOVEMENT DISORD, V11, P453, DOI 10.1002/mds.870110422
   Fahn S, 2007, PRINCIPLES PRACTICE, P554
   MAIMONE D, 1991, ARCH NEUROL-CHICAGO, V48, P427, DOI 10.1001/archneur.1991.00530160097021
   Mount LA, 1940, ARCH NEURO PSYCHIATR, V44, P841, DOI 10.1001/archneurpsyc.1940.02280100143011
   PREVIDI P, 1992, ITAL J NEUROL SCI, V13, P521, DOI 10.1007/BF02230875
   Waubant E, 2001, NEUROLOGY, V57, P2320, DOI 10.1212/WNL.57.12.2320
   Weinshenker BG, 2008, CURR TOP MICROBIOL, V318, P343
NR 9
TC 12
Z9 13
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD APR
PY 2012
VL 70
IS 4
BP 271
EP 273
DI 10.1590/S0004-282X2012005000011
PG 3
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 927EF
UT WOS:000302889200009
PM 22358312
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Lopes, FCR
   Doring, T
   Martins, C
   Cabral, FC
   Malfetano, FR
   Pereira, VCSR
   Alves-Leon, S
   Gasparetto, EL
AF Rueda Lopes, Fernanda C.
   Doring, Thomas
   Martins, Christianne
   Cabral, Fernanda C.
   Malfetano, Fabiola R.
   Pereira, Valeria C. S. R.
   Alves-Leon, Soniza
   Gasparetto, Emerson L.
TI The Role of Demyelination in Neuromyelitis Optica Damage:
   Diffusion-Tensor MR Imaging Study
SO RADIOLOGY
LA English
DT Article
ID WHITE-MATTER DAMAGE; MULTIPLE-SCLEROSIS; SPATIAL STATISTICS; VOXELWISE
   ANALYSIS; ABNORMALITIES; PATHOGENESIS; DISTINCTION; AQUAPORIN-4;
   IMPAIRMENT; CRITERIA
AB Purpose: To test the hypothesis that white matter damage in neuromyelitis optica (NMO) is more extensive than previously described and likely includes involvement of normal-appearing white matter and to explore by using diffusion-tensor (DT) imaging whether white matter lesions are not only related to wallerian degeneration but are also caused by demyelination.
   Materials and Methods: Seventeen patients with NMO (mean age, 45 years; 14 women) were compared with 17 sex-and age-matched control subjects. The institutional review board approved the study, and all subjects gave written informed consent. In addition to conventional magnetic resonance imaging sequences, DT imaging was performed along 30 noncollinear directions by using a 1.5-T imager. For tract-based spatial statistics (TBSS) analysis, the white matter skeleton was created, and a permutation-based inference with 5000 permutations with a threshold of P less than .05 to enable the identification of abnormalities in fractional anisotropy (FA), radial diffusivity (RD), and axial diffusivity (AD) was used. Partial correlation was applied to identify whether the number of clinical relapses and disease duration were correlated with all TBSS parameters.
   Results: TBSS showed multiple areas with significant FA decrease in patients with NMO, mainly located in the corona radiata, uncinate fasciculus, corpus callosum, optic radiation, internal and external capsules, and cerebral peduncles. The mean FA, RD, and AD in the abnormal voxels located on the corpus callosum were, respectively, 0.69 +/- 0.03 (standard deviation), 0.39 x 10(-3) mm(2)/sec +/- 0.04, and 1.53 x 10(-3) mm(2)/sec +/- 0.04 in patients with NMO compared with 0.75 +/- 0.02, 0.33 x 10(-3) mm(2)/sec +/- 0.03, and 1.57 x 10(-3) mm(2)/sec +/- 0.04 in control subjects (P < .0001, P < .0001, and P = .007, respectively). There was a highly significant inverse correlation between FA and RD (r = -0.976, P < .0001).
   Conclusion: The use of TBSS allowed the identification of extensive white matter damage in patients with NMO. Multiple white matter tracts were involved, including the pyramidal tract, optic radiation, and corpus callosum, likely related to both demyelination and wallerian degeneration. (C) RSNA, 2012
C1 [Rueda Lopes, Fernanda C.; Gasparetto, Emerson L.] Univ Fed Rio de Janeiro, Dept Radiol, Ilha Fundao, BR-21941913 Rio De Janeiro, RJ, Brazil.
   [Martins, Christianne; Malfetano, Fabiola R.; Pereira, Valeria C. S. R.; Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Dept Neurol, Ilha Fundao, BR-21941913 Rio De Janeiro, RJ, Brazil.
   [Rueda Lopes, Fernanda C.; Gasparetto, Emerson L.] Clin Diagnost Imagem, Dept Neuroradiol, Rio De Janeiro, Brazil.
   [Cabral, Fernanda C.] Clin Diagnost Imagem, Dept Radiol, Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza] Univ Rio de Janeiro, Dept Neurol, Rio De Janeiro, Brazil.
RP Lopes, FCR (corresponding author), Univ Fed Rio de Janeiro, Dept Radiol, Ilha Fundao, Brigadeiro Trompowsky 255, BR-21941913 Rio De Janeiro, RJ, Brazil.
EM Frueda81@hotmail.com
RI Leon, Soniza V Alves/J-7786-2012
FU CAPESCAPES; Merck SeronoMerck SeronoMerck & Company; Bayer ScheringBayer
   AG; NovartisNovartis
FX F.C.R.L. Financial activities related to the present article: none to
   disclose. Financial activities not related to the present article:
   employed at Clinica de Diagnostico por Imagem. Other relationships: none
   to disclose. T. D. No potential conflicts of interest to disclose. C. M.
   No potential conflicts of interest to disclose. F. C. C. No potential
   conflicts of interest to disclose. F. R. M. Financial activities related
   to the present article: author receives travel support from Bayer
   Schering for medical Congress. Financial activities not related to the
   present article: author receives payment for lectures from Bayer
   Schering. Other relationships: none to disclose. V. C. S. R. P.
   Financial activities related to the present article: author and
   institution receive money from Bayer Schering for being coinvestigator
   in the Beyond Study; author receives travel support from Bayer Schering,
   Biogen Idec, Merck Serono, and Novartis for Congress. Financial
   activities not related to the present article: none to disclose. Other
   relationships: none to disclose. S. A. Financial activities related to
   the present article: author and institution grants from CAPES for
   research presentation in Congress, from Novartis for being speaker and
   member of advisory board and support for Congress, from Biogen Idec for
   being principal investigator, speaker, and member of advisory board and
   support for Congress, from Merck Serono for being speaker and member of
   advisory board and support for Congress; and from Bayer Schering for
   being principal investigator, speaker, and member of advisory board and
   for support for Congress; author and institution receive consulting fee
   or honorarium from Merck Serono, Bayer Schering, and Novartis for
   advisory board; author and institution receive travel support from
   CAPES, from Biogen Idec for meeting as principal investigator in
   clinical trials or Congress, from Merck Serono for meeting as principal
   investigator in clinical trials or Congress, from Novartis for Congress,
   from Bayer Schering for meeting as principal investigator in clinical
   trials or Congress, and from TEVA for meeting as principal investigator
   in clinical trials or Congress. Financial activities not related to the
   present article: author receives money for board membership from Merck
   Serono, Biogen Idec, Novartis, and Bayer Schering; author receives money
   for consultancy from Arquivos de Neuropsiquiatria, Tissue Antigens,
   Seizure, Revista de Oncologia Clinica, FAPERJ, and CAPES; author
   employed at Universidade Federal do Estado do Rio de Janeiro and
   Universidade Federal do Rio de Janeiro; author gives expert testimony
   for Brazilian Academy of Neurology and Brazilian Medical Society; author
   receives payment for lectures from Biogen Idec, Novartis, Merck Serono,
   and TEVA. Other relationships: none to disclose. E. L. G. No potential
   conflicts of interest to disclose.
CR Aboul-Enein F, 2010, AM J NEURORADIOL, V31, P76, DOI 10.3174/ajnr.A1791
   Andersson J. L. R., 2007, TR07JA1 FMRIB
   Andersson J. L. R., 2007, TR07JA2 FMRIB
   Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059
   Barrick TR, 2010, NEUROIMAGE, V51, P565, DOI 10.1016/j.neuroimage.2010.02.033
   Bichuetti DB, 2008, J NEUROL, V255, P1895, DOI 10.1007/s00415-009-0940-0
   He DA, 2011, BRAIN COGNITION, V77, P80, DOI 10.1016/j.bandc.2011.05.007
   Hu W, 2009, SEMIN IMMUNOPATHOL, V31, P439, DOI 10.1007/s00281-009-0178-z
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X
   Li Y, 2008, ACTA NEUROL SCAND, V118, P218, DOI 10.1111/j.1600-0404.2008.01012.x
   Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151
   Marignier R, 2010, BRAIN, V133, P2578, DOI 10.1093/brain/awq177
   Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047
   Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P964, DOI 10.1001/archneur.63.7.964
   Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P390, DOI 10.1001/archneur.63.3.390
   Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023
   Rocca MA, 2004, NEUROLOGY, V62, P476, DOI 10.1212/01.WNL.0000106946.08741.41
   Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026
   Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284
   Shukla DK, 2011, J CHILD PSYCHOL PSYC, V52, P286, DOI 10.1111/j.1469-7610.2010.02342.x
   Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051
   Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267
   Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74
   Yu CS, 2006, AM J NEURORADIOL, V27, P1009
   Yu CS, 2008, RADIOLOGY, V246, P222, DOI 10.1148/radiol.2461062075
NR 28
TC 39
Z9 41
U1 1
U2 11
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD APR
PY 2012
VL 263
IS 1
BP 235
EP 242
DI 10.1148/radiol.12111241
PG 8
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 923TP
UT WOS:000302642700024
PM 22438446
DA 2020-12-01
ER

PT J
AU Sebollela, A
   Freitas-Correa, L
   Oliveira, FF
   Paula-Lima, AC
   Saraiva, LM
   Martins, SM
   Mota, LD
   Torres, C
   Alves-Leon, S
   de Souza, JM
   Carraro, DM
   Brentani, H
   De Felice, FG
   Ferreira, ST
AF Sebollela, Adriano
   Freitas-Correa, Leo
   Oliveira, Fabio F.
   Paula-Lima, Andrea C.
   Saraiva, Leonardo M.
   Martins, Samantha M.
   Mota, Louise D.
   Torres, Cesar
   Alves-Leon, Soniza
   de Souza, Jorge M.
   Carraro, Dirce M.
   Brentani, Helena
   De Felice, Fernanda G.
   Ferreira, Sergio T.
TI Amyloid-beta Oligomers Induce Differential Gene Expression in Adult
   Human Brain Slices
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID RECEPTOR-DEPENDENT MECHANISM; SOLUBLE-PROTEIN OLIGOMERS; D-ASPARTATE
   RECEPTORS; LONG-TERM DEPRESSION; NERVE-CELL LINE; ALZHEIMERS-DISEASE;
   A-BETA; TRANSGENIC MICE; HIPPOCAMPAL-NEURONS; SYNAPTOPHYSIN MESSAGE
AB Cognitive decline in Alzheimer disease (AD) is increasingly attributed to the neuronal impact of soluble oligomers of the amyloid-beta peptide (A beta Os). Current knowledge on the molecular and cellular mechanisms underlying the toxicity of A beta Os stems largely from rodent-derived cell/tissue culture experiments or from transgenic models of AD, which do not necessarily recapitulate the complexity of the human disease. Here, we used DNA microarray and RT-PCR to investigate changes in transcription in adult human cortical slices exposed to sublethal doses of A beta Os. The results revealed a set of 27 genes that showed consistent differential expression upon exposure of slices from three different donors to A beta Os. Functional classification of differentially expressed genes revealed that A beta Os impact pathways important for neuronal physiology and known to be dysregulated in AD, including vesicle trafficking, cell adhesion, actin cytoskeleton dynamics, and insulin signaling. Most genes (70%) were down-regulated by A beta O treatment, suggesting a predominantly inhibitory effect on the corresponding pathways. Significantly, A beta Os induced down-regulation of synaptophysin, a presynaptic vesicle membrane protein, suggesting a mechanism by which oligomers cause synapse failure. The results provide insight into early mechanisms of pathogenesis of AD and suggest that the neuronal pathways affected by A beta Os may be targets for the development of novel diagnostic or therapeutic approaches.
C1 [Sebollela, Adriano; Freitas-Correa, Leo; Oliveira, Fabio F.; Paula-Lima, Andrea C.; Saraiva, Leonardo M.; Martins, Samantha M.; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Mota, Louise D.; Torres, Cesar; Carraro, Dirce M.; Brentani, Helena] AC Camargo Hosp, Int Ctr Educ & Res, BR-01509 Sao Paulo, Brazil.
   [de Souza, Jorge M.] Univ Fed Rio de Janeiro, Div Neurosurg, Clementino Fraga Filho Univ Hosp, BR-21941913 Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Div Neurol, Epilepsy Program, BR-21941913 Rio De Janeiro, RJ, Brazil.
   [Paula-Lima, Andrea C.] Univ Chile, Ctr Mol Studies Cell, Fac Dent, Santiago, Chile.
RP Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM ferreira@bioqmed.ufrj.br
RI Leon, Soniza V Alves/J-7786-2012; Paula-Lima, Andrea C./I-2537-2013;
   Neurociencia, Inct/I-1011-2013; Brentani, Helena/G-6839-2011; Ferreira,
   Sergio/AAZ-1576-2020; Sebollela, Adriano/O-4385-2014; carraro,
   dirce/C-9179-2009
OI Paula-Lima, Andrea C./0000-0002-0466-7561; Brentani,
   Helena/0000-0001-5192-4682; Ferreira, Sergio/0000-0001-7160-9866;
   Sebollela, Adriano/0000-0002-7444-9156; carraro,
   dirce/0000-0001-5667-1418
FU Human Frontiers Science ProgramHuman Frontier Science Program; The John
   Simon Guggenheim Foundation; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio
   de JaneiroNational Council for Scientific and Technological Development
   (CNPq)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); National Institute for Translational
   Neuroscience; Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq)
FX This work was supported by grants from the Human Frontiers Science
   Program and The John Simon Guggenheim Foundation (to F. G. D.-F.) and
   the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico,
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, and National
   Institute for Translational Neuroscience (to S. T. F. and F. G. D.-F.).;
   Recipient of a postdoctoral fellowship from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico. To whom correspondence may be
   addressed. E-mail: sebollela@bioqmed.ufrj.br.
CR Ambree O, 2006, AM J PATHOL, V169, P544, DOI 10.2353/ajpath.2006.051107
   Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9
   Billuart P, 2003, NEURON, V38, P843, DOI 10.1016/S0896-6273(03)00362-3
   Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006
   Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100
   Bossers K, 2010, BRAIN, V133, P3699, DOI 10.1093/brain/awq258
   Brentani RR, 2005, CRIT REV ONCOL HEMAT, V54, P95, DOI 10.1016/j.critrevonc.2004.12.006
   Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552, DOI 10.2174/156720511796391917
   Callahan LM, 1999, J NEUROPATH EXP NEUR, V58, P275, DOI 10.1097/00005072-199903000-00007
   Callahan LM, 2002, J NEUROPATH EXP NEUR, V61, P384, DOI 10.1093/jnen/61.5.384
   Castro NP, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2157
   Chevyreva I, 2008, EXP MOL PATHOL, V84, P71, DOI 10.1016/j.yexmp.2007.08.019
   Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q
   Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351
   Cox WG, 2004, BIOTECHNIQUES, V36, P114, DOI 10.2144/04361RR02
   Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137
   Daily NJ, 2010, J BIOL CHEM, V285, P35320, DOI 10.1074/jbc.M110.145169
   De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029
   De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475
   Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x
   Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010
   Dickey CA, 2003, J NEUROSCI, V23, P5219
   Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10
   ELFERINK LA, 1993, J CELL SCI, P75
   Emilsson L, 2006, NEUROBIOL DIS, V21, P618, DOI 10.1016/j.nbd.2005.09.004
   Ferreira EN, 2010, DIAGN MOL PATHOL, V19, P45, DOI 10.1097/PDM.0b013e3181ae8186
   Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882
   Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003
   Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
   Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016
   Heinitz K, 2006, J NEUROCHEM, V98, P1930, DOI 10.1111/j.1471-4159.2006.04015.x
   Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035
   Ishibashi KI, 2006, J NEUROSCI RES, V84, P632, DOI 10.1002/jnr.20952
   Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901
   Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200
   Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13
   Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012
   Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ma T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012845
   Marwarha G, 2010, J ALZHEIMERS DIS, V19, P1007, DOI 10.3233/JAD-2010-1298
   Mexal S, 2006, BRAIN RES, V1106, P1, DOI 10.1016/j.brainres.2006.05.043
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002
   Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000
   Parachikova A, 2007, NEUROBIOL AGING, V28, P1821, DOI 10.1016/j.neurobiolaging.2006.08.014
   Paula-Lima AC, 2005, NEUROPHARMACOLOGY, V49, P1140, DOI 10.1016/j.neuropharm.2005.06.015
   Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287
   Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003
   Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106
   Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142
   Reddy PH, 2004, HUM MOL GENET, V13, P1225, DOI 10.1093/hmg/ddh140
   Rutten BPF, 2005, AM J PATHOL, V167, P161, DOI 10.1016/S0002-9440(10)62963-X
   SABO S, 1995, NEUROSCI LETT, V184, P25, DOI 10.1016/0304-3940(94)11159-G
   Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667
   Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503
   Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979
   Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107
   Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Vencio RZN, 2005, DNA RES, V12, P211, DOI 10.1093/dnares/dsi007
   Verwer RWH, 2002, FASEB J, V16, P54, DOI 10.1096/fj.01-0504com
   Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X
   Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4
   Wisniewski T, 2010, BBA-MOL BASIS DIS, V1802, P847, DOI 10.1016/j.bbadis.2010.05.004
   Yokota T, 2006, EUR J CLIN INVEST, V36, P820, DOI 10.1111/j.1365-2362.2006.01722.x
   Zahs KR, 2010, TRENDS NEUROSCI, V33, P381, DOI 10.1016/j.tins.2010.05.004
   Zhang C, 1996, NEUROSCI LETT, V211, P187, DOI 10.1016/0304-3940(96)12761-0
   Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com
NR 76
TC 53
Z9 53
U1 0
U2 14
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 2
PY 2012
VL 287
IS 10
BP 7436
EP 7445
DI 10.1074/jbc.M111.298471
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 902SL
UT WOS:000301060200044
PM 22235132
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Andraus, MEC
   Andraus, CF
   Alves-Leon, SV
AF Cosenza Andraus, Maria Emilia
   Andraus, Cesar Fantezia
   Alves-Leon, Soniza Vieira
TI Periodic EEG patterns: importance of their recognition and clinical
   significance
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Review
DE etectroencephalography; PLEDs; BIPLEDs; GPEDs; triphasic waves; SIRPIDs
ID LATERALIZED EPILEPTIFORM DISCHARGES; CREUTZFELDT-JAKOB-DISEASE;
   NONCONVULSIVE STATUS EPILEPTICUS; SHARP WAVE COMPLEXES; CRITICALLY-ILL;
   ELECTROENCEPHALOGRAPHIC PATTERN; TRIPHASIC WAVES; PLEDS; ABNORMALITIES;
   PROGNOSIS
AB Periodic electroencephalographic (EEG) patterns consist of discharges usually epileptiform in appearance, which occur at regular intervals, in critical patients. They are commonly classified as periodic lateralized epileptiform discharges (PLEDs), bilateral independent PLEDs or BIPLEDs, generalized epileptiform discharges (GPEDs) and triphasic waves. Stimulus-induced rhythmic, periodic or ictal discharges (SIRPIDs) are peculiar EEG patterns, which may be present as periodic discharges. The aim of this study is to make a review of the periodic EEG patterns, emphasizing the importance of their recognition and clinical significance. The clinical significance of the periodic EEG patterns is uncertain, it is related to a variety of etiologies, and many authors suggest that these patterns are unequivocally epileptogenic in some cases. Their recognition and classification are important to establish an accurate correlation between clinical, neurological, laboratorial and neuroimaging data with the EEG results.
C1 [Cosenza Andraus, Maria Emilia] Santa Casa de Misericordia Rio de Janeiro, Setor Eletroencefalog, Serv Neurol Prof Sergio Novis, BR-20020022 Rio De Janeiro, RJ, Brazil.
   [Cosenza Andraus, Maria Emilia] Univ Fed Estado Rio de Janeiro UNIRIO, Strictu Sensu Post Grad Program Neurol, Rio De Janeiro, RJ, Brazil.
   [Andraus, Cesar Fantezia] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Neurosurg Serv, Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Serv Neurol, Epilepsy Program, Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Estado Rio de Janeiro, Strictu Sensu Post Grad Program Neurol, Rio de Janeiro, RJ, Brazil.
RP Andraus, MEC (corresponding author), Santa Casa de Misericordia Rio de Janeiro, Setor Eletroencefalog, Serv Neurol Prof Sergio Novis, 25A Enfermaria,Rua Santa Luzia 206, BR-20020022 Rio De Janeiro, RJ, Brazil.
EM cosenzaandraus@yahoo.com
RI Leon, Soniza V Alves/J-7786-2012
CR Anghinah R, 2006, ARQ NEURO-PSIQUIAT, V64, P122, DOI 10.1590/S0004-282X2006000100025
   AU WJ, 1980, NEUROLOGY, V30, P611, DOI 10.1212/WNL.30.6.611
   Bertolucci P H, 1987, Arq Neuropsiquiatr, V45, P364
   BICKFORD RG, 1955, J CLIN INVEST, V34, P790, DOI 10.1172/JCI103134
   Boulanger JM, 2006, CAN J NEUROL SCI, V33, P175, DOI 10.1017/S0317167100004935
   Bouwman NAMG, 2009, CLIN EEG NEUROSCI, V40, P196, DOI 10.1177/155005940904000313
   BRENNER RP, 1990, J CLIN NEUROPHYSIOL, V7, P249, DOI 10.1097/00004691-199004000-00007
   Brenner RP, 2004, J CLIN NEUROPHYSIOL, V21, P319
   Brigo Francesco, 2011, Am J Electroneurodiagnostic Technol, V51, P16
   CHATRIAN GE, 1964, ELECTROEN CLIN NEURO, V17, P177, DOI 10.1016/0013-4694(64)90149-X
   Chong DJ, 2005, J CLIN NEUROPHYSIOL, V22, P79, DOI 10.1097/01.WNP.0000158699.78529.AF
   CHU NS, 1980, ARCH NEUROL-CHICAGO, V37, P551, DOI 10.1001/archneur.1980.00500580047006
   COBB W, 1966, ELECTROEN CLIN NEURO, V21, P278, DOI 10.1016/0013-4694(66)90077-0
   COBB W, 1950, BRAIN, V73, P392, DOI 10.1093/brain/73.3.392
   de los Reyes EC, 2008, J CHILD NEUROL, V23, P167, DOI 10.1177/0883073807307984
   DELAPAZ D, 1981, ARCH NEUROL-CHICAGO, V38, P713, DOI 10.1001/archneur.1981.00510110073012
   Drislane FW, 2008, J CLIN NEUROPHYSIOL, V25, P181, DOI 10.1097/WNP.0b013e31817be70e
   Fernandez-Torre JL, 2004, CLIN NEUROPHYSIOL, V115, P316, DOI 10.1016/j.clinph.2003.10.012
   Fitzpatrick W, 2007, CAN J NEUROL SCI, V34, P443, DOI 10.1017/S0317167100007332
   FOLEY JM, 1950, T AM NEUROL ASSOC, P161
   Fountain NB, 2001, J CLIN NEUROPHYSIOL, V18, P345, DOI 10.1097/00004691-200107000-00006
   Fushimi M, 2003, ACTA NEUROL SCAND, V108, P55, DOI 10.1034/j.1600-0404.2003.00084.x
   Gaches J, 1971, Rev Electroencephalogr Neurophysiol Clin, V1, P9, DOI 10.1016/S0370-4475(71)80003-5
   Gandelman-Marton R, 2003, J CLIN NEUROPHYSIOL, V20, P117, DOI 10.1097/00004691-200304000-00005
   Garcia-Morales I, 2002, J CLIN NEUROPHYSIOL, V19, P172, DOI 10.1097/00004691-200203000-00009
   Garzon E, 2001, NEUROLOGY, V57, P1175, DOI 10.1212/WNL.57.7.1175
   GLOOR P, 1968, BRAIN, V91, P779, DOI 10.1093/brain/91.4.779
   Gross DW, 1999, CLIN NEUROPHYSIOL, V110, P1516, DOI 10.1016/S1388-2457(99)00119-4
   Gross DW, 1998, ELECTROEN CLIN NEURO, V107, P434, DOI 10.1016/S0013-4694(98)00103-5
   HANDFORTH A, 1994, EPILEPSIA, V35, P876, DOI 10.1111/j.1528-1157.1994.tb02526.x
   Hansen HC, 1998, ACTA NEUROL SCAND, V97, P99
   Hirsch LJ, 2005, J CLIN NEUROPHYSIOL, V22, P128, DOI 10.1097/01.WNP.0000158701.89576.4C
   Hirsch LJ, 2004, EPILEPSIA, V45, P109, DOI 10.1111/j.0013-9580.2004.38103.x
   Hirsch LJ, 2010, ATLAS EEG CRITICAL C, P129
   Husain AM, 1999, J CLIN NEUROPHYSIOL, V16, P51, DOI 10.1097/00004691-199901000-00005
   JACOME DE, 1983, CLIN ELECTROENCEPHAL, V14, P27, DOI 10.1177/155005948301400105
   Korabathina Kalyani, 2007, Expert Rev Neurother, V7, P1643, DOI 10.1586/14737175.7.12.1643
   KUROIWA Y, 1980, ARCH NEUROL-CHICAGO, V37, P15, DOI 10.1001/archneur.1980.00500500045005
   Lapergue B, 2010, NEUROLOGY, V74, P1995, DOI 10.1212/WNL.0b013e3181e39703
   MARKAND ON, 1971, NEUROLOGY, V21, P975, DOI 10.1212/WNL.21.10.975
   Neufeld MY, 1997, ELECTROEN CLIN NEURO, V102, P295, DOI 10.1016/S0013-4694(96)95726-0
   Orta DS, 2009, ARCH NEUROL-CHICAGO, V66, P985, DOI 10.1001/archneurol.2009.137
   Ortega-Albas JJ, 2003, REV NEUROLOGIA, V36, P376, DOI 10.33588/rn.3604.2002226
   Parkerson KA, 2011, EPILEPSY BEHAV, V20, P48, DOI 10.1016/j.yebeh.2010.10.012
   PohlmannEden B, 1996, J CLIN NEUROPHYSIOL, V13, P519, DOI 10.1097/00004691-199611000-00007
   Praveen-Kumar S, 2007, CLIN NEUROPHYSIOL, V118, P1947, DOI 10.1016/j.clinph.2007.06.008
   REIHER J, 1991, ELECTROEN CLIN NEURO, V78, P12, DOI 10.1016/0013-4694(91)90013-T
   Sekiguchi K, 2010, CLIN NEUROPHYSIOL, V121, P800, DOI 10.1016/j.clinph.2009.12.031
   Silva A, 1988, ARQ NEURO-PSIQUIAT, V46, P10
   SILVA DF, 1995, ARQ NEURO-PSIQUIAT, V53, P278, DOI 10.1590/S0004-282X1995000200017
   SNODGRASS SM, 1989, J CLIN NEUROPHYSIOL, V6, P159, DOI 10.1097/00004691-198904000-00003
   TRAUB RD, 1981, ANN NEUROL, V10, P405, DOI 10.1002/ana.410100502
   Wang PS, 2008, J CLIN NEUROPHYSIOL, V25, P25, DOI 10.1097/WNP.0b013e318163a7d5
   WESTMORELAND BF, 1986, ARCH NEUROL-CHICAGO, V43, P494, DOI 10.1001/archneur.1986.00520050066024
   Yemisci M, 2003, SEIZURE-EUR J EPILEP, V12, P465, DOI 10.1016/S1059-1311(02)00351-5
NR 55
TC 32
Z9 32
U1 0
U2 3
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD FEB
PY 2012
VL 70
IS 2
BP 145
EP 151
DI 10.1590/S0004-282X2012000200014
PG 7
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 897KT
UT WOS:000300650300014
PM 22311221
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Shearer, KD
   Adoni, T
   Alves-Leon, SV
   Brooks, JBB
   Comini-Frota, ER
   Damasceno, A
   Damasceno, B
   Fiore, APP
   Giacomo, MCB
   Gomes, S
   Goncalves, MVM
   Kaimen-Maciel, DR
   Lin, KT
   Lopes, J
   Lopes, JS
   Lourenco, G
   Machado, G
   Melges, LD
   Morales, NDO
   Morales, RR
   Moreira, M
   Noal, JS
   Oliveira, CLD
   Papais-Alvarenga, RM
   Parolin, M
   Ribeiro, JB
   Ribeiro, SBF
   Ruocco, H
   Siquineli, F
AF Fragoso, Yara Dadaiti
   Shearer, Kirsty D.
   Adoni, Tarso
   Alves-Leon, Soniza Vieira
   Bidin Brooks, Joseph Bruno
   Comini-Frota, Elizabeth Regina
   Damasceno, Alfredo
   Damasceno, Benito
   Peres Fiore, Ana Patricia
   Baptista Giacomo, Maria Cristina
   Gomes, Sidney
   Magno Goncalves, Marcus Vinicius
   Kaimen-Maciel, Damacio Ramon
   Lin, Katia
   Lopes, Josiane
   Lopes, Juarez Silva
   Lourenco, Giselle
   Machado, Gabriela
   Melges, Luiz Domingos
   Oliveira Morales, Nivea de Macedo
   Morales, Rogerio Rizo
   Moreira, Marcos
   Noal, Janaina Silveira
   da Silva Oliveira, Celso Luis
   Papais-Alvarenga, Regina Maria
   Parolin, Monica
   Ribeiro, Joao Batista
   Felix Ribeiro, Sonia Beatriz
   Ruocco, Heloisa
   Siquineli, Fabio
TI Month of Birth Does Not Seem to Interfere with the Development of
   Multiple Sclerosis Later in Life in Brazilian Patients
SO NEUROEPIDEMIOLOGY
LA English
DT Letter
ID POPULATION; RISK; SEASON
C1 [Fragoso, Yara Dadaiti] Univ Metropolitana Santos, Dept Neurol, Sch Med, UNIMES, BR-11015470 Santos, SP, Brazil.
   [Shearer, Kirsty D.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland.
   [Alves-Leon, Soniza Vieira; Papais-Alvarenga, Regina Maria] Univ Fed Rio de Janeiro, Dept Neurol, Rio De Janeiro, Brazil.
   [Comini-Frota, Elizabeth Regina] Univ Fed Minas Gerais, Dept Neurol, Belo Horizonte, MG, Brazil.
   [Damasceno, Alfredo; Damasceno, Benito] Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil.
   [Magno Goncalves, Marcus Vinicius] Clin Neurol Joinville, Joinville, Brazil.
   [Kaimen-Maciel, Damacio Ramon; Lopes, Josiane] Univ Estadual Londrina, Dept Neurol, Londrina, Brazil.
   [Lin, Katia; Machado, Gabriela] Univ Fed Santa Catarina, Dept Neurol, BR-88040900 Florianopolis, SC, Brazil.
   [Lopes, Juarez Silva; Noal, Janaina Silveira] Neurol Clin, Santa Maria, RS, Brazil.
   [Melges, Luiz Domingos] Fac Med Marilia, Dept Neurol, Marilia, Brazil.
   [Oliveira Morales, Nivea de Macedo; Morales, Rogerio Rizo] Univ Fed Uberlandia, Dept Neurol, BR-38400 Uberlandia, MG, Brazil.
   [Moreira, Marcos] FCMS Suprema, Clin Neuroimmunol Unit, Hosp Therezinha de Jesus, Juiz De Fora, Brazil.
   [Parolin, Monica] Neurol Clin, Curitiba, Parana, Brazil.
   [Ribeiro, Joao Batista; Felix Ribeiro, Sonia Beatriz] Univ Fed Triangulo Mineiro, Dept Neurol, Uberaba, Brazil.
   [Ruocco, Heloisa] Neurol Clin, Jundiai, Brazil.
   [Siquineli, Fabio] Univ Reg Blumenau, Sch Med, Hosp Santa Isabel, Blumenau, Brazil.
   [Gomes, Sidney; Lourenco, Giselle] Hosp Beneficencia Portuguesa, Sao Paulo, Brazil.
   [Gomes, Sidney; Lourenco, Giselle] Hosp Paulistano, Sao Paulo, Brazil.
   [Adoni, Tarso] Hosp Heliopolis, Dept Neurol, Sao Paulo, Brazil.
RP Fragoso, YD (corresponding author), Univ Metropolitana Santos, Dept Neurol, Sch Med, UNIMES, Rua Constituicao 374, BR-11015470 Santos, SP, Brazil.
EM yara@bsnet.com.br
RI Lin, Katia/G-4891-2012; Moreira, Marcos A/G-2936-2014; Leon, Soniza V
   Alves/J-7786-2012; Comini-Frota, Elizabeth R./F-8461-2012; Neurociencia,
   Inct/I-1011-2013; Fragoso, Yara/B-1761-2015
OI Lin, Katia/0000-0002-5401-7524; Moreira, Marcos A/0000-0002-2039-6538;
   Comini-Frota, Elizabeth R./0000-0002-2702-0402; Fragoso,
   Yara/0000-0001-8726-089X; SIQUINELI, FABIO/0000-0002-5380-3654
CR Bayes HK, 2010, EUR NEUROL, V63, P36, DOI 10.1159/000268163
   Bharanidharan P, 1997, INT J BIOMETEOROL, V40, P117, DOI 10.1007/s004840050030
   Givon U, 2012, NEUROEPIDEMIOLOGY, V38, P64, DOI 10.1159/000334437
   Saastamoinen KP, 2012, MULT SCLER J, V18, P563, DOI 10.1177/1352458511426814
   SADOVNICK AD, 1994, ACTA NEUROL SCAND, V89, P190
   Salzer J, 2010, ACTA NEUROL SCAND, V122, P70, DOI 10.1111/j.1600-0404.2010.01396.x
   Staples J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1640
   TEMPLER DI, 1992, ACTA NEUROL SCAND, V85, P107, DOI 10.1111/j.1600-0404.1992.tb04007.x
   WIBERG M, 1994, J ORTHOMOL MED, V9, P71
   Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63
NR 10
TC 8
Z9 8
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0251-5350
J9 NEUROEPIDEMIOLOGY
JI Neuroepidemiology
PY 2012
VL 39
IS 1
BP 70
EP 71
DI 10.1159/000338788
PG 2
WC Public, Environmental & Occupational Health; Clinical Neurology
SC Public, Environmental & Occupational Health; Neurosciences & Neurology
GA 980DP
UT WOS:000306874100010
PM 22776826
OA Bronze
DA 2020-12-01
ER

PT J
AU Andraus, MEC
   Alves-Leon, SV
AF Cosenza Andraus, Maria Emilia
   Alves-Leon, Soniza Vieira
TI Non-epileptiform EEG abnormalities An overview
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Review
DE abnormal EEG; non-epileptiform abnormalities; slow activity
ID RHYTHMIC-DELTA-ACTIVITY; ACTIVITY FIRDA; EMERGENT EEG; COMA;
   ELECTROENCEPHALOGRAM; DIAGNOSIS; EPILEPSY
AB More than 80 years after its introduction by Hans Berger, the electroencephalogram (EEG) remains as an important supplementary examination in the investigation of neurological disorders and gives valuable and accurate information about cerebral function. Abnormal EEG findings may include ictal patterns, interictal epileptiform activity and non-epileptiform abnormalities. The aim of this study is to make an overview on the main non-epileptiform EEG abnormalities, emphasizing the pathologic findings and the importance of their recognition, excluding periodic patterns and EEG physiologic changes. Scientific articles were selected from MEDLINE and PubMed database. The presence of non-epileptiform EEG abnormalities provide evidence of brain dysfunction that are not specific to a particular etiology and may be related to a number of disorders affecting the brain. Although these abnormalities are not specific, they can direct attention to the diagnostic possibilities and guide the best treatment choice.
C1 [Cosenza Andraus, Maria Emilia] Santa Casa da Misericordia Rio de Janeiro, Electroencephalog Sect, Serv Neurol Prof Sergio Novis, 24th Infirm, Rio De Janeiro, Brazil.
   [Cosenza Andraus, Maria Emilia] Santa Casa da Misericordia Rio de Janeiro, Electroencephalog Sect, Serv Neurol Prof Sergio Novis, 25th Infirm, Rio De Janeiro, Brazil.
   [Cosenza Andraus, Maria Emilia] Univ Fed Estado Rio de Janeiro UNIRIO, Strictu Sensu Post Grad Program Neurol, Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Epilepsy Program, Serv Neurol, BR-21941 Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Estado Rio de Janeiro, Strictu Sensu Post Grad Program Neurol, Rio de Janeiro, Brazil.
RP Andraus, MEC (corresponding author), Rua Santa Luzia 206, BR-20020022 Rio De Janeiro, Brazil.
EM cosenzaandraus@yahoo.com
RI Leon, Soniza V Alves/J-7786-2012
CR Abou-Khalil B, 2006, ATLAS EEG SEIZURE SE, P99
   Accolla EA, 2011, CLIN NEUROPHYSIOL, V122, P27, DOI 10.1016/j.clinph.2010.06.005
   Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008
   BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x
   Berkhoff M, 2000, CLIN NEUROPHYSIOL, V111, P297, DOI 10.1016/S1388-2457(99)00246-1
   Brigo F, 2011, EPILEPSY BEHAV, V20, P254, DOI 10.1016/j.yebeh.2010.11.009
   CHAPARROHERNAND.P, 2009, REV NEUROL, V32, P542
   COBB WA, 1945, J NEUROL NEUROSUR PS, V8, P65, DOI 10.1136/jnnp.8.3-4.65
   CORDEAU JP, 1959, ELECTROEN CLIN NEURO, V11, P733
   Cosenza-Andraus ME, 2006, REV NEUROLOGIA, V43, P7, DOI 10.33588/rn.4301.2005615
   DALY D, 1953, ELECTROENCEPHALOGR C, V5, P201
   Di Gennaro G, 2003, CLIN NEUROPHYSIOL, V114, P70, DOI 10.1016/S1388-2457(02)00332-2
   FARIELLO RG, 1982, ELECTROEN CLIN NEURO, V54, P194, DOI 10.1016/0013-4694(82)90161-4
   FAURE J, 1951, Electroencephalogr Clin Neurophysiol, V3, P429
   Fernandez-Torre JL, 2003, REV NEUROLOGIA, V37, P744, DOI 10.33588/rn.3708.2003146
   Geyer JD, 1999, NEUROLOGY, V52, P202, DOI 10.1212/WNL.52.1.202
   GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326
   Guilhoto LMFF, 2006, ARQ NEURO-PSIQUIAT, V64, P193, DOI 10.1590/S0004-282X2006000200004
   HOCKADAY JM, 1965, ELECTROEN CLIN NEURO, V18, P575, DOI 10.1016/0013-4694(65)90075-1
   Jabbari B, 2000, CLIN NEUROPHYSIOL, V111, P102, DOI 10.1016/S1388-2457(99)00189-3
   Jasper H, 1953, CLIN NEUROPHYSIOL, V4, P168
   KAMEDA K, 1995, CLIN ELECTROENCEPHAL, V26, P173, DOI 10.1177/155005949502600309
   Kaplan PW, 2000, CLIN NEUROPHYSIOL, V111, P584, DOI 10.1016/S1388-2457(99)00303-X
   Khan SF, 2005, CLIN NEUROPHYSIOL, V116, P2454, DOI 10.1016/j.clinph.2005.06.024
   Lazar LM, 1999, CLIN NEUROPHYSIOL, V110, P1036, DOI 10.1016/S1388-2457(99)00046-2
   LESCHEY WH, 1978, CLIN ELECTROENCEPHAL, V9, P110, DOI 10.1177/155005947800900303
   Martinez-Bermejo A, 2001, REV NEUROLOGIA, V33, P1101, DOI 10.33588/rn.3312.2001198
   NAZARIAN SM, 1987, CLIN ELECTROENCEPHAL, V18, P227
   Oddo M, 2011, CURR OPIN CRIT CARE, V17, P254, DOI 10.1097/MCC.0b013e328344f2ae
   Praline J, 2007, CLIN NEUROPHYSIOL, V118, P2149, DOI 10.1016/j.clinph.2007.07.003
   REIHER J, 1989, CAN J NEUROL SCI, V16, P398, DOI 10.1017/S0317167100029450
   ROWAN AJ, 1974, J NEUROL NEUROSUR PS, V37, P888, DOI 10.1136/jnnp.37.8.888
   Schaul N, 1998, ELECTROEN CLIN NEURO, V106, P101, DOI 10.1016/S0013-4694(97)00111-9
   SCHAUL N, 1981, NEUROLOGY, V31, P157, DOI 10.1212/WNL.31.2.157
   Schneider Anita L, 2005, Am J Electroneurodiagnostic Technol, V45, P102
   STERIADE M, 1994, ELECTROEN CLIN NEURO, V90, P1, DOI 10.1016/0013-4694(94)90108-2
   SYNEK VM, 1984, CLIN ELECTROENCEPHAL, V15, P116, DOI 10.1177/155005948401500209
   van Putten MJAM, 2007, CLIN NEUROPHYSIOL, V118, P2798, DOI 10.1016/j.clinph.2007.08.026
   Vanrumste B, 2005, CLIN NEUROPHYSIOL, V116, P9, DOI 10.1016/j.clinph.2004.07.032
   Walter WG, 1936, LANCET, V2, P305
   Watemberg N, 2002, J CLIN NEUROPHYSIOL, V19, P535, DOI 10.1097/00004691-200212000-00006
   Watemberg N, 2007, EPILEPSIA, V48, P330, DOI 10.1111/j.1528-1167.2006.00937.x
   ZIFKIN BG, 1997, CLIN PRACTICE CLIN E, P253
NR 43
TC 13
Z9 13
U1 0
U2 4
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD OCT
PY 2011
VL 69
IS 5
BP 829
EP 835
DI 10.1590/S0004-282X2011000600020
PG 7
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 839ED
UT WOS:000296347200020
PM 22042190
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Aguayo-Arcelis, A
   Almeida, SMG
   Alves-Leon, SV
   Arruda, WO
   Brooks, JBB
   Carra, A
   Comini-Frota, ER
   Ferreira, MLB
   Finkelsztejn, A
   Freitas, LD
   Gallina, AS
   Gama, PD
   Georgeto, SM
   Giacomo, MC
   Gomes, S
   Goncalves, MVM
   Grzesiuk, AK
   Kaimen-Maciel, DR
   Malfetano, FR
   Lopes, J
   Lourenco, GA
   Macias, MA
   Morales, NMO
   Morales, RR
   Oliveira, CLS
   Onaha, P
   Ribeiro, SBF
   Ribeiro, TAGJ
   Santoro, P
   Seefeld, M
   Soares, PV
   Szymanski, JM
   Tarulla, A
AF Fragoso, Y. D.
   Aguayo-Arcelis, A.
   Almeida, S. M. G.
   Alves-Leon, S. V.
   Arruda, W. O.
   Brooks, J. B. B.
   Carra, A.
   Comini-Frota, E. R.
   Ferreira, M. L. B.
   Finkelsztejn, A.
   Freitas, L. D.
   Gallina, A. S.
   Gama, P. D.
   Georgeto, S. M.
   Giacomo, M. C.
   Gomes, S.
   Goncalves, M. V. M.
   Grzesiuk, A. K.
   Kaimen-Maciel, D. R.
   Malfetano, F. R.
   Lopes, J.
   Lourenco, G. A.
   Macias, M. A.
   Morales, N. M. O.
   Morales, R. R.
   Oliveira, C. L. S.
   Onaha, P.
   Ribeiro, S. B. F.
   Ribeiro, T. A. G. J.
   Santoro, P.
   Seefeld, M.
   Soares, P. V.
   Szymanski, J. M.
   Tarulla, A.
TI The effects of long-term exposure to disease-modifying drugs during
   pregnancy
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
C1 Univ Metropolitana Santos, Santos, Brazil.
   CUCS, Guadalajara, Jalisco, Mexico.
   Univ Fed Estado Rio de Janeiro, Rio de Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
   UFPR, Curitiba, Parana, Brazil.
   HBBA, Buenos Aires, DF, Argentina.
   Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   HR, Recife, PE, Brazil.
   HC POA, Porto Alegre, RS, Brazil.
   SP, Piracicaba, SP, Brazil.
   PUC, Sorocaba, Brazil.
   Univ Estadual Londrina, Londrina, Brazil.
   SP, Sao Paulo, Brazil.
   HBP, Sao Paulo, Brazil.
   CNJ, Joinville, Brazil.
   INCV HSR, Cuiaba, Brazil.
   Univ Fed Uberlandia, Uberlandia, MG, Brazil.
   Univ Fed Triangulo Mineiro, Uberaba, Brazil.
   UF Go, Goiania, Go, Brazil.
   IIM, Buenos Aires, DF, Argentina.
   HUEC, Curitiba, Parana, Brazil.
   Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
RI Arruda, Walter Oleschko/AAJ-8256-2020; Leon, Soniza V Alves/J-7786-2012
NR 0
TC 1
Z9 1
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD OCT
PY 2011
VL 17
SU 10
MA P1026
BP S467
EP S468
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA V35GA
UT WOS:000209137301391
DA 2020-12-01
ER

PT J
AU Miraldi, F
   Rueda, F
   Altamiro, JV
   Alves-Leon, S
   Domingues, R
   Gasparetto, E
AF Miraldi, F.
   Rueda, F.
   Altamiro, J. V.
   Alves-Leon, S.
   Domingues, R.
   Gasparetto, E.
TI DTI of the cervical spinal cord: a new view to MS and NMO radiological
   analysis
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
C1 [Miraldi, F.; Rueda, F.; Altamiro, J. V.; Alves-Leon, S.; Domingues, R.; Gasparetto, E.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD OCT
PY 2011
VL 17
SU 10
MA P407
BP S167
EP S167
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA V35GA
UT WOS:000209137300336
DA 2020-12-01
ER

PT J
AU Lopes, FR
   Elias, C
   Martins, C
   Alves-Leon, S
   Domingues, R
   Gasparetto, E
AF Rueda Lopes, F.
   Elias, C.
   Martins, C.
   Alves-Leon, S.
   Domingues, R.
   Gasparetto, E.
TI The role of demyelination in the brain damage seen in neuromyelitis
   optica: a diffusion tensor MR imaging study
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
C1 [Rueda Lopes, F.; Elias, C.; Martins, C.; Alves-Leon, S.; Domingues, R.; Gasparetto, E.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD OCT
PY 2011
VL 17
SU 10
MA P878
BP S392
EP S392
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA V35GA
UT WOS:000209137301244
DA 2020-12-01
ER

PT J
AU Alves-Leon, SV
   Nunes, RG
   Andraus, MEC
   Biagini, JC
   Hemb, M
   Genofre, MA
AF Alves-Leon, Soniza Vieira
   Nunes, Renata Gomes
   Cosenza Andraus, Maria Emilia
   Biagini Junior, Jose Carlos
   Hemb, Marta
   Genofre, Maria Alice
TI Clinical and electroencephalographic characteristics of benign occipital
   epilepsy of childhood in two tertiary Brazilian hospitals
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE occipital epilepsy; epilepsy of childhood; benign epilepsy of childhood;
   benign occipital epilepsy
ID EARLY-ONSET; SUSCEPTIBILITY SYNDROME; SEIZURES; PAROXYSMS;
   CLASSIFICATION; CHILDREN; EEG
AB This study intended to investigate the clinical and electroencephalographic benign occipital epilepsy of childhood (BOEC) characteristics in a population sample of patients from two tertiary Brazilian hospitals. We analyzed retrospectively 4912 electroencephalograms (EEGs) records, and the included patients were submitted to a new clinical and EEG evaluation. Were included 12 (0.92%) patients; 4(33.3%) with criteria for early BOEC; 6(50%) for late form and 2 (16.7%) with superimposed early and late onset forms. After new investigation, 2 (16.7%) had normal EEG; 4 (33.3%) had paroxysms over the occipital region; 3 (25%) over the temporal posterior regions and 3 (25%) over the posterior regions. Sharp waves were the predominant change, occurring in 8 (66.6%); spike and slow wave complexes in 1 (8.3%) and sharp and slow wave complexes in 1 (8.3%). Vomiting, headache and visual hallucinations were the most common ictal manifestations, presented in 100% of patients with superimposed forms. Vomiting were absent in the late form and headache was present in all forms of BOEC.
C1 [Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Epilepsy Program, Serv Neurol, BR-21941617 Rio de Janeiro, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Estado Rio de Janeiro UNIRIO, Strictu Sensu Post Grad Program Neurol, Rio De Janeiro, Brazil.
   [Cosenza Andraus, Maria Emilia] Santa Casa da Misericorda Rio de Janeiro, Infirm 24, Dept Neurol, Electroencephalog Sect, Rio De Janeiro, Brazil.
   [Cosenza Andraus, Maria Emilia] Univ Fed Estado Rio de Janeiro, Strictu Sensu Post Grad Program Neurol, Rio de Janeiro, Brazil.
   [Hemb, Marta] Pontificia Univ Catolica Riod Grande do Sul, Ctr Clin, Porto Alegre, RS, Brazil.
   Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Nunes, Renata Gomes] Santa Casa Misericarda Rio de Janeiro, Infirm 25, Rio De Janeiro, Brazil.
RP Alves-Leon, SV (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Programa Epilepsias, Unidade Video EEG, Enfermarias 10C2 & 10C4,Rua Prof Rodolpho Paulo R, BR-21941617 Rio de Janeiro, Brazil.
EM sonizavleon@globo.com
RI Leon, Soniza V Alves/J-7786-2012
CR [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x
   Camfield P, 2002, EPILEPSIA, V43, P27, DOI 10.1046/j.1528-1157.43.s.3.3.x
   Caraballo R, 2000, NEUROLOGY, V55, P1096, DOI 10.1212/WNL.55.8.1096
   Caraballo RH, 2004, EPILEPSIA, V45, P1600
   DEONNA T, 1986, EPILEPSIA, V27, P241, DOI 10.1111/j.1528-1157.1986.tb03535.x
   Di Bonaventura C, 2005, SEIZURE-EUR J EPILEP, V14, P1, DOI 10.1016/j.seizure.2004.02.002
   Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x
   Ferrie CD, 1997, EPILEPSIA, V38, P285, DOI 10.1111/j.1528-1157.1997.tb01119.x
   GASTAUT H, 1982, CLIN ELECTROENCEPHAL, V13, P13, DOI 10.1177/155005948201300102
   Genizi J, 2007, J CHILD NEUROL, V22, P588, DOI 10.1177/0883073807302607
   Germano E, 2005, EPILEPSY RES, V64, P137, DOI 10.1016/j.eplepsyres.2005.03.004
   KIVITY S, 1992, J NEUROL NEUROSUR PS, V55, P45, DOI 10.1136/jnnp.55.1.45
   KUZNIECKY R, 1987, EPILEPSIA, V28, P346, DOI 10.1111/j.1528-1157.1987.tb03655.x
   MAHER J, 1995, EPILEPSIA, V36, P52, DOI 10.1111/j.1528-1157.1995.tb01665.x
   Martinovic Z, 2002, EPILEPSIA, V43, P1270
   Morin L, 2009, NEUROLOGY, V72, pE69, DOI 10.1212/01.wnl.0000346690.84004.af
   NAGENDRAN K, 1990, J ROY SOC MED, V83, P804
   Ohtsu M, 2003, EPILEPSIA, V44, P435, DOI 10.1046/j.1528-1157.2003.47702.x
   PAILLAS JE, 1950, REV NEUROL, V83, P393
   Panayiotopoulos CP, 2008, BRAIN, V131, P2264, DOI 10.1093/brain/awn162
   Panayiotopoulos CP, 1999, EPILEPSIA, V40, P1320, DOI 10.1111/j.1528-1157.1999.tb00866.x
   Panayiotopoulos CP, 2000, J CHILD NEUROL, V15, P548, DOI 10.1177/088307380001500810
   Panayiotopoulos CP, 2004, EPILEPSY BEHAV, V5, P286, DOI 10.1016/j.yebeh.2004.01.013
   PANAYIOTOPOULOS CP, 1989, J CHILD NEUROL, V4, P43, DOI 10.1177/088307388900400107
   PANAYIOTOPOULOS CP, 1988, J NEUROL NEUROSUR PS, V51, P1448, DOI 10.1136/jnnp.51.11.1448
   Panayiotopoulos CP, 2001, LANCET, V358, P68, DOI 10.1016/S0140-6736(00)05276-4
   PANAYIOTOPOULOS CP, 1989, ANN NEUROL, V26, P51, DOI 10.1002/ana.410260108
   Taylor I, 2008, BRAIN, V131, P2287, DOI 10.1093/brain/awn138
   VandenHout BM, 1997, EPILEPSIA, V38, P1188
   Verrotti A, 2000, J CHILD NEUROL, V15, P218, DOI 10.1177/088307380001500403
   Vigevano F, 2000, CLIN NEUROPHYSIOL, V111, pS81, DOI 10.1016/S1388-2457(00)00406-5
NR 31
TC 2
Z9 2
U1 0
U2 1
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD AUG
PY 2011
VL 69
IS 4
BP 648
EP 653
DI 10.1590/S0004-282X2011000500014
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 810TE
UT WOS:000294149200014
PM 21877035
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Paiva, CLA
   Paradela, ER
   Figueiredo, ALS
   Agostinho, L
   Rocha, C
   Alves-Leon, S
AF Paiva, C. L. A.
   Paradela, E. R.
   Figueiredo, A. L. S.
   Agostinho, L.
   Rocha, C.
   Alves-Leon, S.
TI Association of hla-class ii genes with susceptibility to multiple
   sclerosis in a Brazilian sample
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 36th FEBS Congress of the Biochemistry for Tomorrows Medicine
CY JUN 25-30, 2011
CL Torino, ITALY
SP Federat Soc Biochem & Mol Biol
C1 [Alves-Leon, S.] Univ Fed Estado Rio de Janeiro, Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012; PARADELA, EDUARDO/AAW-6807-2020;
   Paiva, C. L. A./A-1503-2010
OI Paiva, C. L. A./0000-0003-2877-0296
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUN
PY 2011
VL 278
SU 1
SI SI
BP 270
EP 270
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 786UJ
UT WOS:000292333102079
DA 2020-12-01
ER

PT J
AU Finkelsztejn, A
   Fragoso, YD
   Ferreira, MLB
   Lana-Peixoto, MA
   Alves-Leon, SV
   Gomes, S
   Damasceno, BP
   Mendes, MF
   Salgado, PR
   Correa, EC
   Comini-Frota, ER
   Diniz, DS
   Gama, PD
   Kaimen-Maciel, DR
   Morales, RR
   Arruda, WO
   Grzesiuk, AK
   Khouri, JMN
   Lopes, JS
   Rocha, CF
   Domingues, R
   Goncalves, MVM
   Lorenti, MA
   Parolin, MKF
   Siquineli, F
   Tosta, ED
   Brooks, JBB
   Gallina, AS
   Melges, LDM
   Ruocco, HH
AF Finkelsztejn, A.
   Fragoso, Y. D.
   Ferreira, M. L. B.
   Lana-Peixoto, M. A.
   Alves-Leon, S. V.
   Gomes, S.
   Damasceno, B. P.
   Mendes, M. F.
   Salgado, P. R.
   Correa, E. C.
   Comini-Frota, E. R.
   Diniz, D. S.
   Gama, P. D.
   Kaimen-Maciel, D. R.
   Morales, R. R.
   Arruda, W. O.
   Grzesiuk, A. K.
   Khouri, J. M. N.
   Lopes, J. S.
   Rocha, C. F.
   Domingues, R.
   Goncalves, M. V. M.
   Lorenti, M. A.
   Parolin, M. K. F.
   Siquineli, F.
   Tosta, E. D.
   Brooks, J. B. B.
   Gallina, A. S.
   Melges, L. D. M.
   Ruocco, H. H.
TI The Brazilian database on pregnancy in multiple sclerosis
SO CLINICAL NEUROLOGY AND NEUROSURGERY
LA English
DT Article
DE Multiple sclerosis; Pregnancy; Beta interferon; Glatiramer acetate
ID POPULATION; DELIVERY; OUTCOMES; WOMEN; RISK
AB Objectives: To report the results from the Brazilian database on multiple sclerosis (MS) and pregnancy.
   Methods: Retrospective data from MS patients who became pregnant at any time of their disease were sent to a Brazilian database, using a specific file for this purpose.
   Results: Data on 128 women (142 pregnancies) from 30 neurologists working in 21 cities in Brazil were collected. Patients' average age at pregnancy was 29.8 years (range 16-42). EDSS at start of pregnancy was 1.5 +/- 1.4; and the relapse rate in the year preceding pregnancy was 1.2 +/- 1.5. Exposure to medication at any time during pregnancy was high (69.7%): 48.6% to interferon beta; 14.1% to glatiramer acetate; and 7% to other immunomodulatory and immunosuppressive drugs. There was a significant decrease in relapse rate during pregnancy. The prevalence of complications was relatively low, with 4.9% of obstetric and 1.4% neonatal unfavorable outcomes.
   Conclusions: Our patients had low degrees of disability, short histories of disease, high drug exposure, and relatively high relapse rate in the year previous to pregnancy. Obstetric and neonatal outcomes were successful in over 90% of our patients. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Fragoso, Y. D.] Univ Metropolitana Santos, Dept Neurol, Sch Med, BR-11015470 Santos, SP, Brazil.
   [Fragoso, Y. D.; Brooks, J. B. B.] DRS IV, Santos, SP, Brazil.
   [Finkelsztejn, A.] HC Porto Alegre, Porto Alegre, RS, Brazil.
   [Ferreira, M. L. B.] CRAPPDD HR, Recife, PE, Brazil.
   [Lana-Peixoto, M. A.; Rocha, C. F.] CIEM, Belo Horizonte, MG, Brazil.
   [Lana-Peixoto, M. A.; Comini-Frota, E. R.; Rocha, C. F.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Alves-Leon, S. V.] UFRJ, Rio De Janeiro, Brazil.
   [Alves-Leon, S. V.] HUCFF, Rio De Janeiro, Brazil.
   [Gomes, S.] HBP, Sao Paulo, Brazil.
   [Gomes, S.] H Paulistano, Sao Paulo, Brazil.
   [Damasceno, B. P.] Univ Estadual Campinas, Campinas, SP, Brazil.
   [Mendes, M. F.] FMSCSP, Sao Paulo, Brazil.
   [Salgado, P. R.] Univ Fed Mato Grosso do Sul, Campo Grande, MS, Brazil.
   [Correa, E. C.] ICB, Brasilia, DF, Brazil.
   [Diniz, D. S.] Univ Fed Goias, Goiania, GO, Brazil.
   [Gama, P. D.] PUC, Sorocaba, SP, Brazil.
   [Kaimen-Maciel, D. R.] CCS, Londrina, PR, Brazil.
   [Kaimen-Maciel, D. R.] Univ Estadual Londrina, Londrina, PR, Brazil.
   [Morales, R. R.] Univ Fed Uberlandia, Uberlandia, MG, Brazil.
   [Arruda, W. O.] UFP, Curitiba, PR, Brazil.
   [Grzesiuk, A. K.] INC, Cuiaba, MT, Brazil.
   [Grzesiuk, A. K.] HSR, Cuiaba, MT, Brazil.
   [Khouri, J. M. N.] SCC, Curitiba, PR, Brazil.
   [Khouri, J. M. N.] UP, Curitiba, PR, Brazil.
   [Domingues, R.] EMESCAM, Vitoria, ES, Brazil.
   [Lorenti, M. A.] HSPE, Sao Paulo, Brazil.
   [Parolin, M. K. F.] SESA, Curitiba, PR, Brazil.
   [Tosta, E. D.] HBDF, Brasilia, DF, Brazil.
   [Melges, L. D. M.] FAMEMA, Marilia, SP, Brazil.
   [Ruocco, H. H.] HUJ, Jundiai, SP, Brazil.
RP Fragoso, YD (corresponding author), Univ Metropolitana Santos, Dept Neurol, Sch Med, Rua Constituicao 374, BR-11015470 Santos, SP, Brazil.
RI Domingues, Renan B/H-1351-2012; Leon, Soniza V Alves/J-7786-2012;
   Neurociencia, Inct/I-1011-2013; Comini-Frota, Elizabeth R./F-8461-2012;
   Mendes, Maria Fernanda/AAQ-1170-2020; Lana-Peixoto, Marco
   Aurelio/AAD-2580-2019; Arruda, Walter Oleschko/AAJ-8256-2020; Domingues,
   Renan/N-6003-2019; Fragoso, Yara/B-1761-2015
OI Domingues, Renan B/0000-0002-6058-7937; Comini-Frota, Elizabeth
   R./0000-0002-2702-0402; Lana-Peixoto, Marco Aurelio/0000-0003-2454-681X;
   Domingues, Renan/0000-0002-6058-7937; Fragoso, Yara/0000-0001-8726-089X;
   SIQUINELI, FABIO/0000-0002-5380-3654
CR Chen YH, 2009, MULT SCLER J, V15, P606, DOI 10.1177/1352458508101937
   CONFRAVREUX C, 1998, NEW ENGL J MED, V339, P283
   Dahl J, 2008, J NEUROL, V255, P623, DOI 10.1007/s00415-008-0757-2
   De las Heras V, 2007, MULT SCLER J, V13, P981, DOI 10.1177/1352458507077896
   Fragoso YD, 2009, ARQ NEURO-PSIQUIAT, V67, P657, DOI 10.1590/S0004-282X2009000400015
   Koch M, 2009, J NEUROL NEUROSUR PS, V80, P676, DOI 10.1136/jnnp.2008.160911
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Langer-Gould A, 2009, ARCH NEUROL-CHICAGO, V66, P958, DOI 10.1001/archneurol.2009.132
   Liguori NF, 2009, MULT SCLER J, V15, P555, DOI 10.1177/1352458509102366
   Marrie RA, 2009, NEUROLOGY, V73, P1612, DOI 10.1212/WNL.0b013e3181c17fb5
   McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032
   Sandberg-Wollheim M, 2005, NEUROLOGY, V65, P802, DOI 10.1212/01.wnl.0000168905.97207.d0
   WENZEL D, 2009, MATERN CHILD NUTR
NR 13
TC 38
Z9 38
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0303-8467
J9 CLIN NEUROL NEUROSUR
JI Clin. Neurol. Neurosurg.
PD MAY
PY 2011
VL 113
IS 4
BP 277
EP 280
DI 10.1016/j.clineuro.2010.11.016
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 757EY
UT WOS:000290069200004
PM 21159421
DA 2020-12-01
ER

PT J
AU Ventura, N
   D'Andrea, I
   Cardoso, MFBD
   Alves-Leon, SV
   Gasparetto, EL
AF Ventura, Nina
   D'Andrea, Isabella
   Bento de Souza Cardoso, Maria Fatima
   Alves-Leon, Soniza V.
   Gasparetto, Emerson L.
TI Arachnoid cysts and absence epilepsy An evidence or a coincidence?
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Letter
C1 [Ventura, Nina; D'Andrea, Isabella; Bento de Souza Cardoso, Maria Fatima; Alves-Leon, Soniza V.; Gasparetto, Emerson L.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Epilepsy Program, Rio De Janeiro, Brazil.
RP Ventura, N (corresponding author), Rua Sao Clemente 398-103, BR-22260000 Rio De Janeiro, Brazil.
EM niventura@hotmail.com
RI DAndrea-Meira, Isabella/B-5341-2013; Leon, Soniza V Alves/J-7786-2012
CR Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371
   NAKANISHI MS, 1990, RINSHO SHINKEIGAKU, V30, P1114
NR 2
TC 2
Z9 2
U1 0
U2 1
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD APR
PY 2011
VL 69
IS 2A
BP 262
EP 263
DI 10.1590/S0004-282X2011000200024
PG 2
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 757XV
UT WOS:000290122900024
PM 21537573
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Battistella, V
   de Freitas, GR
   da Fonseca, LMB
   Mercante, D
   Gutfilen, B
   Goldenberg, RCS
   Dias, JV
   Kasai-Brunswick, TH
   Wajnberg, E
   Rosado-de-Castro, PH
   Alves-Leon, SV
   Mendez-Otero, R
   Andre, C
AF Battistella, Valeria
   de Freitas, Gabriel R.
   Barbosa da Fonseca, Lea Mirian
   Mercante, Daniel
   Gutfilen, Bianca
   Goldenberg, Regina C. S.
   Dias, Juliana Vieira
   Kasai-Brunswick, Tais H.
   Wajnberg, Eduardo
   Rosado-de-Castro, Paulo Henrique
   Alves-Leon, Soniza V.
   Mendez-Otero, Rosalia
   Andre, Charles
TI Safety of autologous bone marrow mononuclear cell transplantation in
   patients with nonacute ischemic stroke
SO REGENERATIVE MEDICINE
LA English
DT Article
DE bone marrow stem cells; cell therapy; ischemic stroke; middle cerebral
   artery; stem cells
ID NEURAL STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; CORD BLOOD-CELLS;
   INTRACORONARY INJECTION; PROGENITOR CELLS; FUNCTIONAL RECOVERY;
   FOLLOW-UP; THERAPY; REGENERATION; SEIZURES
AB Aims: To assess the safety and feasibility of intra-arterial transplantation of autologous bone marrow mononuclear cells in patients with middle cerebral artery ischemic stroke within 90 days of symptom onset. Patients & methods: Six patients were included in the study, and they received 1-5 x 10(8) bone marrow mononuclear cell and were evaluated using blood tests, neurological and imaging examination before treatment, and 1, 3, 7, 30, 60, 90, 120 and 180 days after transplantation. Scintigraphies were carried out 2 and 24 h after the procedure to analyze the biodistribution of labeled cells. Electroencephalogram was conducted within 7 days after transplantation. Results: No patients exhibited any complication or adverse events during the procedure. There was no worsening in the neurological scales until the end of the follow-up. Conclusion: Intra-arterial bone marrow mononuclear cell transplantation is feasible and safe in patients with nonacute ischemic strokes of the middle cerebral artery. Further studies are required to evaluate the efficacy of this therapy.
C1 [Battistella, Valeria; de Freitas, Gabriel R.; Barbosa da Fonseca, Lea Mirian; Gutfilen, Bianca; Goldenberg, Regina C. S.; Rosado-de-Castro, Paulo Henrique; Mendez-Otero, Rosalia; Andre, Charles] Univ Fed Rio de Janeiro, Programa Terapia Celular, Rio De Janeiro, Brazil.
   [Battistella, Valeria; de Freitas, Gabriel R.; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Dept Neurol, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Barbosa da Fonseca, Lea Mirian; Gutfilen, Bianca; Wajnberg, Eduardo; Rosado-de-Castro, Paulo Henrique] Univ Fed Rio de Janeiro, Dept Radiol, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Mercante, Daniel] Univ Fed Rio de Janeiro, Dept Hematol, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Goldenberg, Regina C. S.; Dias, Juliana Vieira; Kasai-Brunswick, Tais H.; Mendez-Otero, Rosalia] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
RP Mendez-Otero, R (corresponding author), Univ Fed Rio de Janeiro, Programa Terapia Celular, Rio De Janeiro, Brazil.
EM rmotero@biof.ufrj.br
RI Neurociencia, Inct/I-1011-2013; Gutfilen, Bianca/C-3116-2013;
   Fisiologia, Ciencias Biologicas/C-2407-2012; Kasai-Brunswick, Tais
   Hanae/AAK-9905-2020; de Freitas, Gabriel R/B-1298-2013; Mendez-Otero,
   Rosalia/AAL-7551-2020; de Castro, Paulo Henrique Rosado/F-9310-2013;
   Leon, Soniza V Alves/J-7786-2012
OI Mendez-Otero, Rosalia/0000-0002-1798-9930; de Castro, Paulo Henrique
   Rosado/0000-0003-0091-9714; Kasai-Brunswick, Tais
   Hanae/0000-0002-6361-5980
FU Ministry of HealthMinistry of Health - Turkey; Ministry of Science and
   Technology of Brazil [552201/2005-7]
FX This study was supported by a grant from the Ministry of Health and
   Ministry of Science and Technology of Brazil to R Mendez-Otero (grant
   number 552201/2005-7). The authors have no other relevant affiliations
   or financial involvement with any organization or entity with a
   financial interest in or financial conflict with the subject matter or
   materials discussed in the manuscript apart from those disclosed.
CR Andre C, 2006, STROKE, V37, P2784, DOI 10.1161/01.STR.0000244768.46566.73
   Banerjee SR, 2005, NUCL MED BIOL, V32, P1, DOI 10.1016/j.nucmedbio.2004.09.001
   Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501
   da Fonseca LMB, 2010, EXP NEUROL, V221, P122, DOI 10.1016/j.expneurol.2009.10.010
   da Fonseca LMB, 2009, CIRCULATION, V120, P539, DOI 10.1161/CIRCULATIONAHA.109.863084
   Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617
   Bonita R, 1997, STROKE, V28, P1898, DOI 10.1161/01.STR.28.10.1898
   Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7
   Camilo O, 2004, STROKE, V35, P1769, DOI 10.1161/01.STR.0000130989.17100.96
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038
   Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393
   DAFONSECA LMB, 2010, INT J CARDI IN PRESS
   de Freitas GR, 2006, STROKE, V37, P624
   dos Santos AD, 2010, BRAIN RES, V1306, P149, DOI 10.1016/j.brainres.2009.09.094
   Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099
   FRIEDRICH MA, 2006, INT J STROKE, V1, P35
   Fujiwara Y, 2004, NEUROSCI LETT, V366, P287, DOI 10.1016/j.neulet.2004.05.080
   Gholamrezanezhad A, 2009, NUCL MED COMMUN, V30, P210, DOI 10.1097/MNM.0b013e328318b328
   Giraidi-Guimaraes A, 2009, BRAIN RES, V1266, P108, DOI 10.1016/j.brainres.2009.01.062
   GUPTA SR, 1988, STROKE, V19, P1477, DOI 10.1161/01.STR.19.12.1477
   Huikuri HV, 2008, EUR HEART J, V29, P2723, DOI 10.1093/eurheartj/ehn436
   Jiang M, 2010, EXPERT OPIN BIOL TH, V10, P667, DOI 10.1517/14712591003716437
   Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565
   Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038
   Lasala GP, 2010, ANGIOLOGY, V61, P551, DOI 10.1177/0003319710364213
   Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548
   Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006
   Lossius MI, 2005, EPILEPSIA, V46, P1246, DOI 10.1111/j.1528-1167.2005.57904.x
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Mendez-Otero R, 2007, REGEN MED, V2, P417, DOI 10.2217/17460751.2.4.417
   Mendonca Maria Lucia Furtado de, 2006, Arq Bras Cardiol, V86, P52
   Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118
   Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4
   Nakano-Doi A, 2010, STEM CELLS, V28, P1292, DOI 10.1002/stem.454
   Nowak B, 2007, EUR J NUCL MED MOL I, V34, P715, DOI 10.1007/s00259-006-0275-3
   Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750
   Palestro CJ, 2009, Q J NUCL MED MOL IM, V53, P105
   Penicka M, 2007, HEART, V93, P837, DOI 10.1136/hrt.2006.091934
   Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P299, DOI 10.1089/scd.2009.0403
   Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P351, DOI 10.1089/scd.2009.0049
   Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889
   Pollock K, 2006, EXP NEUROL, V199, P143, DOI 10.1016/j.expneurol.2005.12.011
   PROCHAZKA V, 2010, CELL TRANSP IN PRESS
   Ribeiro-Resende VT, 2009, NEUROSCIENCE, V159, P540, DOI 10.1016/j.neuroscience.2008.12.059
   Ryvlin P, 2006, NEUROLOGY, V67, pS3, DOI 10.1212/WNL.67.12_suppl_4.S3
   Savitz Sean I, 2004, NeuroRx, V1, P406
   Savitz SI, 2005, CEREBROVASC DIS, V20, P101, DOI 10.1159/000086518
   Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218
   Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311
   Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66
   Strauer BE, 2005, J AM COLL CARDIOL, V46, P1651, DOI 10.1016/j.jacc.2005.01.069
   Suarez-Monteagudo C, 2009, RESTOR NEUROL NEUROS, V27, P151, DOI 10.3233/RNN-2009-0483
   Tendera M, 2009, EUR HEART J, V30, P1313, DOI 10.1093/eurheartj/ehp073
   Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595
   Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863
   Wu ZS, 2001, CIRCULATION, V103, P462
   Yasuhara T, 2009, STEM CELLS DEV, V18, P1501, DOI 10.1089/scd.2009.0011
   ZAVERUCHADOVALL.C, 2010, CELL TRANSP IN PRESS
   SAFETY STUDY AUTOLOG
NR 60
TC 110
Z9 113
U1 0
U2 10
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
EI 1746-076X
J9 REGEN MED
JI Regen. Med.
PD JAN
PY 2011
VL 6
IS 1
BP 45
EP 52
DI 10.2217/RME.10.97
PG 8
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 712SG
UT WOS:000286685900006
PM 21175286
DA 2020-12-01
ER

PT J
AU Azevedo-Pereira, RL
   Medei, E
   Mendez-Otero, R
   de Souza, JPBM
   Alves-Leon, SV
AF Azevedo-Pereira, Ricardo Luiz
   Medei, Emiliano
   Mendez-Otero, Rosalia
   Barreto Marcondes de Souza, Jorge Paes
   Alves-Leon, Soniza Vieira
TI Isolation of neurosphere-like bodies from an adult patient with
   refractory temporal lobe epilepsy
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Letter
ID NEURAL STEM-CELLS; HUMAN BRAIN
C1 [Azevedo-Pereira, Ricardo Luiz; Medei, Emiliano; Mendez-Otero, Rosalia] Univ Fed Rio de Janeiro, Inst Biophys, BR-21941913 Rio De Janeiro, Brazil.
   [Barreto Marcondes de Souza, Jorge Paes; Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Dept Neurol & Neurosurg, Univ Hosp Clementino Fraga Filho, BR-21941913 Rio De Janeiro, Brazil.
RP Alves-Leon, SV (corresponding author), Univ Fed Rio de Janeiro, Dept Neurol, Rua Prof Rodolpho Paulo Rocco 255,10 Andar Sala 1, BR-21941913 Rio De Janeiro, Brazil.
EM sonizavleon@globo.com
RI Leon, Soniza V Alves/J-7786-2012; Mendez-Otero, Rosalia/AAL-7551-2020
OI Mendez-Otero, Rosalia/0000-0002-1798-9930; Medei,
   Emiliano/0000-0002-0044-1311
CR Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7
   Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3
   Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028
   Moe MC, 2005, BRAIN, V128, P2189, DOI 10.1093/brain/awh574
   Moe MC, 2005, NEUROSURGERY, V56, P1182, DOI 10.1227/01.NEU.0000159881.09663.6D
   Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X
   Rouvel-Tallec A, 2009, REV MED INTERNE, V30, P335, DOI 10.1016/j.revmed.2008.11.009
   Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301
   Tomson T, 2008, LANCET NEUROL, V7, P1021, DOI 10.1016/S1474-4422(08)70202-3
   Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501
NR 10
TC 3
Z9 4
U1 0
U2 1
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 2010
VL 68
IS 6
BP 956
EP 958
DI 10.1590/S0004-282X2010000600023
PG 3
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 707WA
UT WOS:000286319900023
PM 21243259
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Finkelsztejn, A
   Kaimen-Maciel, DR
   Grzesiuk, AK
   Gallina, AS
   Lopes, J
   Morales, NMO
   Alves-Leon, SV
   de Almeida, SMG
AF Fragoso, Yara D.
   Finkelsztejn, Alessandro
   Kaimen-Maciel, Damacio R.
   Grzesiuk, Anderson K.
   Gallina, Andre S.
   Lopes, Josiane
   Morales, Nivea M. O.
   Alves-Leon, Soniza V.
   de Almeida, Sandra M. G.
TI Long-Term Use of Glatiramer Acetate by 11 Pregnant Women with Multiple
   Sclerosis A Retrospective, Multicentre Case Series
SO CNS DRUGS
LA English
DT Article
ID INTRAVENOUS IMMUNOGLOBULIN; RELAPSES; MS
AB Background: Glatiramer acetate is a US FDA category B drug with regard to use by pregnant women with multiple sclerosis (MS). There are no data currently available for the continuous use of glatiramer acetate during pregnancy.
   Objective: To assess the risks and benefits of glatiramer acetate used throughout pregnancy among women with active MS.
   Design: Retrospective and multicentre case series.
   Settings: Outpatient services of academic and private institutions caring for patients with MS in Brazil. Patients: Eleven women with MS and their children were assessed.
   Intervention: Retrospective evaluation of women with MS who received glatiramer. acetate continuously for at least 7 months during pregnancy. This evaluation was performed by the neurologist responsible for the patient. Children. aged I year and over, born to mothers who received glatiramer acetate during pregnancy, were assessed using the Denver II developmental screening test.
   Main Outcome Measurements: Obstetric, neonatal and developmental outcomes.
   Results: No drug-related obstetric complications were observed. No specific drug-related malformations, neonatal complications or developmental abnormalities were observed in the children. Postnatal MS relapse rates remained significantly lower than antenatal rates in these patients.
   Conclusions: No deleterious effects from glatiramer acetate were observed in these pregnant women with MS or in their offspring. No increment in postnatal relapse rate was observed. However, the use of glatiramer acetate during pregnancy should be restricted to the most difficult cases, in which the benefits clearly outweigh the risks.
C1 [Fragoso, Yara D.] Univ Metropolitan Santos, Dept Neurol, Sao Paulo, Brazil.
   [Fragoso, Yara D.] Dept Reg Saude IV, Sao Paulo, Brazil.
   [Finkelsztejn, Alessandro] Hosp Clin Porto Alegre, Dept Neurol, Porto Alegre, RS, Brazil.
   [Kaimen-Maciel, Damacio R.; Lopes, Josiane] Univ Estadual Londrina, Dept Neurol, Londrina, Parana, Brazil.
   [Grzesiuk, Anderson K.] Centro Reabil Integral Dom Aquino Correa, Cuiaba, Mato Gosso, Brazil.
   [Grzesiuk, Anderson K.] Inst Neurol & Coluna Vertebral, Dept Neurol, Cuiaba, Mato Gosso, Brazil.
   [Gallina, Andre S.] Piracicaba, Sao Paulo, Brazil.
   [Morales, Nivea M. O.] Univ Fed Uberlandia, Dept Neuropediatr, BR-38400 Uberlandia, MG, Brazil.
   [Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Dept Neurol, Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza V.] Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [de Almeida, Sandra M. G.] Univ Fed Rio de Janeiro, Dept Gynecol & Obstet, Rio De Janeiro, Brazil.
RP Fragoso, YD (corresponding author), UNIMES, Sch Med, Dept Neurol, Rua Constituicao 374, BR-11015470 Sao Paulo, Brazil.
EM yara@bsnet.com.br
RI Leon, Soniza V Alves/J-7786-2012; Fragoso, Yara/B-1761-2015
OI Fragoso, Yara/0000-0001-8726-089X
FU Pharmaceutical companies; Biogen IdecBiogen; Bayer-ScheringBayer AG;
   Merck SeronoMerck SeronoMerck & Company; NovartisNovartis; RocheRoche
   Holding; Sanofi AventisSanofi-Aventis; Teva Pharmaceuticals
FX This work was performed without any financial support. All authors
   receive (and have received) financial support from pharmaceutical
   companies, including Biogen Idec, Bayer-Schering, Merck Serono,
   Novartis, Roche, Sanofi Aventis and Teva Pharmaceuticals, to attend
   congresses and medical events. All authors receive (and have received)
   fees for consultancy and lectures sponsored by pharmaceutical companies
   producing and commercializing medications for MS in Brazil, namely Teva
   Pharmaceuticals, Biogen Idec, Merck Serono and Bayer-Schering. None of
   the authors (or their relatives) is employed (or has been employed) by
   pharmaceutical companies.
CR Achiron A, 2004, J NEUROL, V251, P1133, DOI 10.1007/s00415-004-0495-z
   Behague DP, 2002, BMJ-BRIT MED J, V324, P942, DOI 10.1136/bmj.324.7343.942
   Chen M, 2001, MULT SCLER, V7, P209, DOI 10.1177/135245850100700401
   CONFRAVREUX C, 1998, NEW ENGL J MED, V339, P283
   Dudesek A, 2006, J NEUROL, V253, P50, DOI 10.1007/s00415-006-5007-x
   Fazekas F, 2007, J NEUROL SCI, V259, P61, DOI 10.1016/j.jns.2006.12.018
   Fragoso YD, 2009, ARQ NEURO-PSIQUIAT, V67, P657, DOI 10.1590/S0004-282X2009000400015
   FRANKENBURG WK, 1992, PEDIATRICS, V89, P91
   Haas J, 2007, MULT SCLER J, V13, P900, DOI 10.1177/1352458506075654
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Langer-Gould A, 2009, ARCH NEUROL-CHICAGO, V66, P958, DOI 10.1001/archneurol.2009.132
   McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032
   *PER COM, FDA US IN PREGN RAT
   Ringel I, 2006, J NEUROL, V253, P70, DOI 10.1007/500415-006-5012-0
   SALMINEN HJ, J NEUROL
   Weber-Schoendorfer C, 2009, MULT SCLER J, V15, P1037, DOI 10.1177/1352458509106543
   WENZEL D, MATERNAL CHILD NUTR
   MED CORPS PREGNANCY
NR 18
TC 44
Z9 46
U1 0
U2 5
PU ADIS INT LTD
PI AUCKLAND
PA 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 1311, NEW
   ZEALAND
SN 1172-7047
J9 CNS DRUGS
JI CNS Drugs
PY 2010
VL 24
IS 11
BP 969
EP 976
PG 8
WC Clinical Neurology; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA 675LO
UT WOS:000283832400005
PM 20806993
DA 2020-12-01
ER

PT J
AU Schmidt, FR
   Costa, FHR
   Silva, FMLC
   Maultasch, H
   Rosso, ALZ
   Nicaretta, DH
   Mattos, JP
   Novis, SAP
   Alves-Leon, SV
AF Schmidt, F. R.
   Costa, F. H. R.
   Silva, F. M. L. C.
   Maultasch, H.
   Rosso, A. L. Z.
   Nicaretta, D. H.
   Mattos, J. P.
   Novis, S. A. P.
   Alves-Leon, S. V.
TI Paroxysmal dystonia related to neuromyelitis optica
SO MOVEMENT DISORDERS
LA English
DT Meeting Abstract
CT 14th International Congress of Parkinsons Disease and Movement Disorders
CY JUN 13-17, 2010
CL Buenos Aires, ARGENTINA
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0885-3185
J9 MOVEMENT DISORD
JI Mov. Disord.
PY 2010
VL 25
IS 7
SU S
BP S250
EP S250
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 605IL
UT WOS:000278341100193
DA 2020-12-01
ER

PT J
AU Alves-Leon, SV
   Cardoso, MFBD
   Pereira, VCSR
   Meira, ID
AF Alves-Leon, Soniza Vieira
   Bento de Souza Cardoso, Maria Fatima
   Santa Rita Pereira, Valeria Coelho
   Meira, Isabela D'Andrea
TI CLINICAL AND ELECTROENCEPHALOGRAPHIC CHARACTERISTICS OF A COHORT OF
   PATIENTS WITH EPILEPSY AND ABSENCE SEIZURES
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE absence seizures; epilepsy; Panayiotopoulos
ID IDIOPATHIC GENERALIZED EPILEPSY; ILAE CLASSIFICATION; MYOCLONIA; ONSET
AB Background: Epileptic syndromes with absence seizures (AS) possess unique clinical and electroencephalographic (EEG) characteristics. In typical or atypical AS, ictal phenomenology may include various characteristics. Video-EEG monitoring enables findings to be correlated with ictal phenomenology. Objective: To evaluate the different AS in a cohort of patients with drug-resistant epilepsy (DRE) based on the International League against Epilepsy (ILAE)'s 2006 classification, to correlate with ictal phenomenology recorded and to apply the Panayiotopoulos criteria. Method: This study included patients with criteria of AS followed up at the Epilepsy Clinic. A dual, cross-sectional cohort study was carried out between 2005 and 2008. Patients receiving care in the Epilepsy Program of the HUCFF-UFRJ, who had been investigated by video-EEG and who presented clinical and EEG criteria for absence seizures, typical or atypical, according to the criteria defined by the ILAE, were included in the study, independent of age onset, the review of clinical history, age onset, family history, epilepsy onset and evolution, seizures phenomenology, antiepileptic drugs response and neuroimaging studies were used to classify the patients among the different epileptic syndrome associated to absence seizures. Results: Typical absences were more frequent (71.4%) than atypical absences. Cases of juvenile absence epilepsy were the most frequent (19%) in this series, followed by childhood absence epilepsy (14.4%) and juvenile myoclonic epilepsy (4.8%). In 14 patients (66.67%), diagnosis was modified from focal epilepsy to primary generalized epilepsy. Clinical and EEG diagnosis of absence epilepsy resulted in a dramatic improvement in the control of seizures following modification of diagnosis and indication of an appropriate antiepileptic drug. Conclusion: Our results show that typical AS are more frequent than atypical. AS was successfully defined in 10 patients following application of Panayiotopoulos' criteria. The consequent change in diagnosis and therapy resulted in resolution of refractoriness in 9 patients. We concluded that in DRE, AS associated to unusual ictal phenomenology improve dramatically when diagnosed by video-EEG, permitting seizures to be controlled. Clinical and EEG evaluation confirm that myoclonus, automatisms and autonomic disorders are involved and that the consciousness may be affected to different degrees.
C1 [Alves-Leon, Soniza Vieira; Bento de Souza Cardoso, Maria Fatima] Univ Fed Estado Rio de Janeiro UNIRIO, Program Pos Grad, BR-20270002 Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, HUCFF, Serv Neurol, Programa Epilepsias, Rio de Janeiro, Brazil.
   [Santa Rita Pereira, Valeria Coelho] Univ Fed Rio de Janeiro, HUCFF, Programa Epilepsias, Programa Posgrad, Rio de Janeiro, Brazil.
   [Bento de Souza Cardoso, Maria Fatima] Santa Casa Misericordia Rio de Janeiro, Epilepsias Serv Neurol, Rio De Janeiro, Brazil.
   [Meira, Isabela D'Andrea] Univ Fed Sao Paulo, Sao Paulo, Brazil.
RP Alves-Leon, SV (corresponding author), Univ Fed Estado Rio de Janeiro UNIRIO, Program Pos Grad, Rua Mariz & Barros 775, BR-20270002 Rio De Janeiro, Brazil.
EM sonizavleon@globo.com
RI Leon, Soniza V Alves/J-7786-2012; DAndrea-Meira, Isabella/B-5341-2013
CR [Anonymous], 1981, Epilepsia, V22, P489
   [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x
   Arroyo S, 2000, REV NEUROLOGIA, V30, P881, DOI 10.33588/rn.3009.99356
   Bare MA, 1998, J CHILD NEUROL, V13, P498, DOI 10.1177/088307389801301006
   Baykan B, 2005, EPILEPSY BEHAV, V6, P460, DOI 10.1016/j.yebeh.2005.02.007
   Chaix Y, 2003, EPILEPSIA, V44, P944, DOI 10.1046/j.1528-1157.2003.54902.x
   Devinsky O, 1999, NEW ENGL J MED, V340, P1565, DOI 10.1056/NEJM199905203402008
   Duron RM, 2005, EPILEPSIA, V46, P34, DOI 10.1111/j.1528-1167.2005.00312.x
   Engel J, 2006, EPILEPSY RES, V70, pS5, DOI 10.1016/j.eplepsyres.2005.11.014
   Engel J, 2006, EPILEPSIA, V47, P1558, DOI 10.1111/j.1528-1167.2006.00215.x
   Gelisse P, 2004, EPILEPSIA, V45, P1282, DOI 10.1111/j.0013-9580.2004.19704.x
   Genton P, 2000, BRAIN DEV-JPN, V22, P75, DOI 10.1016/S0387-7604(99)00113-8
   Genton P, 2008, EPILEPSIA, V49, P642, DOI 10.1111/j.1528-1167.2007.01467.x
   Giannakodimos S, 1996, EPILEPSIA, V37, P36, DOI 10.1111/j.1528-1157.1996.tb00509.x
   Guilhoto LMFF, 2003, ARQ NEURO-PSIQUIAT, V61, P580, DOI 10.1590/S0004-282X2003000400010
   HOLMES GL, 1999, PEDIAT NEUROLOGY PRI, P643
   Holmes MD, 2004, EPILEPSIA, V45, P1568, DOI 10.1111/j.0013-9580.2004.23204.x
   LIPORACE JD, 1994, EPILEPSIA, V35, P1026, DOI 10.1111/j.1528-1157.1994.tb02549.x
   Lombroso CT, 1997, EPILEPSIA, V38, P797, DOI 10.1111/j.1528-1157.1997.tb01467.x
   Mory SB, 2002, ARQ NEURO-PSIQUIAT, V60, P788, DOI 10.1590/S0004-282X2002000500020
   NIEDERMEYER E, 1998, ELECTROENCEPHALOGRAP, P476
   Panayiotopoulos C., 1997, EPILEPSY COMPREHENSI, P2327
   Panayiotopoulos CP, 1999, ARCH DIS CHILD, V81, P351, DOI 10.1136/adc.81.4.351
   PANAYIOTOPOULUS CP, 2005, EPILIPSIA, V45, pS57
   Shorvon S, 2005, EPILEPSIA, V46, P73, DOI 10.1111/j.1528-1167.2005.00316.x
   STEFAN H, 2007, EPILEPSY COMPREHENSI, P572
   Titomanlio L, 2007, EUR J PAEDIATR NEURO, V11, P178, DOI 10.1016/j.ejpn.2006.12.005
   Trinka E, 2005, ACTA NEUROL SCAND, V112, P12, DOI 10.1111/j.1600-0404.2005.00522.x
   Valentin A, 2007, EPILEPSIA, V48, P2187, DOI 10.1111/j.1528-1167.2007.01226.x
   Winawer MR, 2005, NEUROLOGY, V65, P523, DOI 10.1212/01.wnl.0000172920.34994.63
NR 30
TC 1
Z9 2
U1 0
U2 4
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 2009
VL 67
IS 4
BP 986
EP 994
DI 10.1590/S0004-282X2009000600005
PG 9
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 532HG
UT WOS:000272736500005
PM 20069206
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Alves-Leon, S
   D'Andrea-Meira, I
   Coelho, SR
   Pereira, V
   Cardoso, MBD
   Reis, M
   Gaspareto, E
   De Souza, JPBM
AF Alves-Leon, S.
   D'Andrea-Meira, I.
   Coelho, S. R.
   Pereira, V.
   de Souza Cardoso, M. Bento
   Reis, M.
   Gaspareto, E.
   Barreto Marcondes De Souza, J. Paes
TI TEMPORAL LOBE EPILEPSY ASSOCIATED TO MESIAL HIPPOCAMPUS SCLEROSIS:
   FREQUENCY OF INITIAL PRECIPITANT INCIDENTS AND CLINICAL OUTCOME
SO EPILEPSIA
LA English
DT Meeting Abstract
CT 28th International Epilespy Congress
CY JUN 28-JUL 01, 2009
CL Budapest, HUNGARY
SP Int League Epilepsy, Int Bureau Epilepsy
C1 [Alves-Leon, S.] Univ Fed Estado Rio de Janeiro, Rio De Janeiro, Brazil.
   [Alves-Leon, S.; D'Andrea-Meira, I.; Pereira, V.; de Souza Cardoso, M. Bento; Reis, M.; Gaspareto, E.; Barreto Marcondes De Souza, J. Paes] Univ Fed Rio de Janeiro, Univ Hosp Clementino Fraga Filho, BR-21941 Rio De Janeiro, Brazil.
RI DAndrea-Meira, Isabella/B-5341-2013; Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PD OCT
PY 2009
VL 50
BP 55
EP 55
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 502DB
UT WOS:000270433800197
DA 2020-12-01
ER

PT J
AU Alves-Leon, S
   Meira, ID
   Coelho, SR
   Pereira, V
   Chimelli, L
   Gaspareto, E
   De Souza, JPBM
AF Alves-Leon, S.
   Meira, I. D'Andrea
   Coelho, S. R.
   Pereira, V.
   Chimelli, L.
   Gaspareto, E.
   Barreto Marcondes De Souza, J. Paes
TI CYSTICERCUS INSIDE OF A HIPPOCAMPUS WITH SCLEROSIS MESIAL: DUAL
   PATHOLOGY OR AN INDIRECT INFLAMMATORY RESPONSE?
SO EPILEPSIA
LA English
DT Meeting Abstract
CT 28th International Epilespy Congress
CY JUN 28-JUL 01, 2009
CL Budapest, HUNGARY
SP Int League Epilepsy, Int Bureau Epilepsy
C1 [Alves-Leon, S.; Meira, I. D'Andrea; Pereira, V.; Chimelli, L.; Gaspareto, E.; Barreto Marcondes De Souza, J. Paes] Univ Fed Estado Rio de Janeiro, Univ Hosp Clementino Fraga Filho, Rio De Janeiro, Brazil.
RI DAndrea-Meira, Isabella/B-5341-2013; Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PD OCT
PY 2009
VL 50
BP 55
EP 55
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 502DB
UT WOS:000270433800196
DA 2020-12-01
ER

PT J
AU Alves-Leon, S
   Batistela, V
   Andre, C
   Coelho, SR
   Pereira, V
   Mendez-Otero, R
AF Alves-Leon, S.
   Batistela, V.
   Andre, C.
   Coelho, S. R.
   Pereira, V.
   Mendez-Otero, R.
TI ELECTROPHYSIOLOGICAL FEATURES OF STROKE'S PATIENTS SUBMITTED TO
   AUTOLOGOUS BONE MARROW STEM CELLS TRANSPLANT
SO EPILEPSIA
LA English
DT Meeting Abstract
CT 28th International Epilespy Congress
CY JUN 28-JUL 01, 2009
CL Budapest, HUNGARY
SP Int League Epilepsy, Int Bureau Epilepsy
C1 [Alves-Leon, S.] Univ Fed Estado Rio de Janeiro, Rio De Janeiro, Brazil.
   [Alves-Leon, S.; Andre, C.; Pereira, V.] Univ Hosp Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Batistela, V.; Mendez-Otero, R.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.
RI Mendez-Otero, Rosalia/AAL-7551-2020; Leon, Soniza V Alves/J-7786-2012
OI Mendez-Otero, Rosalia/0000-0002-1798-9930; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PD OCT
PY 2009
VL 50
BP 55
EP 55
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 502DB
UT WOS:000270433800195
DA 2020-12-01
ER

PT J
AU Alves-Leon, S
   Mussi, M
   Thuler, L
AF Alves-Leon, S.
   Mussi, M.
   Thuler, L.
TI DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR: SISTEMATIC REVIEW OF CLINICAL
   SPECTRUM, SEIZURE OUTCOME, NEURORADIOLOGY, AND SURGERY RESPONSE
SO EPILEPSIA
LA English
DT Meeting Abstract
CT 28th International Epilespy Congress
CY 2009
CL Budapest, HUNGARY
C1 [Alves-Leon, S.; Mussi, M.; Thuler, L.] Univ Fed Estado Rio de Janeiro, Rio De Janeiro, Brazil.
   [Alves-Leon, S.] Univ Fed Rio de Janeiro, Univ Hosp Clementino Fraga Filho, BR-21941 Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PD OCT
PY 2009
VL 50
BP 56
EP 56
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 502DB
UT WOS:000270433800198
DA 2020-12-01
ER

PT J
AU Alves-Leon, S
   Azevedo, R
   Medei, E
   De Souza, JM
   Mendez-Otero, R
AF Alves-Leon, S.
   Azevedo, R.
   Medei, E.
   De Souza, J. Marcondes
   Mendez-Otero, R.
TI ISOLATION OF NEURAL STEM CELLS FROM ADULT PATIENTS WITH REFRACTORY
   EPILEPSY: GOAL FOR A BETTER UNDERSTANDING OF EPILEPSY MECANISM
SO EPILEPSIA
LA English
DT Meeting Abstract
CT 28th International Epilespy Congress
CY 2009
CL Budapest, HUNGARY
C1 [Alves-Leon, S.] Univ Fed Estado Rio de Janeiro, Rio De Janeiro, Brazil.
   [Alves-Leon, S.; De Souza, J. Marcondes] Univ Fed Rio de Janeiro, Univ Hosp Clementino Fraga Filho, BR-21941 Rio De Janeiro, Brazil.
   [Azevedo, R.; Medei, E.; Mendez-Otero, R.] Univ Fed Rio de Janeiro, Inst Biofis, BR-21941 Rio De Janeiro, Brazil.
RI Medei, Emiliano/F-6685-2012; Mendez-Otero, Rosalia/AAL-7551-2020; Leon,
   Soniza V Alves/J-7786-2012
OI Mendez-Otero, Rosalia/0000-0002-1798-9930; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PD OCT
PY 2009
VL 50
BP 79
EP 79
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 502DB
UT WOS:000270433800284
DA 2020-12-01
ER

PT J
AU Alves-Leon, S
   Cardoso, MBDS
   Monteiro, M
   Meira, ID
AF Alves-Leon, S.
   Cardoso, M. Bento de Souza
   Monteiro, M.
   Meira, I. D'Andrea
TI ICTAL PHENOMENOLOGY RECORDED DURING VIDEO-ELECTROENCEPHALOGRAPHIC
   EVALUATION IN PATIENTS WITH ABSENCE SEIZURES IDENTIFIED FROM A COHORT OF
   PATIENTS WITH DRUG-RESISTANT EPILEPSY
SO EPILEPSIA
LA English
DT Meeting Abstract
CT 28th International Epilespy Congress
CY 2009
CL Budapest, HUNGARY
C1 [Alves-Leon, S.; Cardoso, M. Bento de Souza; Monteiro, M.; Meira, I. D'Andrea] Univ Fed Rio de Janeiro, Univ Hosp Clementino Fraga Filho, BR-21941 Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012; DAndrea-Meira, Isabella/B-5341-2013
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PD OCT
PY 2009
VL 50
BP 92
EP 93
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA 502DB
UT WOS:000270433800334
DA 2020-12-01
ER

PT J
AU Alves-Leon, S
   Monteiro, ML
   Brito, GO
AF Alves-Leon, S.
   Monteiro, M. Leite
   Brito, G. Ottoni
TI NEUROPSYCHOLOGICAL ASSESSMENT PROTOCOL FOR TEMPORAL LOBE EPILEPSY
   PHARMACO-RESISTANT ADULT PATIENTS CANDIDATES FOR NEUROSURGERY PROCEDURE
SO EPILEPSIA
LA English
DT Meeting Abstract
CT 28th International Epilespy Congress
CY 2009
CL Budapest, HUNGARY
C1 [Alves-Leon, S.] Univ Fed Estado Rio de Janeiro, Rio De Janeiro, Brazil.
   [Alves-Leon, S.; Monteiro, M. Leite] Univ Fed Estado Rio de Janeiro, Univ Hosp Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Brito, G. Ottoni] Univ Fed Fluminense, BR-24220000 Niteroi, RJ, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PD OCT
PY 2009
VL 50
BP 143
EP 143
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 502DB
UT WOS:000270433800517
DA 2020-12-01
ER

PT J
AU Alves-Leon, SV
   Veluttini-Pimentel, ML
   Gouveia, ME
   Malfetano, FR
   Gaspareto, EL
   Alvarenga, MP
   Frugulhetti, I
   Quirico-Santos, T
AF Alves-Leon, Soniza Vieira
   Veluttini-Pimentel, Maria Lucia
   Gouveia, Maria Emmerick
   Malfetano, Fabiola Rachid
   Gaspareto, Emerson L.
   Alvarenga, Marcos P.
   Frugulhetti, Izabel
   Quirico-Santos, Thereza
TI ACUTE DISSEMINATED ENCEPHALOMYELITIS Clinical features, HLA DRB1*1501,
   HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602, and HLA DPA1*0301 allelic
   association study
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE ADEM; HLA class II; demyelinating disease
ID MULTIPLE-SCLEROSIS; CRITERIA
AB We evaluated the frequency, demographic, clinical, disability evolution and genetic association of HLA DRB1*1501, DRB1*1503, DQA1*0102, DQB1*0602 and DPA1*0301 alleles in patients diagnosed as acute disseminated encephalomyelitis (ADEM) among a population of CNS demyelinating diseases. Fifteen patients (8.4%) of our series were diagnosed as ADEM. The mean age onset was 35.23 years ( range 12 to 77), 53.3% were male and follow-up range was 8.5 to 16 years. Two cases (13.3%) had a preceding infection before neurological symptoms, one presented a parainfectious demyelinating, and one case had been submitted to hepatitis B vaccination four weeks before the clinical onset. The EDSS range was 3.0 to 9.5. Eight patients (53.3%) presented MRI with multiple large lesions. CSF was normal in 73.3%. The severe disability observed at EDSS onset improved in 86.66% patients. The genetic susceptibility for ADEM was significantly associated with the HLA DQB1*0602, DRB1*1501 and DRB1*1503 alleles (<0.05) in monophasic ADEM.
C1 [Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Neurol, BR-21941913 Rio de Janeiro, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Estado Rio de Janeiro UNIRIO, Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza Vieira; Alvarenga, Marcos P.] Univ Fed Estado Rio de Janeiro, Neurol Postgrad Program, Rio de Janeiro, Brazil.
   [Veluttini-Pimentel, Maria Lucia] Serv Neurol Santa Casa Misericordia Rio de Janeir, Rio De Janeiro, Brazil.
   [Gouveia, Maria Emmerick; Malfetano, Fabiola Rachid] Univ Fed Fluminense, Mol Biol Lab, Hosp Naval Marcilio Dias, Rio De Janeiro, Brazil.
   [Gaspareto, Emerson L.; Frugulhetti, Izabel] Univ Fed Rio de Janeiro, Dept Radiol, BR-21941913 Rio de Janeiro, Brazil.
RP Alves-Leon, SV (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Neurol, Rua Prof Rodolpho Paulo Rocco 255, BR-21941913 Rio de Janeiro, Brazil.
EM sonizavleon@globo.com
RI Paixao, Izabel/AAM-1668-2020; Leon, Soniza V Alves/J-7786-2012; Paixao,
   Izabel/S-7490-2019
CR Alves-Leon SV, 2007, ACTA NEUROL SCAND, V115, P306, DOI 10.1111/j.1600-0404.2006.00750.x
   Alves-Leon SV, 2008, ARQ NEURO-PSIQUIAT, V66, P671, DOI 10.1590/S0004-282X2008000500012
   ALVESLEON SV, 2000, REV NEUROL ARGENTINA, V25, P3
   ALVESLEON SV, 2002, REV NEUROLOGICA, V12, P1184
   Brinar VV, 2008, CLIN NEUROL NEUROSUR, V110, P913, DOI 10.1016/j.clineuro.2008.06.015
   Caballero A, 1999, TISSUE ANTIGENS, V54, P524, DOI 10.1034/j.1399-0039.1999.540511.x
   Chopra B, 2002, NEUROL INDIA, V50, P41
   Dale RC, 2003, NEUROPEDIATRICS, V34, P141
   Duran I, 2001, MULT SCLER, V7, P151, DOI 10.1191/135245801678438366
   Garg RK, 2003, POSTGRAD MED J, V79, P11, DOI 10.1136/pmj.79.927.11
   Gupte G, 2003, J PAEDIATR CHILD H, V39, P336, DOI 10.1046/j.1440-1754.2003.00154.x
   HARTUNG HP, 1995, NEUROLOGY, V45, pS22, DOI 10.1212/WNL.45.6_Suppl_6.S22
   Hollinger P, 2002, J NEUROL, V249, P320, DOI 10.1007/s004150200012
   Holtmannspotter M, 2003, J NEUROL SCI, V206, P27, DOI 10.1016/S0022-510X(02)00310-6
   Ichiyama T, 2002, EUR J PEDIATR, V161, P133, DOI 10.1007/s00431-001-0888-2
   Idrissova ZR, 2003, EUR J NEUROL, V10, P537, DOI 10.1046/j.1468-1331.2003.00639.x
   JIN S, 2007, NEUROLOGY S2, V68, pS13
   Kadhim H, 2003, HUM PATHOL, V34, P293, DOI 10.1053/hupa.2003.34
   Khong PL, 2002, PEDIATR RADIOL, V32, P59, DOI 10.1007/s00247-001-0582-6
   Krupp LB, 2007, NEUROLOGY, V68, pS7, DOI 10.1212/01.wnl.0000259422.44235.a8
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Lim KE, 2003, CLIN IMAG, V27, P281, DOI 10.1016/S0899-7071(02)00552-1
   Maranhao PA, 1996, ARQ NEURO-PSIQUIAT, V54, P505, DOI 10.1590/S0004-282X1996000300024
   Menge T, 2005, ARCH NEUROL-CHICAGO, V62, P1673, DOI 10.1001/archneur.62.11.1673
   OLERUP O, 1993, TISSUE ANTIGENS, V41, P119, DOI 10.1111/j.1399-0039.1993.tb01991.x
   Ozawa H, 2001, PEDIATR NEUROL, V24, P325, DOI 10.1016/S0887-8994(01)00242-9
   PAPAISALVARENGA RM, 2002, ESCLEROSIS MULTIPLE, P35
   Poser CM, 2008, ARCH NEUROL-CHICAGO, V65, P674, DOI 10.1001/archneur.65.5.674-a
   POSER CM, 1993, MED PRIN PRACT, V3, P1
   Schwarz S, 2001, NEUROLOGY, V56, P1313, DOI 10.1212/WNL.56.10.1313
   Tenembaum S, 2007, NEUROLOGY, V68, pS23, DOI 10.1212/01.wnl.0000259404.51352.7f
   Tenembaum SN, 2008, CLIN NEUROL NEUROSUR, V110, P928, DOI 10.1016/j.clineuro.2007.12.018
   Tintore M, 2000, AM J NEURORADIOL, V21, P702
   Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74
   Wingerchuk DM, 2006, NEUROL RES, V28, P341, DOI 10.1179/016164106X98251
NR 35
TC 13
Z9 13
U1 0
U2 2
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2009
VL 67
IS 3A
BP 643
EP 651
DI 10.1590/S0004-282X2009000400013
PG 9
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 489YR
UT WOS:000269463500013
PM 19722042
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Fragoso, YD
   Finkelsztejn, A
   Comini-Frota, ER
   da Gama, PD
   Grzesiuk, AK
   Khouri, JMN
   Alves-Leon, SV
   Morales, RD
   Lana-Peixoto, MA
   da Rocha, CF
AF Fragoso, Yara Dadalti
   Finkelsztejn, Alessandro
   Comini-Frota, Elizabeth Regina
   da Gama, Paulo Diniz
   Grzesiuk, Ansderson Kuntz
   Netto Khouri, Jussara Mathias
   Alves-Leon, Soniza Vieira
   Morales, Rogerio de Rizo
   Lana-Peixoto, Marco Aurelio
   da Rocha, Cristiane Franklin
TI PREGNANCY AND MULTIPLE SCLEROSIS The initial results from a Brazilian
   database
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE multiple sclerosis; pregnancy; prematurity; low birth weight; obstetric
   complications; interferon beta; glatiramer acetate
ID HORMONE ESTRIOL; OUTCOMES; WOMEN; BETA
AB Purpose: Pregnancy management poses an extra challenge to physicians and their multiple sclerosis ( MS) patients. There are few papers reporting databases on the subject. Method: Brazilian database from nine MS clinical and research units, with complete data on 47 pregnant women ( 49 pregnancies). Results: Despite relatively high exposure to MS medications, no birth defects were reported. Low birth weight and prematurity were similar to those for developing countries. Three complications may have been associated with these medications, while three others were considered to be of purely obstetric nature. Conclusion: Our results confirm previous findings on lower relapse rate during pregnancy and add to the present literature informing on data related to drug exposure.
C1 [Fragoso, Yara Dadalti] Univ Metropolitana Santos, Dept Neurol, Sch Med, BR-11015470 Santos, SP, Brazil.
   [Fragoso, Yara Dadalti] DRS IV, SP, Coastal Reg Sao Paulo, MS Reference Ctr, Santos, SP, Brazil.
   [Finkelsztejn, Alessandro] Hosp Clin Porto Alegre, MS Reference Ctr, Porto Alegre, RS, Brazil.
   [Comini-Frota, Elizabeth Regina] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.
   [da Gama, Paulo Diniz] Pontificia Univ Catolica Sao Paulo, Sch Med, Sorocaba, SP, Brazil.
   [Grzesiuk, Ansderson Kuntz] Hosp Sant Rosa, Inst Neurol & Coluna Vertebral, Cuiaba, MT, Brazil.
   [Netto Khouri, Jussara Mathias] Pontificia Univ Catolica Parana PUCPR, Sch Med, Curitiba, PR, Brazil.
   [Netto Khouri, Jussara Mathias] Univ Posit, Curitiba, PR, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Estado Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Res Unit Idiopat Inflammatory Demyelinating Dis, CNS, Rio De Janeiro, Brazil.
   [Morales, Rogerio de Rizo] Univ Fed Uberlandia, BR-38400 Uberlandia, MG, Brazil.
   [Lana-Peixoto, Marco Aurelio; da Rocha, Cristiane Franklin] Univ Fed Minas Gerais, CIEM, Invest Ctr MS, Belo Horizonte, MG, Brazil.
RP Fragoso, YD (corresponding author), Univ Metropolitana Santos, Dept Neurol, Sch Med, Rua Constituicao 374, BR-11015470 Santos, SP, Brazil.
EM yara@bsnet.com.br
RI Lana-Peixoto, Marco Aurelio/AAD-2580-2019; da Gama, Paulo
   Diniz/Q-7962-2019; Comini-Frota, Elizabeth R./F-8461-2012; Leon, Soniza
   V Alves/J-7786-2012; Fragoso, Yara/B-1761-2015
OI Lana-Peixoto, Marco Aurelio/0000-0003-2454-681X; Comini-Frota, Elizabeth
   R./0000-0002-2702-0402; Fragoso, Yara/0000-0001-8726-089X
CR Argyriou AA, 2008, REPROD SCI, V15, P755, DOI 10.1177/1933719108324138
   Bebo Bruce F. Jr, 2005, Current Drug Targets - Inflammation and Allergy, V4, P231
   Boskovic R, 2005, NEUROLOGY, V65, P807, DOI 10.1212/01.wnl.0000180575.77021.c4
   Cocco E, 2008, MULT SCLER J, V14, P1225, DOI 10.1177/1352458508094882
   CONFRAVREUX C, 1998, NEW ENGL J MED, V339, P283
   De las Heras V, 2007, MULT SCLER J, V13, P981, DOI 10.1177/1352458507077896
   Hellwig K, 2008, ACTA NEUROL SCAND, V118, P24, DOI 10.1111/j.1600-0404.2007.00978.x
   Lee M, 2008, J NEUROL NEUROSUR PS, V79, P1308, DOI 10.1136/jnnp.2007.116947
   Lopez C, 2006, MULT SCLER J, V12, P421, DOI 10.1191/1352458506ms1287oa
   MURGITA RA, 1978, CLIN EXP IMMUNOL, V33, P347
   Patti F, 2008, J NEUROL, V255, P1250, DOI 10.1007/s00415-008-0909-4
   Sandberg-Wollheim M, 2005, NEUROLOGY, V65, P802, DOI 10.1212/01.wnl.0000168905.97207.d0
   Saraste M, 2007, GENDER MED, V4, P45, DOI 10.1016/S1550-8579(07)80008-8
   Sicotte NL, 2002, ANN NEUROL, V52, P421, DOI 10.1002/ana.10301
   Soldan SS, 2003, J IMMUNOL, V171, P6267, DOI 10.4049/jimmunol.171.11.6267
NR 15
TC 30
Z9 30
U1 0
U2 6
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2009
VL 67
IS 3A
BP 657
EP 660
DI 10.1590/S0004-282X2009000400015
PG 4
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 489YR
UT WOS:000269463500015
PM 19722044
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Finkelsztejn, A
   Fragoso, YD
   Comini-Frota, ER
   Gama, PD
   Grzesiuk, AK
   Khouri, JMN
   Alves-Leon, SV
   Maciel, DRK
   Mendes, MF
   Morales, RR
   Lana-Peixoto, MA
   Rocha, CF
AF Finkelsztejn, A.
   Fragoso, Y. D.
   Comini-Frota, E. R.
   Gama, P. D.
   Grzesiuk, A. K.
   Khouri, J. M. N.
   Alves-Leon, S. V.
   Kaimen Maciel, D. R.
   Mendes, M. F.
   Morales, R. R.
   Lana-Peixoto, M. A.
   Rocha, C. F.
TI Pregnancy and multiple sclerosis: the initial results from a Brazilian
   database
SO MULTIPLE SCLEROSIS
LA English
DT Meeting Abstract
CT 25th Congress of the
   European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis
CY SEP 09-12, 2009
CL Dusseldorf, GERMANY
SP European Comm Treatment & Res Multiple Sclerosis
C1 H Clin, Porto Alegre, RS, Brazil.
   Univ Metropolitana Santos, Santos, Brazil.
   PUC Sorocaba, Sorocaba, Brazil.
   H Santa Rosa, Cuiaba, Brazil.
   Univ Posit, PUC PR, Curitiba, Parana, Brazil.
   UFRJ, Rio De Janeiro, Brazil.
   Univ Estadual Londrina, Londrina, Brazil.
   Santa Casa SP, Sao Paulo, Brazil.
   Univ Fed Uberlandia, BR-38400 Uberlandia, MG, Brazil.
   Univ Fed Minas Gerais, CIEM, Belo Horizonte, MG, Brazil.
RI Lana-Peixoto, Marco Aurelio/AAD-2580-2019; Mendes, Maria
   Fernanda/AAQ-1170-2020
OI Lana-Peixoto, Marco Aurelio/0000-0003-2454-681X; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER
JI Mult. Scler.
PD SEP
PY 2009
VL 15
IS 9
BP S162
EP S162
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 492JW
UT WOS:000269652500481
DA 2020-12-01
ER

PT J
AU Tilbery, C
   Gabbai, A
   Alvarenga, R
   Leon, S
   Ferreira, MB
   Callegaro, D
   Saraiva, S
   Pericles, C
AF Tilbery, C.
   Gabbai, A.
   Alvarenga, R.
   Leon, S.
   Ferreira, M. Brito
   Callegaro, D.
   Saraiva, S.
   Pericles, C.
CA Brazilian MS Hlth Economics
TI Cost-effectiveness analysis and time-trade-off for natalizumab in
   recurrent-remitting multiple sclerosis in Brazil: a pharmaco-economic
   evaluation
SO MULTIPLE SCLEROSIS
LA English
DT Meeting Abstract
CT 25th Congress of the
   European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis
CY SEP 09-12, 2009
CL Dusseldorf, GERMANY
SP European Comm Treatment & Res Multiple Sclerosis
RI Callegaro, Dagoberto/D-1415-2014; Leon, Soniza V Alves/J-7786-2012
NR 0
TC 1
Z9 1
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER
JI Mult. Scler.
PD SEP
PY 2009
VL 15
IS 9
BP S57
EP S57
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 492JW
UT WOS:000269652500161
DA 2020-12-01
ER

PT J
AU Campos-de-Magalhaes, M
   de Almeida, AJ
   Papaiz-Alvarenga, RM
   Gadelha, T
   Morais-de-Sa, CA
   Alves-Leon, SV
AF Campos-de-Magalhaes, Marilza
   de Almeida, Adilson Jose
   Papaiz-Alvarenga, Regina Maria
   Gadelha, Telma
   Morais-de-Sa, Carlos Alberto
   Alves-Leon, Soniza Vieira
TI Normal plasma antithrombin activity in patients with relapsing-remitting
   and secondary progressive multiple sclerosis
SO CLINICAL NEUROLOGY AND NEUROSURGERY
LA English
DT Article
DE Antithrombin; Coagulation; Hemostasis; Inflammation; Multiple sclerosis;
   Thrombin
ID EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ADHESION MOLECULES;
   BIOLOGICAL MARKERS; THROMBIN; INFLAMMATION; FIBRIN; COAGULATION;
   NEUROPROTECTION; DEMYELINATION; PATHOGENESIS
AB Objective: Multiple sclerosis (MS) is an inflammatory disease characterized by multifocal areas of central nervous system (CNS) demyelination. Activation of coagulation factors and fibrin deposition are observed around CNS blood vessels in experimental autoimmune encephalomyelitis, an animal model of MS. Antithrombin (AT) is a potent anticoagulant with remarkable anti-inflammatory properties, and its inhibitory effects on coagulation and inflammation may play a role in the pathogenesis and clinical course of MS. We studied the association between plasma AT activity and clinical forms of MS.
   Patients and methods: A total of 69 patients, 37 with relapsing-remitting and 32 with secondary progressive MS, were included in the study. A control group (CG) of 34 normal subjects was also studied. Plasma AT activity (Stachrom ATIII) was quantified using a chromogenic activity assay with normal reference values ranging from 70% to 120% of AT activity.
   Results: We found no difference between plasma AT levels in patients and those in CG. We also found no association of AT levels with activity of disease, duration of disease progression, level of neurological disability, and treatment.
   Conclusion: We found no association between plasma AT activity and RRMS or SPMS. It remains to be studied whether exists or not an association between abnormal plasma AT activity and other MS forms. (C) 2009 Published by Elsevier B.V.
C1 [Campos-de-Magalhaes, Marilza; de Almeida, Adilson Jose] Fed Univ State Rio de Janeiro, UNIRIO, Gaffree & Guinle Univ Hosp, Hematol Unit, BR-20270004 Rio De Janeiro, Brazil.
   [Campos-de-Magalhaes, Marilza; Papaiz-Alvarenga, Regina Maria; Alves-Leon, Soniza Vieira] Fed Univ State Rio de Janeiro, UNIRIO, Postgrad Program, BR-20270004 Rio De Janeiro, Brazil.
   [Papaiz-Alvarenga, Regina Maria; Alves-Leon, Soniza Vieira] Fed Univ State Rio de Janeiro, UNIRIO, Gaffree & Guinle Univ Hosp, Neurol Unit, BR-20270004 Rio De Janeiro, Brazil.
   [Morais-de-Sa, Carlos Alberto] Fed Univ State Rio de Janeiro, UNIRIO, Gaffree & Guinle Univ Hosp, Med Clin B, BR-20270004 Rio De Janeiro, Brazil.
   [Gadelha, Telma] Univ Fed Rio de Janeiro, UFRJ, Clementino Fraga Filho Univ Hosp, Hematol Unit, Rio De Janeiro, Brazil.
RP Campos-de-Magalhaes, M (corresponding author), Fed Univ State Rio de Janeiro, UNIRIO, Gaffree & Guinle Univ Hosp, Hematol Unit, Rua Mariz & Barros 775, BR-20270004 Rio De Janeiro, Brazil.
EM marilzacm@terra.com.br
RI Leon, Soniza V Alves/J-7786-2012; Neurociencia, Inct/I-1011-2013
OI Campos de Magalhaes, Marilza/0000-0003-0438-258X
CR Adams RA, 2004, MOL INTERV, V4, P163
   Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P6698, DOI 10.1073/pnas.0303859101
   Aksungar FB, 2008, J CLIN NEUROSCI, V15, P393, DOI 10.1016/j.jocn.2007.02.090
   Aktas O, 2007, ARCH NEUROL-CHICAGO, V64, P185, DOI 10.1001/archneur.64.2.185
   Alves-Leon SV, 2001, ARQ NEURO-PSIQUIAT, V59, P18, DOI 10.1590/S0004-282X2001000100005
   Beilin O, 2005, J NEUROSCI RES, V79, P351, DOI 10.1002/jnr.20270
   Bielekova B, 2004, BRAIN, V127, P1463, DOI 10.1093/brain/awh176
   Chapman J, 2006, AUTOIMMUN REV, V5, P528, DOI 10.1016/j.autrev.2006.02.011
   CHOI BH, 1990, AM J PATHOL, V137, P741
   Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229
   DIHANICH M, 1991, NEURON, V6, P575, DOI 10.1016/0896-6273(91)90060-D
   Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X
   Friedmann I, 2001, J NEUROIMMUNOL, V121, P12, DOI 10.1016/S0165-5728(01)00397-6
   HARTUNG HP, 1995, ANN NEUROL, V38, P186, DOI 10.1002/ana.410380210
   HOHLFELD R, 1995, IMMUNOL TODAY, V16, P259, DOI 10.1016/0167-5699(95)80176-6
   Inaba Y, 2001, J NEUROL SCI, V185, P89, DOI 10.1016/S0022-510X(01)00468-3
   Kaneider NC, 2001, BIOCHEM BIOPH RES CO, V287, P42, DOI 10.1006/bbrc.2001.5534
   Kirichuk VF, 2003, ZH NEVROPATOL PSIKH, P34
   Kuenz B, 2005, J NEUROIMMUNOL, V167, P143, DOI 10.1016/j.jneuroim.2005.06.019
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A
   Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907
   Matsuo T, 2000, SEMIN THROMB HEMOST, V26, P101, DOI 10.1055/s-2000-9811
   McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032
   Mosesson MW, 1998, SEMIN THROMB HEMOST, V24, P169, DOI 10.1055/s-2007-995837
   OLSON ST, 1981, J BIOL CHEM, V256, P1073
   Peterson LK, 2007, J NEUROIMMUNOL, V184, P37, DOI 10.1016/j.jneuroim.2006.11.015
   PRATT CW, 1991, SEMIN HEMATOL, V28, P3
   Quinsey NS, 2004, INT J BIOCHEM CELL B, V36, P386, DOI 10.1016/S1357-2725(03)00244-9
   Roemisch J, 2002, BLOOD COAGUL FIBRIN, V13, P657, DOI 10.1097/00001721-200212000-00001
   Strukova SM, 2001, BIOCHEMISTRY-MOSCOW+, V66, P8, DOI 10.1023/A:1002869310180
   Teunissen CE, 2005, LANCET NEUROL, V4, P32, DOI 10.1016/S1474-4422(04)00964-0
   Uccelli A, 2003, NEUROL SCI, V24, pS271, DOI 10.1007/s10072-003-0172-5
   Uchiba M, 1996, AM J PHYSIOL-LUNG C, V270, pL921
   VILLANUEVA G, 1979, BIOCHEMISTRY-US, V18, P810, DOI 10.1021/bi00572a011
   WEINSHENKER BG, 1995, NEUROL CLIN, V13, P119
   YAMAUCHI T, 1989, BIOCHEM BIOPH RES CO, V163, P1404, DOI 10.1016/0006-291X(89)91135-2
NR 37
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0303-8467
EI 1872-6968
J9 CLIN NEUROL NEUROSUR
JI Clin. Neurol. Neurosurg.
PD JUN
PY 2009
VL 111
IS 5
BP 407
EP 411
DI 10.1016/j.clineuro.2008.11.016
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 454RL
UT WOS:000266700100002
PM 19168277
DA 2020-12-01
ER

PT J
AU Alves-Leon, SV
   Malfetano, FR
   Pimentel, MLV
   Estrada, CLD
   Pereira, VCSR
   Liem, AM
   Novis, SAP
AF Alves-Leon, Soniza Vieira
   Malfetano, Fabiola Rachid
   Veluttini Pimentel, Maria Lucia
   Duque Estrada, Claudio Luiz
   Santa Rita Pereira, Valeria Coelho
   Liem, Assuncion Martinez
   Pereira Novis, Sergio Augusto
TI MULTIPLE SCLEROSIS OUTCOME AND MORBI-MORTALITY OF A BRAZILIAN COHORT
   PATIENTS
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE multiple sclerosis; mortality; morbidity; epidemiology; Brazil
ID CLINICAL CHARACTERISTICS; DIAGNOSTIC-CRITERIA; FOLLOW-UP; GUIDELINES;
   DISABILITY; ALLELES
AB We studied the clinical and evolution characteristics of multiple sclerosis (MS) patients followed since the onset of HUCFF/UFRJ in 1978. The diagnosis of MS was based on Poser's et al. and MC Donald's et al. criteria. From 188 patients, 122 were included. Eighty-five were females. The mean age onset was 32.2 years-old (range 6.0 to 61.0 +/- 10.3), mainly Caucasians (82/67%). The relapsing-remitting course (MSRR) was more frequent (106/86.8%). Monosymptomatic onset was significantly more frequent in Caucasians than in Afro-Brazilians (p<0.05). Seventeen patients had benign form of MS and these patients presented association with MSRR when compared with severe form (p=0.01). The mortality rate was 2.12% (4 patients died). This study was similar to other Brazilian series with regard to sex and age, and lack of correlation between EDSS and number of relapses; it confirmed south-southeast African-descendants gradient distribution and association between first mono-symptomatic relapses and Caucasian; we found lower frequency of benign forms.
C1 [Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Setor Doencas Desmielinizantes, BR-21941913 Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Estado Rio de Janeiro, Disciplina Neurol, Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Estado Rio de Janeiro, Programa Posgrad Strictu Senso Neurol, Rio de Janeiro, Brazil.
   [Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Programa Clin Med Neurol, Rio De Janeiro, Brazil.
   [Malfetano, Fabiola Rachid] Mestre Pela UFRJ, Hosp Naval Marcilio Dias, Rio De Janeiro, Brazil.
   [Veluttini Pimentel, Maria Lucia] Doutora Pela UFRJ, Rio De Janeiro, Brazil.
   [Duque Estrada, Claudio Luiz; Santa Rita Pereira, Valeria Coelho; Liem, Assuncion Martinez] Univ Fed Rio de Janeiro, Fac Med, Programa Posgrad Clin Med Neurol, Rio de Janeiro, Brazil.
   [Pereira Novis, Sergio Augusto] Univ Fed Rio de Janeiro, HUCFF, Serv Neurol, Rio de Janeiro, Brazil.
RP Alves-Leon, SV (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Setor Doencas Desmielinizantes, Rua Prof Rodolpho Paulo Rocco 255, BR-21941913 Rio De Janeiro, Brazil.
EM sonizavleon@globo.com
RI Leon, Soniza V Alves/J-7786-2012
CR Alves-Leon SV, 2007, ACTA NEUROL SCAND, V115, P306, DOI 10.1111/j.1600-0404.2006.00750.x
   ALVESLEON SV, 1999, THESIS RIO DE JANEIR
   ARNASON B, 1995, NEUROLOGY, V45, pS54, DOI 10.1212/WNL.45.6_Suppl_6.S54
   Arruda WO, 2001, ARQ NEURO-PSIQUIAT, V59, P165, DOI 10.1590/S0004-282X2001000200002
   Bergamaschi R, 2005, NEUROEPIDEMIOLOGY, V25, P15, DOI 10.1159/000085308
   Bronnum-Hansen H, 2004, BRAIN, V127, P844, DOI 10.1093/brain/awh104
   BROSNAN CF, 1995, NEUROLOGY, V45, pS16, DOI 10.1212/WNL.45.6_Suppl_6.S16
   Callegaro D, 2001, ACTA NEUROL SCAND, V104, P208, DOI 10.1034/j.1600-0404.2001.00372.x
   CARVALHO A, 2002, MUL SCLER, V7, P407
   Correale J, 2006, MULT SCLER, V12, P412, DOI 10.1191/135248506ms1282oa
   Davenport CB, 1922, ARCH NEURO PSYCHIATR, V8, P51, DOI 10.1001/archneurpsyc.1922.02190130054008
   De Oliveira EML, 1999, ARQ NEURO-PSIQUIAT, V57, P51, DOI 10.1590/S0004-282X1999000100010
   Ekestern E, 2004, EUR J NEUROL, V11, P511, DOI 10.1111/j.1468-1331.2004.00818.x
   Ferreira MLB, 2004, ARQ NEURO-PSIQUIAT, V62, P1027, DOI 10.1590/S0004-282X2004000600018
   Ghezzi A, 2004, NEUROL SCI, V25, pS336, DOI 10.1007/s10072-004-0336-y
   Glad S, 2006, ACTA NEUROL SCAND, V113, P55, DOI 10.1111/j.1600-0404.2006.00617.x
   Hawkins SA, 1999, J NEUROL NEUROSUR PS, V67, P148, DOI 10.1136/jnnp.67.2.148
   Imitola J, 2006, ARCH NEUROL-CHICAGO, V63, P25, DOI 10.1001/archneur.63.1.25
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Lana-Peixoto MA, 2002, MULTIPLE SCLEROSIS S, V8, pS38
   LEITE ACC, 1990, ARQ NEUROPSIQUIATR S, V48, pS66
   Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907
   Martinelli V, 2004, NEUROL SCI, V25, pS350, DOI 10.1007/s10072-004-0339-8
   McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032
   Merkler D, 2006, MULT SCLER J, V12, P369, DOI 10.1191/1352458506ms1290oa
   Moreira MA, 2000, ARQ NEURO-PSIQUIAT, V58, P460, DOI 10.1590/S0004-282X2000000300010
   Papais-Alvarenga R M, 1995, REV BRAS NEUROL, V31, P89
   POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302
   Ramsaransing G, 2001, MULT SCLER, V7, P345, DOI 10.1177/135245850100700512
   RIBEIRO Darcy, 1995, POVO BRASILEIRO FORM
   Ristori G, 2000, J NEUROIMMUNOL, V107, P216, DOI 10.1016/S0165-5728(00)00219-8
   Rudick R, 1996, ANN NEUROL, V40, P469, DOI 10.1002/ana.410400321
   TILBERY CP, 1995, ARQ NEURO-PSIQUIAT, V53, P203, DOI 10.1590/S0004-282X1995000200003
   Weinshenker BG, 1998, NEUROLOGY, V51, P742, DOI 10.1212/WNL.51.3.742
NR 34
TC 7
Z9 8
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2008
VL 66
IS 3B
BP 671
EP 677
DI 10.1590/S0004-282X2008000500012
PG 7
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 365DV
UT WOS:000260387000012
PM 18949260
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Alves-Leon, SV
   Pimentel, MLV
   Sant'Anna, G
   Malfetano, FR
   Estrada, CD
   Quirico-Santos, T
AF Alves-Leon, Soniza Vieira
   Vellutini Pimentel, Maria Lucia
   Sant'Anna, Gabrielle
   Malfetano, Fabiola Rachid
   Estrada, Claudio Duque
   Quirico-Santos, Thereza
TI IMMUNE SYSTEM MARKERS OF NEUROINFLAMMATION IN PATIENTS WITH CLINICAL
   DIAGNOSE OF NEUROMYELITIS OPTICA
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE neuromyelitis optica; autoantigens; cytokines; myelin basic protein
ID MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS; T-CELLS; ANTIBODIES; CRITERIA;
   DISEASE; NMO
AB Neuromyelitis optica (NMO) is an inflammatory, demyelinating disease of the central nervous system characterized by the association of a serious myelitis and unilateral or bilateral optic neuritis. The present study aimed to analyze the immunological parameters of NMO patients with diagnosis established based on Wingerchuck et al. (1999) criteria. Production of IgG and IgA antibodies to antigens of MBP, PLP 95-116, MOG 92-106, and the cytokines interleukin-4 (IL-4) and interferon-gamma(INF-gamma) were assessed by Elisa assay. The cohort was formed by 28 NMO patients and a matched healthy control group. NMO patients had significant high levels of IgG to MOG (p< 0.0001), PLP (p=0.0002) and MBP (p<0.0001), and solely IgA to MBP (p< 0.0001). INF-gamma(p=0.61) levels were similar to healthy controls. Increased production of IL-4 (p= 0.0084) indicates an important role for this cytokine in the activation of Th2 regulatory cells and of the IgA producers B lymphocyte indicating activation of humoral immunity.
C1 [Alves-Leon, Soniza Vieira] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Neurol, Inflammatory Demyelinating Dis Res Unit, BR-21941913 Rio De Janeiro, Brazil.
   [Sant'Anna, Gabrielle; Quirico-Santos, Thereza] Univ Fed Fluminense, Dept Biol, Niteroi, RJ, Brazil.
   [Alves-Leon, Soniza Vieira; Malfetano, Fabiola Rachid; Estrada, Claudio Duque] Univ Fed Rio De Janeiro State, Postgrad Program, Rio De Janeiro, Brazil.
RP Alves-Leon, SV (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Neurol, Inflammatory Demyelinating Dis Res Unit, Rua Prof Rodolpho Paulo Rocco 255,8 Andar,Sala, BR-21941913 Rio De Janeiro, Brazil.
EM sonizavleon@globo.com
RI Leon, Soniza V Alves/J-7786-2012
CR Alves-Leon SV, 2007, ACTA NEUROL SCAND, V115, P306, DOI 10.1111/j.1600-0404.2006.00750.x
   Bergamaschi R, 2004, NEUROL SCI, V25, pS364, DOI 10.1007/s10072-004-0342-0
   Berger T, 2003, NEW ENGL J MED, V349, P139, DOI 10.1056/NEJMoa022328
   Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334
   Correale J, 2004, NEUROLOGY, V63, P2363, DOI 10.1212/01.WNL.0000148481.80152.BF
   Cree BAC, 2002, SEMIN NEUROL, V22, P105, DOI 10.1055/s-2002-36534
   de Seze J, 2003, ARCH NEUROL-CHICAGO, V60, P1336, DOI 10.1001/archneur.60.9.1336
   Filippi M, 1999, NEUROLOGY, V53, P1705, DOI 10.1212/WNL.53.8.1705
   Ghezzi A, 2004, J NEUROL, V251, P47, DOI 10.1007/s00415-004-0271-0
   Haase CG, 2001, NEUROSCI LETT, V307, P131, DOI 10.1016/S0304-3940(01)01949-8
   Kikuchi S, 2005, LANCET NEUROL, V4, P594, DOI 10.1016/S1474-4422(05)70179-4
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Lana-Peixoto MA, 2008, ARQ NEURO-PSIQUIAT, V66, P120, DOI 10.1590/S0004-282X2008000100034
   Lassmann H, 1998, MULT SCLER J, V4, P93, DOI 10.1191/135245898678909367
   Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X
   Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304
   Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151
   MANDLER RN, 1993, ANN NEUROL, V34, P162, DOI 10.1002/ana.410340211
   MYERS KJ, 1992, J NEUROIMMUNOL, V41, P1, DOI 10.1016/0165-5728(92)90188-Q
   ORiordan JI, 1996, J NEUROL NEUROSUR PS, V60, P382, DOI 10.1136/jnnp.60.4.382
   Papais-Alvarenga RM, 2002, J NEUROL NEUROSUR PS, V73, P429, DOI 10.1136/jnnp.73.4.429
   Pirko I, 2004, ARCH NEUROL-CHICAGO, V61, P1401, DOI 10.1001/archneur.61.9.1401
   Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P964, DOI 10.1001/archneur.63.7.964
   POSER CM, 1993, B SOC PATHOL EXOT, V86, P428
   RIBEIRO Darcy, 1995, POVO BRASILEIRO FORM
   Rubiera M, 2006, NEUROLOGY, V66, P1568, DOI 10.1212/01.wnl.0000216233.56611.c2
   Schmidt S, 1999, MULT SCLER J, V5, P147, DOI 10.1177/135245859900500303
   Scolding N, 2005, LANCET NEUROL, V4, P136, DOI 10.1016/S1474-4422(05)00996-8
   SOBEL RA, 1992, J IMMUNOL, V149, P1444
   Vernant JC, 1997, NEUROLOGY, V48, P58, DOI 10.1212/WNL.48.1.58
   Weinshenker BG, 2003, LANCET, V361, P889, DOI 10.1016/S0140-6736(03)12784-5
   Weinstock-Guttman B, 2006, ARCH NEUROL-CHICAGO, V63, P957, DOI 10.1001/archneur.63.7.957
   Wingerchuk D M, 2006, Int MS J, V13, P42
   Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74
   Wingerchuk DM, 2005, NEUROLOGY, V64, pA38
   Wingerchuk DM, 2003, NEUROLOGY, V60, P848, DOI 10.1212/01.WNL.0000049912.02954.2C
   Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107
NR 37
TC 8
Z9 9
U1 0
U2 2
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2008
VL 66
IS 3B
BP 678
EP 684
DI 10.1590/S0004-282X2008000500013
PG 7
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 365DV
UT WOS:000260387000013
PM 18949261
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Pimentel, MLV
   Sant'Ana, G
   Malfetano, FR
   Pereira, VC
   Santos, TQ
   Alves-Leon, SV
AF Pimentel, Maria Lucia V.
   Sant'Ana, Gabriela
   Malfetano, Fabiola R.
   Pereira, Valeria C.
   Santos, Thereza Q.
   Alves-Leon, Soniza V.
TI Parameters of the immune system activation in patients with clinical
   diagnosis of neuromyelitis optica
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 13th Annual Meeting of the
   Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of
   the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th
   Congress of the
   Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis
CY SEP 17-20, 2008
CL Montreal, CANADA
SP Amer Comm Treatment & Res Multiple Sclerosis, European Comm Treatment & Res Multiple Sclerosis, Latin Amer Comm Treatment & Res Multiple Sclerosis
C1 [Alves-Leon, Soniza V.] Univ Fed Estado Rio de Janeiro, Rio De Janeiro, Brazil.
   [Malfetano, Fabiola R.; Pereira, Valeria C.] Univ Fed Estado Rio de Janeiro, Rio De Janeiro, Brazil.
   [Pimentel, Maria Lucia V.] Santa Casa Misericordia Rio de Janeiro, Rio De Janeiro, Brazil.
   [Sant'Ana, Gabriela; Santos, Thereza Q.] Univ Fed Fluminense, Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER J
JI Mult. Scler. J.
PD SEP
PY 2008
VL 14
SU 1
BP S114
EP S114
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 354YL
UT WOS:000259675700367
DA 2020-12-01
ER

PT J
AU Alvarenga, M
   Papais-Alvarenga, R
   Alves-Leon, S
   Fernandez, O
AF Alvarenga, M.
   Papais-Alvarenga, R.
   Alves-Leon, S.
   Fernandez, O.
TI Brainstem syndrome prevalence in recurrent neuromyelitis optica
SO JOURNAL OF NEUROLOGY
LA English
DT Meeting Abstract
CT 18th Meeting of the European-Neurological-Society
CY JUN 07-11, 2008
CL Nice, FRANCE
SP European Neurolog Soc
C1 [Alvarenga, M.; Papais-Alvarenga, R.; Alves-Leon, S.; Fernandez, O.] UNIRIO, Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 1
PU DR DIETRICH STEINKOPFF VERLAG
PI DARMSTADT
PA PO BOX 10 04 62, D-64204 DARMSTADT, GERMANY
SN 0340-5354
J9 J NEUROL
JI J. Neurol.
PD JUN
PY 2008
VL 255
SU 2
MA O150
BP 34
EP 34
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 299HP
UT WOS:000255747000116
DA 2020-12-01
ER

PT J
AU Meira, ID
   Monteiro, ML
   Pereira, VS
   Cardoso, MF
   Souza, JM
   Quirico-Santos, T
   Alves-Leon, SV
AF Meira, Isabella D.
   Monteiro, M. L.
   Pereira, V. S.
   Cardoso, M. F.
   Souza, J. M.
   Quirico-Santos, T.
   Alves-Leon, Soniza V.
TI SERUM LEVELS OF TUMORAL NECROSIS FACTOR ALPHA AND TRANSFORMING GROWTH
   FACTOR BETA 1 IN OPERATED AND NOT OPERATED PATIENTS WITH TEMPORAL LOBE
   EPILEPSY WITH HIPPOCAMPAL SCLEROSIS
SO EPILEPSIA
LA English
DT Meeting Abstract
CT 62nd Annual Meeting of the American-Epilepsy-Society
CY DEC 05-09, 2008
CL Seattle, WA
SP Amer Epilepsy Soc
C1 [Meira, Isabella D.; Monteiro, M. L.; Pereira, V. S.; Cardoso, M. F.; Souza, J. M.; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Quirico-Santos, T.] Univ Fed Fluminense, Dept Mol & Cellular Biol, Niteroi, RJ, Brazil.
RI DAndrea-Meira, Isabella/B-5341-2013; Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PY 2008
VL 49
BP 469
EP 469
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 363ZS
UT WOS:000260306601093
DA 2020-12-01
ER

PT J
AU Malfetano, FR
   Alves-Leon, SV
   Pimentel, MLV
   Estrada, CLD
   Lion, AM
   Coelho, VSR
AF Malfetano, F. Rachid
   Alves-Leon, S. V.
   Pimentel, M. L. V.
   Estrada, C. L. Duque
   Lion, A. M.
   Coelho, V. S. R.
TI Multiple sclerosis outcome and morbi-mortality of a Brazilian cohort
SO MULTIPLE SCLEROSIS
LA English
DT Meeting Abstract
CT 23rd Congress of the
   European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/12th
   Annual Conference of Rehabilitation in MS
CY OCT 11-14, 2007
CL Prague, CZECH REPUBLIC
SP European Comm Treatment & Res Multiple Sclerosis
C1 [Malfetano, F. Rachid; Alves-Leon, S. V.; Pimentel, M. L. V.; Estrada, C. L. Duque; Lion, A. M.; Coelho, V. S. R.] Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER
JI Mult. Scler.
PD OCT
PY 2007
VL 13
SU 2
BP S105
EP S105
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 238BX
UT WOS:000251423400310
DA 2020-12-01
ER

PT J
AU Alves-Leon, SV
   Papais-Alvarenga, R
   Magalhaes, M
   Alvarenga, M
   Thuler, LCS
   Fernandez, OFY
AF Alves-Leon, S. V.
   Papais-Alvarenga, R.
   Magalhaes, M.
   Alvarenga, M.
   Thuler, L. C. S.
   Fernandez, O. Fernandez y
TI Ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in
   Brazilian multiple sclerosis patients
SO ACTA NEUROLOGICA SCANDINAVICA
LA English
DT Article
DE pharmacogenetics; multiple sclerosis; human leukocyte antigen
ID CLASS-II; GENETIC SUSCEPTIBILITY; EXPEDICION-HUMANA; POPULATIONS;
   HAPLOTYPE; MEDICINE
AB Objective - The present study focused on human leukocyte antigen (HLA) DQB1, DQA1 and DRB1 allelic variation according to ethnicity and analyzed whether susceptibility to multiple sclerosis (MS) depends on population characteristics. Methods - Eighty-eight healthy African-Brazilians and 92 healthy white Brazilians living in Rio de Janeiro City were selected and the HLA phenotype between the two ethnic groups was compared with 44 MS patients of African descent and 40 patients of European descent. HLA class II genes were performed using polymerase chain reaction (PCR) and PCR-sequence-specific primer amplification. Results - DQA1*0201-0301 alleles were associated with the white Brazilian population (P < 0.001). The DRB*1501 allele was present in White Brazilians (P = 0.003), and DRB1*03-1503 in African-Brazilians. The DRB1*1501 allele confers an ethnicity-dependent MS susceptibility in White patients and the DQB1*0602 allele confers genetic susceptibility regardless of ethnicity. Conclusion - Heterogeneous phenotypes occur in both Brazilian ethnic groups. Taking into account that the response to immunomodulator drugs for MS treatment changes according to the DRB1*1501 allele and African-American MS patients presented poor response to the interferons, phenotype heterogeneity of HLA loci found in this study could influence therapeutic decisions in the Brazilian MS population.
C1 Univ Fed Rio de Janeiro, Dept Neurol, Postgrad Program, BR-20270004 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, BR-20270004 Rio De Janeiro, Brazil.
   Lagoa Hosp, Rio De Janeiro, Brazil.
   Carlos Haya Univ Hosp, Malaga, Spain.
RP Alves-Leon, SV (corresponding author), Univ Fed Rio de Janeiro, Dept Neurol, Postgrad Program, Rua Maris & Barros,775,tijuca, BR-20270004 Rio De Janeiro, Brazil.
EM sonizavleon@globo.com
RI Leon, Soniza V Alves/J-7786-2012
CR Alves-Leon SV, 2001, ARQ NEURO-PSIQUIAT, V59, P18, DOI 10.1590/S0004-282X2001000100005
   ALVESLEON SV, 1999, THESIS UFRJ
   BAE SC, 1998, ARTHRITIS RHEUM, V41, P1
   Barcellos LF, 2002, BRAIN, V125, P150
   BRODNER JG, 1997, TISSUE ANTIGENS, V49, P297
   BROOKE G, 2004, DRUG MARKET DEV, V15, P475
   BUYSE I, 1993, TISSUE ANTIGENS, V41, P1, DOI 10.1111/j.1399-0039.1993.tb01970.x
   Caballero A, 1999, TISSUE ANTIGENS, V54, P524, DOI 10.1034/j.1399-0039.1999.540511.x
   CALLEGARO D, 1992, NEUROEPIDEMIOLOGY, V11, P11, DOI 10.1159/000110901
   COULOMBIER P, 2001, EPI INFO 6 0 WORD PR
   Cree BAC, 2005, ARCH NEUROL-CHICAGO, V62, P1681, DOI 10.1001/archneur.62.11.1681
   DEABREU JC, 1997, CHAPTERS BRAZILS COL
   Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X
   Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626
   Fernandez O, 2005, ACTA NEUROL SCAND, V112, P391, DOI 10.1111/j.1600-0404.2005.00415.x
   Fusco C, 2001, NEUROLOGY, V57, P1976, DOI 10.1212/WNL.57.11.1976
   Just JJ, 1996, TISSUE ANTIGENS, V48, P636, DOI 10.1111/j.1399-0039.1996.tb02686.x
   KAPPOS L, 2005, J NEUROL S3, V252
   KELLY MA, 1995, TISSUE ANTIGENS, V45, P197, DOI 10.1111/j.1399-0039.1995.tb02439.x
   Kenealy SJ, 2003, J NEUROIMMUNOL, V143, P7, DOI [10.1016/j.jneuroim.2003.08.005, 10.1016/j.jneuroim.2003.08.009]
   Kirstein-Grossman I, 2002, DRUG NEWS PERSPECT, V15, P558, DOI 10.1358/dnp.2002.15.9.740230
   Nesci S, 1997, TISSUE ANTIGENS, V49, P53, DOI 10.1111/j.1399-0039.1997.tb02710.x
   PAPAISALVARENGA RM, 2002, ESCLEROSIS MULTIPLE, P35
   RIBEIRO Darcy, 1995, POVO BRASILEIRO FORM
   Santos CCC, 2002, ARQ NEURO-PSIQUIAT, V60, P1051, DOI 10.1590/S0004-282X2002000600037
   Spurkland A, 1997, TISSUE ANTIGENS, V50, P15, DOI 10.1111/j.1399-0039.1997.tb02828.x
   Sriram U, 2003, GENES IMMUN, V4, P147, DOI 10.1038/sj.gene.6363946
   Trachtenberg EA, 1996, TISSUE ANTIGENS, V48, P174, DOI 10.1111/j.1399-0039.1996.tb02625.x
   Trachtenberg EA, 1996, TISSUE ANTIGENS, V48, P192, DOI 10.1111/j.1399-0039.1996.tb02628.x
NR 29
TC 45
Z9 45
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6314
EI 1600-0404
J9 ACTA NEUROL SCAND
JI Acta Neurol. Scand.
PD MAY
PY 2007
VL 115
IS 5
BP 306
EP 311
DI 10.1111/j.1600-0404.2006.00750.x
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA 163YI
UT WOS:000246198900003
PM 17489940
DA 2020-12-01
ER

PT J
AU Quirico-Santos, T
   Suppiah, V
   Heggarty, S
   Caetano, R
   Alves-Leon, S
   Vandenbroeck, K
AF Quirico-Santos, Thereza
   Suppiah, Vijayaprakash
   Heggarty, Shirley
   Caetano, Regina
   Alves-Leon, Soniza
   Vandenbroeck, Koen
TI Study of polymorphisms in the interleukin-4 and IL-4 receptor genes in a
   population of Brazilian patients with multiple sclerosis
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE multiple sclerosis; interleukin-4; IL-4 receptor; single nucleotide
   polymorphism; ethnicity
ID CLINICAL CHARACTERISTICS; CAUCASIAN-AMERICANS; AFRICAN-AMERICANS;
   SUSCEPTIBILITY; BINDING; CHAIN
AB This study aimed to investigate in a population of Brazilian patients with multiple sclerosis (MS) single-nucleotide polymorphisms (SNP) in the promoter region of IL4 (*33C-T) and receptor IL4R (*Q551R A-G) genes proposed to interfere with disease progression. No significant differences were observed in either of the SNPs investigated between healthy controls (n=135) and MS patients (n=129). However, the IL4+33 TT genotype was significantly (p=0.039) higher in African descendants MS (AF-MS= 9.09%) than in Caucasian MS (CA-MS= 1.35%). It was also observed a significant (p=0.016) increase for the IL4R* Q551R CC genotype in AF-MS compared to those of Caucasian ethnicity (AF-MS= 21.62%; CA-MS= 4.35%). These results suggest that IL4+33 and IL4R*Q551 polymorphisms may have a disease-promoting role of TH2 mediators in African MS descendants. Additionally neither IL4 nor IL4R genes are susceptibility factors for Brazilian MS but may be able to modify ethnicity-dependent disease risk and penetrance of susceptibility factors.
C1 Queens Univ Belfast, Sch Pharm, Appl Genom Res Grp, Belfast BT7 1NN, Antrim, North Ireland.
   Univ Fed Fluminense, Inst Biol, Lab Cellular Pathol, Dept Cellular & Mol Biol, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Dept Specialized Med, BR-21941 Rio De Janeiro, Brazil.
RP Quirico-Santos, T (corresponding author), Inst Biol, Lab Patol Celular, Campus Valonguinho,Rua Visconde Rio Branco S-N, BR-24030120 Niteroi, RJ, Brazil.
EM tquirico@vm.uff.br
RI Suppiah, Vijay/D-4174-2011; Leon, Soniza V Alves/J-7786-2012;
   Vandenbroeck, Koen/D-6845-2012
OI Suppiah, Vijay/0000-0001-5496-935X; Vandenbroeck,
   Koen/0000-0002-6967-6485
CR Caballero A, 1999, TISSUE ANTIGENS, V54, P524, DOI 10.1034/j.1399-0039.1999.540511.x
   Chaudhuri A, 2004, ARCH NEUROL-CHICAGO, V61, P1610, DOI 10.1001/archneur.61.10.1610
   Compston A, 2004, CLIN MED, V4, P346, DOI 10.7861/clinmedicine.4-4-346
   Cree BAC, 2004, NEUROLOGY, V63, P2039, DOI 10.1212/01.WNL.0000145762.60562.5D
   Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X
   Gimsa U, 2001, J NEUROIMMUNOL, V119, P73, DOI 10.1016/S0165-5728(01)00343-5
   Hackstein H, 2001, J NEUROIMMUNOL, V113, P240, DOI 10.1016/S0165-5728(00)00455-0
   Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357
   Heggarty S, 2003, J NEUROIMMUNOL, V143, P93, DOI 10.1016/j.jneuroim.2003.08.019
   Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333
   Jansson A, 2003, MULT SCLER J, V9, P440, DOI 10.1191/1352458503ms951oa
   Kantarci OH, 2005, GENES IMMUN, V6, P153, DOI 10.1038/sj.gene.6364164
   Kawakami K, 2001, BLOOD, V97, P2673, DOI 10.1182/blood.V97.9.2673
   Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982
   Lock CB, 2003, TRENDS MOL MED, V9, P535, DOI 10.1016/j.molmed.2003.10.008
   Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907
   McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032
   Mirel DB, 2004, GENES IMMUN, V5, P138, DOI 10.1038/sj.gene.6364048
   Papais-Alvarenga RM, 2002, J NEUROL NEUROSUR PS, V73, P429, DOI 10.1136/jnnp.73.4.429
   Rivera VM, 2005, NEUROLOGY, V64, P2163, DOI 10.1212/WNL.64.12.2163
   Rockman MV, 2003, CURR BIOL, V13, P2118, DOI 10.1016/j.cub.2003.11.025
   Sakagami T, 2004, GENES IMMUN, V5, P389, DOI 10.1038/sj.gene.6364109
   Scarel-Caminaga RM, 2002, EUR J IMMUNOGENET, V29, P293, DOI 10.1046/j.1365-2370.2002.00314.x
   Sotgiu S, 2004, NEUROBIOL DIS, V17, P131, DOI 10.1016/j.nbd.2004.07.015
   Vandenbroeck K, 1997, J NEUROIMMUNOL, V76, P189, DOI 10.1016/S0165-5728(97)00058-1
   Vandenbroeck K, 2003, TRENDS PHARMACOL SCI, V24, P284, DOI 10.1016/S0165-6147(03)00131-7
NR 26
TC 8
Z9 8
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD MAR
PY 2007
VL 65
IS 1
BP 15
EP 19
DI 10.1590/S0004-282X2007000100005
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 147XZ
UT WOS:000245040400004
PM 17420820
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Alvarenga, MP
   Alvarenga, RP
   Vasconcelos, CCF
   Leon, SVA
   Catharino, AMD
   Erthal, F
   Brandao, L
AF Alvarenga, M. Papais
   Alvarenga, R. Papais
   Vasconcelos, C. Cristina Ferreira
   Leon, S. Vieira Alves
   da Silva Catharino, A. Marcos
   Erthal, F.
   Brandao, L.
TI Conventional MRI and diffusion tensor imaging in Brazilian patients with
   optic spinal multiple sclerosis Asian type
SO MULTIPLE SCLEROSIS
LA English
DT Meeting Abstract
CT 22nd Congress of the
   European-Committee-for-the-Treatment-and-Resarch-in-Multiple-Sclerosis
CY SEP 27-30, 2006
CL Madrid, SPAIN
SP European Comm Treatment & Res Multiple Sclerosis
C1 UNIRIO, Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
J9 MULT SCLER
JI Mult. Scler.
PD SEP
PY 2006
VL 12
SU 1
BP S40
EP S40
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 103XV
UT WOS:000241921400130
DA 2020-12-01
ER

PT J
AU Cosenza-Andraus, ME
   Nunes-Cosenza, CA
   Gomes-Nunes, R
   Fantezia-Andraus, C
   Alves-Leon, SV
AF Cosenza-Andraus, M. E.
   Nunes-Cosenza, C. A.
   Gomes-Nunes, R.
   Fantezia-Andraus, C.
   Alves-Leon, S. V.
TI Video-electroencephalography prolonged monitoring inpatients with
   ambulatory diagnosis of medically refractory temporal lobe epilepsy.
   Application of fuzzy logic's model
SO REVISTA DE NEUROLOGIA
LA Spanish
DT Article
DE electroencefalography; fuzzy logic; medically refractory epilepsy;
   prolonged monitoring; temporal lobe epilepsy; video-EEG
ID SEIZURES
AB Introduction. The video-electroencephalography (video-EEG) prolonged monitoring is an important auxiliary diagnostic instrument in epilepsy, and provides valuable information to classify the type of crisis and epileptic syndromes and to localize the epileptogenic zone. The fuzzy logic gives an efficient and intelligent analysis method, able to make inferences over ambiguous systems, and has been increasing used in several areas. Aims. To correlate clinical and electro-encephalographic data obtained with video-EEG of patients with clinical and interictal electroencephalography criteria of medically refractory temporal lobe epilepsy (TLE) and to make inferences of diagnosis precision with the application of the Fuzzy Hierarchy COPPE/Cosenza Model; to investigate the frequency in which the clinical, syndromic and topographic diagnosis can be modified in these patients; to evaluate the usefulness and applicability of fuzzy logic on the analysis of this type of study. Patients and methods. Transversal, prospective study, that included 22 adult outpatients with ambulatory diagnosis of medically refractory TLE, submitted to video-EEG monitoring that varied from 48 hours to 10 days. The grade of diagnosis precision was infered by fuzzy logic. Results. The clinical diagnosis of epilepsy was modified in two (9%) patients, the syndromic in six (27.2%) and the topographic in 16 (72.7%). The fuzzy indicators of ambulatory diagnostic precision were: 0.91 to clinical diagnosis; 0.74 to syndromic diagnosis and 0.36 to topographic diagnosis, considering 1 the maximal precision diagnostic value (attributed to the video-EEG results). Conclusions. The video-EEG prolonged monitoring established the clinical, syndromic and topographic correct diagnosis in these patients; the fuzzy logic best defined a mathematical value of the correspondence between ambulatorial diagnosis of TLE and the video-EEG prolonged monitoring.
C1 Hosp Univ Clementino Fraga Filho, Serv Neurol, Program Epilepsias, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Programa Ingn Prod, COPPE, Rio De Janeiro, Brazil.
RP Cosenza-Andraus, ME (corresponding author), Rua Djalma Ulrich,201-1201, BR-22071020 Rio De Janeiro, Brazil.
EM andrauscm@aol.com
RI Leon, Soniza V Alves/J-7786-2012
CR Andraus MEC, 2002, ARQ NEURO-PSIQUIAT, V60, P779, DOI 10.1590/S0004-282X2002000500019
   [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x
   Arroyo S, 2000, REV NEUROLOGIA, V30, P881, DOI 10.33588/rn.3009.99356
   BARRETO JM, 1991, 10 INT C MED INF VIE
   Bauer J, 2001, SEIZURE-EUR J EPILEP, V10, P208, DOI 10.1053/seiz.2000.0488
   CARRETE H, 2002, REV NEUROCIENCIAS, V10, P94
   Cascino GD, 2002, EPILEPSIA, V43, P80, DOI 10.1046/j.1528-1157.43.s.3.14.x
   Cascino GD, 2001, NEUROL CLIN, V19, P271, DOI 10.1016/S0733-8619(05)70019-0
   COSENZA CAN, 1981, IND LOCATION MODEL P
   DANDREA I, 2000, BRAZILIAN J EPILEPSY, V6, P123
   Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5
   Engel Jerome Jr, 2003, Epilepsy Curr, V3, P37, DOI 10.1046/j.1535-7597.2003.03201.x
   Fossas P, 2005, REV NEUROLOGIA, V40, P257, DOI 10.33588/rn.4005.2004543
   Groppel G, 2000, EPILEPSIA, V41, P610, DOI 10.1111/j.1528-1157.2000.tb00216.x
   Groppel G, 1999, WIEN KLIN WOCHENSCHR, V111, P469
   GUERREIRO CAM, 1999, EPILEPSIA PACIENTE O
   Jedrzejczak J, 1999, EUR J NEUROL, V6, P473, DOI 10.1046/j.1468-1331.1999.640473.x
   Jorge CL, 2000, ARQ NEURO-PSIQUIAT, V58, P919, DOI 10.1590/S0004-282X2000000500022
   KLIR GJ, 1988, FUZZY SETS UNCERTAIN, P355
   MANFORD M, 1996, BRAIN, V17, P119
   McBride AE, 2002, EPILEPSIA, V43, P165, DOI 10.1046/j.1528-1157.2002.24401.x
   MOSHE SL, 1998, EPILEPSY COMPREHENSI, P801
   NUNES RG, 2002, ARQ NEUROPSIQUIAT S1, V60, pS374
   SARMENTO MR, 1992, ARQ NEUROPSIQUIATR S, V50, pS45
   Shaw I. S., 1999, CONTROLE MODELAGEM F
   Tanaka K, 1997, INTRO FUZZY LOGIC PR
   Terano T., 1992, FUZZY SYSTEMS THEORY, P147
   TOLEDO OM, 2000, EVOLUCAO MODELO COPP
   Walczak TS, 1998, EPILEPSY COMPREHENSI, P831
   YACUBIAN EMT, 1996, REV NEUROCIENCIAS, V4, P122
   ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X
   Zentner J, 1997, NEUROSURGERY, V41, P378, DOI 10.1097/00006123-199708000-00008
   Zimmermann H.-J., 1991, FUZZY SET THEORY ITS
NR 33
TC 4
Z9 4
U1 0
U2 2
PU REVISTA DE NEUROLOGIA
PI BARCELONA
PA C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN
SN 0210-0010
EI 1576-6578
J9 REV NEUROLOGIA
JI Rev. Neurologia
PD JUL 1
PY 2006
VL 43
IS 1
BP 7
EP 14
DI 10.33588/rn.4301.2005615
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA 060UA
UT WOS:000238825900003
PM 16807866
DA 2020-12-01
ER

PT J
AU Alvarenga, M
   Brandao, L
   Teixeira, G
   Leon, SVA
   Alvarenga, RP
AF Alvarenga, M
   Brandao, L
   Teixeira, G
   Leon, SVA
   Alvarenga, RP
TI Neuro myelitis optica associated with brainstem bouts clinical and
   diffusion tensor imaging: preliminary findings
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Meeting Abstract
CT 18th World Congress of Neurology
CY NOV 05-11, 2005
CL Sydney, AUSTRALIA
C1 Fed Univ Rio De Janeiro, Rio De Janeiro, Brazil.
   Luiz Felippe Mattoso Radiol Ctr, Rio De Janeiro, Brazil.
   Hosp Lagoa, Rio De Janeiro, Brazil.
RI Leon, Soniza V Alves/J-7786-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD NOV 15
PY 2005
VL 238
SU 1
BP S217
EP S217
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 009CF
UT WOS:000235088002084
DA 2020-12-01
ER

PT J
AU Fiszman, A
   Alves-Leon, SV
   Nunes, RG
   D'Andrea, I
   Figueira, I
AF Fiszman, A
   Alves-Leon, SV
   Nunes, RG
   D'Andrea, I
   Figueira, I
TI Traumatic events and posttraumatic stress disorder in patients with
   psychogenic nonepileptic seizures: a critical review
SO EPILEPSY & BEHAVIOR
LA English
DT Review
DE nonepileptic seizures; etiology; traumatic events; posttraumatic stress
   disorder; dissociative disorders
ID HYSTERICAL SEIZURES; CLINICAL-FEATURES; FOLLOW-UP; PSEUDOSEIZURES;
   EPILEPSY; DIAGNOSIS; PREDICTORS; PTSD; DISSOCIATION; COMORBIDITY
AB Although video-EEG monitoring has revolutionized the diagnosis of psychogenic nonepileptic seizure (PINES), the etiology of this condition remains poorly understood. This article is a critical review of studies on the prevalence of traumatic events, abuse, and/or posttraumatic stress disorder (PTSD) in patients with PINES. Searches carried out on MEDLINE (1966-2004) and Web of Science (1945-2004) identified 17 relevant studies. PINES samples showed very high rates of trauma (44-100%) and abuse (23-77%), which were 15-40% higher than those found in control groups. This suggests that traumatic experiences may be a potential risk factor for PINES. PINES samples also showed a higher prevalence of PTSD than control groups, raising the possibility that PINES may arise as a clinical expression of a hypothetical PTSD subtype the core symptoms of which are dissociative. Methodological limitations do not permit the confirmation of these hypotheses. Stronger research designs are needed, such as prospective and case-control studies in both hospital and community settings. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Fed Rio de Janeiro, Inst Psychiat, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Dept Neurol, Epilepsy Program, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Sch Med, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Psychiat & Mental Hlth Dept, Rio De Janeiro, Brazil.
RP Fiszman, A (corresponding author), Univ Fed Rio de Janeiro, Inst Psychiat, Rio De Janeiro, Brazil.
EM adrianafiszman@terra.com.br
RI Leon, Soniza V Alves/J-7786-2012; DAndrea-Meira, Isabella/B-5341-2013;
   figueira, ivan/B-4577-2008
CR Abubakr A, 2003, EPILEPSY BEHAV, V4, P241, DOI 10.1016/S1525-5050(03)00082-9
   Ahluwalia S, 1999, NEUROLOGY, V52, pA415
   ALPER K, 1993, NEUROLOGY, V43, P1950, DOI 10.1212/WNL.43.10.1950
   Alper K, 1997, EPILEPSIA, V38, P991, DOI 10.1111/j.1528-1157.1997.tb01481.x
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Arnold LM, 1996, PSYCHOSOMATICS, V37, P438, DOI 10.1016/S0033-3182(96)71531-1
   Benbadis SR, 2001, NEUROLOGY, V57, P915, DOI 10.1212/WNL.57.5.915
   Benbadiz SR, 2002, NEUROLOGY, V58, P990
   Binzer M, 2004, SEIZURE-EUR J EPILEP, V13, P146, DOI 10.1016/S1059-1311(03)00184-5
   Bowman ES, 1996, AM J PSYCHIAT, V153, P57
   BOWMAN ES, 1993, PSYCHOSOMATICS, V34, P333, DOI 10.1016/S0033-3182(93)71867-8
   Brewin CR, 1999, AM J PSYCHIAT, V156, P360
   Britton Jeffrey W., 2002, Epilepsia, V43, P161
   Bryant RA, 2000, AM J PSYCHIAT, V157, P1889, DOI 10.1176/appi.ajp.157.11.1889
   Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625
   Cartmill A, 1992, Seizure, V1, P33, DOI 10.1016/1059-1311(92)90052-3
   Classen C, 1998, AM J PSYCHIAT, V155, P620, DOI 10.1176/ajp.155.5.620
   de Wet CJ, 2003, J NEUROL NEUROSUR PS, V74, P639, DOI 10.1136/jnnp.74.5.639
   DeToledo JC, 2001, EPILEPSY BEHAV, V2, P601, DOI 10.1006/ebeh.2001.0269
   Devinsky O, 1998, EPILEPSIA, V39, P458, DOI 10.1111/j.1528-1157.1998.tb01405.x
   Devinsky O, 1996, NEUROLOGY, V46, P1530, DOI 10.1212/WNL.46.6.1530
   Dikel TN, 2003, EPILEPSY BEHAV, V4, P644, DOI 10.1016/j.yebeh.2003.08.006
   EDLUND MJ, 1985, J PSYCHIAT RES, V19, P563, DOI 10.1016/0022-3956(85)90074-3
   Ettinger AB, 1999, EPILEPSIA, V40, P1292, DOI 10.1111/j.1528-1157.1999.tb00860.x
   FAKHOURY T, 1993, EPILEPSIA, V34, P1049, DOI 10.1111/j.1528-1157.1993.tb02133.x
   Farias ST, 2003, EPILEPSY BEHAV, V4, P424, DOI 10.1016/S1525-5050(03)00143-4
   Fleisher W, 2002, AM J PSYCHIAT, V159, P660, DOI 10.1176/appi.ajp.159.4.660
   FOA EB, 1995, AM J PSYCHIAT, V152, P116
   GATES JR, 1995, SEMIN NEUROL, V15, P167, DOI 10.1055/s-2008-1041020
   Gates JR, 2002, EPILEPSY BEHAV, V3, P28, DOI 10.1006/ebeh.2001.0310
   GATES JR, 1993, NON-EPILEPTIC SEIZURES, P21
   GOODWIN J, 1979, AM J PSYCHIAT, V136, P1231
   GREEN BL, 1999, MEASUREMENT STRESS T, P366
   GROSS M, 1979, AM J ORTHOPSYCHIAT, V49, P704, DOI 10.1111/j.1939-0025.1979.tb02656.x
   Harden CL, 1997, SEIZURE, V6, P151, DOI 10.1016/S1059-1311(97)80070-2
   Harvey AG, 1999, J CONSULT CLIN PSYCH, V67, P985, DOI 10.1037/0022-006X.67.6.985
   Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P507, DOI 10.1037/0022-006X.66.3.507
   Harvey AG, 1999, J TRAUMA STRESS, V12, P673, DOI 10.1023/A:1024773202939
   Jongsma MJ, 1999, SEIZURE-EUR J EPILEP, V8, P146, DOI 10.1053/seiz.1998.0247
   Kanner AM, 1999, NEUROLOGY, V53, P933, DOI 10.1212/WNL.53.5.933
   KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012
   KOOPMAN C, 1994, AM J PSYCHIAT, V151, P888
   Kuyk J, 1997, J NEUROL NEUROSUR PS, V63, P689, DOI 10.1136/jnnp.63.5.689
   LABARBERA JD, 1980, PSYCHOSOMATICS, V21, P897
   LaFrance WC, 2002, EPILEPSY BEHAV, V3, pS19, DOI 10.1016/S1525-5069(02)00505-4
   LaFrance WC, 2002, NEUROLOGY, V58, P990, DOI 10.1212/WNL.58.6.990
   Lanius RA, 2002, BIOL PSYCHIAT, V52, P305, DOI 10.1016/S0006-3223(02)01367-7
   Lesser RP, 2002, EPILEPSY BEHAV, V3, P34, DOI 10.1006/ebeh.2001.0309
   LISKE E, 1964, NEUROLOGY, V14, P41, DOI 10.1212/WNL.14.1.41
   LITWIN R, 2000, J TRAUMA DISSOCIATIO, V1, P99, DOI DOI 10.1300/J229V01N04_06
   Marshall RD, 1999, AM J PSYCHIAT, V156, P1677
   Martin RL, 2000, NONEPILEPTIC SEIZURE, P253
   Mokleby K, 2002, EPILEPSIA, V43, P193, DOI 10.1046/j.1528-1157.2002.20901.x
   Nemiah JC, 1998, PROG PSYCH, P1
   Nijenhuis E. R., 2001, J TRAUMA DISSOCIATIO, V1, P7, DOI DOI 10.1300/J229V01N04_02
   Prigatano GP, 2002, EPILEPSY BEHAV, V3, P343, DOI 10.1016/S1525-5050(02)00053-7
   Reuber M, 2002, J NEUROL NEUROSUR PS, V72, P141
   Reuber M, 2004, NEUROLOGY, V62, P834, DOI 10.1212/01.WNL.0000113755.11398.90
   Reuber M, 2003, SEIZURE-EUR J EPILEP, V12, P561, DOI 10.1016/S1059-1311(03)00064-5
   Reuber M, 2003, EPILEPSY BEHAV, V4, P205, DOI 10.1016/S1525-5050(03)00104-5
   Reuber M, 2003, ANN NEUROL, V53, P305, DOI 10.1002/ana.3000
   Reuber M, 2002, NEUROLOGY, V58, P493, DOI 10.1212/WNL.58.3.493
   Rosenbaum M, 2000, PSYCHOSOMATICS, V41, P147, DOI 10.1176/appi.psy.41.2.147
   Rosenberg HJ, 2000, EPILEPSIA, V41, P447, DOI 10.1111/j.1528-1157.2000.tb00187.x
   Rusch MD, 2001, EPILEPSY BEHAV, V2, P277, DOI 10.1006/ebeh.2001.0180
   Salmon P, 2003, PSYCHOSOM MED, V65, P695, DOI 10.1097/01.PSY.0000075976.20244.D8
   Scull DA, 1997, J NEUROL NEUROSUR PS, V62, P200, DOI 10.1136/jnnp.62.2.200-a
   Scull DA, 1997, J NEUROL NEUROSUR PS, V63, P689
   Shalev AY, 1996, AM J PSYCHIAT, V153, P219
   Sigurdardottir KR, 1998, EPILEPSIA, V39, P749, DOI 10.1111/j.1528-1157.1998.tb01161.x
   Silva W, 2001, EPILEPSIA, V42, P398, DOI 10.1046/j.1528-1157.2001.45299.x
   SMITH PE, 2001, J NEUROL NEUROSU S2, V70, P119
   Spiegel D, 2000, AM J PSYCHIAT, V157, P1890, DOI 10.1176/appi.ajp.157.11.1890
   Spiegel David, 1996, P367
   Szaflarski JP, 2000, NEUROLOGY, V55, P1561, DOI 10.1212/WNL.55.10.1561
   Thapar A, 1996, PSYCHOL MED, V26, P813, DOI 10.1017/S0033291700037831
   Vineis P, 2002, SOZ PRAVENTIV MED, V47, P156, DOI 10.1007/BF01591887
   VOSSLER DG, 1995, J EPILEPSY, V8, P1, DOI 10.1016/0896-6974(94)00014-Q
   World Health Organization, 1992, CID 10 CLASS MENT BE
   Wyllie E, 1999, ARCH PEDIAT ADOL MED, V153, P244
NR 80
TC 131
Z9 137
U1 0
U2 13
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1525-5050
EI 1525-5069
J9 EPILEPSY BEHAV
JI Epilepsy Behav.
PD DEC
PY 2004
VL 5
IS 6
BP 818
EP 825
DI 10.1016/j.yebeh.2004.09.002
PG 8
WC Behavioral Sciences; Clinical Neurology; Psychiatry
SC Behavioral Sciences; Neurosciences & Neurology; Psychiatry
GA 881NL
UT WOS:000225874100005
PM 15582828
DA 2020-12-01
ER

PT J
AU Alvarenga, R
   Leon, S
   Caballero, A
   Fernandez, O
   Alonso, A
AF Alvarenga, R
   Leon, S
   Caballero, A
   Fernandez, O
   Alonso, A
TI HLA DQB1*0602 and the course, clinical manifestations of MS
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Meeting Abstract
CT 11th Pan American Congress of Neurology
CY OCT 08-12, 2003
CL SANTIAGO, CHILE
RI Leon, Soniza V Alves/J-7786-2012; Miranda, Claudia/K-3786-2019
OI Miranda, Claudia/0000-0003-2670-5247
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD OCT 15
PY 2003
VL 214
IS 1-2
BP 95
EP 95
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 729TD
UT WOS:000185789400137
DA 2020-12-01
ER

PT J
AU Andraus, MEC
   Cosenza, CAN
   da Fonseca, LMB
   Andraus, CF
   D'Andrea, I
   Alves-Leon, SV
AF Andraus, MEC
   Cosenza, CAN
   da Fonseca, LMB
   Andraus, CF
   D'Andrea, I
   Alves-Leon, SV
TI Interictal brain SPECT in patients with medically refractory temporal
   lobe epilepsy
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Spanish
DT Article
DE brain SPECT; temporal lobe epilepsy; refractory epilepsy; fuzzy logics
ID EMISSION COMPUTED-TOMOGRAPHY; CEREBRAL-BLOOD-FLOW; PERFUSION PATTERNS;
   CYSTEINATE DIMER; HMPAO-SPECT; LOCALIZATION; MRI
AB The objective of this study was to evaluate the utility of interictal brain SPECT in localizing the epileptogenic focus in a population of patients of Epilepsy Clinic of Hospital Universitario Clementino Fraga Filho (HUCFF/UFRJ), with medically refractory temporal lobe epilepsy (TLE) and normal computed tomography (CT) scans, studying the correlation between SPECT, electroencephalogram (EEG) and, in 11 cases, brain magnectic resonance imaging (MRI), and to compare the results to the other six literatura series. Twelve (52.2%) patients presented abnormal SPECT. Among these, five (41.6% of abnormal SPECTs) presented unilateral SPECT changes at the same side of EEG (hypoperfusion in four and hyperperfusion in one), three (25% of abnormal SPECTs) presented bilateral hypoperfusion and bilateral EEG changes too, and four (33.3%) presented unilateral hypoperfusion and bilateral EEG changes. The statistical analysis was based on fuzzy logic. The correlation index among SPECT X EEG, SPECT X MRI and SPECT X EEG X MRI were highly significant, with significance levels at 0.01, p < 0.0005 and trust interval at 99% in all correlations. The correlation studies between the series presented similar results.
C1 Univ Fed Rio de Janeiro, Programa Epilepsias, Neurol Serv, Hosp Univ Clemintino Fraga Filho, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, COPPE, Programa Engn Prod Coordenacao, BR-21945 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, COPPE, Programas Posgrad Engn, BR-21945 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Fac Med, BR-21945 Rio De Janeiro, Brazil.
   Lab Anal & Architecture Syst, Toulouse, France.
   Univ Fed Sao Paulo, Escola Paulista Med, Sao Paulo, Brazil.
   Univ Fed Rio de Janeiro, HUCFF, Neurol Serv, Programa Epilepsias, Rio De Janeiro, Brazil.
EM andrauscm@aol.com
RI DAndrea-Meira, Isabella/B-5341-2013; Leon, Soniza V Alves/J-7786-2012
CR ALVESLEON SV, 1999, 1 S NEUR INT NEUR IM, P20
   [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x
   BERKOVIC SF, 1998, EPILEPSY COMPREHENSI, P969
   BONTE FJ, 1983, AM J NEURORADIOL, V4, P544
   BUCHPIGUEL CA, 1999, MED HC FMUSP, V7, P40
   BUSTAMANTE VCT, 1999, VIDEO ELETRENCEFALOG, P73
   Carrilho P G, 1994, Arq Neuropsiquiatr, V52, P149
   Crespel A, 2001, REV NEUROL-FRANCE, V157, P639
   Devous MD, 1998, J NUCL MED, V39, P285
   Duncan JS, 1997, BRAIN, V120, P339, DOI 10.1093/brain/120.2.339
   Duncan R, 1996, EPILEPSIA, V37, P134, DOI 10.1111/j.1528-1157.1996.tb00004.x
   Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5
   GUERREIRO CAM, 1999, EPILEPSIA PACIENTE O
   Guillon B, 1998, EPILEPSIA, V39, P67, DOI 10.1111/j.1528-1157.1998.tb01276.x
   HO SS, 1995, ANN NEUROL, V37, P738, DOI 10.1002/ana.410370607
   Hogan RE, 1997, J NEUROL NEUROSUR PS, V63, P235, DOI 10.1136/jnnp.63.2.235
   KUIKKA JT, 1994, EUR J NUCL MED, V21, P1247
   Lamusuo S, 1997, J NEUROL NEUROSUR PS, V63, P743, DOI 10.1136/jnnp.63.6.743
   Lancman ME, 1997, EPILEPSIA, V38, P466, DOI 10.1111/j.1528-1157.1997.tb01737.x
   Lee BI, 1997, NEUROLOGY, V49, P981, DOI 10.1212/WNL.49.4.981
   Lewis DH, 1997, NEUROSURG CLIN N AM, V8, P337
   O'Brien TJ, 1999, NEUROLOGY, V52, P137, DOI 10.1212/WNL.52.1.137
   Oliveira AJ, 1999, EPILEPSIA, V40, P693, DOI 10.1111/j.1528-1157.1999.tb00765.x
   OLIVEIRA AJ, 1998, FUNDAMENTOS NEUROBIO, V1, P659
   Runge U, 1997, ACTA NEUROL SCAND, V96, P271
   SARMENTO MR, 1992, ARQ NEURO-PSIQUIAT, V50, P45
   SCHMITZ EB, 1995, EPILEPSY RES, V21, P159, DOI 10.1016/0920-1211(95)00020-B
   Shaw I. S., 1999, CONTROLE MODELAGEM F
   Teodorescu HNL, 1998, FUZZY NEUROFUZZY SYS
   TREVES ST, 1995, NEUROSURG CLIN N AM, V6, P473
   Varma AR, 1996, ACTA NEUROL SCAND, V94, P88, DOI 10.1111/j.1600-0404.1996.tb07035.x
   Wichert-Ana L, 2001, EPILEPSIA, V42, P660, DOI 10.1046/j.1528-1157.2001.41900.x
   ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X
   Zentner J, 1997, NEUROSURGERY, V41, P378, DOI 10.1097/00006123-199708000-00008
   ZUBAL IG, 1995, J NUCL MED, V36, P684
NR 35
TC 6
Z9 6
U1 0
U2 1
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2002
VL 60
IS 3B
BP 779
EP 787
DI 10.1590/S0004-282X2002000500019
PG 9
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 595JU
UT WOS:000178106200019
PM 12364949
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Alves-Leon, SV
   Batista, E
   Papais-Alvarenga, R
   Quirico-Santos, T
AF Alves-Leon, SV
   Batista, E
   Papais-Alvarenga, R
   Quirico-Santos, T
TI Determination of soluble ICAM-1 and TNF alpha R in the cerebrospinal
   fluid and serum levels in a population of Brazilian patients with
   relapsing-remitting multiple sclerosis
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE multiple sclerosis; cytokines; soluble receptor of tumor necrosis factor
   (TNF alpha R); intercellular adhesion molecule ICAM-1
ID INTERCELLULAR-ADHESION MOLECULE-1; NECROSIS-FACTOR RECEPTOR;
   MESSENGER-RNA; T-CELLS; CYTOKINE; PATHOGENESIS; LESIONS; INFLAMMATION;
   EXPRESSION; PROFILE
AB Cytokines and adhesion molecules have been implicated in the pathogenesis of multiple sclerosis (MS), a chronic inflammatory disease of the central nervous system. In this study we analyzed intrathecal (CSF) and serum levels of soluble intercellular adhesion molecule (ICAM-1) and TNF alphaR (60kD) from 20 patients with clinically definite MS during acute relapse or stable disease. Comparing to control groups of healthy individuals and patients with intervertebral herniated disc, MS patients showed increased levels (p< 0.001) of slCAM-1 and TNF<alpha>R in both serum and CSF samples. Regardless stage of disease there was no significant difference in the levels of slCAM-1 during acute relapse (657 +/- 124.9 ng/ml) or remission (627 +/- 36.2 ng/ml). A steady increase of TNF alphaR (60kD) in both serum and CSF, indicate the existence of a continuous inflammatory process within the brain tissue of MS patients despite absence of clinical signs of disease activity.
C1 Univ Fed Fluminense, Inst Biol, Dept Cellular & Mol Biol, Lab Cellular Pathol, BR-24020130 Niteroi, RJ, Brazil.
   Univ Fed Rio de Janeiro, Dept Specialized Med, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Neurol, Rio De Janeiro, Brazil.
   Univ Fed Fluminense, Hosp Lagoa, Rio De Janeiro, Brazil.
EM tquirico@urbi.com.br
RI Leon, Soniza V Alves/J-7786-2012
CR Amor S, 1997, IMMUNOL TODAY, V18, P368, DOI 10.1016/S0167-5699(97)01100-6
   BECK J, 1988, ACTA NEUROL SCAND, V78, P318, DOI 10.1111/j.1600-0404.1988.tb03663.x
   Bo L, 1996, J NEUROPATH EXP NEUR, V55, P1060, DOI 10.1097/00005072-199655100-00006
   CANNELLA B, 1995, ANN NEUROL, V37, P424, DOI 10.1002/ana.410370404
   Chofflon M, 1998, MULT SCLER, V4, P188, DOI 10.1177/135245859800400319
   COMPSTON DAS, 1995, ACTA NEUROL SCAND, V91, P43, DOI 10.1111/j.1600-0404.1995.tb05855.x
   COULOMBIER D, 1994, EPIINFO WORD PROCESS
   Ewing C, 1998, IMMUNOL CELL BIOL, V76, P47, DOI 10.1046/j.1440-1711.1998.00718.x
   HARTUNG HP, 1995, ANN NEUROL, V38, P186, DOI 10.1002/ana.410380210
   Huang WX, 1999, MULT SCLER, V5, P342
   Hvas J, 1997, SCAND J IMMUNOL, V46, P195, DOI 10.1046/j.1365-3083.1997.d01-100.x
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Link H, 1998, MULT SCLER, V4, P12, DOI 10.1191/135245898678909141
   Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078
   Monteyne P, 1998, MULT SCLER, V4, P143, DOI 10.1191/135245898678909420
   Muller WA, 1999, J LEUKOCYTE BIOL, V66, P698
   Navikas V, 1996, J NEUROSCI RES, V45, P322, DOI 10.1002/(SICI)1097-4547(19960815)45:4<322::AID-JNR1>3.0.CO;2-B
   OWENS T, 1995, NEUROL CLIN, V13, P51
   POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302
   Pouly S, 1999, J AUTOIMMUN, V13, P297, DOI 10.1006/jaut.1999.0321
   Rohowsky-Kochan C, 2000, MULT SCLER, V6, P69, DOI 10.1191/135245800678827554
   Sacca R, 1997, CURR OPIN IMMUNOL, V9, P851, DOI 10.1016/S0952-7915(97)80189-6
   Sharief MK, 1998, MULT SCLER, V4, P169, DOI 10.1191/135245898678909484
   SHARIEF MK, 1993, J NEUROIMMUNOL, V43, P15, DOI 10.1016/0165-5728(93)90070-F
   Trojano M, 1998, MULT SCLER, V4, P39, DOI 10.1191/135245898678909204
   TSUKADA N, 1993, NEUROLOGY, V43, P2679, DOI 10.1212/WNL.43.12.2679
   Vora AJ, 1997, MULT SCLER J, V3, P171, DOI 10.1177/135245859700300301
   Wekerle H, 1998, MULT SCLER J, V4, P136
   Whalen MJ, 2000, J LEUKOCYTE BIOL, V67, P160
   Zhang GX, 2000, MULT SCLER J, V6, P3, DOI 10.1191/135245800678827446
NR 30
TC 11
Z9 11
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD MAR
PY 2001
VL 59
IS 1
BP 18
EP 22
DI 10.1590/S0004-282X2001000100005
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 417ZH
UT WOS:000167865000004
PM 11299425
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Caballero, A
   Alves-Leon, S
   Papais-Alvarenga, R
   Fernandez, O
   Navarro, G
   Alonso, A
AF Caballero, A
   Alves-Leon, S
   Papais-Alvarenga, R
   Fernandez, O
   Navarro, G
   Alonso, A
TI DQB1*0602 confers genetic susceptibility to multiple sclerosis in
   Afro-Brazilians
SO TISSUE ANTIGENS
LA English
DT Article
DE Afro-Brazilian; HLA; multiple sclerosis
ID HLA; ASSOCIATIONS; HAPLOTYPES
AB We studied the distribution of the HLA-DRB1, -DQA1 and -DQB1 alleles in 44 Afro-Brazilian patients with multiple sclerosis and 88 controls. Although no significant differences were found between the patients and controls for the DRB1 and DQA1 alleles, the HLA-DQB1*0602 allele was positively associated with multiple sclerosis (45.0% vs. 17.0%, P-c=0.024, RR=3.31). The positive extended haplotypes for DQB1*0602 were more frequent in patients than controls, although the differences were not statistically significant in any of them. These results in Afro-Brazilians are in line with Other studies which have found DQB1*0602 to be associated with the disease in the absence of the DRB1*1501 allele. We therefore think that the association with the disease in this ethnic group is more allelic than haplotypic.
C1 Hosp Reg Carlos Haya, Serv Immunol, Malaga 29010, Spain.
   Hosp Reg Carlos Haya, Serv Neurol, Malaga 29010, Spain.
   Univ Fed Rio de Janeiro, Sch Med & Surg, Rio De Janeiro, Brazil.
RP Alonso, A (corresponding author), Hosp Reg Carlos Haya, Serv Immunol, Malaga 29010, Spain.
RI Leon, Soniza V Alves/J-7786-2012
CR ALDIN ASN, 1995, J NEUROL SCI, V131, P144, DOI 10.1016/0022-510X(95)00092-G
   Coraddu F, 1998, J NEUROIMMUNOL, V87, P130, DOI 10.1016/S0165-5728(98)00074-5
   HAUSER SL, 1989, NEUROLOGY, V39, P275, DOI 10.1212/WNL.39.2.275
   KURSTZKE JF, 1995, ACTA NEUROL SCAND  S, V161, P23
   KURSTZKE JF, 1983, NEUROLOGY, V33, P1444
   Ma JJ, 1998, J NEUROIMMUNOL, V92, P109, DOI 10.1016/S0165-5728(98)00189-1
   Marrosu MG, 1997, AM J HUM GENET, V61, P454
   Mignot E, 1997, TISSUE ANTIGENS, V49, P329, DOI 10.1111/j.1399-0039.1997.tb02761.x
   MORAES ME, 1997, HLA, P314
   OKSENBERG JR, 1993, JAMA-J AM MED ASSOC, V270, P2362, DOI 10.1001/jama.270.19.2362
   Ono T, 1998, TISSUE ANTIGENS, V52, P539, DOI 10.1111/j.1399-0039.1998.tb03084.x
   Papais-Alvarenga R., 1997, Journal of the Neurological Sciences, V150, pS229, DOI 10.1016/S0022-510X(97)85989-8
   Papais-Alvarenga R., 1997, Journal of the Neurological Sciences, V150, pS187, DOI 10.1016/S0022-510X(97)85778-4
   POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302
   Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464
   SERJEANTSON SW, 1992, EUR J IMMUNOGENET, V19, P11, DOI 10.1111/j.1744-313X.1992.tb00043.x
   Spurkland A, 1997, TISSUE ANTIGENS, V50, P15, DOI 10.1111/j.1399-0039.1997.tb02828.x
   SVEJGAARD A, 1994, TISSUE ANTIGENS, V43, P18, DOI 10.1111/j.1399-0039.1994.tb02291.x
NR 18
TC 60
Z9 63
U1 0
U2 1
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0001-2815
J9 TISSUE ANTIGENS
JI Tissue Antigens
PD NOV
PY 1999
VL 54
IS 5
BP 524
EP 526
DI 10.1034/j.1399-0039.1999.540511.x
PG 3
WC Cell Biology; Immunology; Pathology
SC Cell Biology; Immunology; Pathology
GA 257WJ
UT WOS:000083805200011
PM 10599893
DA 2020-12-01
ER

EF